sars-coronavirus	coronaviruses
f3	ch-c	increased	observed	livercirrhosis
cancer	lines	±	estrogen
inflammation	showed	rats	treated	sulindac
aids-affected	hiv
multiplemyeloma	treating	activity	has	bortezomib
influenza	spread	potential	understand	measured	amount	particles	containing	influenzavirus
stroke	patients	anticoagulant	warfarin
aids	hiv
vehicle	therapy	tumor
influenza	measure	developed	avianinfluenzaviruses
uti	aminoglycosides	cystitis	used	nitrofurantoin
hypoglycemia	prevent	infused	glucose	glimepiride	ingestion	measured	diazoxide

asthmatic	patients	bronchoconstriction	development	characterized	ingestion	anti-inflammatorydrugs	aspirin
obesity	risks	raised	circulating	triglyceride
bladdertumors	resections	chemotherapy	fluorouracil/cisplatin
ptg	factors	each	focusing	ptg	examined	posttraumaticstressdisorder
enzyme	set9	methylated	ar
osteoporosis	studies	includes	beginning	2013	â	$	œantibodies
alcohol	3-octadecylglycerol	described	considered	obesity
denguehemorrhagicfever	agents	dengueviruses
antianginal	agent	those	bradycardia
cardiopathy-related	disorders	diabetic	disorders	ic	dm
aki	impact	furosemide
pain	reducing	effective	drugs	added	lidocaine
type2diabetes	hospitalized	bloodglucose	mean	determine	improves	template	insulin
hbv	polymerase/rt	adefovir
smallpox	relevant	design	vaccines
respiratoryacidosis	result	co2-elimination
asthmatics	number	cause	clear	have	seen	challenge	asa
type2diabetesmellitus	risk	associated	reported	correlation	sensitivity	insulin
type2diabetesmellitus	patients	treatment	glimepiride	rosiglitazone
glucocorticoid	revealed	represent	cause	hypercortisolism
schistosomiasis	program	arising	using	morbidity	treatment	praziquantel

listeriosis	outbreak	isolates	performed	listeriamonocytogenes
amnesia	scopolamine-induced
statin	treatment	efficacy	determine	patients	familialhypercholesterolaemia
o2	conditions	hypoxic
dyspnea	c	required	dose	morphine
tuberculous	encephalitis	year	been	drugs	isoniazid	rifampin
irondeficiencyanemia	evaluated	depletion	lack	stores	iron
asthma	quality	questionnaire	twice	âµg	budesonide
hyperglycemia	subjects	showed	levels	glucose
cancer	patients	tissues	breast	marrow	increased	concentration	formaldehyde
vitamink-dependent	domain	gla
salivaryhypersecretion	congestion	tachycardia	risperidone
headache	patients	responded	than	to	tray	bleaching
cr	administration	stay	duration	amnesia
antituberculosis	treatment	initiating	weeks	experienced	infection	aids-defining
neuropathicpain	model	adjuvant
goitre	rate	antibody	thyroglobulin
5-fu	5-fluorouracil	one	chemotherapeuticagents	treatment	cancers
ssri	fluoxetine	administration	amplify	hypoglycemia	patients	type1diabetes
hiv/aids
cancer	cells	utilization	sugar
mrsa	activity	showed	ca
pain	responses	attenuated	scavengers	formaldehyde
aids	patients	treat	reduce	deliver	carry	understand	epidemic	hiv/aids
nitricoxide	synthase	expression	induced	treatment	mice	tumor-bearing
mono	formed	post-translationally	hydrolyze	enzymes
inflammation	associated	model	investigate	relevant	cd
hypertension	inhibited	caused	anesthesia	ketamine/xylazine
apl	patient	derived	atra
lipids	cavity
anti-tuberculosis	drugs	isoniazid
schizophrenia	with	combined	conducted	olanzapine
septicemicplagues	found	results	y.pestis
gastroesophagealrefluxdisease	treatment	literature	review	esomeprazole
bradycardia	those	agent	considered	ranolazine
gabapentin	effects	expression	model	neuropathicpain
staph	accurate	superior	identification	species	staphylococcus
gbs	patients	effective	dose	ivig
vitaminb12deficiency	associated	unclear	association	concentrations	vitaminb12
serumhepatitisb	antigen	hbsag
type2diabetes	had	metformin
ranibizumab	atrophy	occurrence	report	caused	age-relatedmaculardegeneration
virus	used	lacking	viruses
speed	loss	dr
hiv/aids
type2diabetes	similar	subjects	failure	degree	treatment	insulin
pain	relief	achieve	found	used	formulation	fentanyl
virus	viruses

seizures	using	magnesiumsulfate
type2diabetes	using	metformin
hydrogensulfide	have	sdisease	effects	models	hypertension
renalcellcarcinoma	ve	approved	bevacizumab	combination	alfa	interferon
trachoma	caused	chlamydiatrachomatis
insulin-resistant	mice	obese
adiposity	measured	markers	glucose
oliveoil	mitigated	osteoporosis
type2diabetes	%	documented	%	glucose
leptospirosis	agents	comprise	members	genusleptospira
metastasis	patients	receiving	antibody
hepatitisb	treatment	options	licensed	adefovir
deep-veinthrombosis	treatment	licensed	anticoagulant	fondaparinux
pde5inhibitor	administration	led	permeability	tumor
cholesterol	hypertension
osteoporosis	pathophysiology	important	levels	vitamind
diabeticfootulcers	management	evaluate	effect	therapy	oxygen
rheumatoidarthritis	biologicals
nsaid	drug	used	analgesic	rheumatism
base	increased	accompanied	value	cavity
malaria	incidence	reduced	reduced	reduced	sulphadoxine-pyrimethamine
adhd	history	treated	atomoxetine
hydroxypropylmethylcellulose	consumption	effect	examined	lipids	insulinresistance
virus	induce	vaccines
hyperglycemia	treated	insulin
hyperglycemia	hospitalized	bloodglucose	mean	determine	improves	template	insulin
uc-mscs	effect	mediating	mechanism	indoleamine	ido	nitricoxide
spasticity	treatment	used	baclofen
rop	models	oxygen-induced
oa	effects	treatment	analgesic
high-speed	g	outcomes	compare	pars	vitrectomy	ppv	management	retinaldetachment
pain	showed	evoked	showed	exhibited	applied	patches	lidocaine
fungalinfections	treatment	antifungal	become	introduced	terbinafine
erythropoietin	losses	hemodilution	factors	related	associated	renalinsufficiency
metal-on-metal	arthroplasty	offer	osteoarthritis
jia	juvenileidiopathicarthritis	methotrexate
irondeficiency	impact	investigate	compared	content	iron
schizophrenia	treatment	advance	development	injection	olanzapine
tuberculosis	vaccine	employed	japan	bcg
hivseropositive	tested	hiv
malaria	changed	cq	artemisinin	therapies	sulphadoxine/pyrimethamine
flu	trends	developed	correlate	influenzavirusinfections
juvenileidiopathicarthritis	methotrexate
irondeficiency	causing	regulation	alters	synthesis	feâˆ	defective
hiv/aids
hbv	mutation	resistant	adefovirdipivoxil
basic	mechanisms	help	studies	history	fibrosis
type2diabetes	evaluation	secretion	insulin
cancer	provide	lapatinib	combination	letrozole
tb	infection	those	quantiferon	compared	mycobacteriumtuberculosis	mtb
hivinfection
minocycline	compounds	identified	inflammation
condylomataacuminata	caused	humanpapillomavirus
mrsa	â	articles	emergence	-rrb-	s.aureus
pain	resulted	block	lidocaine
hyperglycemia	insulin
stz-induced	hyperglycemia
cd	11a	cluster	dna	lupuserythematosus	sle
antibodies	tests	most	used	diagnosis	dengue
adrenalinsufficiency	diagnostic	considered	<	values	cortisol
virus	samples	sequencing	performed	assess	prevalence	variants	viruses
alcohol	intake	vary	history	cancer

postpartumhaemorrhage	and	medline	ergonovine	oxytocin
malaria	strains	therapies	development	implications	have	results	shedding	mechanism	resistance	chloroquine
lipid	transfection	gave	containing	amount	co-lipid	fa-peg570-diether
atopicdermatitis	lesions	skin	atopic
kidneydisease	worsening	shown	indicated	role	estrogen
kuru	pathogenesis	similar	suggesting	showed	evidence	colonization	prion
vitamins	determine	>	stress	type2diabetes
virus	isolated	development	aids	caused	mdm	isolated	viruses
hiv/aids
hyperglycemia	insulin
ham/tsp	isolated	cells	profiles	examined	understand	changes	diseases	htlv-1-associated
cll	cells	response	increases	association	quercetin	fludarabine
hypothyroidism	overt	patients	syndrome	unresponsiveness	tsh
heparin	reduced	rats	followed	transientcerebralischemia
pain	incidence	reducing	injection	propofol
bipolardisorder	disorders	treatment	approved	antipsychoticdrug
pain	increasing	dose	lidocaine
spottedfever	rickettsiae
falciparummalaria	patients	found	occurring	treatment	infection	atovaquone-proguanil
insulin	infused	others	ten
h5n1	antibodies
b-nhl	detected	restriction	lcr
epilepsy	investigated	tested	hypothesis	inhibits	vigabatrin
breasttumors	proportion	expressed	correlate	receptor	estrogen
hiv/aids	immunopathogenesis	dysfunction	role	remains	affects	hiv
aids	died	living	hiv
antibiotic	use	reported	infections	vomiting
malaria	treatment	sp	sulphadoxine-pyrimethamine
falciparummalaria	chemoprophylaxis	played	chloroquine
cancer	risk	women	altered	upa	expression	fluid	naf
shock	infused	norepinephrine
rapamycin	target	inhibitor	rapamycin	agent	has	effects	tumors
hbv	hepatitisbvirus
hiv/aids
amyotrophiclateralsclerosis	characteristic	binding	redistribution	dna	tar
hypertension	provided	hctz
inflammation	injury	reduce	act	indicating	plays	models	induced	indomethacin
hypoglycemia	prevent	infused	glucose
type2diabetes	therapy	patients	status	improvements	leads	conclusions	insulinglargine
hbv	dna	adefovir	superior	used	adefovir
bacterialinfection	persistence	occurred	be	regimen	treating	bacteria
tuberculosis	agents	genetically	suggest	regarded	mycobacteriumtuberculosiscomplex
rheumatoidarthritis	diagnosed	patients	receive	combination	p.o.	hydroxychloroquine
atp	i.e.	levels	virus
pancreatitis	risk	similar	sitagliptin
irondeficiencyanemia	high	demands	iron
hepatitisc	viruses	hcv
androgens	insulinresistance
antibody	conjugates	caused	suppression	growth	tumour
viruses
malignantmelanoma	pegylatedinterferonalpha-2b
metastases	shrinkage	showed	uptake	fdg	18f-fluoro-deoxy-glucose
uti	protect	injury	induced	bacterialendotoxin
hiv/aids
hypogonadism	treat	tested	administration	testosterone
epilepsy	children	assess	efficacy	lacosamide
rsvinfection	risk	individuals	provide	guidance	timing	prophylaxis	rsv
alcohol	intake	cancer
pain	associated	injection	propofol
pulmonaryembolism	event	receiving	phenprocoumon
paraneoplasticsyndromes	secretion	hormone
cutaneousmelanoma	nature	implies	molecules	study	performed	compare	profile	variant	p-cad	blm
attention-deficit/hyperactivitydisorder	treatment	studied	modafinil
nphinsulin	n	using	individuals	5,365	had	incidence	dka
acne	isotretinoin
jointdiseases	management	beneficial	prove	calcitonin
tb	control	essential	detection	resistance	mycobacteriumtuberculosis
asthma	exacerbations	definitions	aligned	metric	bud	effect	inhaler	pressurized	budesonide/formoterol
hyperglycemia	levels	association	examine	determined	test	glucose
malaria	treatment	derivatives	used	doxycycline
estrogen	majority	cancers
rapamycin	target	inhibitor	rapamycin	agent	has	effects	tumors
cd	patients	had	levels	patients	ibs
seizures	prevention	choice	drug	magnesiumsulfate
prions	distinct	cjd
ibs	irritablebowelsyndrome	treatment	used	tegaserod
impairedglucosetolerance	metabolism	glucose
thromboembolism	comparing	use	oralcontraceptives	containing	use	those	containing	levonorgestrel
scd	form	making	constitute	heterozygous	hbs
malaria	death	effect	quinine
hiv/aids	living	people	followed	punishment	hiv
hbv	dna	hepatitisbvirus
hypoglycemia	threefold	blockade	glucagon
chemical	strain	raynaudâ	divided	mentioned	maurice	raynaud
high-fat	diet	contained	found	's	decreases	fa
hbv	hepatitisbvirus
chronichepatitisc	therapy	interferon
ticdisorders	drug	aripiprazole
scrubtyphus	caused	orientiatsutsugamushi
bosentan	months	groups	different	time	progression	tumor
nausea	congestion	insomnia	aes	common	er	paliperidone
hivinfections	account	crf02_ag	hiv-1
ocularbacterialinfections	variety	treatment	levofloxacin
tsc	model	generated	study	development	hamartomas
drugallergies	history	patients	using	propofol
hivdisease	study	hiv
hiv/aids	living	associated	perceptions	treatment	hiv
hivinfection	acquired	enrolled	transmission	hiv
adhd	responders	methylphenidate
asthmatic	subjects	reduced	response	terbutaline
pain	judged	subjects	induced	min	application	capsaicin
hivinfection
zinc	receive	children	suffering	diarrhoea
cryptococcusneoformans	strains	cryptococcus
obesity	induction	prevented	fattyacids
lymedisease	cases	considered	therapy	antibiotic
fattyacid	production	ibd
infarction	impacts	timing	rhythms	melatonin
hiv/aids
melanoma	cells	secretion	ifn-î
cachexia	loss	consisting	wasting	fat
influenza-specific	model	enhance	understanding	evolution	influenzaviruses
lidocaine	patches	applied	part	painful
lys-7	$	$	number	expression	associated	bacterialinfection	susceptibility	result	deficiencies	gla
multiplesclerosis	patients	adherence	initiated	therapy	intramuscular	interferonbeta-1a
hbv	recurrence	prevention	effective	prophylaxis	lamivudine
oil	groups	times	ten
relapsingfever	caused	bacteria	borrelia
varicella	infected	reported	receiving	vaccination	vzv
pain	produces	injection	propofol
chf	increase	reported	used	doxorubicin	dox
celiac	patients	cases	published	disappeared	diet	gluten-free
h5n1	emergence	strains	influenzaviruses
virus	evolved	viruses
fat	mass	suggesting	independent	phenotypes	obesity
dopaminergic	neurons	loss	caused	phenotypes	parkinsonism-like
asthma	therapy	proven	product	inhaler	containing	salmeterol
ehrlichiosis	responsible	bacterium	e.	-lrb-	ehrlichia
aml	patients	bu/cy	series	patients	treated	cyclophosphamide
hiv/aids
malaria	programme	mali	efficacy	sulphadoxine-pyrimethamine
aids	hiv
prions	kuru
thromboembolism	prophylaxis	licensed	anticoagulant	fondaparinux
malaria	cases	treatment	prophylaxis	used	drug	atovaquone-proguanil
bacterialdisease	involved	variety	bacteria
plasmodiumfalciparummalaria	chloroquine
virus	limited	viruses
enzymes	²	glucosidase	xylosidase	1,4-xylanase	endo-î
chronichepatitisc	patients	treated	therapy	interferon
diarrhea	treated	loperamide
type2diabetes	youth	have	defect	insulin
juvenileidiopathicarthritis	treated	etanercept
melanoma	cells	secreted	²	interferon
allergicreactions	hypersensitivity
asthma	use	²	agonist	theophylline
candidiasis	women	detect	size	women	colonisation	candida
methicillin-resistantstaphylococcusaureus	staphylococcusaureus
hbv	infection	called	replication	genome	liver	absence	markers	hepatitisbvirus
edema	due	anestheticdrug
virus	pathogenicity	revealed	distinct	viruses
smallpox	agent	variolavirus
enzymes	targeting	combinations	produced	inhibition	replication	hepatitisc
shigella	induces	bacteria
hiv/aids
dengue	infections	distinguish	classifier	kits	denguevirus
virus	viruses
tb	diagnosis	relies	microscopy	mycobacteriumtuberculosis
osteoporosis	markers	concentrations	alkaline	telopeptides	collagen
cancer	therapy	adjuvant
sars	severeacuterespiratorysyndrome	disease	caused	coronavirussars-cov
tuberculosis	treatment	used	drugs	one	isoniazid	inh
lymeborreliosis	agent	lato	borreliaburgdorferi
tuberculosis	pathogenesis	induction	response	infection	mtb
influenza	pandemic	originating	influenzaviruses
acquiredimmunedeficiencysyndrome	pandemic	humanimmunodeficiencyvirus	hiv
hiv/aids
pain	decrease	administration	ibuprofen
obese	subjects	characterized	months	evaluation	fat
cmv	humancytomegalovirus
hypoglycaemia	risk	including	relevant	therapies	issues	associated	glucose
tb	patients	collected	samples	altered	vivo	mtb
rheumatoidarthritis	patients	opportunity	window	notion	reached	recognition	methotrexate
stroke	protection	associated	use	warfarin
myocardialinfarction	reducing	efficacy	is	therapy	clopidogrel
anti-tb	selection	provide	transmission	strains	resistant	inh
hyperglycemia	indexes	using	measures	glucose
ptg	factors	each	focusing	ptg	examined	posttraumaticstressdisorder
pain	compare	lidocaine
interferons	characterized	autoimmunedisease	inflammation
inform	assessment	created	selected	zoonoses
mrsa	-rrb-	-lrb-	s.aureus
asthma	rats	treated	rn	dxm
h5n1	influenzaviruses
renaltubularacidosis	type	occur	deposits	crystal
ca-mrsa	caused
asbestos	burden	hazard	view	origins	mesothelioma
bleeding	risk	associated	demonstrated	clopidogrel
rickettsialinfection	mediating	mechanisms	remain	vectors	transmission	rickettsia
type2diabetesmellitus	secretion	insulin
pulmonaryhypertension	treat	inhalation	prostacyclin
pvcs	reduced	lidocaine
iron	function	result	pathogenesis	hereditaryferritinopathy
hiv/aids
jia	severity	forecast	positivity	antibodies
glucose	investigated	association	activity	adiposity
aids	patients	untreated	patients	hiv-infected
interferon	alfa	combination	bevacizumab	approved	ve	renalcellcarcinoma
ppi	deficit
breastabscess	resolution	associated	treatment	drugs	antituberculosis
cross-talk	cells	mediator	species	oxygen
phosphoric	acid	treatments	impacts	gas	anneal	investigated	forming	gas	ar
hiv/aids
rise	prevalence	viralinfections
high-fat	diet	condition	reduced	obesity
asthmatics	intolerance	aspirin
deficit	conditions	increased	oil	estimated	phenolics	correlated	activity	dpph	oil
atherosclerosis	predisposing	damage	causes	harmful	oil
type2diabetes	assessed	sensitivity	insulin
tumor	starting	necrosis	rituximab
type2diabetes	therapy	mixtures	insulin
hypoglycemia	monitoring	glucose
tb	caused	-lrb-	â	opposed	m.tuberculosis
osteoporosis	$	50â	aged	women	demonstrate	efficacy	strontiumranelate
type1diabetes	subacute	afford	opportunity	determine	induces	insulin
mdr-tb	tuberculosis	resistance	isoniazid
mtbdr	plus	validated	isolates	resistance	inh
hyperglycemias	provide	excursions	glucose
malaria	al	-rrb-	sulphadoxine-pyrimethamine
ocd	those	treatment	remains	respond	clomipramine
antithrombin	c-inhibitor	inhibitors	involved	functions	inflammation
cancer	choice	chemotherapeuticagent
non-steroid	drug	used	analgesic	rheumatism
aspergilloma	invasive	disease	aspergillus
aceinhibitors	arbs	diabetescomplications
leucine	supplementation	effects	investigated	multifold	cause	obesity
immunodeficiencies	deficiencies	ig-csr-ds
lipid	parameters	values	acknowledging	generates	metabolicdisorders
pv	atom	attached	substituents	lie	coplanar	substituent	attached	carbon
adhd	retardation	patients	prescribing	methylphenidate
influenzavirus
tachycardias	analyzed	performed	stimulation	infusion	isoproterenol
hbv	infection	hepatitisbvirus
hereditaryhemochromatosis	produce	characterized	absorption	iron
uc	cd
antibiotics	available	shop
melanoma	patients	treatment	approved	interferon
hiv/aids
atp-cra	assay	test	offers	potential	selecting	responsiveness	tumors
tuberculosisinfection	diagnosed	received	mg	isoniazid	inh
convulsions	severity	rates	dose50	bupropionhcl
hbv-specific	productions	percentages	monotherapy	entecavir
type2diabetesmellitus	tolerated	results	coverage	concentrations	exenatide
gastritis	characterized	dog	induced	tetracycline
rickets	patients	measurements	rickets	vitamind-dependent
meningococcalmeningitis	agent	neisseriameningitidis
oxaliplatin-based	regimens	established	accepted	patients	cancer
lungtumors	mice	pde5inhibitor	administration	led	permeability	dextran
pain	reduce	dose	lidocaine
asthmatics	intolerance	aspirin
pain	control	had	infusion	remifentanil
poliomyelitis	eradication	challenges	include	reinfection	areas	outbreaks	circulating	polioviruses
virus	pattern	reveal	undertaken	considering	number	cases	genome	based	circulating	viruses
tuberculosis	control	requires	mycobacteriumbovis	guerin	bcg
pain	level	evaluate	instillation	eyedrops	combination	gel	%	lidocaine
mrsa	-rsb-	s.aureus	s.aureus
mono	vaccines
cjd	distinct	prions	those	equivalent	prion
type2diabetes	risk	individuals	function	play	d	associated	sensitivity	insulin
pain	incidence	reduced	injection	propofol
malaria	prevention	recommended	treatment	malaria	sulphadoxine-pyrimethamine
systemicmycosis	paracoccidioidomycosis	caused	fungus

atp	levels	resulted	protected	inhibition	ar
hbv	hepatitisbvirus
lvh	regression	favor	concluded	considered	employing	nitrates
hivinfections	result	avoided	costs	treatment	hiv
type2diabetesmellitus	treatment	indicated	mimetic	exenatide	known	exendin-4
osteoporosis	care	standard	encompass	intake	vitamind
type2diabetes	phenotypes	compared	investigated	need	treatment	insulin
chronichepatitisc	patients	number	time	hcv
stroke	recurrence	reduce	pioglitazone	benefit	warfarin
hbv	infections	pool	forming	million	prevalence	hbsag
rheumatoidarthritis	patients	adalimumab-treated
chlamydialinfections	generation	result	infections	chlamydia
cholera	-rrb-	toxins	produces	v.cholerae
hypercalcemia	intoxication	vitamind
irondeficiency	effects	determine	fed	control	id	fe
hyperglycemia	results	nigricans	manifestation	autoantibodies	receptor	insulin
chemically	samples	ratio	adhesion
pulmonarytuberculosis	caused	mycobacteriumtuberculosis
virus	associated	cbd
hiv/aids
pml	progressivemultifocalleukoencephalopathy	disease	caused	infection	oligodendrocytes	jcvirus
vaccinia	naive	donors	those	immunized	vacciniavirus
insulin	birth	factors	predict	assess	examine	adiposity
immunodeficiency	therapy	require	patients	preferable	infusions	g	immunoglobulin
osteoarthritis	osteoarthritis	oa	treated	chondroitinsulfate
virus	levels	reduced	therapy	ribavirin
cross-linking	available	interest	protein	antibody
tb	drug	treatment	regimen	components	isoniazid
insulin-resistant	mice	tissue	insulinresistance	obesity-linked
hbv	infection	hepatitisbvirus
sugar	ingest	produce	necrosis	tumor
kpd	diabetes	africans	characterize	action	insulin
melioidosis	agent	burkholderiapseudomallei
pain	remission	gave	treatment	ketamine
non-tuberculosis	samples	2846	specific	·	·	sensitivity	mtb/rif
type2diabetes	insulin
irondeficiency	excess	iron
mrsa	-rrb-	used	-lrb-	cultures	strains	s.aureus
schizophrenia	research	used	model	in	namely	haloperidol
hiv/aids
anti-cmv	therapy	valganciclovir
hiv/aids
virus	had	responses	viruses
priondisease	regimens	efficacy	monitoring	useful	possibly	deferring	donors	be	risk	transmitting	infections	prion
adhd	treatment	relied	formulations	methylphenidate
type2diabetes	investigate	sensitivity	insulin
rheumatoidarthritis	has	case	treated	methotrexate
insulin	substrate	level	signaling	impaired	insulinresistance
tb	+	segregation	cluster	recognition	proteins	mtb
tuberculosis	tb	especially	resistance	prevalence	worsening	noted	strains	inh
5-aza-dc	treatment	status	alterations	brought	level	reversion	associated	hypomethylation	tss
hbv	hepatitisbvirus
viraldiseases	developed	viruses
latex	condom	contacturticaria
anti-tb	selection	provide	transmission	strains	resistant	inh
groupb	received	randomized	groups	‰	ï	mct
hiv/aids	care	barriers	stigma	hiv
bcg-based	trials	tb
tuberculosis	cases	933	detected	testing	mtb/rif
cholesterol	levels	showed	patients	transientischemicattack
virus	viral	shares	kong/g1/97	replicates	efficiently	replicate	viruses
tb-antigens	boost	increased	compared	to	animals	primed	bcg
mrsa	carriers	develop	likely	than	in	carriers	s.aureus
hbv	reduce	predicted	approaches	lamivudine
analgesic	strength	association	was	resulted	pain
obesity	effect	known	blunt	rise
hl-1	line	demonstrated	using	knockdown	ii	nm
asthmatic	model	generate	used	administered	budesonide
cd	crohn	64	patients	73	ibs
tb	incidence	area	study	demonstrate	detect	-rrb-	m.tuberculosis
pain	reduce	dose	determine	sought	induced	injection	propofol
adenosinetriphosphate-based	assay	test	offers	potential	selecting	responsiveness	tumors
hypertension	type	hormone
h5n1	particles	inhalation	infected	clear	is	knowledge	routes	transmission	influenzavirus
swelling	periorbital	improvements	resulting	administered	steroid
hypothyroidism	that	higher	t3	t4
chronichepatitisc	virus	hcv
ozone	acutely	induces	cch	independent	inflammation
irondeficiency	drawn	present	suggesting	exerts	circulating	stores	iron
h5n1	replication	influenzaviruses
hiv/aids
onychomycosis	treatment	compare	itraconazole
irondeficiency	defined	receptor	plus	depletion	iron
aids	provided	plan	fight	hiv
asbestosis	exposure	asbestos
melioidosis	cause	burkholderiapseudomallei
malaria	falciparum	sulfadoxine-pyrimethamine
cross-habituation	contributed	chemicals
scurvy	recovery	benefits	provided	vitaminc
typhoid	samples	similar	cfu	increase	enrichment	salmonellatyphi
hiv/aids-focused
chronichepatitisc	patients	frequency	genotype	genotype	hcv
measles	elucidate	analyzed	measlesvirus	mice	transgenic	receptor	measlesvirus
anti-inflammatory	mechanisms	examined	interaction	expression	model	neuropathicpain
cavity	escherichiacoli	weight	bacteria/kg
malaria	countries	implemented	treatment	sulphadoxine-pyrimethamine
bovinetuberculosis	caused	mycobacteriumbovis
malaria	treated	drug	artemether-lumefantrine
terbutaline	study	patients	type1diabetes
hyperglycemia	responses	sensitivity	insulin
hyperglycemia	duration	delayed	results	concentrations	glucose
thromboembolism	prophylaxis	licensed	heparin
tuberculosis	efficacy	©	vaccine	bcg
rsvinfection	occurrence	screened	rsv
hyperglycemia	assessed	secretion	insulin
cancer	patients	receive	mg/m2	paclitaxel
type2diabetes	patients	has	detemir	insulin
tb	infection	those	quantiferon	compared	mycobacteriumtuberculosis	mtb
fattyacid	oxidation	suggesting	different	control	obese
desferrioxamineb	-RSB-	,4,7,10	chelates	tumor
cancer	involvement	treated	regimen	paclitaxel
colony-stimulatingfactor	production	higher	lower	factor-î	necrosis	tumor
basalcellcarcinoma	excision	recurrence	likelihood	given	alternatives	chemotherapy	5-fluorouracil
pain	the	piloted	factors	rate	stimulation	temperature	-rrb-	capsaicin
acne	treatment	isotretinoin
anti-tb	selection	provide	transmission	strains	resistant	inh
hiv/aids
autoimmunediseases	implicates	role	vitamind
promyelocyticleukemia	protein	fused	alpha	retinoicacid
hivpositive	learning	children	process	interviewed	cost	hiv
pneumocystispneumonia	agent	pneumocystiscarinii
tb	patients	isolated	strains	mycobacteriumtuberculosis
fungalinfections	preventing	delivery	use	evidence	limited	voriconazole	itraconazole
mdr-tb	resistance	rifampin
antispasmodics	peppermintoil	treatment	irritablebowelsyndrome
aids	database	center	conducted	patients	hiv-infected
nsclc	non-smallcelllungcancer	treatment	proven	combinations	docetaxel
cholesterol	showed	boys	anthropometry	insulinresistance
streptococcalbacteremia	1998â	had	equisimilis	streptococcus
pain	capsaicin
type2diabetes	included	addition	glimepiride
agitation	scores	patients	unit	given	saline	mixture	midazolam
infectiousmononucleosis	patients	epstein-barr-virus	ebv
hiv/aids
cjd	distinct	prions
hbv	hepatitisbvirus
fattyacids	composition	exist	acid	one	fas	found	depressivedisorders
bleeding	complications	reduction	associated	safe	undergoing	administration	abciximab
dengue	diagnosis	marker	used	ns1	denguevirus
cancer	women	options	better	tool	addition	bisphosphonates
insulin-like	receptor	play	metastasis
cancer	setting	chemotherapy	platinum-based
type2diabetes	characterized	deficiency	secretion	insulin
virus	amounts	containing	quantified	wt	series	viruses
viruses
acquiredimmunedeficiencysyndrome	recognized	investigate	tested	women	participated	1959-1964	hiv
type2diabetes	individuals	weeks	added	metformin
malaria	episodes	incidence	reduces	treatment	infants	sulphadoxine-pyrimethamine
hiv/aids	field	identified	strengthen	prevention	hiv
alcohol	consumption	subjects	infections	hepatitisb
inflammation	diabetes	test	glucose
cancer	incidence	higher	that	-lrb-	users	insulin
hbv	dna	adefovir	superior	used	adefovir
epilepsy	treatment	drug	topiramate
interleukin-2	±	gene	il2ra/cd25	emerging	gene	type1diabetesmellitus
cholesterol	synthesis	inhibition	prevented	formation	virusinfection
eclampsia	treatment	informed	making	use	magnesiumsulphate
hiv/aids	related	assess	investigate	prevalence	hiv
tb	resistance	detection	determine	inh
virus	concentration	mechanism	suggests	oysters	show	viruses
aspergillosis	invasive	warrant	study	interaction	occur	levels	interplay	sp	aspergillus
hypoglycemia	demonstrated	release	epinephrine
mrsa	isolates	observed	contained	antibiotics	penicilling	methicillin
acutehivinfection	stage	occurs	described	patients	stages	infection	hiv
cancer	regimens	adjuvant
malaria	treat	rely	markers	indicate	increasing	resistance	pyrimethamine/sulfadoxine
fibrosis	exacerbates	retinoicacid
malnutrition	estimated	albumin
methicillinresistantstaphylococcusaureus	staphylococcusaureus
myelomas	treatment	efficient	proteasome	inhibitor	bortezomib
aminoacids	domain	ovalocytosis	proximity	results	increase	rigidity
asthma	control	function	association	budesonide
aaa	frequency	lead	mismatch	adalimumab
staphylococcusaureusbacteraemia	endocarditis	therapy	non-inferior	daptomycin
bacteremia	associated	endocarditis	bacteria
obesity	children	screened	diabetes	test	glucose
insulin	circulating	raised	increases	risk	type2diabetes
neuroblastoma	lines	mechanism	questions	ellipticine	mechanisms	etoposide
westnileencephalitis	occurring	undertook	investigate	plays	infection	wnv
trachoma	diseases	causes	chlamydiatrachomatis
hiv/aids
statin	use	persistence	‰	proportion	include	outcomes	secondary
spottedfever	â	rickettsia
infarct	size	correlation	direction	phase	melatonin
aids	hiv
hepatitiscantigens	response	herein	evaluated	transfers	ester	labelled	mice	hcv
marrowembolism	fat
postmenopausalosteoporosis	treatment	approved	administration	dosed	bisphosphonate	risedronate
interferons	administered	patients	cancer
methamphetamineabuse	treatments	rates	high	-lrb-	$	contribute	likely	addiction	persist	remission	methamphetamine
chickenpox	agent	alpha-herpesvirus	varicellazostervirus	vzv
hivdisease
uncoordinated	connected	units	pentaâaquaâmanganese
obese	subjects	linked	triglycerides
mycosis	representing	azole	activity	fungi
vaccinia	vv
sars	related	than	member	coronavirus
hypothyroid	patients	therapy	report	continue	dissatisfied	outcome	monotherapy	levothyroxine
msa	atrophy	disease	cause	manifesting	±	parkinsonism
bleeding	risk	increase	be	clopidogrel
chronichepatitisc	isolated	populations	hcv-1a
evans	dye	elicits	excitation	345-nm
nephropathy	demonstrated	demonstrated	use	statin
flush	response	niacin
shingles	risk	reduces	seen	used	vaccine	vzv
chronichepatitisc	chc	interferon
lymeneuroborreliosis	evidenced	2	patients	submitted	employing	detect	borreliaburgdorferi
chronichepatitisb	mutations	occurring	transcriptase	hepatitisbvirus
pain	treatment	become	opioid	formulation	oxymorphone
adhd	symptoms	changes	reliable	changes	outcomes	atomoxetine
chronichepatitiscinfection	evaluate	therapy	interferonalpha-2b
virus	benefit	manipulate	ability	due	encode	viruses
tb	disease	discriminate	response	hbha	mtb
epilepsy	efficacy	have	vigabatrin
schizophrenia	assess	impact	polypharmacy	antipsychotic
problemdrinking	consumption	consumption	alcohol
enzymopathy	worldwide	enzyme
renalcellcarcinoma	management	use	available	inhibitor	tyrosine
tb	-rrb-	agent	member	-rrb-	complex	m.tuberculosis
infectiousmononucleosis	manifested	cadets	infected	ebv
familialmediterraneanfever	patients	determined	assessed	influence	treatment	colchicine
gonorrhoea	therapy	used	ceftriaxone
excessiron	stored	transported	iron
insulin	results	delayed	duration	marked	present	insulinresistance
h5n1	-rrb-	influenzavirus
malaria	prevention	recommended	treatment	malaria	sulphadoxine-pyrimethamine
hbv	hepatitisbvirus
vomiting	treat	prochlorperazine	compare	effectiveness	ondansetron
tumor	regression	achieved	response	significant
pge2	prostaglandine2	ido	indoleamine	mechanism	mediating	effect	uc-mscs
virus	make	ability	construct	allows	using	viruses
caries	inhibition	important	properties	fluoride
hypovitaminosisd	patients	serum	levels	increased	supplementation	vitamind
osteoporosis	status	vitamind
swelling	the	decreased	result	treatment	prednisolone
ttx-resistant	channels	received	sensation	pain
evans	dye	elicits	excitation	345-nm
tuberculosis	risk	reduce	-rrb-	bcg
diabeticretinopathy	pregnancy	effects	understanding	essential	treatment	sight	threatening	complication	diabetesmellitus
vehicle	survivors	ptsd
prostaglandins	e2	factors	action	results	anorexia	inflammation-associated
adhd	received	methylphenidate
schizophrenia	risperidone
adiposity	control	changes	remained	adjustment	use	statin
seizures	approved	formulation	lamotrigine
cancer	rates	highest	prevalence	pap
celiac	diet	eliminate	neutralized	effect	epitopes	gluten
fat	loss	hamper	fibrosis
antiviral	resistance	assessed	hbeag	chronichepatitisb
aids	syndrome	hiv/acquired
sugars	presence	produce	biofilm	becoming	microorganisms	caused	caries
high-fat	dietâ	$	lean	obese
type1diabetes	study	requires	enhance	postexercise	insulin
nitricoxide	production	inhibited	gla
insecticide	chemicals	use	relies	reduce	number	vectors	malaria
tuberculosis	causes	mycobacteriumtuberculosis
malaria	cases	treatment	prophylaxis	used	drug	atovaquone-proguanil
lipid	sensor	serves	regulate	cancer
cross-sectional	sample	$	individuals	metabolism	glucose
virus	virus	outline	discuss	expand	viruses
falciparummalaria	resistant	proven	combination	proguanil
carbohydrate-fermenting	bacteria	group	group	abundance	examined	feces	patients	ibd
tb	contraindication	vaccine	bcg
eczema	infancy	prescribed	antibiotics
sulphasalazine	start	proves	treatment	patients	jia
falciparummalaria	therapy	mefloquine-artesunate
alcoholdependencesyndrome	treatment	prescribed	drug	disulfiram
deficit	conditions	increased	oil	estimated	phenolics	tocopherols
oa	okadaicacid	yessotoxin	marinetoxins
type2diabetes	predisposition	associated	expansion	sensitivity	insulin
insulin-free	period	kpd
gout	treatment	options	allopurinol
hbv	levels	reductions	produced	baseline	log10iu/ml	lamivudine
melioidosis	infection	burkholderiapseudomallei
flu	pandemic	outbreak	strain	h1n1influenzavirus
mrsa	staphylococcusaureus	bacteria	species	effective	demonstrated	methicillin	staphylococcusaureus	staphylococcusaureus
cholera	model	provide	protection	challenge	v.cholerae
cancer	risk	contribute	exposure	tobacco-smoke
hiv/aids	living	prevalence	hiv
tb	patients	recruited	trial	inhibitor	treated	treatment	antituberculosis
cavity	volume	3	found	ã	3	needed	molecule	solvent
pain	incidence	reducing	effective	premixed	lidocaine
atopicdermatitis	rhinitis	atopic/non-atopicasthma
hiv/aids	program	effect	examine	using	analyzed	changes	volume	services	hiv
aids-relatedcomplex	arc	manifestations	infection	hiv
hiv/aids
schizophrenia	symptoms	improving	chlorpromazine
hiv/aids	identify	analyzed	hiv
malaria	diagnosed	recommends	use	rdt	treat	artemether-lumefantrine
hbv	hepatitisbvirus
hbv	dna	group	entecavir
chronicmyeloidleukemia	domain	mechanism	contributing	suboptimal	tyrosine
highbloodpressure	amlodipinebesylate	trial	combination	observed	doses	monotherapy	olmesartan
pain	experienced	day	day	%	vs	treatment	tramadol
chronichepatitisc	treatment	evolved	therapy	combination	interferon	plus	ribavirin
hepatitisc	compounds	therapy	study	inhibitors	ires	hcv
tb	regimen	pyrazinamide
hypersensitivity
anti-hiv-1antibody	2g12	forms	dimers	potent	2g12	neutralization	strains	hiv-1
influenza	continues	availability	vaccines
tuberculous	encephalitis	year	been	drugs	isoniazid
hivseroconversion	dates	ie	negative	detected	antibodies	hiv
tuberculosis	regimen	eradicate	sub-population	m.tuberculosis
cryptococcalmeningitis	patients	isolates	c.neoformans
sugar-phosphate	backbones	bonds	rigidity
h5n1	avianinfluenzavirus
hivinfection	transmitted	tested	hiv
rotavirusvaccine	factors	reducing	resulting	from	to	gastroenteritis
cytomegalovirusretinitis	patient	treated	ganciclovir
squamouscellcarcinoma	complicated	paraneoplasticsyndromes	secretion	hormone
hypertension	inhibited	caused	anesthesia	ketamine/xylazine
cross-sectional	design	using	tested	compared	microscopy	reference	gold
virus	genetics	progress	need	considering	viruses
estrogen	receptor	expression	tumor
tuberculosis	disease	reservoir	representing	estimated	infected	mycobacteriumtuberculosis
aids	policies	evaluating	prevention	hiv
type2diabetes	treatment	metformin
collagen	telopeptides	alkaline	concentrations	necrosis	tumor
hiv/aids
priondiseases	event	accumulation	form	prionprotein
vomiting	domperidone	prescriptions	having	treatment	ors	antibiotics
cancer	epidermoid	capsaicin
gonorrhoea	therapy	used	pakistan	be	ciprofloxacin
stz	trail	co-injected	mice	characterized	expression	markers	pancreatic	molecule	adhesion
tuberculosis	incidence	bcgvaccine	bcg
hbv	infection	marker	served	hepatitisbsurfaceantigen
hotflashes	agents	therapies	estrogens
amoxicillin	dose	efficacy	assess	dexamethasone	preventing	postoperativecomplications
schizophrenia	management	choice	treatments	medications	clozapine
cross-tolerance	effects	alcohol
duckviralenteritis	caused	duckenteritisvirus
hivdisease	study	hiv
ibs	patients	tegaserod
htlv-1-associatedmyelopathy	tropicalspasticparaparesis	agent	humant-celllymphotropicvirustype1
irondeficiency	limit	availability	iron
groupb	iron
aids	hiv
hypertension	compared	study	hctz
pancreatitis	occurs	patients	receiving	asnase
geminiviruses	exhibit	shown	replicated	viruses
type1diabetes	sitagliptin
attention-deficit/hyperactivitydisorder	diagnosed	children	evaluate	methylphenidate
ammonia	concentration	cultures	treatment	resulted	diminished	suggesting	mechanism	astrocyte	swelling
hypoglycaemia	episode	glucose
melanoma	treatment	used	dacarbazine	dtic
tb	caused	mycobacteriumtuberculosis	mtb
diarrhea	castoroil-induced
septicshock	support	norepinephrine	administered	phenylephrine
glucagon	suppression	impaired	delayed	duration	hyperglycemia
tb	therapy	component	rifampicin
hypoxia	factors	expressions	end	evaluate	tocopherol
hiv/aids
fishoil-supplemented	diet	feeding	reduces	inhibition	proliferation	cancer
hypertension	peaks	experienced	taking	mg	day	amlodipine
allergicreactions	suggesting	appears	seem	types	hypersensitivity
mrsa	-rrb-	s.aureus
gvhd	mimicking	colitis	mycophenolatemofetil
base	-RSB-	dilute	pretreatments	subjected	glucan	loading	optimized	proportions	enzymes	²	glucosidase	xylosidase	1,4-xylanase	endo-î
obesity	microbiota	interaction	data	brought	relationship	obesity/fat
oil	groups	times	ten
tb	cases	controls	bcg
hbv	infection	outcome	improved	treatment	adefovirdipivoxil
tumor	necrosis	factor-î	resulted	transport	glucose
sodiumretention	less	restricted	given	intake	sodiumchloride
type2diabetes	added	demonstrates	options	insulin
virus	efforts	contributed	analysis	sequences	rubellaviruses
malaria	treated	drug	artemether-lumefantrine
hbv	dna	region	detected	was	observed	determinant	hbsag
pulmonaryhypertension	monocrotaline	evaluate	effect	bosentan
steroid-independent	expression	center	arc
rheumatoidarthritis	commenced	etanercept
antiemeticdrug	used	treat	vomiting
pain	preventing	effective	mg	ketamine
hypoglycaemia	higher	associated	glucose
nephropathy	children	outcome	evaluate	evaluated	children	treated	steroids
hypertension	treatment	used	drug	acta	$	c16h20n4o3s	-RSB-	tâ	$	torasemide
pain	=	scale	measured	seconds	injection	propofol
malaria	prevent	fails	areas	resistance	sulfadoxine-pyrimethamine
vitaminadeficiency	levels	associated	levels	being	awareness	vitamina
mrsa	-rrb-	-lrb-	concern	treatment	s.aureus
htlv-i-associatedmyelopathy/tropicalspasticparaparesis	agent	htlv-i
influenza	reached	emergence	h1n1influenzavirus
hiv/aids
sirs	syndrome	patients	analyzed	evaluated	bacteria

pain	occasions	associated	use	nonsteroidalantiinflammatorydrugs	nsaids
l-asparaginase	immediately	features	seizures
hbsag	antigen	correlation	observed	donors	vaccinated	virus	hbv
hypercholesterolemia	patients	practice	therapy	combination	ezetimibe
diarrhea	infections	reported	use	antibiotic
attentiondeficithyperactivitydisorder	treated	immediate-release	methylphenidatehcl
hbv-specific	productions	percentages	monotherapy	entecavir
falciparummalaria	patients	found	occurring	treatment	infection	atovaquone-proguanil
mrsa	-rrb-	-lrb-	s.aureus
rickets	findings	disorder	i	referred	±	vitamind
cancer	treating	useful	chemotherapy	chosen	atp-cra
hyperglycemia	exchanged	medium	containing	glucose
pain	level	evaluate	instillation	eyedrops	eyedrops	tetracaine
hypercholesterolemia	impact	evaluating	directed	correlated	include	results	cholesterol
cholesterol	¥	hyperlipidemia
positivehiv
virus-derived	sirnas	produced	viruses
lymedisease	agent	borreliaburgdorferi
alcohol	abusive	analyzed	virusinfection
inhalationalanthrax	believed	internalization	spores	bacillusanthracis
pain	required	fentanyl
malaria	diagnosed	recommends	use	rdt	treat	artemether-lumefantrine
antiviral	therapy	efficacy	provided	reducing	burden	pain
meningococcaldisease	fight	strategy	involves	meningococcus	neisseriameningitidis
oxygen	atom	uncoordinated
aids/hiv	transmission	assessing	testing	hiv
tuberculosis	pathogenesis	population	significance	remains	arise	infection	mtb
macularedema	patients	option	implant	dexamethasone
hl	documented	effect	dacarbazine
hiv/aids
virus	detection	containing	system	concentrating	viruses
allergicreactions	history	referred	challenged	doses	penicilling
pain	severity	reduced	pretreatment	kg	sufentanil
antibody	titers	had	identifying	sub-type	ham/tsp
malaria	treatment	derivatives	quinine
acromegalic	patients	evaluated	biomarkers	glucose
type1diabetes	sitagliptin
ammonia	pre-treated	cultures	astrocyte	swelling
fats	financing	programme	cvd
ocd	obsessive-compulsive-disorder	treatment	effective	chlomipramine
irondeficiency	impacted	suggesting	assimilation	iron
insulin	rate	increasing	induced	hypoglycemia
cancer	diseases	monitoring	is	biology	basic
eclampsia	manage	used	included	included	recording	incidence	effect	resulting	use	magnesiumsulfate
asthma	control	function	association	budesonide
hiv/aids
tumor	necrosis	fattyacids	increases	injection	induced	increase	concentrations	nitrate
cavity	examine	mechanisms	bacteria
t2d	pathogenesis	driver	impairment	function	secretion	insulin
type2diabetes	subjects	treated	metformin
ponv	postoperativenauseaandvomiting	prevention	dexamethasone	metoclopramide
pancreatitis	sitagliptin
virus	that	sequence	have	viruses
hiv/aids
tb	vaccines	development	hope	represent	regimens	utilizing	bcg
tb	used	vaccine	bacillus	matter	efficacy	bcg
pain	preventing	effective	mg	ketamine
rabies	deaths	associated	species	rabiesviruses
viralinfection	risk	reducing	idus
osteoarthritis	osteoarthritis	oa	treated	chondroitinsulfate
trachoma	due	prevent	history	infections	chlamydiatrachomatis
irondeficiency	anemia	anemia	lack	resources	iron
virus	wdv	viruses
cholera	patients	stools	produce	subpopulation	v.cholerae
virus	all	isolates	isolated	measlesviruses
mumps	retroviruses	mumpsvirus
enterotoxin	investigated	patients	urticaria
hypoglycemia	mediate	regulate	neurons	glucose-sensing
hepatitisb	antibody	markers	tested	hbsag
hbv	reverse-transcription	±	eradicate	hepatitisbvirus
tuberculosisinfection	-rrb-	t-cells	m.tuberculosis
fattyacid	storage	capacities	depots	hypoxia
type2diabetes	compare	effects	combining	rosiglitazone
bacterialinfection	osteomyelitis	treatment	filling	bone	rifampicin
malaria	al	-rrb-	sulphadoxine-pyrimethamine
lymedisease	species	borrelia
thyroxine	receiving	subjects	excluded	had	history	hypertension
hivan	found	second	infected	hiv
pain	tourniquet	adjuncts	compare	effect	adding	as	ketamine
virus	escape	ribavirin
hivpositive	subjects	higher	high	warrant	recommendation	screen	status	hiv
leptospirosis	sera	sera	leptospira

triglycerides	insulinresistance
lvh	regression	favor	concluded	considered	employing	antihypertensiveagents
gout	management	remain	allopurinol
cancer	risk	women	altered	upa	expression	expression	upa
hbv	genotypes	showed	missed	hbsag
leucine	supplementation	therapy	obesity
anti-fibrinolyticagents	use	proposed	limit	transfusions	associated	bloodloss
infectiousmononucleosis	patients	epstein-barr-virus	ebv
aids	pandemic	cause	carbohydrate	type	hiv
chickenpox	epidemiology	investigate	studied	population	bissau	has	age	infection	vzv
hiv/aids
hiv/aids
aids	met	patients	hiv-positive
priondisease	transmission	route	expected	women	exposed	prions
gancyclovir	treatment	viremia	cytomegalovirus
malaria	treatment	consists	administration	dose	sp	sulphadoxine-pyrimethamine
oa	osteoarthritis	progression	determine	glucosamine
tuberculosis	incidence	bcgvaccine	bcg
hyperglycemia	activity	increased	incorporation	glucose
pain	treatment	developed	film	fentanyl
pain	management	reported	trials	obtained	results	growing	hyaluronicacid
virus	activator	observed	destructor	acting	disseminator	viruses
autoimmunediseases	implicates	capacity	anti-inflammatory
juvenileidiopathicarthritis	etanercept
cutaneousmelanoma	therapy	dacarbazine
progesterone	receptor	status	size	tumour
hivinfections	reduce	deliver	carry	understand	epidemic	hiv/aids

cholera	pandemics	contribute	factors	strains	vibriocholeraeo1
dr	triglycerides
hivinfection	problems	investigated	impact	insufficiency	behavior	hiv
sodiumphosphate	bowel	acute	due	preparation	related	spasm
ticdisorders	patients	antipsychotic
pain	$	outcome	compare	manual	anesthesia	supplemented	lignocaine
rsvinfection	associated	bronchiolitis	infants	function	data	collected	involve	manifestations	infection	rsv
androgen	therapy	contribute	development	cancer
open-angleglaucoma	patients	latanoprost

influenza	a/h1n1	a/california/12	influenzaviruses
gonorrhoea	therapy	used	pakistan	be	ciprofloxacin	tetracycline
ifn	patients	sle
cancers	carcinomas	ca
ion	nitrite	ige	râ	â	asthmatics
anti-cancer	agent	focused	has	chloroquine
vehicles	able	prevent	infestations
hbv	kits	antigen	hbsag
cholesterol-lowering	drug	trial	data	analyze	risk	events	myocardialinfarction
pain	while	flares	experience	individuals	benefit	boluses	ketamine
ironoverload	irondeficiency	causing	regulation	homeostasis	iron
anti-inflammatory	response	counterbalance	disturbances	precede	type2diabetes
atherosclerosis	disease	development	preventing	capable	molecules	plasma	precursors	pgi2
veinthrombosis	months	warfarin
tb	regimen	treatment	rifampin	isoniazid
cancer	patients	treated	analogs	â	capecitabine
virus	showed	antisera	raised	virus	reacted	viruses
asthma	outcomes	achieves	monotherapy	budesonide
base	allele	health	sle	lupus
cancer	examined	study	beta-carotene
estrogen	receptor	differ	metastases
hypertension	patients	compare	efficacy	telmisartan
crohnâ	disease	patients	controls	hc
viremia	had	rna	sequences	env	analyzed	evaluate	strategy	identifying	viruses
insulin	replacement	receiving	patients	type1diabetes
tb	vaccines	designing	stimulate	contribute	bcg
lymeborreliosis	group	species	lusitaniae	borrelia
hiv/aids-related	vaccine	help	reduce	likelihood	transmission	hiv
hiv/aids	candidate	protein	gp160	hiv-1
lymedisease	associated	clones	borreliaburgdorferisensustricto
hypertension	performed	olmesartanmedoxomil
uc	ng/ml	cd
hepatitiscantigens	response	herein	evaluated	transfers	ester	labelled	mice	hcv
ham/tsp	tropicalspasticparaparesis	disorder	agent	type	htlv-1
arc	manifestations	infection	hiv
acidophilus	treatment	tilt	regulatory	models	colitis
tumor	location	characteristics	evaluated	terms	rate	dm
aminoacid	changes	contained	virus
thromboembolism	factors	started	episode	use	oralcontraceptive	containing	oestrogen
breasttumor	line	expression	suppression	eliminated	estrogen
mrsa	s.aureus	prevalence	remains	staphylococcusaureus
type2diabetes	risk	individuals	cohort	genotyped	polymorphisms	known	affect	secretion	insulin
gout	patients	reducing	comparing	doses	allopurinol
olanzapine	index	evaluate	patients	fulfilling	criteria	schizophrenia
type1diabetes	type2diabetes	insulin
zn	atom	coordinated
hiv/aids
oil	groups	times	ten
vomiting	treat	used	antiemeticdrug	ondansetronhydrochloride

cross-neutralizing	titers	induce	vaccines
anti-inflammatorydrugs	drugs	inflammation
osteoporosis	guidelines	recommend	supplementation	vitamind
hemorrhage	manifestations	sediments	renalfailure	observed	considered	possibility	mpa
coronaryheartdisease	in	treated	model	time	use	statin
denguehemorrhagicfever	agent	denguevirus
pain	procedures	modulating	using	menthol
immunosuppressive	exosomes	release	enhancing	considered	designed	therapies	anti-cancer
adiposity	measured	markers	glucose
cardiovasculardisease	indicated	shown	studies	therapy	hormone
ar	associates	binding	hormone
goitre	rate	thyroxine
severeacuterespiratorysyndrome	epidemic	caused	coronavirus	sars-cov
ponv	prevent	way	treatment	combination	metoclopramide
tuberculosis	drug	pyrazinamide
asthma	symptoms	intercurrent	showed	smokers	treated	budesonide/formoterol
hyperglycaemia	glycaemia	variability	glucose
melanoma	observed	expression	d3
mdr-tb	tuberculosis	resistance	isoniazid
cytomegalovirus	measurements	received	ganciclovir
tuberculosis	study	enrolled	participants	isolates	lineages	m.tuberculosis

aml	patients	therapy	arabinoside	mitoxantrone
hepatitisb	received	telbivudine
transmissiblespongiformencephalopathy	activity	converted	prionprotein
nausea	=	control	had	patients	receiving	prochlorperazine
type1diabetes	$	examine	relationship	status	zn
fungalinfections	prophylaxis	modality	become	poised	appears	posaconazole
tb	shifted	treated	bcg-vaccination
tb	candidate	work	suggested	compromise	diversity	strains	m.tuberculosis
congenitalheartdefects	result	dysfunction	dependent	part	decreases	nitricoxide
lymedisease	occurring	those	similar	symptoms	result	infections	caused	pathogens	patients	infected	borreliaburgdorferi
oic-hivpositives	%	agreement	oic-hiv
malaria	case-management	describe	$	lumefantrine
malaria	exposure	-rrb-	trial	doxycycline
hivinfection	abrogating	hiv
hivinfection	stages	collected	msm	hiv-positive
hbv	hepatitisbvirus
cholesterol	levels	reduction	prevention	reduced	incidence	stroke
venezuelanequineencephalitis	vee
hereditaryhemochromatosisâ	$	drawn	present	suggesting	exerts	circulating	stores	iron
schizophrenia	patients	dosages	antipsychotic	lai	olanzapine
atopicdermatitis	is	alternative	steroids
uti	treatment	used	ciprofloxacin
glucose	abnormalities	frequency	evaluate	children	obese
rheumatoidarthritis	patients	monotherapy	efficacy	investigated	methotrexate
uc	ulcerativecolitis	patients	hc
trachoma	risk	modulate	suggesting	regulates	demonstrate	studies	organism	chlamydiatrachomatis
crohndisease	reduced	immunomodulators	form	azathioprine
insulin	secretion	induces	contributing	development	liver	insulinresistance
pioglitazone	inhibited	necrosis	expression	tumor
opioid	analgesia	postoperativepain
type1diabetes	calcitriol	form	supplementation	improve	control	assessed	requirement	insulin
virus	strains	infection	coinfections	result	suggested	experiments	viruses
cutaneousmelanoma	nature	implies	molecules	study	performed	compare	profile	variant	p-cad	blm
virus	transmitted	emerged	lineage	viruses
hiv/aids
glucose	levels	patients	have	rates	cancer
h5n1	strains	efficacious	antibodies
pain	incidence	causes	propofol
malaria	prevention	recommended	treatment	malaria	sulphadoxine-pyrimethamine
sugar	ointment	anorexia
antibodies	circulating	using	igm	dengue
leprosy	pathogenesis	nerves	caused	mycobacteriumleprae
insulin-like	receptor	play	metastasis	cancer
cd	uc	34	diagnosed	cases	ibd
sars	epidemic	caused	coronavirus	sars-cov
typhus	group	tg	rickettsiae

mrsa	-rrb-	-lrb-	cause	staphylococcusaureus
hiv/aids
h5n1	humaninfluenzaviruses
hivseroconversion	dates	ie	negative	detected	antibodies	hiv
type1diabetes	associated	insulinglargine
sars	patient	revealed	presence	coronavirus
hypoglycemia	prevent	infused	glucose	glimepiride	ingestion	measured	diazoxide
tb	patients	isolated	strains	mycobacteriumtuberculosis
melanoma	therapy	used	chemotherapeutics	dacarbazine
alcoholdependencesyndrome	syndrome	diagnosis	india	institute	administered	drug	alcohol
ibs	patients	tegaserod
type2diabetesmellitus	prescribed	metformin
malaria	risk	reducing	recommended	treatment	ulphadoxine-pyrimethamine
pain	management	programme	practice	tread	days	ether
h5n1	influenzaviruses
hiv/aids
hivinfection	reduce	vital	country	infected	hiv
antiviral	treatment	including	countered	halve	proportion	ulcers
hivpositive/ks	negative	negative/ks	positive	negative/ks	hiv
terbutaline	mg	administration	causes	hyperglycemia
aids-susceptible	species	infection	hiv/siv
h5n1	strains	using	carried	isolated	avianinfluenzaviruses
columnarisdisease	causes	flavobacteriumcolumnare
type2diabetes	those	investigated	sensitivity	insulin
cancers	associated	associations	age	use	hormone
hiv/aids
onchocerciasis	control	decades	used	ivermectin
schizophrenia	exacerbation	evaluate	efficacy	ziprasidone	risperidone
irondeficiency	anemia	anemia	lack	resources	iron
metal	hypersensitivity
spottedfever	group	ag	rickettsiae	define	ogs	identifying	bolster	reclassification	rickettsia
uc	controls	patients	cd
endocrinedisease	caused	secretion	hormone

aids	patients	untreated	patients	hiv-infected
insulin	delivery	predicted	hypoglycemia
sexhormone	estrogen	protect	atherosclerosis
postpartumhaemorrhage	and	medline	ergonovine	methylergonovine
hbv	expression	screened	sites	hepatitisbvirus
hypertension	inhibited	ea
depressivedisorder	treatment	labeling	approved	system	system	selegiline
renalfailure	limited	use	csa
myeloma	patients	treated	bortezomib
pain	effect	had	study	mg	gabapentin
hyperglycemia-induced	changes	consequences	studied	ingestion	meal	using	approach	glucose
hivinfection	course	worsens	highlight	effects	proteins	hiv-encoded
malaria	exposure	-rrb-	trial	doxycycline
pain	resulted	block	lidocaine
lipid	profile	include	outcomes	secondary
cancers	up-regulated	anti-estrogens
vomiting	treat	prochlorperazine
hypoglycemia	augments	administration	fluoxetine	ssri
malaria	exposure	-rrb-	trial	doxycycline	chloroquine
basic	number	infection	rates	sars
rheumatoidarthritis	treating	granted	mtx
type1diabetes	insulin-dependent
echinococcosis	recurrence	found	accepted	take	albendazole
viralgastroenteritis	outbreaks	understanding	gain	compiled	viruses
hiv/aids
jia	children	parents	expected	knowledge	mtx
melanoma	mda5	rig	retinoicacidâ
polio	free	declared	countries	poses	persistence	poliovirus
shingles	agent	alpha-herpesvirus	varicellazostervirus
influenzaviruses
insulin	substrate	level	signaling	impaired	insulinresistance
silicosis	induces	inhalation	particles	silica
plasmodiumfalciparummalaria	treatment	quinine
non-hodgkin	lymphoma	chest	treated	chop	cyclophosphamide
hiv/aids
pain	tolerable	hr	patches	fentanyl
malaria	treatment	investigated	sulphadoxine-pyrimethamine
ami	aspirin
cocaineaddiction	reveal	regulators	control	actions	cocaine
adhd	symptoms	reduce	l-amphetamine
ar	gas
hiv/acquiredimmunodeficiencysyndrome
chemotherapy-inducednauseaandvomiting	treatment	effective	aprepitant
plasmodiumfalciparummalaria	children	treated	mefloquine
insulin	sensitivity	suggesting	proinsulin	insulinresistance
epilepsy	investigated	tested	hypothesis	inhibits	vigabatrin
osteoarthritis	knee	compared	chondroitin
hereditaryhemochromatosisâ	$	drawn	present	suggesting	exerts	circulating	stores	iron
mtb	assessed	kit	m.tuberculosis
penicillin	prevents	congenitalsyphilis
hiv/aids	-rrb-	center	program	hiv
dm	diabetesmellitus
familialhypercholesterolemia	patients	treatment	practice	therapy	combination	ezetimibe
denguehaemorrhagicfever	range	infection	denguevirus
polio	vaccine	two	consisting	schedule	received	doses	inactivatedpoliovaccine
pain	intensity	enhanced	capsaicin
obesity	those	to	compared	times	have	levels	cholesterol
h5n1	proteins	encoding	by	provided	evaluated	pre-exposed	h1n1influenzavirus
tb	infection	elispot	controls	bcg-vaccinated
hbv	hbsag
adjuvant	therapies	trials	reviews	cancer
hiv/aids	fears	factors	lack	confidentiality	results	hiv
aids	industry	gluten
hypertension	patients	proved	superior	antihypertensiveagents	losartan
etoposide	patients	acutemyeloidleukaemia
adhd	children	took	showed	similar	degree	improvement	speed
5-fu	effect	anti-cancer
type2diabetes	insulin	dose	insulin	add-on	evaluate	effects	combination	sitagliptin
type2diabetes-low	below	divided	groups	content	triglyceride
mrsa	obtained	identified	isolates	s.aureus
inh	isoniazid	treated	compared	lungs	mtb
asthma	exacerbation	mimicking	challenges	tested	effect	budesonide
antibody-positive	vasculitis	bacteremia
diabeticretinopathy	complications	associated	diabetesmellitus
bleeding	complications	reduction	associated	shown	safe	administration	protamine
infectiousmononucleosis	follow	epstein-barrvirus	ebv
hiv/aids
type2diabetes	diagnosis	youth	have	evidence	autoimmunity	contributing	deficiency	insulin
hepatitisb	treatment	options	licensed	entecavir
tuberculosis	treatment	used	drugs	one	isoniazid
hbv	infection	suffer	administrated	immunoprophylaxis	hepatitisbimmunoglobulin
cancer	risk	are	women	levels	testosterone
tb	coinfected	patients	high	titres	bcg-specific
antiemetics	ors	treatment	having	prescriptions	domperidone	vomiting
leptospirosis	suggestive	positive	igm	testing	latex
depressivedisorder	associated	observed	onset	activity	fluvoxamine
fibre	comparing	adults	irritablebowelsyndrome
virus	class	viruses
falciparummalaria	resistant	proven	combination	proguanil
zinc-free	insulin	decrease	suppressed	increased	decrease	insulin	hypoglycemia
priondisease	pathogenesis	understanding	designing	prevent	infection	prion
tumor	samples	patients	sts
lymeborreliosis	disease	caused	bacteria
asthmatics	number	cause	clear	have	seen	challenge	asa
calcium	gluconate	resolved	preparation	related	spasm
hiv/aids
scabies	include	use	ivermectin
cancer	therapy	adjuvant
virus	use	exposure/release	concerns	alleviating	antibodies
diarrhea	prevented	loperamide
tuberculosis	research	challenge	develop	test	help	distinguish	those	control	replication	mtb
dr	pose	prevalence	diabetes	projected	rise
antidepressant	activity	onset	observed	associated	depressivedisorder
anaphylaxis	symptoms	developed	5â	$	enoxaparin
virus	shed	failed	inoculated	shed	viruses
malaria	unit	treated	falciparummalaria	patients	mefloquine
hbv-seropositivity	documented	positive	hbsag
schizophrenia	symptoms	effective	risperidone
hivinfection	history	aspects	factors	modes	transmission	hiv
irondeficiency	suffer	given	important	understand	influence	status	iron
drugallergy	induced	amoxicillin
adiposity	assessed	%	index	fat
contrastagent	$	30â	detectable	majority	segments	patients	cad
virus	feature	suggesting	influenzaviruses	comparable	responses	induced	viruses
calcitonin	receptor	expression	elisa	pro-peptides	formation	quantification	activation	camp	signaling	eia
typhoid	cause	cause	gastroenteritis	humans	salmonellatyphi
prednisone	predict	systemiclupuserythematosus
glucose	metabolism	individuals	$	sample	cross-sectional
acetaminophen	effective	relief	pain
cancer	phytochemicals	strategy	factor	belongs	family	leucine
type2diabetes	individuals	present	induced	meals	high-fat
tuberculosis	strategies	guide	mycobacteriumtuberculosis	mtb
type2diabetesmellitus	investigate	effect	metformin
ham/tsp	patients	cohort	carriers	htlv-1
acquiredimmunedeficiencysyndrome	pandemic	humanimmunodeficiencyvirus
ocularbacterialinfections	variety	treatment	levofloxacin
tumor	extracts	level	factor	patients	sts
mdr-tb	isoniazid
cerebralischemia	factor	resistance	clopidogrel
leprosy	patients	controlling	effective	proved	drugs	analogues	thalidomide
rheumatoidarthritis	patients	tb	risk	thought	risk	adalimumab
ecstasy	preference	suppressed	strengthening	facet	anorexia
hiv/aids

tb	infection	efficacy	>	bcg
sars	homologues	offered	virus	felv	coronavirus
tuberculosis	detect	test	mtb/rif
stroke	risk	is	shown	is	level	exposure	smoke
pain	$	outcome	compare	manual	anesthesia	supplemented	lignocaine
depressivedisorder	patients	received	escitalopram
hiv/aids
hypertension	effective	one	calciumchannelblocker
carbon	dose	evaluating	control	tumor
tb	-rrb-	detect	m.tuberculosis
allergy	developing	odds	had	children	heredity	allergies
dengue	infections	distinguish	classifier	kits	denguevirus
type1diabetes	phenotype	has	mean	years	bmi	%	autoantibodies	positive	decarboxylase	glutamicacid
constipation	induced	administration	loperamide

hypercholesterolemia	history	reported	had	levels	cholesterol
hsvinfection	regulation	in	viruses	role	demonstrating	extends	arena	antiviralagents
aids	provided	plan	fight	hiv
obstructivepulmonarydisease	patients	likely	patients	received	oxygen
insulin	users	risk	cancer
metastases	setting	adjuvant
melanoma	line	variant	p-cad	blm
hemochromatosis	gene	that	downregulated	upregulated	expression	protein-1	iron-regulatory
rsvinfection	risk	individuals	provide	guidance	timing	prophylaxis	rsv
hbv	-rrb-	isolates	hepatitisbvirus
ami	studies	superior	des
rifampicin	treated	osteomyelitis
hbv	dna	defined	hepatitisbvirus

aids	knowledge	hiv
hiv/aids
breasttumours	estrogen
acquiredimmunodeficiencysyndrome	humanimmunodeficiencyvirus
type2diabetes	treatment	option	pioglitazone
ironoverload	result	characterized	absorption	iron
pain	relief	evaluate	added	lidocaine
juvenileidiopathicarthritis	treated	protein	etanercept
bosentan	addition	had	progression	tumor
melanoma	cells	melanocytes	basal	±	ifn-î
hypertension	hundred	randomized	groups	receiving	fosinopril
h5n1	avianinfluenzavirus
hiv/aids
jia	taking	mtx
ea	males	sle
mycobacteriumtuberculosis	complex	-rrb-	belonging	isolates	identification	important	resistant	drug	pyrazinamide
hypertension	syndrome	triglycerides
aids	hiv
ironoverload	promotes	iron
obstructivepulmonarydisease	subgroup	mortality	%	arm	%	arm	oxygen
corticosteroids	respond	patients	safe	patients	focalsegmentalglomerulosclerosis
ebvinfection	diseases	the	correlates	genotypes	ebv
malaria	treatment	investigated	sulphadoxine-pyrimethamine
stz	trail	co-injected	mice	characterized	levels	hyperglycemia
cutaneousinflammation	suppress	treat	calcineurininhibitors	tacrolimus
ibs-qol	responders	treatment	tegaserod
chronichepatitisc	virus	treatment	infection	ribavirin
serotonin-transporter	fluoxetine	abolished	response	acidosis
aids	syndrome	acquired	humanimmunodeficiencyvirus
contagiousecthyma	causes	prototype	orfvirus
ifn-gamma-responses	represents	marker	vaccine-take	trials	tb
fat	associated	nonalcoholicfattyliverdisease
opioid	analgesia	intensity	pain
type2diabetes	loci	model	discriminate	power	increases	adding	snps	associated	fasting	insulin
type2diabetes	diagnosis	patients	matched	adjusted	use	insulin
insulin	resistant	protected	obesity
cholesterol	criteria	definition	obesity
hiv/aids
pain	severity	degree	included	included	time	weighted	mean	dose	remifentanil
virus	showed	viruses
dwarf	shown	associated	cbd
malaria	prevention	recommended	treatment	malaria	sulphadoxine-pyrimethamine
aids	presenting	decreased	increased	illness	hiv
ea	offers	insulinresistance
smallpox	model	rabbits	infection	discuss	test	antiviral
hiv/aids
methicillinresistantstaphylococcusaureus	%	staphylococcusaureus
retinol-binding	protein	links	insulinresistance
obesity	composition	fattyacid
pml	progressivemultifocalleukoencephalopathy	jcvirusinfection
hbv	hepatitisbvirus
œhypersensitivityâ
t2d	combined	objective	compare	costs	insulinglargine
malaria	treated	artemether
virus	studies	borne	idus
hivpositive	in	hiv
m.tb	defining	reasons	deterioration	patients	receiving	treatment	antitubercular
bisphosphonate-associatedosteonecrosisofthejaws	effect	treatment	bisphosphonate
hivinfection	exists	appreciated	plays	part	pathogenesis	hiv
cancerdrug	development	candidates	mc	expressed	cancers
aids	rates	incidence	hiv
pain	reduced	dosage	lidocaine
ecstasy	receptors	stimulation	stimulated	transcripts	accumbens	discovered	facet	anorexia
non-smallcelllungcancer	treatment	proven	combinations	docetaxel
mrsa	isolates	s.aureus
cardiopathy-related	disorders	diabetic	disorders	ic	dm
type2diabetesmellitus	t2d	disorder	characterized	deficiency	insulin
chronichepatitisb	tenofovir	analog	activity	hepatitisbvirus
vehicle	therapy	modify	microenvironment	tumor
albuminsolutionallergy	patients	antihistamines
i-deficient	cells	cta	expression	makes	serve	i-restricted	antigens	tumor-specific
type2diabetes	exenatide
intracranialhypotension	resulted	cerebrospinalfluidleakage
candidemia	therapy	species	candida
tg/gg	associated	risk	ratio	aml
hbv	positive	hbsag
aids	mortality	decline	associated	rates	pre	counseling	hiv
fungalinfections	teatment	role	focusing	reviews	available	data	posaconazole
tb	resistance	detection	determine	inh
type1diabetes	amplify	use	fluoxetine	ssri
uc	patients	assigned	66	receive	formulation	mesalamine
hiv/aids
insulin	sensitivity	nafld	non-alcoholicfattyliverdisease
anti-inflammatory	capacity	implicates	autoimmunediseases	multiplesclerosis
alcoholism	research	areas	some	dysregulated	consumption	alcohol
aids	emerged	mode	hiv-acquisition
t2d	risk	contribute	ratio	sensitivity	insulin
hiv/aids	cases	tested	hiv
ham/tsp	patients	/	htlv-1-associatedmyelopathy
mycobacterialdisease	isolated	complex	gordonae	mycobacteria

adhesion	pds	prg
tuberculosis	caused	strains	mtb
pain	rated	intensity	reduced	comparable	groups	%	tramadol
aids	hiv
tuberculosis	respiratorydisease	caused	mycobacteriumtuberculosis
autoimmunediseases	interferons
tumor	growth	showed	dox
vasculitis	hydralazine-induced
hbv	positive	positive	viruses
ipp	protrusion	adenoma
cancer	patients	treated	analogs	â	mg/m2/day	200	5fu
bulimia	treatment	fluoxetine
aids	progressed	tb	inmates	hiv-negative
atherosclerosis	predisposing	damage	causes	harmful	oil
mrsa	-rsb-	s.aureus	s.aureus
hivinfection	disclosing	related	dilemmas	complicated	becoming	woman	hiv-infected
type2diabetes	compare	placebo	glimepiride
formaldehyde	concentrations	enhanced	ph	mimicking	microenvironment	tumor

influenza	avianinfluenzaviruses
virus	strain	varied	viruses
virus	genetics	progress	need	considering	viruses
epidemiccholera	control	africa	causing	strains	known	variants	biotype	vibriocholeraeo1
rcc	risk	increase	factors	some	smoking	carcinogens	organicsolvents
type1diabetes	used	therapy	insulin
psoriaticarthritis	treatment	demonstrated	necrosis	etanercept
granulomaannulare	man	duration	prednisolone
hypoxic-ischemic	damage	correlated	gradation	expression	antibodies
tuberculosis	strain	agent	mycobacteriumtuberculosis
asbestos	burden	hazard	has	correlate	tumour
antibody	blocked	adhesion
hivinfections	acquiring	populations	target	estimates	hiv
lipid	transfection	gave	containing	amount	co-lipid	fa-peg570-diether
cr	effects	exercise	model	insulinresistance
malaria	parasites	examined	recorded	use	sulfadoxine-pyrimethamine
hiv/aids
triglyceride	content	relation	assess	using	studied	men	type2diabetes
hivinfection	status	assess	visited	centres	hiv
glucose	insulinresistance
type2diabetes	patients	completed	mg	mg	glimepiride
ea	european	composed	polymorphisms	cases	sle
melanoma	treatment	used	dacarbazine
cholera	pandemic	causing	causing	elimination	biotype	vibriocholeraeo1
arginine	l	supplementation	treat	melas	stroke
rcc	renalcellcarcinoma	management	use	available	inhibitor	tyrosine
virus	passaging	created	those	viruses
mrsa	isolated	subjected	protein	s.aureus
hypertension	patients	received	monotherapy	mg	candesartancilexetil
acnevulgaris	patients	groups	clindamycin
cmv	humancytomegalovirus
pain	relief	evaluate	added	acetaminophen
anti-inflammatory	mediates	protein	related	obesity
ham/tsp	medium	differed	expression	cell	htlv-1-infected
nsclc	non-smallcelllungcancer	patients	regimen	compare	regimen	cisplatin-plus-vinorelbine
neuroblastoma	lines	agent	5-aza-2
alcoholdependence	development	involve	chemistry	physiological	alcohol
hiv/aids
priondisease	mice	surveyed	distribution	infectivity	prion
tuberculosis	have	suggest	drives	bcgvaccine
virus	antibodies	antibodies
hbv	-rrb-	transcriptase	virus	occurring	mutations	treatment	administration	approved	analogue	adefovir
nsaids	term	take	patients	osteoarthritis

leucine	supplementation	models	obese/diabetes
calcium	levels	elevated	cardiomyopathy
hyperglycaemia	group	mmol/l	¥	glucose
necrotizingfasciitis	pathogen	groupastreptococcus	gas	streptococcuspyogenes
hypoglycemia	syndrome	niphs	development	use	octreotide
hypersensitivity
hiv/aids
tb	used	vaccine	bacillus	matter	efficacy	bcg
melanoma	lines	is	data	reported	cells	treated	tmz
schizophrenia	symptoms	improving	chlorpromazine	clozapine
newcastledisease	viruses	sequences	ndv
inflammation	contribute	depots	capacities	storage	fattyacid
hbv-seropositive	-RSB-	hbsag
malaria	emphasized	recommended	implementation	ipti	sp	sulfadoxine-pyrimethamine
magnesiumdeficiency	occurs	intake	magnesium
rcc	activity	shown	agent	patients	failed	interferon
hbv	hepatitisbvirus
statin	ae	gene	encoding	transposon	containing	injected	mice	tumor-bearing
hiv/aids
nac-5-htr4	overexpression	upregulated	nac-cart	provoked	anorexia
virus	discovery	highlights	need	expand	source	viruses
hypoglycemia	pressure	glucose
pains	begun	prescription	tramadol
antidepressant	treatment	response	topic	studied	depressivedisorder
pgg-ptx	tested	line	vitro	cancer
metal	hypersensitivity
hiv/aids
virus	genes	usage	variations	observed	viruses
plague	infection	y.pestis
nicotinedependence	test	high	nicotine
hiv/aids
type2diabetes	contributed	prescription	premix	insulinaspart
alcohol	effects	related	clarified	livercirrhosis
mrsa	activity	antibacterial
tb	agent	mycobacteriumtuberculosis
mtbdr	plus	validated	isolates	resistance	resistance	rif
glucose	metabolism	atherosclerosis
bacterialinfections	pathophysiology	important	avenue	inflammation	bacterial-induced
tuberculosis	burden	populations	protected	variation	sequences	m.tuberculosis
antiviral	state	protected	enterovirusinfection
pml	detect	performed	patients	jcvirus
virus	isolated	development	aids	caused	mdm	isolated	viruses
tb	laboratory	isolates	compared	specimens	assay	tube	testing	resistance	inh
lipid	content	glucoseintolerance
melanoma	dissemination	treatment	activity	have	temozolomide
the	1,25-dihydroxyvitamind3
osteoarthritis	osteoarthritis	oa	treated	chondroitinsulfate	glucosamine
rheumaticfever
asthma	quality	questionnaire	twice	âµg	budesonide
rituximab	b-celllymphoma
gastriculcers	treatment	used	drug	lansoprazole
cholesterol	levels	have	times	compared	to	those	obesity
tumor	originates	support	stoichiometries	produce	availability	glucose
chickenpox	causes	varicella-zostervirus
multiplesclerosis	development	factor	and/or	associated	levels	vitamind
falciparummalaria	efficacious	followed	emerged	treatment	sulphadoxine-pyrimethamine
type2diabetes	therapy	insulin
ion	transport	targeting	aid	management	cornealulcers
insulin	autoantibodies	reduced	delayed	mice	nod-scid
tannin-containing	plants	use	explain	treatment	variety	inflammatorydiseases
asthma	brushings	cells	treated	formoterol
h5n1	avianinfluenzavirus
hyperglycemia	decreased	modify	glucose
collagen	elisa	expression	receptor	chondrocytes	oa
psoriasis	treatment	cyclosporine
pain	pain	consumption	fentanyl
asbestosis	asbestos	inhalation	fibres	asbestos
domperidone	efficacy	compare	treatment	vomiting
acnevulgaris	isotretinoin
virus	structure	involved	genes	compared	analyzed	investigate	diversity	viruses
autoimmunedisease	characterized	interferons
antiviral	therapy	role	knowledge	predictors	pain
tumor	program	improve	attempt	aiming	clearance	followed	therapy	adjuvant
sle	belimumab	role	supporting	evidence	summarize	discuss	aspects	basic
hypoglycemia	$	spent	min	results	excursions	glucose
anthrax	cases	received	number	samples	submissions	negative	bacillusanthracis
tumor	factor	dmards	modifying	refractory	study	efficacy	patients	rituximab
ironoverload	associated	variants	promote	iron
epilepsy	patients	seizures	¥	include	populations	approved	drug	levetiracetam
aml	blasts	response	â	revealed	exposure	etoposide
hbv	hepatitisbvirus
h5n1	vaccine	exceeded	responses	antibody
hiv/aids
aids	hiv
gbs	patients	study	showed	recovered	patients	increase	level	dose	ivig
malaria	treatment	changed	artemether-lumefantrine
aids	epidemic	drivers	conclude	led	strength	evidence	linking	hiv
glucose	biomarkers	presented	group	patients	acromegalic
5-fu	patients	ten
disseminatedintravascularcoagulation	dic
hypersensitivity
isoniazid	treated	compared	lungs	mtb
hbv	polymerase/rt	adefovir
virus	particles	interactions	reflecting	cause	cultured	viruses
malaria	treatment	artemether-lumefantrine
cyclosporina	analogue	is	development	treatment	autoimmunediseases
acquiredimmunedeficiencysyndrome	recognized	investigate	occurrence	humanimmunodeficiencyvirus
adrenocorticotropin	hormone	secretion	caused	endocrinedisease
malaria	therapy	recommended	emergence	resistance	chloroquine
open-angleglaucoma	had	us	living	examine	efficacy	chloride	travoprost
asthma	symptoms	relief	used	combination	budesonide/formoterol
anti-tb	selection	provide	transmission	strains	resistant	inh
systemichypertension	treating	used	case	intake	chlorthalidone
plague	bacterium	yersiniapestis
tuberculosis	therapy	component	rifampicin
asthma	treatment	relief	supports	use	budesonide/formoterol
lupuspanniculitis	evolution	characterized	treated	antimalarialdrugs
asthma	control	function	association	budesonide
scabies	mites	tolerance	ivermectin
contactallergy	link	unexplained	examined	cells	allergens
insulin	activation	contribute	development	type2diabetes
bradycardia	cause	potent	found	signal	bradycardia	associated	propranololhydrochloride
pain	medications	acetaminophen
irondeficiency	reversing	programs	iron
lymphoma	lines	using	agent	demonstrates	efficacy	nanoparticles	silver
shock	protein	kda	found	cells	albumin
hbv	infection	leading	factors	one	contribute	clearance	infection	hepatitisbvirus
cancer	patients	majority	experience	consisting	wasting	fat
antidiabetics	therapy	controlled	age	was	incidence	patients	diabeticfoot
type2diabetesmellitus	patients	treatment	glimepiride	metformin
malaria	pregnancy	sulphadoxine-pyrimethamine
atp	synthesis	plays	pathophysiology	syndrome	fatigue
hbv	infections	pool	forming	million	prevalence	hbsag
malaria	incidence	reduced	reduced	reduced	sulphadoxine-pyrimethamine
formalin	fixed	lines	cancer
melanoma	cells	melanocytes	basal	±	ifn-î
schizophrenia	taken	risperidone
tb	diagnosed	isolation	m.tuberculosis
hyperglycaemia	insulin
rheumatoidarthritis	treatment	action	have	formulations	mtx
dexamethasone	treated	age	rats	macrophages	examined	immunosuppressed	develop	pneumocystisinfection
hbv	polymerase	domain	detected	mutations	known	causing	resistance	adefovir
priondiseases	causing	agent	constituent	prpsc	form	prpc	prionprotein
multiplemyeloma	lesions	increased	inhibited	suggesting	result	bortezomib
hepatitisc	viruses
tb	screened	reported	persons	number	%	reported	therapy	isoniazid
rheumatoidarthritis	patients	monotherapy	efficacy	investigated	methotrexate	mtx
tb	case	sharing	require	transmission	mycobacteriumtuberculosis
complexregionalpainsyndrome	-RSB-	phenomena	receptors	proliferation	forms	use	ketamine
insulin-like	concentrations	validity	addressed	acromegaly
intracranialtuberculomas	tuberculosis
hypertension	glomerulosclerosis	attenuated	ramipril
type2diabetes	studied	patients	treated	patients	treated	insulin
tuberculosis	development	inform	characterized	isolates	total	mycobacteriumtuberculosiscomplex
breasttumours	prognosis	predict	genes	continuous/late/estrogen-response
virus	challenge	conferred	elicits	antibodies
aids	hiv
pravastatin	grade	significant	qualifying	syndrome	revascularization	history	stroke
hbv	hepatitisbvirus
transmissiblespongiformencephalopathies	group	disorders	triggered	folding	molecule	prionprotein
kd	â	log	negligible	sorption	carbamazepine
pain	incidence	reduced	groups	received	remifentanil
humaninfluenza	that	resembles	used	study	pathogenesis	influenzavirus
hbv	reactivation	developed	developed	therapy	lamivudine
malaria	attributable	fevers	number	standard	gold
hbv	hepatitisbvirus
phototoxicity	immunoreactivity	antibody
atrialfibrillation	patients	management	dronedarone
aaa	antibodies
tumor	nodules	number	plasmid	animals	injected	transposon	statin
hepatitisc	-lrb-	epidemiology	information	hcv
pain	propofol
neurologicdisorders	children	used	understanding	sedatives
hypoglycaemia	weight	glucose
genitalwarts	type	hpv
cancer	incidence	higher	that	-lrb-	users	insulin
fluoxetine	administration	amplify	hypoglycemia	patients	type1diabetes
type1diabetes	diagnosis	investigated	requirements	insulin
hypoglycemia	risk	increasing	has	variability	variability	levels	bloodglucose
hyperglycemia	model	glucose
hiv/aids
hbv	infection	control	role	play	children	born	mothers	hbsag-positive
aids	syndrome	acquired	humanimmunodeficiencyvirus	hiv
mtbdr	plus	validated	isolates	resistance	inh
groupb	in	-lrb-	8.20	change	bloodglucose
pramlintide	using	replacement	slowed	reduced	hyperglycemia
triglycerides	biomarkers	evaluated	patients	acromegalic
excessiron	provided	experience	toxicity	iron
cross	lack	activity	co2
priondiseases	transmitting	remain	prions
plague	yersiniapestis
sepsis	patients	plasma	stimulation	vitro	albumin
rheumatoidarthritis	patients	joints	pannus	vessels	resulted	anakinra
corticosteroids	demonstrated	worsening	asthma
pain	adding	ketamine
scabies	treated	treated	creams	permethrin
asthma	control	function	association	budesonide
onchocerciasis	control	achieve	sustain	understand	trying	provides	attempts	determine	factors	associated	community	directed	ivermectin
hypercholesterolemia	assessed	effects	therapy	simvastatin
fa	fluoranthene	cadmium
carbohydrates	components	meal	known	induce	inflammation
h5n1	avianinfluenzaviruses	influenzaviruses
h5n1	virus	recombinant	modified	genetics	compared	studied	understand	avianinfluenzavirusinfection
anemia	irondeficiency
coeliacdisease	disorder	intestine	caused	gluten
asthma	quality	questionnaire	twice	âµg	evaluated	effects	therapy	âµg	formoterol
insulin	secretion	responsible	glucoseintolerance
humanimmunodeficiencyviruspositive	negative	humanimmunodeficiencyvirus
malaria	adopted	artemether/lumefantrine
uc	patients	had	levels	compared	hc

hbv	dna	defined	hepatitisbvirus
non-tuberculosis	samples	2846	specific	·	·	sensitivity	mtb/rif
vomiting	presenting	children	evaluated	administration	ondansetron
m.tb	rifampin-resistant
cognitivedecline	vocabulary	adjusted	persisted	associations	speed
jia	juvenileidiopathicarthritis	treatment	methotrexate	mtx
tb	increases	become	critical	burden	infection	mtb
vomiting	-lrb-	experienced	patients	receiving	ondansetron
hiv/aids	knowledge	understand	conducted	provide	information	prevention	hiv
lymedisease	spirochetes	similar	borrelia
allergy
rheumatoidarthritis	allergicreactions
tuberculosisinfection	diagnosing	assays	mycobacteriumtuberculosis
pain	procedures	modulating	using	capsaicin
hbv	hepatitisbvirus
diarrhea	treated	diphenoxylate
vitamind	status	optimization	impact	risk	and/or	course	multiplesclerosis
influenza	pandemic	resulting	spread	ah1n1	influenzavirus
severeacuterespiratorysyndrome	coronavirus
hyperglycemia	study	study	examine	levels	glucose
aids	patients	restricted	higher	%	prevalence	tb	population	hiv/aids
type2diabetesmellitus	results	and/or	action	insulin
hypersensitivity	allergicreactions
pain	relieving	fentanyl
virus	eliminate	regimen	consisting	interferon	ribavirin
inositol	concentration	region	system	infects	pathogen	cryptococcusneoformans
oa	cartilage	investigated	synthesis	collagen-type-ii
silicosis	those	diagnosed	duration	exposure	silica
type2diabetesmellitus	subjects	enrolled	dose	pioglitazone
calcium-phosphorus	levels	type	hypertension
irondeficiency	anemia	evaluated	depletion	lack	stores	iron
alcoholdependence	data	severity	questionnaire	evaluated	assessment	scale	alcohol
rsvinfection	prevent	palivizumab
inflammation	site	elastase	inhibition	have	properties	anti-inflammatory
epileptic	activity	induced	pentylenetetrazol	ptz
hbv	-rrb-	hepatitisbvirus
multiplemyeloma	patients	%	rates	results	bortezomib
aids	hiv
virus	eradicates	standard	treatment	ribavirin
pain	proved	use	gabapentin
type2diabetes	well-known	reported	association	factors	homa-ir	insulin-resistance
malaria	programme	mali	efficacy	sulphadoxine-pyrimethamine
end-stagekidneydisease	contribution	increased	used	strategies	control	control	reninâ	$	statins
rheumatoidarthritis	treatment	used	adalimumab
ar	selectivity	was	preserved	attachment	chains	thiourea-containing
gerd	patients	bâ	$	40	more	pantoprazole
melanoma	patients	therapy	trial	establishment	interferon
tropicalspasticparaparesis	disorder	agent	type	htlv-1
hiv/aids
rotavirusinfection	protect	colostrum	containing	antibodies	rotavirus-specific
hbv	reactivation	incidence	reducing	assess	efficacy	lamivudine
alcoholism	prevent	antagonist	naltrexone
pain	showed	evoked	showed	exhibited	applied	patches	lidocaine
tb	drug	pyrazinamide
insulin	concentrations	measured	men	aged	delhi
tb	coinfected	patients	high	titres	bcg-specific
hyperglycemia	incidence	view	desirable	studies	effect	insulin
cancer	treatments	selecting	potential	offers	test	assay	adenosinetriphosphate-based
osteoporosis	treatment	used	analogues	vitamind3
triglyceride	levels	obesity
open-angleglaucoma	patients	monotherapy	daily	travoprost
asthma	exacerbations	definitions	aligned	metric	bud	effect	inhaler	pressurized	budesonide/formoterol
type2diabetesmellitus	patients	improves	miglitol
postmenopausalosteoporosis	prevention	indicated	raloxifene
lupusnephritis	patients	received	therapy	cyclophosphamide
malaria	diagnosed	recommends	use	rdt	treat	cq	chloroquine
hbv	hepatitisbvirus
hypoxic	areas	number	changes	same	carbondioxide
malignancy	represents	cancer	hormone-dependent
sle	belimumab	role	supporting	evidence	summarize	discuss	aspects	basic
hypertension	patients	valsartan
paraffin	samples	allow	help	studies	history	fibrosis
hiv/aids
h5n1	results	influenzaviruses
hbv	reactivation	incidence	reduced	lamivudine
open-angleglaucoma	patients	preference	dorzolamide/timolol
t2d	-rrb-	patients	beginning	-rsb-	progression	thrice	progression	-rrb-	-rrb-	insulinlispro
hypertension	risk	bp	p-glucose
diarrhea	absence	therapy	antibiotic
hypertension	had	carvedilol-naive
hbv	hepatitisbvirus
hivinfection
chf	congestiveheartfailure	development	complicated	treatment	dox
enzyme	immunoassay	sensitivity	evaluated	developed	detect	serum	patients	infected	hav
alcohol	effects	related	cause	alcoholabuse
vaginalthrush	patients	isolated	stellatoida	investigated	candida
anorexic	action	reduced	rats	rapamycin-treated
antiemeticdrug	used	treat	nausea
indomethacin	induced	models	plays	indicating	act	reduce	injury	inflammation
aids	examined	hiv
priondiseases	agents	propagation	requires	conversion	prionprotein
type2diabetes	individuals	comparison	received	insulin
hypoglycemia	responses	amplify	use	fluoxetine	ssri
nonsteroidalanti-inflammatorydrugs	term	control	pain
nitricoxide	bioavailability	stress	oxidative	related	injury	ischemia/reperfusion
celiacdisease	intolerance	fraction	gluten
melanoma	patients	received	2b	ifn-î
atherosclerosis	develop	explain	trigger	atherogenesis	fat
pain	preventing	effective	mg	lidocaine
ham/tsp	samples	proteins	htlv-i
non-atopicasthma	immunopathology	role	play	³	ifn-î
hypertension	eg	limited	use	antidepressants	tranylcypromine
hiv/aids
asthma	quality	questionnaire	twice	âµg	evaluated	effects	therapy	âµg	formoterol
type2diabetes	improved	decreased	requirements	insulin
tb	infection	those	quantiferon	compared	mycobacteriumtuberculosis
rotavirusinfections	prevalence	show	children	admitted	gastroenteritis	caused	strains	rotavirus

lipid	profile	hamper	fibrosis
hiv/aids
type2diabetes	â	metformin
ischemia	model	using	examined	h	levels	levels	alanine
viralinfection	malignancy	association	establish	difficult	seen	variety	viruses
glucose	impairedglucosetolerance
silicosis	development	cells	implication	evaluate	generated	exposed	silica
hiv/aids	knew	identified	modes	hiv
asthma	symptoms	intercurrent	showed	smokers	treated	budesonide/formoterol
hypoglycaemia	higher	associated	glucose
melioidosis	disease	caused	burkholderiapseudomallei
hypoglycemia	prevent	infused	glucose	glimepiride	ingestion	measured	diazoxide
cancer	cells	differentiation	promotes	activation	receptor	vitamind
whoopingcough	pertussis	continues	caused	bordetellapertussis
aids	strategies	hiv
brucellosis	organisms	bacteria	genusbrucella
scrubtyphus	zoonosis	caused	orientiatsutsugamushi
calcium	concentration	modulation	involved	examined	systems	islets	cells	insulinoma
hbv	hepatitisbvirus
cancer	risk	collected	samples	naf
tb	patients	recruited	trial	inhibitor	treated	treatment	rifampicin-based
myeloma	patients	treated	approach	underwent	stem	transplantation	received	bortezomib/thalidomide/dexamethasone
hypersensitivity
herpesvirusinfection	model	derived	³	herpesvirus
pain	than	groups	lidocaine
schizophrenia	patients	plurality	treated	followed	haloperidol
antibiotic	use	without	following	difficile	colitis
pain	procedures	modulating	using	capsaicin
dronedarone	considered	strategy	atrialfibrillation
varicella	vzv
denguefever/denguehemorrhagicfever	viruses	denguevirus
asthmatics	number	cause	ibuprofen
t2d	-rrb-	patients	beginning	-rsb-	progression	thrice	progression	-rrb-	+	lispro
type2diabetes	alleles	associated	secretion	insulin
paraffin	samples	allow	help	studies	history	fibrosis
hg	$	â	â	hbp
osteoarthritis	drugs	chondroitinsulfate
insulin	release	involved	examined	systems	islets	cells	insulinoma
nausea	congestion	tachycardia	risperidone
pain	incidence	minimize	injection	propofol
htlv-iantibody	1959-1964	participated	women	tested	investigate	occurrence	htlv-i
hypertension	effective	one	agent	beta-blocker	angiotensinconvertingenzymeinhibitor
hypoglycemia	prevent	infused	glucose	glimepiride	ingestion	measured	diazoxide
hiv/aids	populations	tb	screening	attached	indicated	deserves	prevalence	co-infection	hiv/tb
hbv	dna	adefovir	entecavir
malaria	case-management	describe	replaced	pyrimethamine
cancer	risk	women	altered	upa	expression	expression	pge2
l-asparaginase	chemotherapy	leukemia
obesity	resistant	indicating	condition	diet	fat-enriched
virus	identified	revealed	viruses
obese	subjects	present	types	collagen
adhd	symptoms	changes	reliable	changes	outcomes	atomoxetine
immune-mediatedthrombocytopenia	complications	avoid	bleeding	occurrence	hypersensitivity
schizophrenia	criteria	classification	meeting	patients	assigned	40â	ziprasidone
chronichepatitisc	virus	hcv
humangrowthhormone	effects	evaluated	model	osteoarthritis
type2diabetes	patients	metoprolol	blunted	while	preserved	sensitivity	insulin
virus	viruses
type1diabetes	youth	glargine
hbv	burden	associated	hepatitisbvirus
hepatitiscviral	infection	hcv
mrsa	tested	-lrb-	s.aureus
myelopathy/tropicalspasticparaparesis	ham/tsp	called	presentation	contributing	mechanisms	elucidate	investigated	cohort	patients	htlv-1
tuberculosis	have	received	bcg
sars	patients	epithelium	disruption	role	plays	hijacking	pals1	e	sars-cov
type2diabetes	patients	cvd	rate	contribute	responsible	i.e.	insulin
e.coliinfection	underlying	mechanisms	understanding	necessary	develop	prevent	escherichiacoli
hypothyroidism	that	higher	t3
pituitary-adrenalinsufficiency	indicating	affect	concentrations	cortisol
mineral	density	reduction	osteoporosis
hypoxia	grade	transporter-1	glucose
coeliacdisease	allergy/intolerance	suffering	subjects	adopt	avoidance	gluten
cancer	risk	users	insulin
calcium-binding	protein	s100a12	associated	diseases	inflammatoryboweldisease
pain	intensity	difference	cm	cm	chondroitin
h5n1	humans	subtype	avianinfluenzavirus
hypoglycaemia	included	routine	testing	bloodglucose
atopicdermatitis	is	alternative	calcineurininhibitors
virus	variant	belong	share	viruses
hiv/aids	misconceptions	factors	suggesting	increasing	hiv
hivdisease	relationship	markers	patients	hiv-infected
malaria	control	issue	development	known	performed	efficacy	arthemeter-lumefantrine
il-2	cd40	mediated	resulted	responses	anti-tumor
bleedingdisorder	hereditary	deficiency	clottingfactors
mpa	mycophenolicacid	parameters	determined	patients	sle
type2diabetes	obesity	risks	raised	circulating	triglyceride
hiv/aids
malaria	risk	reducing	recommended	treatment	ulphadoxine-pyrimethamine
acidophilus	treatment	tilt	regulatory	models	cancer
hepatitisb	antigen	antigen	hbsag
pain	had	required	high	use	sedation	propofol
pain	treatment	used	acetaminophen	paracetamol
falciparummalaria	treatment	update	programme	mali	efficacy	sulphadoxine-pyrimethamine
hbv	transmission	knowledge	had	transmission	viruses
celiacdisease	inflammatorydisease	intestine	precipitated	ingestion	gluten
sars	related	than	member	coronavirus
hiv/aids
asthma	assess	seretide	fluticasone/salmeterol
viralinfections	importance	finding	developed	viruses
promyelocyticleukemia	bodies	stimulates	-rrb-	activation	triggers	-rrb-	atra
dcm	coronaryarterydisease	cad
hiv/aids
enzymes	involved	shows	analysis	effects	over-expression	cells	cancer
ironoverloaddisease	models	using	demonstrate	altered	levels	iron
type1diabetes	sitagliptin	therapy	insulin
atrialfibrillation	treated	warfarin
pain	relief	iv	lidocaine
hivdisease	progression	influence	factors	reflect	differences	level	diversity	infants	hiv-infected
pain	management	containing	lidocaine
neuroblastoma	lines	agent	5-aza-2
cholesterol	obesity
reovirusinfection	apoptosis	regulator	î	reovirus
cancers	types	treat	used	encouraging	sent	success	bortezomib
psoriasis	severity	reduces	treatment	cyclosporine
mineral	density	reduction	osteoporosis	represents	metabolicbonedisease
cross-linking	degree	variation	regulating	suggest	analyses	warfarin-polymer
rheumatoidarthritis	conditions	treat	used	drug	methotrexate
bacteraemia	persisting	occurred	occurred	daptomycin
antiviral	therapies	hepatitisc
carbon	nanotube	constructs	appended	tumor
adiposity	associated	speed
melioidosis	agent	burkholderiapseudomallei
dcm	dilatedcardiomyopathy
ebvinfection	associated	infections	ebv
antipyretics	received	patients	characteristics	compare	evaluate	children	upperrespiratorytractinfections	urti
hbv	infection	hepatitisbvirus
cross-sectional	study	enrolled	test	glucose
pulmonarytuberculosis	presenting	patients	isolates	analysis	mycobacteriumtuberculosis
exenatide	injection	examined	individuals	type2diabetes
type2diabetes	patients	predicts	associated	usage	insulin
aids	ratio	â	2.1	comparing	efavirenz
nicotinamide	dinucleotide	down-regulation	accompanied	mdsc	synthase	caused	microenvironment	tumor
hl-1	line	demonstrated	using	knockdown	ii	nm
diabetesmellitustype1	diabetes	requiring	therapy	insulin
pain	response	rat	induced	formaldehyde
asthma	exacerbations	definitions	aligned	metric	bud	effect	inhaler	pressurized	budesonide/formoterol
triglyceride	levels	obesity
highbloodpressure	amlodipinebesylate	trial	combination	observed	olmesartan/amlodipine
cross-tolerance	assess	effects	thc
fip	virus	that	sequence	elements	genome	fipv
hiv/aids
oxygen	produce	stoichiometries	support	originates	tumor
cholesterol	program	group	study	insulinresistance
enzyme-linked	assays	measured	±	necrosis	tumor
type2diabetes	patients	function	have	nateglinide
cjd	patients	isolated	those	compared	likely	relate	propagation	strains	prion
aids	idus	proportion	estimate	determine	factors	associated	diagnosis	hiv
swineinfluenza	virus	isolation	observed	evidence	swineinfluenzavirusinfections
bisphosphonates	effective	reducing	growth	breasttumour
hbv	dna	groups	included	defined	presence	hbsag
hbv	hepatitisbvirus
myeloma	cells	signaling	identified	advanced	understanding	action	bortezomib
hiv/aids
aids	policies	evaluating	prevention	hiv
chickenpox	prevention	lead	virus	replication	gives	profiling	genome	vzv
hypoglycemia	stimulates	secretion	glucagon
bal	response	inflammation
allergicbronchopulmonarymycosis	syndrome	associated	fungi
allergicbronchopulmonarymycosis
irondeficiency	reversing	programs	iron
pain	shortens	addition	acetaminophen	lidocaine
hiv/aids
tb	vaccine	calmette-guerin	bcg
nicotineaddiction	mimics	extent	suggests	drug	abuse	nicotine
cmv	hcmv
melanoma	cells	melanocytes	basal	±	ifn-î
ten	million	difference	caused	perturbations	increasing	concentration	glucose
nm	-RSB-	-LSB-	cultured	explants	oa
anti-malarials	consumption	reduce	confirmed	malaria
nahco3	bhin	grown	reduced	was	espd	eae
fivinfection
pramlintide	using	replacement	slowed	reduced	hyperglycemia
androgens	circulating	risk	cancer
mycobacteriumtuberculosis	mutants	isolated	msha	gene	encoding	enzyme	involved	biosynthesis	mycothiol	thiol	m.tuberculosis
anti-rheumaticdrugs	dmards	factor	tumor
virusinfection	±	plays	cholesterol
type2diabetes	initiators	monotherapy	glimepiride
hg	$	â	â	hbp
pml	pathogenesis	play	different	that	jcpolyomavirus
virus	pamps	recognition	associated	infection	cells	viruses
tb	resistant	inh
type2diabetes	-rrb-	patients	beginning	insulin
hivinfection	acquired	enrolled	transmission	$	breast-milk	of	trial	nvp
rif.tb	-lrb-	probe	analyzed	samples	positive	complex	m.tuberculosis

shock	duration	reduce	modify	rates	noradrenaline
obese	patients	reduced	association	antibodies
renalcellcarcinoma	kaposi	tumors	respond	shown	studied	ifn
cancer	diseases	involved	reported	proteins	kinases	tyrosine
hiv/aids	cases	tested	hiv
hiv/aids
rise	give	carcinomas
scrubtyphus	agent	bacterium	orientiatsutsugamushi
asthma	quality	questionnaire	twice	âµg	budesonide
hiv/aids
tb	patterns	changes	compared	samples	mtb
androgens	insulinresistance
psittacosis	agent	chlamydiapsittaci
melatonin	time	shift	determined	changed	stroke
irondeficiencyanemia	high	demands	iron
openangleglaucoma	patients	timololmaleate
acnevulgaris	treatment	used	antibiotic	derivatives	tetracycline
tb	vaccines	designed	mycobacteriumbovis	rin	bcg
hiv/aids	prevalence	stably	tip	engineered	properties	based	trial	hiv
asthmatic	children	%	seen	have	clear	cause	ibuprofen
stroke	patients	anticoagulant	warfarin
methamphetamineabuse	have	likely	users	methamphetamine
hemophiliaand	factorviii
tacrolimus	calcineurininhibitors	treat	lupus
indomethacin	administration	induced	evaluated	measuring	area	lesions	ulcerative
hemorrhagicfever-causing	viruses
hypoglycaemia	example	zones	bloodglucose
osteoporosis	tool	component	including	importance	device	using	related	accuracy	extracting	results	mineral
ketamine	use	forms	proliferation	receptors	phenomena	-RSB-	crps
uc	cd
veinthrombosis	heparins	prevention	efficacious	fondaparinux
cross-sectional	study	evaluated	value	parameters	basic
hydralazine-induced	vasculitis	woman	presented	syndrome	otalgia
carbohydrate	content	modulation	influence	demonstrates	play	refilling	embolism
hypertension	patients	therapy	profile	has	effective	terazosin
aids	patients	presentation	acquired	manifestations	occur	%	humanimmunodeficiencyvirus
sinovenousthrombosis	complication	chemotherapy	l-asparaginase
type2diabetes	people	taking	insulin
vasculitis	antibody-positive
enzyme	profile	lines	cancer
hc	controls	hundred	45	sz
hepatitisb	treatment	options	licensed	telbivudine
mrsa	s.aureus
hypoglycemia	predicted	levels	glucose
mdr-tb	tuberculosis	is	rifampicin
vibriocholerae	proteobacteria	regulating	phenotypes	bacterial
tb	laboratory	isolates	compared	specimens	assay	tube	testing	resistance	resistance	rif
asthma	steps	prescribed	patients	introducing	maintenance	budesonide/formoterol
cancer	characterized	basis	expressed	receptors	estrogen
melanoma	cells	treatment	enhances	³	interferon
type2diabetes	develop	risk	result	indicates	increase	ratio	insulin-to-glucose
cd	celiacdisease	based	established	model	glutensensitivity
obesity	investigate	effects	feeding	high-fat
5-fu	cells	cancer
rheumatoidarthritis	choice	methotrexate
b-celllymphoma	have	rituximab
type1diabetes	patients	receiving	replacement	insulin
renalcellcarcinoma	model	using	showed	resulted	mediated	cd40	il-2
malaria	treat	piloting	use	artemether-lumefantrine
cancer	lines	mda-mb-231	er	negative	receptor	estrogen
pain	control	benefits	has	ropivacaine
pneumonias	19	group	associated	disorders	collagen
hiv/aids
chronichepatitisc	progress	therapies	interferon
statin	doses	advised	conclusion	reduced	extent	anticipated	patients	familialhypercholesterolaemia
thromboembolism	prevention	enoxaparin
tb	establishment	result	control	infection	mtb
malaria	treatment	trial	context	carried	iptp-sp	sulphadoxine-pyrimethamine
postmenopausalosteoporosis	treatment	candidate	mitigated	oliveoil
adiposity	secretion	markers	age	use	antihypertensiveagents
cancer	active	demonstrated	synergy	capecitabine
hyperglycemia	reduce	used	greater	appears	plays	role	administered	doses	insulin
tuberculosis	incidence	compare	objective	vaccinated	bcg
mtb
aids	presentation	renaldisease	second	infected	hiv
thromboembolicevent	matter	therapy	warfarin
rheumatoidarthritis	patients	opportunity	window	notion	reached	recognition	methotrexate
enzymes	reductase	ar
hivpositive/ks	negative	negative/ks	positive	negative/ks	hiv
aids-defining	infection	experienced	weeks	initiating	treatment	antituberculosis
tb	+	segregation	cluster	recognition	proteins	mtb
anti-hbs	hbsag	incidence	determine	studied	anti-hcc	indices	frequency	hepatitisbvirusinfection
nevirapine	pis	substitution	made	showed	and/or	hyperlipidemia
bacterialdiseases	disease	bacterial
asthma	quality	questionnaire	twice	âµg	budesonide
5-aza-dc	treatment	featured	site	tss
aminoacids	chains	modify	termed	leading	increase	linked	insulinresistance
cholesterol	those	hiv/aids
apl	patients	undergoing	treatment	arsenic
impairedglucosetolerance	pressure	glucose
mcp-1	protein-1	expression	examined	understand	mechanism	linking	inflammation
hemophiliaa	results	deficiency	activity	factorviii
laxative	-RSB-	vomiting
multiplemyeloma	improve	undergoing	inhibitors	distinct	bortezomib
asthmatic	children	%	seen	have	patients	acetylsalicylicacid
astrocytoma	patients	treatment	temozolomide
jia	patients	received	mg/kg	methotrexate
hbv	infection	chronichepatitisbvirus
basic	intervention	implementation	burden	sporadic	countries	congenitalsyphilis
type1diabetes	children	management	seen	favor	mimicking	infusions	insulin
tuberculosis	pathogen	cytokine	mycobacteriumtuberculosis
malaria	strategy	launch	sp	sulphadoxine-pyrimethamine
pulmonaryhypertension	treatment	strategies	include	inhibitors	pge1
diarrhea	castoroil-induced
mpa	<	associated	patients	sle
pain	propofol
rabies-control	campaign	make	country	become	free	rabiesvirus
virus	viruses
hiv/aids
psoriasis	studies	concentrated	lipids	parameters	lipid
type2diabetes	evolution	observed	production	glucose
abciximab	intervention	undergoing	associated	reduction	occurrence	complications	bleeding
multiplemyeloma	exposure	bortezomib
pulmonaryhypertension	reduced	administration	bosentan
neutropenia	incidence	assess	patients	treated	docetaxel
hypertension	patients	profile	survey	examine	candesartan
fungalinfections	patients	caspofungin

chronicrenaldisease	established	use	diuretic
benzodiazepines	exert	raising	possibility	like	epilepsies
severeacuterespiratorysyndrome-coronavirus	coronaviruses
hyperglycemia	regulation	activities	glucose-regulating
scabies	mites	determine	tested	pbo
sepsis	diagnosis	patients	indicated	treatment	amikacin
12,14-prostaglandin	j2	ligands	injury	ischemia-reperfusion
hiv/aids
falciparummalaria	patients	treated	q	quinine
inflammation	activation	hepatic	reproduced	reduced	compared	to	hc
thromboembolism	factors	started	episode	use	oralcontraceptive	containing	levonorgestrel
hbv	hepatitisbvirus
tb	vaccines	designed	mycobacteriumbovis	rin	bcg
hypertension	patients	valsartan	dose	starting	improved	initiating	combination	results	hctz
depressivedisorder	treatment	efficacy	indication	inhibitor	escitalopram
nsaid-related	events	risk	pepticulcer
hypercholesterolemia	risk	history	association	cholesterol
transmissiblespongiformencephalopathies	role	plays	prionprotein
plague	severity	role	plays	mechanism	used	y.pestis
cross-sectional	area	thickness	dp
hbv	humanhepatitisbvirus
cjd	patients	isolated	those	compared	properties	prions
asthmatics	randomized	puffs	test	terbutaline
collagenase-induced	osteoarthritis
hbv	virus	hepadnaviruses	viruses
htlv-1-associatedmyelopathy	tropicalspasticparaparesis	carriers	htlv-1
tb	infection	surveillance	complicates	part	bcg
melanoma	cells	responsiveness	influence	±	ifn-î
dm	occurrence	minimizing	tamoxifen	deaths	compare	context	reviews	cancer
type1diabetes	adults	function	loss	retard	provides	evidence	induced	insulin
malaria	incidence	high	low	recommended	treatment	infants	sulfadoxine-pyrimethamine
tsutsugamushidisease	orientiatsutsugamushi
hyperglycemia	correction	involved	risk	given	seem	treatments	insulin
irondeficiency	anemia	anemia	lack	resources	iron
adhd	data	safety	methylphenidate
hypertension	hundred	randomized	groups	receiving	lisinopril
tuberculosis	infection	transition	cause	transmission	m.tuberculosis
hydrogenperoxide	lesions	produced	cotyledons	abundant	underwent	arrest
aids-related	deaths	third	causing	estimated	burden	cryptococcalmeningitis	hiv-associated
the
hypercholesterolemia	management	decades	used	vitamin	niacin
cancer	diseases	prevent	prescribed	regimens	thwarted	resistance	antibiotic
pain	prevention	examined	doses	premixing	lidocaine
chickenpox	agent	alpha-herpesvirus	varicellazostervirus
collagen	elisa	expression	receptor	chondrocytes	oa
pain	formalin
giardiasis	efficacy	restrict	emergence	strains	metronidazole-resistant
diabeticretinopathy	diabetesmellitus
chf	f	concentrate	replaced	lipids	diet	chow	low-fat
hbv	hepatitisbvirus

mrsa	-rrb-	s.aureus
celiacdisease	likelihood	determines	efficiency	presentation	gluten
hiv/aids
virus	genome	sections	deleted	replicated	viruses
type2diabetes	compared	bid	exenatide
tick-borneencephalitis	virus	outline	discuss	expand	viruses
leukemia	growth	inhibit	influence	activity	vincristine
breasttumors	treated	anastrozole
prion	equivalent	those	prions	distinct	cjd
alcoholism	field	used	problems	alcohol
antibodies	ama	profile	established	diagnosis	pbc
cancer	radiotherapy	adjuvant
pain	propofol-induced
tuberculosis	tb	burden	countries	one	important	information	genotypes	mycobacteriumtuberculosis
infectiousmononucleosis	patients	ebv
influenza	surveillance	revealed	detected	influenzaviruses
tuberculosis	care	due	now	era	surveillance	antituberculosis
tuberculosis	rin	bcg

nitricoxide	synthase	expression	induced	treatment	mice	tumor-bearing
shock	±	levels	increased	aripiprazole
hypercalcemia	consequences	controlled	reducing	supplementation	vitamind
hivpositives	identified	1989	one	hiv
insulin	doses	skipping	fasting	using	aids
cancer	center	treated	tnbc	women	caucasian	ca
pneumococcalinfections	provided	vaccines	pneumococcal
acne	use	isotretinoin
hiv/aids	$	chinaâ	had	review	conducted	methods	response	hiv
hypertension	patients	evaluating	efficacy	hydrochlorothiazide	hctz
virus	is	indicating	isolated	viruses
mono-drug	resistance	proportions	%	%	rifampicin
antibody-positive	vasculitis
hiv/aids
hypoglycaemia	prevented	octreotide
scabies	communities	collected	mites	show	increasing	ivermectin
interferon-alpha	basal	melanocytes	cells	melanoma
statin	therapy	associated	incidence	stroke
hiv/aids
pills	observed	intake	urticaria
mrsa	-rrb-	-lrb-	concern	treatment	s.aureus
eczema	association	antibiotics
enzyme	production	advantages	have	ibs
juvenilerheumatoidarthritis	methotrexate
aml-cr1	patients	randomized	mg/kg	cyclophosphamide
hiv/aids
bcg	bacilluscalmette-guerin	treatment	cancer
interferon	responses	i	discovery	suggests	mediated	virus
adiposity	markers	increased	had	levels	triglyceride
medicalgases	entrapment	venousairembolism
lymedisease	agent	borreliaburgdorferi
malaria	strains	chloroquine	resistance	associated	protein	named	pfcrt	form	able	reduce	accumulation	chloroquine
dsp	profiles	showed	presence	oa
chemical	carcinogens	smoking	some	factors	increase	risk	rcc
alcoholicliverdisease	increases	patients	increases	intake	alcohol
pain	level	evaluate	instillation	eyedrops	eyedrops	tetracaine
hivpositive	those	likely	those	negative	hiv
bacterialinfection	associated	expression	number	$	$	lys-7
malaria	treatment	investigated	sulphadoxine-pyrimethamine
respiratoryinfections	absenteeism	use	antibiotics
anorexia	facet	discovered	accumbens	transcripts	stimulated	cocaine
bronchialasthma	attacks	used	budesonide
thromboembolism	ratio	adjusted	use	oralcontraceptives	containing	drospirenone
myelopathy/tropicalspasticparaparesis	ham/tsp	called	presentation	contributing	mechanisms	elucidate	investigated	cohort	patients	htlv-1
cancer	risk	circulating	androgens
hivinfection	patients	cause	continues	advances	treatment	hiv
estrogen	tumors
tuberculosis	tb	caused	mycobacteriumtuberculosis	mtb
fa	fluoranthene	cadmium	based	used	identify	associated	changes	expression	exposure	chemicals
hypertension	treated	under-prescribed	diuretics
anti-inflammatory	response	counterbalance	disturbances	precede	type2diabetes
falciparummalaria	chloroquine-resistant
mito-mice	induced	resulting	phenotypes	ischemia
pain	scores	ml/h	appears	bupivacaine
hivpositive	mothers	practiced	controversy	brought	knowledge	risk	transmission	hiv
gonorrhoea	therapy	used	pakistan	be	ciprofloxacin	penicilling
antidepressants	action	affectivedisorders
virus	were	differences	levels	pathogenicity	viruses
dopamine	modulates	function	sustaining	fatigue
insulin	naive	type2diabetes	free	cancer
abscess	causing	bacterial
maldi-tof-tof	spectrometry	ion
colony-stimulatingfactor	expression	correlated	expression	factor-î	necrosis	tumor
hbv	genotypes	comprising	origin	members	specificity	comparatively	a-f	subtypes	hbsag
type1diabetes	onset	had	had	profile	insulin
virus	escape	ribavirin
interferon	signals	hypoxia
type2diabetes	feature	insulin
stroke	risk	reduces	warfarin
hiv/aids
hiv/aids	epidemic	face	attributes	attitudes	hiv
hiv/aids	information	neglected	hiv
bacterialinfection	observed	low	reads	flora	bacteria
plasmodiumfalciparummalaria	laos	patients	conducted	trial	dihydroartemisinin-piperaquine	artesunate-mefloquine
sugar	ointment	improved	ulcer
systemiclupuserythematosus	antibody
hivinfection	developed	commencing	zidovudine
cancer	treatments	dm
hbv	hepatitisbvirus
cancer	risk	associated	usage	insulin
hepatitisc	hcv	co-infection	common	accelerates	due	hcv
sars	presentation	resembles	emergence	coronavirus
influenza	virusisolation
inflammation	indexes	including	increased	intake	glucose
asthma	trials	meta-analysis	have	fluticasone/salmeterol
interferon-binding	protein	factor	i	smallpox
hbv	variants	lamivudine
malaria	treatment	sp	sulphadoxine-pyrimethamine
arterialhypertension	olmesartan	hydrochlorothiazide
lowbackpain	activity	treatment	analgesic
type2diabetes	deficiency	insulin
systemiclupuserythematosus	as	alternative	â	$	œgold
cardiacinfarction	suffer	nicotine
obstructivepulmonarydisease	patients	subgroup	arm	n	226	n	oxygen
tb	see	make	emerging	mycobacteriumtuberculosis
bronchialasthma	patients	evaluated	levels	treated	theophylline
tuberculosis	pathogenesis	role	plays	death	infection	mycobacteriumtuberculosis
influenza	those	humaninfluenzaviruses
type2diabetes	risk	reducing	pursuit	option	represents	fdc	repaglinide/metformin
acidophilus	proteins	signals	characterization	critical	treatment	gastrointestinaldiseases
cancer	cells	deregulated	incorporate	amounts	sugar

type1diabetes	children	management	seen	favor	mimicking	infusions	insulin
malaria	exposure	-rrb-	trial	doxycycline	chloroquine
septicemia	fulminant	due	died	combination	antibiotics
leukemia	lines	exhibited	cytarabine
irondeficiency	causing	regulation	alters	synthesis	feâˆ	defective
cancer	reviews	context	compare	deaths	tamoxifen
nicotinedependence	extend	association	polymorphism	receptor	acetylcholine
irondeficiency	cause	prpsc	implicating	â	show	increase	iron
hivinfections	determine	testing	persons	diagnosed	hiv
biocatalysts	fit
type2diabetes	compared	bid	exenatide
anti-htlv-iantibody	responses	suggest	feature	found	patients	ham/tsp
insulin	irs1	particular	akt1	signaling	insulin	stimulating	induced	insulinresistance
clonorchiasis	praziquantel
sars	related	than	member	coronavirus
obesity	treat	approach	disruption	orlistat
priondiseases	associated	agents	prions	comprised	prpsc	isoform	prpc	prionprotein
type2diabetesmellitus	treatment	developed	rosiglitazone
depressivedisorder	observed	venlafaxine
type2diabetes	caused	respond	insulin
plague	bacterium	yersiniapestis
irondeficiency	suffer	given	important	understand	influence	status	iron
type2diabetesmellitus	treat	combined	glibenclamide
hyperglycemia	induced	inhibits	uptake	glucose
irondeficiency	ironoverloaddiseases	observed	contributing	sequestration	iron
hyperglycemias	provide	excursions	glucose
bradycardia	require	atropine
cancer	setting	adjuvant
cll	chroniclymphocyticleukemia	convincing	established	alemtuzumab
aids	markers	length	stay	patients	hiv
hyperglycemia	reducing	increased	saline	â	minâˆ	-rrb-	uptake	-lrb-	glucose
carbohydrate-to-protein	ratio	differing	outcomes	cardiovasculardisease	cvd
tb	trial	entering	cells/mm3	‰	â	subjects	scars	bcg
type2diabetes	presumably	reduced	stimulation	insulin-induced
alcohol	abusive	analyzed	rates	carcinoma
hiv/aids	program	effect	examine	using	analyzed	changes	volume	services	hiv
high-fat	steatosis	hyperglycemia
type1diabetes	individuals	diabeticketoacidosis	risk	decrease	analogs	insulin
enzyme	activity	decreased	strains	lacking	rida

pain	incidence	causes	propofol
hdag	translation	replication	hdv
hiv/aids
tb	cases	resistance	presence	rifampicin
ironoverload	damage	ironoverload	provides	overview	metabolism	iron
tumors	showed	suggesting	suggesting	development	sts
ventriculartachycardia	abolished	therapy	levothyroxine
daptomycin	alternative	vancomycin/gentamicin	bacteraemia
tineacapitis	infection	dermatophyte
tsc	patients	have	hamartomas
type2diabetes	p	secretion	correlations	showed	supporting	influence	affecting	secretion	insulin
high-fat	diet	contained	found	's	decreases	fa
hypoglycemia	regulate	altering	glucose
hbv	genotypes	comprising	origin	members	specificity	comparatively	a-f	subtypes	hbsag
obese	men	pads	fat
type1diabetes	type2diabetes	insulin	dose	insulin	add-on	evaluate	effects	combination	sitagliptin
hereditarydisease	causes	due	alterations	receptor	glucocorticoid
virus	levels	reduced	therapy	ribavirin
sexuallytransmittedinfection	diagnosed	drugs/money	had	analysis	used	methamphetamine
zncl2	-RSB-	structure	consists	ring	tetraâhedrally	coordinated
malaria	transmission	area	children	investigated	effect	treatment	sulphadoxine-pyrimethamine
pain	showed	evoked	showed	exhibited	applied	patches	lidocaine
hypertension	co-existence	induce	has	treatment	felodipine
iodide	staining	using	measured	modulated	using	methods	rna	virus-induced
pain	neuropathy	rats	stz-diabetic
psychosis	patients	year	treatment	quetiapine
sda	acid	fat-3	productsâ	18-carbon
acne	therapy	used	antibiotics	one	clindamycin
breasttumours	estrogen
allergies
oa	pain	reducing	effective	ibuprofen
apl	patients	investigated	outcome	chemotherapy	atra/anthracycline
ham/tsp	leukemia	agent	humant-celllymphotropicvirustype1
ca-mrsa	-rrb-	caused	s.aureus
non-atopicasthma	atopic
depressivedisorder	individuals	treated	escitalopram
t2d	subjects	determined	intake	achieve	infusion	insulin
fungalinfections	patients	caspofungin
onychomycosis	cure	achieving	effective	analysis	terbinafine
coagulopathy	induce	hydroxyethylstarch
cross-linked	materials	gelatin
aids	hiv
insulin	naive	type2diabetes	free	cancer
type1diabetes	autoantibodies	tested	patients	screen	gene	insulin
influenza	causing	influenzavirus
type2diabetes	liraglutide	subjects	â	lowered	glimepiride
tuberculousmeningitis	confirmation	delayed	due	limitations	mycobacteriumtuberculosis
adiposity	accounting	insulin	triglycerides
obstructivepulmonarydisease	exacerbations	oxygen
alcohol	consumption	established	obesity
melphalan	chemotherapy	children	undergoing	retinoblastoma
vomiting	effect	have	dexamethasone
tuberculosis	treatment	require	regimen	rifampicin
impairedglucosetolerance	glucose
tumor	environment	induces	formaldehyde
malaria	treatment	consists	administration	dose	sp	sulphadoxine-pyrimethamine
acidosis	response	abolished	fluoxetine
ifn-î	³	interferon-gamma	effect	interleukin-17	growth	evoked	water-extracts	prepared	leaves	tissues	mice	meth-a-fibrosarcoma
m.tuberculosisinfection	lipid
lymedisease	spirochetes	borrelia
hivinfection	acquired	enrolled	transmission	$	nevirapineâ
adrenalinsufficiency	patients	repeated	management	glucocorticoid
gas	exchange	affects	inflammation
nsaid	treatment	effects	documented	ranging	ulceration
melanoma	therapy	used	chemotherapeutics	dacarbazine	temozolomide	tmz
vomiting	treat	prochlorperazine
cd	mucosa	alteration	enterocytes	proliferation	causing	mediated	damage	mucosa	celiacdisease
hiv/aids	people	adapted	mos-hiv
retinol-binding	protein	links	adiposity
mineral	density	group	sle
constipation	evaluate	effect	patients	tegaserod
cancers	patients	assessment	revealed	cr
scurvy	cure	responsible	vitaminc
chronichepatitisc	infection	>	hcv
nsaid-related	events	risk	complications	bleeding
viralinfection	biology	studies	allows	applied	range	viruses
asthma	quality	questionnaire	twice	âµg	budesonide
rickets	occurrence	preventing	permitted	vitamind
alcoholdependence	free	recruited	revealed	patterns	use	alcohol
tb	regimen	treatment	rifampin	pyrazinamide
hiv/aids
aids	hiv
malaria	treat	rely	markers	indicate	increasing	resistance	pyrimethamine/sulfadoxine
hyperglycemia	precipitate	suggesting	associated	secretion	insulin
apl	patients	treated	chemotherapy	atra/anthracycline
inflammation	stimulates	induces	alters	metabolism	lipid
ham/tsp	samples	proteins	htlv-i
malaria	infections	treatment	chloroquine
h5n1	viruses	pandemic	developed	option	provide	potential	has	identification	neutralizing	mutation	prone	regions	regions	hemagglutinin	influenzavirus
mody	diabetes	include	hypoglycemia	responsive	diazoxide
atopy	8.36	for	ci	methacholine
priondisease	pathogenesis	implicating	feature	cells	prion
mdr-tb	tuberculosis	resistance	rifampin
hypoglycemia	delivered	showed	amplify	response	epinephrine
kuru	patient	observed	evidence	colonization	prions
cancer	patients	accepted	regimens	fluorouracil-based
anti-tuberculous	drugs	ethambutol
tb	efficacy	©	vaccine	bcg
rubella	agent	rubellavirus
adrenocorticotropin	hormone	secretion	caused	adenoma	-RSB-	cushingdisease
myocardialinfarction	history	use	heparin
osteomyelitis	treatment	material	bone	related	ciprofloxacin
type2diabetes	p	secretion	correlations	showed	supporting	influence	affecting	secretion	insulin
melanoma	cells	growth	regulate	interferons
malaria	incidence	reduced	reduced	reduced	sulphadoxine-pyrimethamine
melanoma	lines	proteins	over-expression	led	expression	stimulation	±	ifn-î
htlv-1infection	risk	higher	subjects	mother	htlv-1
cancer	institute	enrolled	examined	grade	receptor	estrogen
analwarts	development	contributes	infection	hpv
falciparummalaria	resistant	proven	chloroquine
hivinfection	provided	studies	conference	pathogenesis	hiv
inflammation	expression	showed	hc
cancer	risk	vitamind
insulin	action	characterize	africans	diabetes	kpd
adhd	treatment	approved	atomoxetine
ppi	effects	habituation
virus	viruses
ulcerativecolitis	patients	determined	assay	enzyme-linked
virus-derived	rnas	viruses
malaria	treatment	observed	use	chloroquine
nasalpolyposis	aspirin
breasttumors	receptor-positive	estrogen
mh	events	occurring	those	similar	events	triggered	anestheticagents
insulinresistance	induction	prevented	fattyacids
antifungal	treatment	unresponsive	cornealabscess
schizophrenia	patients	soc	aripiprazole
scabies	treatment	increased	mediate	resistance	ivermectin
cutaneousinflammation	suppress	treat	calcineurininhibitors
ipp	volume	pv
cr	decreased	insulinresistance
rsvinfections	prophylaxis	used	injection	palivizumab
hepatitisc	coinfection	hcv
tb	patients	obtained	determined	detected	m.tuberculosis
pain	incidence	reducing	injection	propofol
hypoglycemia	seen	hormones	rise	precedes	sensitive	decrements	levels	glucose
sugars	women	for	experience	hypoglycemia
denguefever	lead	denguevirusinfection
retinoblastoma	children	eyes	treated	infusion	melphalan
toxin	²	alpha-hemolysin	similar	factor	pathogenesis	aviannecroticenteritis
post-operativepain	relief	ropivacaine
vaginalthrush	patients	isolated	stellatoida	investigated	candida
hivinfection
ischemia	terms	enoxaparin	fondaparinux
lymedisease	satisfied	patients	cohort	followed	later	demonstrating	growth	borrelia
malaria	treatment	investigated	sulphadoxine-pyrimethamine
mrsa	strain	strains	staphylococcusaureus
shingles	agent	alpha-herpesvirus	varicellazostervirus	vzv
cancers	ablation	candidates	generation	contrastagents
gluten	toxicity	patients	celiacdisease
vehicle	surgery	cataract
œburuliulcerâ	$	called	advises	treatment	disease	mycobacteriumulcerans
allergen-specific	response	context	events	dep	effects	the	examined	accepted	exhaust	exacerbates	allergicasthma
prionprotein	scrapie
tumor	necrosis	markers	levels	evaluated	anticipating	yield	additive	combining	dexamethasone
cancer	pain	induces	formaldehyde
worldwide.rsvinfection	poses	cause	virus	respiratorysyncytialvirus
type2diabetes	caused	defects	secretion	insulin
pain	preventing	effective	mg	lidocaine
tb	caused	mycobacteriumtuberculosis
lipid	oxidation	concentration	different	control	obese
inflammation	result	response	trigger	proteins	gluten
obese	model	lipids	glucose
ig	immunoglobulin	d	accounts	multiplemyeloma
ironoverload	irondeficiency	causing	regulation	alters	synthesis	feâˆ	defective
multiplemyeloma	treating	inhibitor	bortezomib
pml	pathogenesis	play	different	that	jcpolyomavirus
hbv	active	chronichepatitisbvirus
gvhd	mimicking	colitis	mycophenolatemofetil
leptospirosis	vaccine	usefulness	limited	serovars	spp	leptospira
adhd	associated	demonstrated	shown	methylphenidate
ea	patients	sle
virus	activator	observed	destructor	acting	disseminator	viruses
asthma	assess	seretide	fluticasone/salmeterol
depressivedisorder	treatment	mirtazapine-augmented
urticaria	patients	investigated	focusing	differences	prevalences	patients	cu
influenza	described	association	influenzavirus
hyperglycemia	cultured	containing	glucose
cll	patients	treated	fludarabine
paromomycinsulphate	mg/kg/day	dose	visceralleishmaniasis
interferon	pegylated	therapy	patients	chronichepatitisc
hiv/aids
ham/tsp	patients	subjects	donors	htlv-1
vancomycin/gentamicin	bacteraemia
schizophrenia	patients	study	assess	therapy	clozapine
rabies	enzootics	associated	rvs	studied	identify	relatives	rabiesviruses
gonorrhea	agent	neisseriagonorrhoeae
kd	domain	mechanism	contributing	suboptimal	tyrosine
acuteinfection	consistent	levels	ig
genitalwarts	show	reduce	vaccination	hpv
ovariantumor	growth	abrogated	completely	cisplatin
ranolazine	reduced	incidence	supraventriculartachycardia
hivinfection	prevalence	evaluate	using	test	hiv
virus	codivergence	reflect	sequences	have	viruses
progesterone	pr	defined	subtypes	enrolled	institute	cancer
post-methacholine	challenge	test	investigated	bakers	suffering	asthma
graftversushostdisease	reconstitution	related	responsive	methylprednisolone
hypovitaminosisd	vitamind
type2diabetesmellitus	therapy	miglitol
chronichepatitisc	response	patients	developed	therapy	interferon
hyperglycemia	glucoseintolerance
hypoxia	factors	factor	synthase	nitricoxide
bipolardisorder	diagnosed	patients	proportion	maintained	monotherapy	quetiapine
aml	patients	bu/cy	series	patients	treated	cyclophosphamide
arbovirusinfection	analysis	provide	describe	arboviruses
hypoglycemic	events	had	were	prevented	hypoglycemia
cmv	infection	model	lack	reason	one	characteristics	cytomegaloviruses
hbv	hepatitisbvirus
anti-rheumaticdrugs	dmards	modifying	refractory	study	efficacy	patients	rituximab	rheumatoidarthritis
typeiidiabetes	individuals	provide	suggest	lowered	sensitivity	mice	insulin
breathless	patients	co2
asthma	medications	advantages	number	has	montelukast
heavymetals	levels	experience	worms
myocardialinfarction	statin
pain	incidence	is	propofol
aaa	frequency	lead	mismatch	adalimumab
stroke	rates	associated	warfarin
hemochromatosis	iron
hbv	infection	control	role	play	children	born	mothers	hbsag-positive
hiv/aids
dyskinesia	system	investigate	therapy	antiparkinsonian
pain	clinic	attending	in	analysis	received	respectively	lyrica	brand	brand	gabapentin
denguefever	agents	dengueviruses
ischemia	dysfunction	myocardial
hypoglycemia	gain	resulting	combining	therapies	sensitivity	glucose
bipolardisorder	diagnosed	patients	preventing	treatment	determine	effectiveness	quetiapine
pain	propofol-induced
androgen	therapy	contribute	development	cancer
tumour	cells	expressed	receptors	estrogen
mtb	lungs	compared	treated	isoniazid
virus	originate	insertion	motif	5	ncr	occurred	origin	viruses
alcoholabuse
hivinfection	either	effects	occur	common	course	infection	hiv
uc	cd	p	hc
corticosteroid	receptors	expression	calcyon	gene	attention-deficit/hyperactivitydisorder
methaemoglobinaemia	diagnosed	consisted	methyleneblue
hepatitisbviral	markers	differences	detected	patients	stages	hepatitisbvirusinfection
hbv	carriers	chronichepatitisb	carriers	hbsag
hiv/aids
pre-eclampsia	manage	used	included	included	recording	incidence	effect	resulting	use	magnesiumsulfate
asbestosis	diseases	causes	knowledge	people	handled	handle	asbestos
hypoglycemia	responsive	diazoxide
hypothyroidism	defined	level	t4
virusinfection	avoidance	improved	combination	ribavirin
chlamydialinfection	reduce	distributions	azithromycin
hypertension	patients	evaluate	effect	excretion	lisinopril
osteolysis	associated	metal-polyethylene
type1diabetes	obtained	therapy	insulin
hiv/aids
swineinfluenzaviruses	contain	genes	derived	swine	polymerase	influenzaviruses
o2	augmented	exposed	hypoxia
hiv/aids
hdl-cholesterol	had	increased	markers	adiposity
cancer	treatment	warrants	properties	possesses	suggesting	inhibits	inhibition	production	pge2
hiv/aids
hemorrhagicfever	contribute	viruses
breasttumours	measured	evaluated	benefit	patients	receptor	oestrogen
type2diabetesmellitus	results	and/or	action	insulin
malaria	recommendations	promoting	accompanied	change	policy	malaria	sulfadoxine-pyrime-thamine	artemether-lumefantrine
thyroidtumors	treatment	need	withdrawal	substitution	thyroxin
hypercholesterolemia	rabbits	observe	compare	simvastatin
virus	viruses
pulmonarytb	cases	strains	tested	mtb
pain	level	evaluate	instillation	eyedrops	eyedrops	tetracaine
hbv	hepatitisbvirus
virus	eliminate	regimen	consisting	interferon	ribavirin
capsaicin-induced	arrest
type2diabetes	metformin-controlled
dm	type1diabetesmellitus
type2diabetes	secretion	insulin
irondeficiency	drawn	present	suggesting	exerts	circulating	stores	iron
psychoticdisorder	patients	divided	olanzapine
acquiredimmunodeficiencysyndrome	infected	people	number	estimates	used	constructed	take	hiv
malaria	shown	combination	artemether-lumefantrine
herpeszoster	vaccination	varicellazostervirus	vzv
tuberculosis	rin	bcg
tuberculosisinfection	diagnosing	assays	mycobacteriumtuberculosis	mtb
heparin	reduced	deficit
hepatitisc	disease	variability	hcv
tb	identify	assessment	plasmablasts	bcg-specific
type2diabetes	participants	techniques	insulin
uti	treatment	choice	amp	tmp/smx
humaninsulin	receptor	overexpression	generated	examine	effects	specific	insulinresistance
hiv/aids
infarct	stenting	administration	protamine
hypothyroid	patients	therapy	report	continue	dissatisfied	outcome	monotherapy	levothyroxine
tuberculosis	disease	incidence	preventing	evaluated	effectiveness	chemoprophylaxis	isoniazid
cannabinoid	compounds	doses	exposure	drugsofabuse
t2d	subjects	determined	intake	achieve	infusion	insulin
tb	infection	value	investigated	individuals	bcg-vaccinated
hivpositives	history	individuals	observed	prevalence	hbsag
bacteraemia	persisting	occurred	%	patients	vancomycin/gentamicin
avianinfluenzaviruses

withdrawalsyndrome	associated	abstinence	nicotine

antipyretics	received	patients	characteristics	compare	evaluate	children	upperrespiratorytractinfections	urti
hiv/aids
tb	diagnose	investigations	mantoux	rate	bcg
cutaneousmelanoma	nature	implies	molecules	study	performed	compare	profile	variant	p-cad	blm
rubella	serostatus	determine	schoolgirls	aged	11â	$	india	of	institute	safety	rubellavaccine
hiv/aids
statusepilepticus	induced	soman
type2diabetes	evolution	observed	production	suppression	insulin-induced
heparin-inducedthrombocytopenia	cause	drug	employed	substitute	heparin
hiv/aids
deoxycorticosterone	acetate	progression	hypertension
gerd	treatment	observed	review	esomeprazole
rheumatoidarthritis	therapy	mainstay	includes	use	agents	sulfasalazine
hiv/aids	care	associated	plha	live	-LSB-	spent	diagnosis	hiv
hiv/aids
hiv/aids
precociouspuberty	depot	leuprolideacetate
hbv	dna	adefovir	superior	used	adefovir
melioidosis	agent	burkholderiapseudomallei
plague	agent	yersiniapestis
arthritis	associated	pain	manage	development	remains	given	issues	associated	nsaids
melanoma	cells	melanocytes	basal	interferon-alpha
uc	cd
candidaemia	cases	caused	dubliniensis	prevalent	tropicalis	candida
cancer	treatment	understanding	revolutionized	discovery	regimens	adjuvant
influenza	control	production	substitute	antiviraldrugs
adrenalinsufficiency	defined	â	rise	cortisol
anthrax	history	defined	isolates	b.anthracis
type2diabetes	metformin
patentductusarteriosus	occurrence	small	gestations	use	indomethacin
asthma	outcomes	achieves	monotherapy	budesonide
pain	relief	iv	injected	injection	propofol
malaria	falciparum	sulfadoxine-pyrimethamine
cd	mucosa	alteration	enterocytes	proliferation	causing	inflammation
aids	epidemic	affected	population	status	optimize	develop	objective	studies	florida	epicenters	-RSB-	humanimmunodeficiencyvirus
pain	provides	study	bupivacaine
hiv/aids
cancer	risk	users	insulin
zinc	supplement	reduce	incidence	diarrhea
cancer	vaccines
gangrene	footulcer	patients	seen	hospital	vergata	tor
pain	group	patients	received	bupivacaine
cll	patients	become	fludarabine-refractory
malaria	case-management	describe	replaced	pyrimethamine
hiv/aids	knowledge	understand	conducted	provide	information	prevention	hiv
virus	expressing	inhibit	viruses
glucose	concentrations	results	delayed	duration	marked	present	insulinresistance
hivinfection	degree	track	development	resistance	hiv
acuteqfever	patients	identified	patients	co-infected	coxiellaburnetii
cross-tolerance	assess	effects	alcohol
virus-exposed	turkeys	developed	response	antibody
œasthmaticâ	$	improves	produces	enhancement	activity	albuterol
obesity	development	influence	ups	involved	regulating	synthesis	production	lipid
rheumatoidarthritis	diagnosed	patients	receive	combination	p.o.	methotrexate
dextran	sodium	ischemia-reperfusion
breasttumors	classified	status	estrogen
tb	patients	recruited	trial	inhibitor	treated	treatment	rifampicin-based
cd	model	investigated	result	associated	inflammation
insulin	sensitivity	regulation	support	prevent	insulinresistance
petroleum-based	polyol	replaced	preparing	foam	rigid
prostaglandins	beneficial	reducing	injury	ischemia-reperfusion
hiv/aids
aids	humanimmunodeficiencyvirus
virus	itâ	viruses
hiv/aids
methicillin-susceptible	s	observed	worse	outcomes	bacteraemia
hbv	infection	patients	found	comparison	status	viruses
virus	divergence	have	efforts	develop	vaccines
hyperglycemia	presence	performed	clamp	glucose
denguefever	agents	dengueviruses
priondisease	studies	utilized	susceptible	bse	prions
thromboembolism	prophylaxis	licensed	heparin
buruliulcer	caused	mycobacteriumulcerans
painful	hips	caused	considered	hypersensitivity	metal
hivpositive	recipients	received	transduced	confer	hiv
type2diabetes	alleles	number	associated	concentration	insulin
cross-tolerance	presence	latter	potentiated	effects	thc
anthrax	agent	toxin	produced	bacillusanthracis
obese	$	subjects	plasma	triglyceride	performed	trial	diet	low-fat
gonadotropins	emerging	regulators	progression	tumor
type2diabetes	insulinglargine	men	response	î	in	sitagliptin
metastasis	resection	diagnosis	developed	meningitis	nm
lipid	aldehydes	production	part	leading	increase	linked	insulinresistance
malaria	prophylaxis	chloroquine
type1diabetes	patients	establish	independence	insulin
aids	monitor	is	â	$	gauteng	in	clinic	outpatient	stavudine
htlv-iantibody	found	conclude	was	evidence	infection	htlv-i
carbohydrate	metabolism	association	reduced	patients	obese

hiv/aids
vehicle	therapy	improve	concentration	therapeutics	tumors
h5n1	avianinfluenzavirus
tb	caused	mycobacteriumtuberculosis	mtb
virus	infected	bite	mosquito	infected	viruses
hivinfection	probability	%	%	babies	regimen	zidovudine
infectiousmononucleosis	associated	infections	ebv
medroxyprogesteroneacetate	-LSB-	induced	carcinomas
arthritis	patients	option	require	therapy	nsaid
rsvinfection	hospitalization	predictors	seasons	severity	independent	found	number	children	family	age	onset	season	rsv
vehicle	therapy	modify	microenvironment	tumor
irondeficiency	anemia	anemia	lack	resources	iron
tuberculosis	containing	rifampicin
tb	cases	higher	circulating	secretion	antibodies	bcg-specific
hyperglycemia	predicts	associated	usage	insulin
acne	lesions	reduction	observed	groups	clindamycin
cancer	metastasis	play	receptor	tyrosine
nonsteroidalanti-inflammatorydrugs	use	requires	treatment	oa
tc-wg	dachshund	tc-prd
h5n1	humaninfluenzaviruses
uc	ulcerativecolitis	patients	determined	assay	enzyme-linked
aids	nevirapine
enzymes	oxidant	hyperglycemia
seizures	prevention	choice	drug	magnesiumsulfate
pain	injection	propofol
glucose	metabolism	individuals	$	subjects	type2diabetes
hypoglycemia	risk	results	inhibition	secretion	glucagon
aids-related	diseases	presence	increases	shown	hiv
irondeficiency	phenotype	indicates	levels	iron
chronichepatitisc	patients	treated	therapy	ribavirin
scrapie	prionprotein	prionprotein	conversion	considered	event	replication	prion
tuberculosis	detection	systems	case	mtb
cd-group	patients	patients	ten
adhd	patients	psychostimulant	effects	need	suggests	amphetamine
hiv/aids	epidemic	humanimmunodeficiencyvirus/acquiredimmunodeficiencysyndrome
obese	control	greater	reduced	excretion	bodies	glucose
type2diabetes	deficiency	insulin
asthma	outcomes	achieves	monotherapy	budesonide
melanoma	line	variant	p-cad	blm
tuberculosis	exposure	history	tst	tst	combination	vaccination	bcg
hbv	hepatitisbvirus
chf	congestiveheartfailure	development	complicated	treatment	patients	doxorubicin
terbutaline	effective	prevention	hypoglycemia
virus	antibody
benzodiazepines	care	treat	alcoholwithdrawal
toxin	toxicshocksyndrome
tuberculosisinfection	diagnosed	received	rifampicin
cjd	distinct	prions
nm	$	source	measuring	diagnosing	basalcellcarcinomas	bcc
hiv/aids
hyperglycemia	mediator	suggests	prevention	neovascularization	control	glucose
pain	injection	propofol
asthma	evaluate	safety	inhaler	mometasonefuroate/formoterol
tuberculosis	diagnosis	made	suggesting	infected	m.tuberculosis
fibrosis	decreasing	modulating	expression	enzymes
type2diabetes	individuals	therapy	sitagliptin
bronchitis	adjusted	1.79	with	use	antibiotics
malaria	changed	cq	artemisinin	therapies	sulphadoxine/pyrimethamine
virus	neutralize	antibodies
leukopenia	episodes	cyclophosphamide
hypertension	patients	evaluate	effect	amlodipine
hbv	resulting	liverdiseases	remains	advances	treatment	infection	chronichepatitisbvirus
hypoglycemia	risk	parameters	levels	glucose
rickets	-RSB-	form	vitamind
osteoarthritis	osteoarthritis	oa	treated	chondroitinsulfate
type2diabetes	release	insulin
lipid	emulsion	safe	patients	ards
anti-inflammatory	mediates	risk	type2diabetes	individuals	obese
methicillin-resistant	s.aureus	introduced	scheme	bacteraemia
hiv/aids	testing	hiv
hivpositive	females	attending	attending	females	hiv
cross-talk	suggest	corroborate	confirm	controls	metabolism	carbon
omega-3	fas	found	depressivedisorders
lymedisease	satisfied	patients	cohort	followed	later	demonstrating	growth	borrelia
onchocerciasis	co-infection	treatment	ivermectin
cpt-1b	expression	increased	metabolism	associated	induced	glucoseintolerance
xanthine	oxidase	implicated	pathogenesis	hypertension
inflammation	observed	observed	tissue	adjacent	particles	metal

type2diabetes	increase	sensitivity	insulin
insulin	therapy	ratios	obtain	risk	cancer
pain	experiencing	reported	participants	examined	ibuprofen
malaria	episodes	incidence	reduces	treatment	infants	sulphadoxine-pyrimethamine
osteoarthritis	treatment	used	injection	celecoxib
hyperglycemia	euglycemia	mmol/l	9â	glucose
asthmatics	response	affects	aspirin
cr	rehabilitation	cvd
staph	kit	depends	features	identify	staphylococcus
type2diabetes	cancer	factor	has	insulin
ironoverload	degree	appropriate	export	iron
irondeficiency	profiles	group	had	cell	iron
pain	evaluate	role	methadone-lidocaine
adenoma	show	uptake	octreotide
pain	scores	assessed	reported	trials	plaster	lidocaine
insulin	signaling	versus	insulinresistance
aids/std	control	centre	consolidating	activities	hiv
hsv	acyclovir-resistant
hemorrhagicfeverwithrenalsyndrome	hantaanvirusinfection
tb	laboratory	isolates	compared	specimens	assay	tube	testing	resistance	inh
obese	model	lipids
atherosclerosis	develop	explain	trigger	atherogenesis	fat
neutropenia	schedules	cancer	treatment	regimens	ac	pegfilgrastim
plague	infection	outcome	affect	sufficient	suggesting	attenuated	mutant	y.pestis
pain	recorded	started	infusion	propofol
type2diabetes-low	below	divided	groups	content	triglyceride
congenitalshortbowelsyndrome	condition	sbs
mycobacterialinfection	study	technology	application	step	optimised	use	luciferases	mycobacteria
nitrogen	gas	anneal	investigated	forming	gas	ar
hypertension	treatment	spironolactone
pain	incidence	reduced	injection	propofol
insulin	results	delayed	duration	hyperglycemia
hyperglycemia	lowering	compare	antidiabetes	insulinglargine
naa/cr	adc	reduced	values	fa
dengue	rna	structure	interacts	regulator	replication	denguevirus
pain	reduce	dose	determine	sought	induced	injection	propofol
irondeficiency
hiv/aids
hiv/aids
systemiccryptococcosis	cause	c.neoformans
cancer	studies	summarises	highlights	effects	bisphosphonates
thromboembolism	risk	reduce	drug	warfarin
insulin	hypoglycemia
tuberculosisinfection	diagnosed	received	mg	isoniazid
vibriocholerae	proteobacteria	regulating	phenotypes	bacterial
cmvretinitis	treat	strategy	injections	ganciclovir
h5n1	²	neutralization	increased	tgf-î	²	mortality	$	influenzavirusâ
h5n1	influenzavirusinfection
acutehepatitisc	factors	practices	leading	rectal	snorting	settings	hcv-prevalence
cancer	had	patient	years	therapy	hormone
granulomas	analysis	confirmed	biochemical	caseum	identified	triacylglycerols
hodgkinlymphoma	patients	documented	effect	bleomycin
westnilefever	fever	westnilevirus
psoriasis	treatment	undergone	infliximab	alefacept
pain	score	patients	class	asa
nsclc	line	0.43	index	had	effect	irinotecan
hg	$	mmâ	19.0	â	â	hbp
hbv	infection	data	lamivudine
uc	remission	maintenance	administration	approved	mesalamineproduct	mesalamine
celiacdisease	patients	toxicity	gluten
pain	prevention	examined	doses	premixing	lidocaine
pre-eclampsia	treatment	informed	making	use	magnesiumsulphate
necrotizingfasciitis	causes	humans	pathogen	streptococcuspyogenes
postoperativepain	reduce	xaracoll	implant	collagen-based
breasttumor	retention	allows	doxorubicin
aminoacid	biosynthesis	involved	enzyme	activity	decreased	strains	lacking	rida
dentalfluorosis	prevalence	associated	element	fluoride
hiv/aids
ifn	production	responsible	feature	virus
priondiseases	diseases	associated	prionprotein
virus	days	had	rna	sequences	env	analyzed	evaluate	strategy	identifying	viruses
rotavirusdisease	resolution	correlate	demonstrated	strains	rotavirus
retinopathy	associations	speed
retroviralinfections	detected	questions	remain	studied	retroviruses
louse-bornerelapsingfever	agent	borreliarecurrentis
hemophiliaa	bleedingdisorder	caused	lack	coagulationfactorviii
virus	resistant	renders	reducing	load	viruses
tb	caused	mycobacteriumtuberculosis
cr	effects	exercise	model	obesity
schizophrenia	symptoms	proven	agent	clozapine
hypoglycemia	prevent	infused	glucose	glimepiride	ingestion	measured	concentrations	glucagon
pollenallergy	agent	allergen	pollen
antihypertensive	treatment	effectiveness	compare	reducing	rate	cardiovasculardisease
lymedisease	spirochetes	resemble	borrelia
virus	challenge	conferred	elicits	antibodies
type2diabetesmellitus	defect	insulinresistance	response	insulin
virus	activator	observed	destructor	acting	disseminator	viruses
virus	types	adapted	have	viruses
mycobacteriumtuberculosis
metastasis	alive	underwent	irinotecan
hypercholesterolemia	impact	evaluating	directed	correlated	include	results	cholesterol
hypothyroidism	confirmed	concentration	tsh
hiv/aids
avianinfluenzaviruses	h5n1	influenzaviruses
impairedglucosetolerance	igt	â	$	mmol/l	11.1	mmol/l	¥	dm
ami	pci	become	abciximab	clopidogrel
hyperglycemia	control	used	has	efficacy	agents	glucose-lowering
type2diabetes	subjects	measured	secretion	insulin
virus	detected	viruses
mrsa	staphylococcusaureus
h5n1	strain	avianinfluenzavirus
hiv/aids
pain	score	had	group	fentanyl
aids	hiv
glaucoma	valve	trabeculectomy	mitomycinc
tb	tuberculosis	rin	bcg
type1diabetes	differed	quartile	quartiles	measures	secretion	insulin
tuberculosis	consortium	study	phase	examining	mycobacteriumtuberculosis
hypertension	effective	one	calciumchannelblocker	diuretic
olmesartanmedoxomil	combination	provides	option	treatment	hypertension
hypertension	found	albumin
duckviralenteritis	agent	duckenteritisvirus
bleeding	events	increase	reduced	ticagrelor	compared	clopidogrel
apl	acutepromyelocyticleukemia	beneficial	anthracycline	trans	atra
pain	severity	lower	group	group	âµg	sufentanil
cd	patients	controls	patients	ulcerativecolitis
dentalfluorosis	prevalence	determining	fluorosis	caused	concentrations	fluoride
glucose	monitoring	assessed	type1diabetes
cancer	shows	treatments	adjuvant
vomiting	treating	effective	prochlorperazine
manganese-enhanced	resonance	assess	known	elevated	cardiomyopathy
peanutallergy	patients	defined	history	wheal	kulâˆ	peanut
uc-group	patients	cd-group
priondiseases	role	proposed	form	prionprotein
hiv/aids
hyperglycaemia	development	prevented	maintained	stores	insulin
malaria	episodes	incidence	reduces	treatment	infants	sulphadoxine-pyrimethamine
graftversushostdisease	reconstitution	related	responsive	methylprednisolone
hiv/aids
nephropathy	children	outcome	evaluate	effects	cyclosporina
nausea	episode	tolerate	administration	antiemetics
epilepsy	children	lacosamide
epilepsy	valproicacid
falciparummalaria	isolates	analyzed	polymorphisms	pfcrt	linked	chloroquine
bubonicplague	model	required	required	phenotype	y.pestis
non-smallcelllungcancer	target	making	sensitive	paclitaxel
cancer	cells	killing	paclitaxel
virus	activator	observed	destructor	acting	disseminator	viruses
enzymes	activities	determined	cells	astrocytoma
hivinfection
enzyme	activity	affect	cofactors	mono-nucleotide
collagen	types	increase	iii	inhibit	sufficient	confirmed	amelioration	fibrosis
abciximab	therapy	stenting	artery	used	patients	acutemyocardialinfarction
tuberculosis	-rrb-	agent	mycobacteriumtuberculosis
tularaemia	agent	francisellatularensis
ondansetron	molecule	efficacy	shows	evidence	treatment	vomiting
malignancies	those	groups	effective	caspofungin
hyperglycemia	euglycemia	mmol/l	9â	glucose
glucose	concentrations	supports	tested	premise	receiving	patients	type1diabetes
carcinoma	tissues	analyzed	antibody
titanium	pin	mimic	arthroplasty	followed	induce	osteolysis
hiv/aids
base	adaptation	results	cramp
pain	increasing	dose	lidocaine
multiplemyeloma	introduced	challenge	therapy	melphalan
acuteqfever	infections	causes	bacterium	coxiellaburnetii
breasttumors	lacking	±	estrogen
infectiouspustularvulvovaginitis/balanoposthitis	designated	entities	cause	bovineherpesvirustype1
highbloodpressure	amlodipinebesylate
aids	programs	recruited	hiv/aids
hiv/aids
type1diabetes	provides	evidence	relationship	intake	zn
melanoma	cells	apoptosis	induces	tmz
tuberculousmeningitis	disease	caused	mycobacteriumtuberculosis
hyperglycemia	age	months	rats	treated	insulin
autoimmunedisease	has	interferon
enzymes	oxidant	hyperglycemia
alcoholdependency	reinforcement	alcohol
gabapentin	effects	expression	model	neuropathicpain
type2diabetes	nature	need	insulin
low-fat	chow	diet	lipids	replaced	concentrate	f	chf
daunomycin	accumulation	increased	mice	blood	reduced	pumps	mrsa
m.tuberculosis
dronedarone	atrialfibrillation
falciparummalaria	isolates	analyzed	polymorphisms	pfcrt	linked	pyrimethamine/sulfadoxine
tyrosine	phosphorylation	triggers	hypoxia
non-a	non-bhepatitis
painful	mildly	surgery	represent	paracetamol
atopicasthma	associated	³	ifn-î
hbv	hepatitisbvirus
lunginflammation	blocked	treatment	n-acetylcysteine
hivpositive/ks	negative	negative/ks	positive	negative/ks	hiv
hivdementia	scale	using	determine	individuals	hiv-positive
hyperglycemia	activity	increased	incorporation	glucose
insulin-resistant	mice	tissue	insulinresistance
hyperglycemia	secretion	insulin
v.cholerae
melanomas	history	change	want	have	analyze	targets	interferon
androgen	receptor	ar
anti-cmv	therapy	ganciclovir
impairedglucosetolerance	glucose
thromboembolism	risk	reduce	drug	warfarin
vitaminadeficiency	continue	vitamina
cholera	agent	showed	circulation	v.cholerae
melanoma	enrolled	trial	treated	interferon-alfa-2b
gout	patients	reducing	comparing	doses	allopurinol
kd	kd	showed	frequency	antibodies
asthma	trials	meta-analysis	have	budesonide/formoterol
adiposity	glucose
severeacuterespiratorysyndrome	sars	outbreak	revealed	presence	coronavirus
aids	epidemic	decades	lower	women	infection	hiv
malaria	treatment	drug	chloroquine
priondisease	revealing	mice	is	activity	infection	prion
chloroquine	has	focused	agent	anti-cancer
obesity	established	use	diuretic
hyperglycemia	decreased	insulin
cyclophosphamide	cystitis
mrsa	bacteraemia	vancomycin/gentamicin
dengue	infection	caused	dengueviruses
hemangioma	case	tetracycline
virus	tomatoes	diseases	causing	viruses
cancer	patients	tissues	breast	marrow	increased	concentration	formaldehyde
plague	pathogenesis	play	potential	revealed	projects	yersiniapestis
immunoglobulin	significance	investigated	patients	urticaria
oralcontraceptive	pills	observed	intake	urticaria
hypertension	had	carvedilol-naive
pain	cause	replacements	metal-on-metal
melphalan	chemotherapy	role	establish	retinoblastoma
virus	-rrb-	examined	-lrb-	used	classification	viruses
pain	induces	formaldehyde
lymphomas	approved	$	monotherapy	in	combination	agents	fludarabine	mitoxantrone
immunedeficiency	patients	therapy	method	evaluate	benefits	scig	immunoglobulin
hivinfection
tuberculosis	cases	resistance	presence	inh
priondisease	pathogenesis	understanding	designing	prevent	infection	prion
hiv/aids
bladdertumor	therapy	bacilluscalmette-guerin	bcg
cancer	model	expression	observed	expressed	residue	lysine
asthmatic	control	treatment	budesonide
scabies	treatment	increased	mediate	resistance	permethrin
mesothelioma	retention	synthesise	nanotubes	carbon
murinetyphus	rickettsiatyphi
asthmatic	model	generate	used	administered	budesonide
vasculitis	antibody-associated
groupb	discontinued	agent	beta-blocker
type2diabetes	insulin
bacteraemia	conditions	organisms	bacteria
aids	hiv
blackleg	causes	clostridiumchauvoei
aids	hiv
oa	patients	recruited	trial	evaluating	twice	naproxen
h5n1	surveillance	need	highlight	findings	possess	implications	influenzavirus
malignancies	settings	adjuvant
hiv/aids
lymphomas	approved	$	monotherapy	in	combination	agents	fludarabine	mitoxantrone
insulinresistance	obesity	diet	high-fat
malaria	prophylaxis	chloroquine
oil-based	diet	corn	chow	diet	lipids	replaced	concentrate	f	chf
genitalwarts	effectiveness	had	increased	range	types	hpv
hiv/aids
breasttumors	proportion	expressed	correlate	receptor	estrogen
paliperidone	er	common	aes	insomnia	congestion	restlessness
aids	agent	humanimmunodeficiencyvirus
stroke	risk	problems	warfarin
rosiglitazone	rosi	function	using	techniques	participants	type2diabetes
ebvinfection	diseases	the	correlates	genotypes	ebv
cmv	reactivation	humancytomegalovirus
cross-sectional	area	csa
virus	mechanisms	ranging	allows	antibody
hiv/aids
hemorrhagicfever	contribute	viruses
vitaminadeficiency	levels	associated	levels	being	awareness	vitamina
chronichepatitisc	virus	treatment	infection	±	interferon
h5n1-neutralizing	antibodies
cholera	entity	known	recognized	non-vibriocholera
hypercalcemia	resolution	leads	choice	use	pamidronate
tb	see	make	emerging	mycobacteriumtuberculosis
atrialfibrillation	suffering	patients	prevention	associated	embolism	similar	those	associated	warfarin
adenoma	caused	secretion	hormone
inflammation	identified	compounds	anti-inflammatory
hypoglycemia	prevent	infused	glucose
hiv/aids	centres	treated	patients	hiv-infected
i-bar	subfamily	member	missing-in-metastasis
irondeficiency	suggests	existence	disorders	metabolism	iron
hbv	carriers	chronichepatitisb	carriers	hbsag
sars	epidemic	caused	coronavirus
androgen	receptor	receptor	ar
domperidone	used	authorized	supporting	treating	vomiting
shortstature	etiology	identified	have	deficiency	growthhormone
ammonia	treated	hand	occurred	potentiation	cell	swelling
hbv	hepatitisbvirus
nsaids	alleviate	pain
hiv/aids	testing	hiv
virusisolation	time	suffering	swab	isolated	reovirus	named	virus
anti-dengue	antibody
vancomycin/gentamicin	patients	%	occurred	persisting	bacteraemia
obstructivepulmonarydisease	disease	lung	caused	smoke
rheumatoidarthritis	criteria	rf	support	inclusion	antibodies
etoposide	patients	aml
hbv	insertion	hbsag
uc	1.5	1.0	cd
mrsa	methicillin-resistantstaphylococcusaureus	oxacillin	effect	antibacterial
virus	related	viruses
pancreatitis	sitagliptin	exenatide
calcium	deposits	occur	common	hypocalcemia
asthma	therapy	proven	product	inhaler	containing	fluticasone
pneumoniae	-rrb-	platform	-rrb-	arrays	silver
hypercholesterolemia	received	ezetimibe/simvastatin
tumour	development	mechanisms	suggesting	similar	dynamics	dm
nausea	assessed	31â	administration	ondansetron
allopurinol	inhibition	alter	progression	hypertension
breasttumors	chemotherapy	implicated	development	independence	estrogen
hypertension	patients	received	combination	mg	hctz
hivinfection	preventing	value	considered	risk	resistance	associated	prophylaxis	nvp
virus	bursaria	algae	infecting	viruses
celiacdisease	caused	gluten
malaria	areas	strains	resistant	chloroquine
htlv-1-associatedmyelopathy
infectiousmononucleosis	manifested	-rrb-	shown	finding	ebv
hiv/aids
cancer	patients	accepted	guidelines	settings	adjuvant
hemochromatosis	-LSB-	polymorphisms	genes	iron
insulin	sensitivity	nafld	non-alcoholicfattyliverdisease
cross-neutralized	titers	antibody
adhesion	molecule-1	levels	propeptide	vwf
hiv/aids
dextrose/h	-rrb-	ml	units/h	infused	-lrb-	type	ten
listeriosis	cases	listeriamonocytogenes
obesity	associated	bronchitis	adjusted	1.79	with	use	antibiotics
strokes	prevent	determine	warfarin
gemcitabine	combinations	proven	treatment	non-smallcelllungcancer	nsclc
hiv/aids
bladdertumor	therapy	bacilluscalmette-guerin
zygomycetes	fungi
septicemia	fulminant	due	died	combination	ceftazidime	doxycycline
pain	while	flares	experience	individuals	benefit	boluses	ketamine
type2diabetes	goals	control	benefits	reviews	overcoming	initiation	insulin
typhus	group	antigens	using	immunofluorescence	evaluated	seroprevalence	%	rickettsiae
tularemia	agent	intracellular	francisellatularensis
lymedisease	spirochetes	borrelia
tyrosine	phosphorylation	src	phosphorylation	hypoxia
tb	infection	surveillance	complicates	part	bcg
hyperglycemia	resultsâ	produced	indicated	rate	increased	-rrb-	uptake	âˆ	glucose
pulmonarytb	individuals	carried	obtain	view	pattern	mtb
pain	underlying	population	remain	suggests	role	analgesic
type2diabetes	using	insulin
fishoil	consumption	protect	vasculardisease
virus	similar	mice	caused	lethal	viruses
inhalationalanthrax	model	infection	b.anthracis
type2diabetes	sensitivity	insulin
leucine	neuronals	neurexins	series	links	disorder	autism
type2diabetesmellitus	sdisease	linked	degrades	²	insulin
malaria	treatment	changed	artemether-lumefantrine
pneumonia	given	supplementation	oxygen
colitis	develop	used	model	cd
hbv	loads	examined	treated	adefovirdipivoxil
hypoglycaemia	rates	recorded	defined	glucose
h2o2	injury	preventing	protect	atherosclerosis
crystal	packing	mediated	network	$	uncoordinated
pcos	polycysticovarysyndrome	patients	evaluate	affects	administration	metformin
entericfever	caused	styphi
pain	reduce	dose	determine	sought	induced	injection	propofol
rickets	vitamind-dependent
constipation	history	presented	polyethyleneglycol3350
nsaid	treatment	effects	documented	ranging	bleeding
cml	chronicmyeloidleukemia	domain	mechanism	contributing	suboptimal	tyrosine
aids	campaigns	successful	making	aware	hiv
virus	related	viruses
cancer	lines	mda-mb-231	er	negative	receptor	estrogen
hydroxypropylmethylcellulose	consumption	effect	examined	lipids	model	obese
softtissueinfections	-rrb-	cause	staphylococcusaureus	s.aureus	methicillin-resistant
nsclc	treatment	docetaxel
hypertension	triglycerides
aids	battle	playing	chinese	vct	2	increasing	understanding	individuals	hiv
tb	diagnose	investigations	mantoux	rate	bcg
insulin	activation	contribute	development	insulinresistance
t2d	dynamometry	air	using	bc	therapy	insulin
osteoarthritis	osteoarthritis	oa	treated	chondroitinsulfate	glucosamine

dextrose/h	-rrb-	ml	units/h	infused	-lrb-	type	ten
melatonin	has	lupus
hiv/aids
hiv/aids
hivinfections	%	accounts	transmission	hiv
ifn-î	â	expression	tumors
nitricoxide	inhibitor	administration	improved	bcg	mice	bladdertumor
contagiouspustulardermatitis	agent	orfvirus
antibiotic-associatedcolitis	cause	clostridiumdifficile
irondeficiency	drawn	present	suggesting	exerts	circulating	stores	iron
tuberculosis	detect	test	mtb/rif
hypercholesterolemia	defined	levels	cholesterol
ards	patients	fattyacids	enriched	emulsion	effects	exchange	gas
lymphaticfilariasis	endemic	areas	feasible	management	basic
attentiondeficithyperactivitydisorder	treated	immediate-release	methylphenidatehcl

gan	microsatellite	characterized	promoter	truncated	models	lupus
hg	$	mmâ	â	proportions	included	endpoints	secondary
hbp	relationship	investigated	study	olmesartan
tertiarysyphilis	infection	caused	treponemapallidum
cross-linked	materials	incorporate	chondroitinsulfate
gout	management	remain	allopurinol
hiv/aids
aids	organization	utilize	using	clients	hiv-infected
pain	treatment	prescribed	acetaminophen
condylomaacuminatum	activate	promoted	%	papulosis	hpv
transmissiblespongiformencephalopathies	variety	express	prionprotein
pvcs	number	reducing	effective	lidocaine
virus	viruses
type2diabetes	men	studied	using	assess	glucose	insulin-stimulated
interferon	alfa	combination	bevacizumab	approved	ve	renalcellcarcinoma	rcc
hiv/aids
bacterialinfections	treatment	approved	levofloxacin
asthma	symptoms	relief	used	combination	budesonide/formoterol
alcoholabusers	remain	diseases	linked	thiaminedeficiency
vasomotorrhinitis	patients	studies	confirm	improves	spray	azelastine
pain	reduce	dose	determine	sought	induced	injection	propofol
tumor-bearing	mice	treatment	cd40	il-2
insulinresistance	model	glucose
convulsions	risk	dose	bupropion
melanoma	therapy	remains	treatment	tmz
hivinfection	eradicate	reactivation	expression	humanimmunodeficiencyvirus
hypertension	prevalence	glucose
psychotic	features	bpd	treated	dose	clozapine
pulmonarytuberculosis	presenting	patients	isolates	analysis	mycobacteriumtuberculosis	mtb
chronichepatitisc	male	treated	therapy	-rrb-	peg-ifn
plasmacellneoplasm	multiplemyeloma	treatment	approved	inhibitor	bortezomib
thromboembolism	risk	reduces	raloxifene
malaria	treatment	derivatives	quinine
melanoma	cells	melanocytes	basal	interferon-alpha
catscratchdisease	agent	angiomatosis	bartonellahenselae
hivinfections	upstream	consider	evaluate	effectiveness	prevention	hiv
hyperglycemia	incidence	view	desirable	studies	effect	insulin
tb	burden	countries	one	important	information	genotypes	mycobacteriumtuberculosis
coeliacdisease	enteropathology	triggered	ingestion	proteins	gluten
brucellosis	had	cultures	species	brucella
viraldiseases	preventing	means	viruses
hes	efficacy	impact	inflammation
obese	men	pads	fat
tumor	originates	add
fibrocysticdisease	containing	tissue	reaction	was	demonstrated	detected	antibodies
openangleglaucoma	anglerecessionglaucoma	reduced	way	comparable	that	achieved	beta-adrenergicreceptorantagonist
virus	wdv	viruses
calcium	deposits	nephrocalcinosis
bleeding	case	hemophiliaand	factorviii	aminocaproicacid
ham/tsp	higher	carriers	htlv-i
aspirin	risk	gastrointestinalbleeding
type2diabetes	assessed	kinetics	analog	insulin
ifn-î	±	basal	melanocytes	cells	melanoma
atherosclerosis	pathogenesis	contribute	fattyacids
cmvretinitis	diagnosed	failed	treatment	ganciclovir
sars-coronavirus	coronaviruses
malaria	treatment	intramuscular	artemether
falciparummalaria	efficacious	followed	emerged	treatment	sulphadoxine-pyrimethamine
type2diabetes	-rrb-	patients	beginning	-rsb-	progression	thrice	progression	-rrb-	+	lispro
hiv/aids
oa	treatment	option	celecoxib
hiv/aids
hypopituitarism	complications	reevaluate	patients	cd
tuberculosis	vaccine	calmette-guerin	bcg
prednisone	predict	lupuserythematosus	sle
pain	associated	injection	propofol
immunosuppressive	effect	uc-mscs
oil	groups	times	ten
plague	countermeasures	efficacy	pathogenesis	y.pestis
dengue	arthropod	caused	any	serotypes	denguevirus
oestrogen	anti-oxidant	recovery	injury	ischemia-reperfusion
malaria	exposure	-rrb-	trial	doxycycline	chloroquine
depressivedisorder	diagnosis	comprised	receiving	one	escitalopram	sertraline
type2diabetes	-rrb-	patients	beginning	-rsb-	progression	thrice	progression	-rrb-	-rrb-	insulinlispro
tb	programs	burden	worsening	noted	strains	inh
type1diabetes	phenotype	has	mean	years	bmi	dose	insulin
severeacuterespiratorysyndrome	sars-cov
autoimmunediseases	associated	number	genes	involved	signalling	interferon
cavity	bacteria
uc	patients	differ	hc
type2diabetes	patients	taken	examine	uptake	insulin-stimulated
hivinfection	cure	present	infected	reservoirs	humanimmunodeficiencyvirus	hiv
bacterialinfection	involves	resulting	penetration	bacteria
cvd	factors	reduce	understood	concepts	basic
cmv	hcmv
sugar	bait	methods	decimate	based	determined	control	malaria
ironoverload	irondeficiency	disorders	develop	help	understanding	interplay	factors	involved	regulation	metabolism	iron
anti-hbv	vaccines
infectiousmononucleosis	evidence	occurred	entering	antibody	ebv
cardiopathy-related	disorders	diabetic	disorders	ic	dm
type2diabetes	predisposition	individuals	underwent	measure	sensitivity	insulin
asthma	steps	prescribed	patients	introducing	maintenance	budesonide/formoterol
psychoticdisorder	investigated	role	cnp	ice
pain	associated	injection	propofol
hiv/aids-focused
mycosis	forms	treat	used	agent	itraconazole
open-angleglaucoma	had	us	living	free	use	%	0.005	latanoprost
hbv	hepatitisbvirus
rotavirusgastroenteritis	burden	reduce	introduction	programme	rotavirus
insulin	signal	resulting	offers	insulinresistance	mice	obese
hbv	vaccination	lack	procedures	contact	carriers	hepatitisbvirus
asthma	condition	characterized	ingestion	anti-inflammatorydrugs	aspirin
sicklecellanaemia	condition	producing	molecules	hbs
nonsteroidalantiinflammatorydrugs	use	associated	presence	evidence	oa
type2diabetesmellitus	sensitivity	adaptation	secretion	insulin
cancer	lines	±	proliferation	inhibit	hormone	melatonin
pain	scores	assessed	reported	trials	plaster	lidocaine
asthma	treatment	relief	supports	use	budesonide/formoterol
postmenopausalosteoporosis	treatment	approved	administration	dosed	bisphosphonate	risedronate
hypercholesterolemia	options	become	therapies	decrease	circulating	cholesterol
cancer	patients	accepted	established	treatment	gold
hypertension	aged	patients	option	comparing	association	chlorthalidone
hyperglycemia	targeting	strategy	insulin
atopicdermatitis	undertook	gain	signatures	distinguish	atopicdermatitis
priondiseases	therapy	advances	employ	suppress	neuropathology	prion
irondeficiency	causing	regulation	homeostasis	iron
chronichepatitisb	patients	levels	relationship	expression	serumhepatitisbvirus
chf	caused	dox
mrsa	in	prevalence	resistance	s.aureus
campylobacteriosis	cases	2007	identify	flocks	testing	positive	spp	campylobacter
insulin	circulating	raised	risks	obesity
essentialthrombocythemia	hydroxycarbamide
type2diabetes	are	given	impairment	secretion	insulin
high-fat	diet	condition	reduced	insulinresistance
allergies
acquiredimmunedeficiencysyndrome	hiv
nsaids	anti-inflammatorydrugs	use	requires	treatment	oa
lymedisease	people	controls	born	children	screen	assay	antibody
hiv/aids
metastases	improving	reduce	toxicity	cisplatin
h5n1	influenzavirus
cjd	distinct	prions
uti	aminoglycosides	cystitis	used	nitrofurantoin
nausea	dizziness	receiving	therapy	anticonvulsant
cd	ng/ml	uc	ng/ml	patients	ibs
hyperglycaemia-related	indicators	reach	needed	time	range	bloodglucose
tuberculosis	cases	resistance	presence	rif
hiv/aids
alcoholicliverdisease	treatment	presentation	approach	disorders	alcohol
stroke	differences	were	stay	heparin
typhoid	agent	s.typhi
bovinetuberculosis	controls	effective	uncommon	tb	mycobacteriumbovis
oxygen	species	mediator	cells	cross-talk	involves	mechanism	underlying	priming	pulmonaryinflammation
lymphoma	management	defined	era	rituximab
tb	development	infection	mtb
inform	need	known	regarding	with	kidneydisease
pituitary	necrosis	complicate	uncontrolled	levels	glucose
anti-tuberculous	drugs	ethambutol	pyrazinamide
juvenileidiopathicarthritis	reduced	immunomodulators	form	methotrexate
estrogens	circulating	risk	cancer
nausea	episode	tolerate	patients	offer	bioequivalent	aprepitant
insecticide-resistant	mosquitoes	compromising	control	vectors	malaria
adhd	children	have	response	dexamphetamine
upa	overexpression	suppress	growth	tumor
cfs/me	syndrome	pathophysiology	plays	synthesis	atp
erythropoietin-stimulating	agents	effect	examine	control	patients	kidneydisease
fits	consequence	considered	co-exist	suggested	series	pyridoxine
insulin	suspension	trigger	required	scheme	use	prevented	hypoglycemia
hepatitisb	viruses
hbv	antibody	sampling	tested	hepatitisbsurfaceantigen
dle	patients	patients	lupuserythematosus
collagen	disorders	associated	group	16	pulmonaryfibrosis
schizophrenia	action	possess	indicating	exhibits	profile	clozapine-like
chemical	strain	raynaudâ	related	connectivetissuediseases
apl	patient	derived	atra	all-transretinoicacid
calcitonin	receptor	expression	elisa	pro-peptides	formation	quantification	activation	camp	signaling	eia
vldl-tg	levels	determined	liverdisease
sheeppox	strains	identical	gene	$	sheeppoxvirus
cll	patients	treatment	failed	alemtuzumab
antibody	value	inhibitor	metastasis
n-3fattyacids	levels	's	contained	found	's	decreases	fa
impairedglucosetolerance	glucose
multiplemyeloma	activities	have	regimens	bortezomib-based
anti-inflammatory	mechanisms	pre/postconditioning	associated	signalling	ar
antidepressant	medication	u.s.	collected	data	cross-sectional
abscess	resection	perform	led	effect	abscess	antibiotics
h5n1	r606/2006	isolated	calves	inoculated	avianinfluenzavirus
mhs	patients	anestheticagents
vitamind	status	optimization	impact	risk	and/or	course	multiplesclerosis
mesothelioma	retention	hypothesis	behaviour	fibres
hiv/aids
collagen	destruction	leaving	dissolving	capable	produce	biofilm	becoming	microorganisms	caused	caries
hiv/aids
type2diabetes	similar	subjects	failure	degree	treatment	insulin
hiv/aids	management	identify	develop	important	light	effectiveness	prevention	hivinfection
inflammation	associated	evaluated	comparison	controls	hc
thromboembolism	prophylaxis	licensed	heparin	enoxaparin
virus	variants	viruses
neutropenia	prophylaxis	received	pegfilgrastim
chickenpox	infection	vzv
oralhypoglycemicagent	prescribed	record	identified	type2diabetes
starch	content	dynamics	embolism
malaria	falciparum	sulfadoxine-pyrimethamine
type1diabetes	insulin-dependent

obesity	many	characterize	perturbations	metabolism	lipid
sda	acid	fat-3	productsâ	18-carbon
uc	remission	maintenance	administration	approved	mesalamineproduct
type2diabetes	alleles	associated	secretion	insulin

rickets	findings	disorder	i	referred	±	vitamind
tumor	program	improve	attempt	aiming	clearance	followed	therapy	adjuvant
interferon	treatment	contraindication	unjustified	ptsd
glucose	flux	changes	effect	inhibition	ar
atherosclerosis	protect	estrogen
softtissueinfections	cause	recognised	staphylococcusaureus	meticillin-resistant
dextrose	ml/h	injection	infused	others	ten
neoplasia	softtissuesarcoma	sts
type2diabetes	modify	secretion	insulin
vomiting	effect	have	dexamethasone
aids	hiv
seizure	episodes	number	resulted	treatment	phenobarbital
vomiting	patients	percentage	administration	prochlorperazine
tumor	model	image	collect	data	antibody-alone
tuberculosis	confirmed	treated	chemotherapy	antitubercular
enzymes	family	rida
increasedheartrate	lead	atropine
hiv/aids	knowledge	preponderance	characterized	hiv
virus	studies	carried	panels	viruses
chikungunya	presentation	modifying	demonstrates	study	showing	role	albopictus	transmission	chikungunyavirus
stroke	risk	patients	anticoagulation	warfarin
basidiobolomycosis	consistent	material	surrounded	fungus
formalin-fixed	tissues	reaction	using	using	pyrosequencing	tumor
convulsions	induced	injection	mg/kg	showed	administration	120	bupropionhcl
hbv	suggesting	hbv	levels	have	likely	given	epidemiology	viruses
problemdrinking	consumption	consumption	alcohol
tumor	factor	tnf	$	$	mipâ	lipopolisaccharides	of	america	$	lpsâ	protein	forming	cultures	$	â	molecule	icam	ami	dm
asthma	worsening	demonstrated	â	‰	long-acting-beta2-agonists	+	beclomethasone
priondiseases	prionprotein
aids	humanimmunodeficiencyvirus	hiv
schizophrenia	trial	-RSB-	aripiprazole
hiv/aids
virus	neutralizing	elicited	viruses
avianinfluenzaviruses
high-speed	imaging	correlating	identified	expansion	cavity
hiv/aids	candidate	protein	gp160	humanimmunodeficiencyvirus
carcinoma	care	standard	chemotherapy	cisplatin-based
diabetesmellitustype1	diabetes	requiring	therapy	insulin
chikungunyafever	caused	â	$	œchikungunyavirus
tb	coinfected	patients	high	<	cells/ml	produced	levels	mycobacteriumtuberculosis
hiv/aids
ovineprogressivepneumonia	virus	known	visna/maedivirus
rheumatoidarthritis	treatment	chloroquine
uc	ulcerativecolitis	cd
breasttumours	oestrogen
uti	treatment	used	ampicillin
tuberculosis	models	infections	establish	required	m.tuberculosis
vehicle	treatment	inflammation
hypothyroid	had	concentration	t3
chronichepatitisc	therapy	effects	management	documented	discussion	therapy	interferon
arc	manifestations	infection	humanimmunodeficiencyvirus
cancer	active	demonstrated	synergy	capecitabine
terbutaline	study	patients	type1diabetes
ssri	fluoxetine	administration	amplify	hypoglycemia
irondeficiency	effects	determine	fed	control	id	fe
diabeticretinopathy	dr	loss	speed
non-hodgkinâ	patients	therapy	agents	fludarabine	vincristine
hiv/aids
myeloma	patients	treated	bortezomib
rheumatoidarthritis	treatment	tolerated	leflunomide
atherosclerosis	development	demonstrated	gained	nicotinicacid
type2diabetes	insulin
hiv/aids
methemoglobinemia	treatment	clinically	used	methyleneblue
tacrolimus	coadministration	produce	treatment	dermatomyositis	polymyositis
typeiidiabetes	individuals	provide	suggest	lowered	sensitivity	mice	insulin
hiv/aids	fears	factors	lack	confidentiality	results	hiv
lungtumor	lines	decrease	observed	drug.we	correlate	levels	activity	paclitaxel-induced
pain	score	assessed	injection	mg	propofol
anthrax	disease	beings	caused	encapsulated	spore-forming	bacillusanthracis
rheumatoidarthritis	had	response	mtx
hiv/aids
h5n1	subtypes	detected	avianinfluenzavirus	isolated	influenzavirus
ischemia/reperfusion-induced	increases	alanine
hbv	recurrence	prevention	effective	prophylaxis	hbig
ami	aspirin	clopidogrel
pain	group	patients	received	bupivacaine
il-2	cd40â	$	donors	of	application	that	control	metastases
asthma	exacerbations	definitions	aligned	metric	bud	effect	inhaler	pressurized	budesonide/formoterol
tick-borneencephalitis	virus	outline	discuss	expand	viruses
hiv/aids
asthma	steps	prescribed	patients	introducing	maintenance	budesonide/formoterol
swinedysentery	spirochete	brachyspirahyodysenteriae
malaria	treatment	six-dose	three-dose	suspension	artemether-lumefantrine
typhoidandparatyphoidfevers	salmonellaenterica
r5-enzyme-linked	assay	ability	noted	measure	validated	toxicity	patients	celiacdisease
type2diabetes	those	decrease	lower	function	relative	sensitivity	insulin
immunoglobulin	consistent	acuteinfection
abscess	isolated	based	therapy	antibiotic
hivpositive	someone	knowing	included	living	talked	status	hiv
cmv	humancytomegalovirus
malaria	evaluated	safety	artemether-lumefantrine
hypersensitivity
hypoglycemia	leading	counterregulation	$	$	hypoglycemia	more	euglycemia	making	harder	driving	utilization	carbohydrate
serotonin	reuptake	fluoxetine	administration	augments	hypoglycemia
hypocalcemia	common	occur	deposits	crystal
scabies	communities	collected	mites	show	increasing	permethrin
cr	patients	aml
acidosis	normalization	occurred	patients	received	sodiumacetate
celiacdisease	disorder	precipitated	gluten
asbestos	carcinogens	smoking	some	factors	increase	risk	rcc
ham/tsp	bladder	patients	represent	given	paucity	studies	characterizing	effects	continence	htlv-1
tick-borneencephalitis	virus	tbev
hbv	dna	adefovir	entecavir
mcp-1	âˆ	g	polymorphism	patients	sle
ethyleneglycol	poisoning	peripheralneuropathies
mono	formed	post-translationally	hydrolyze	bond	amide
dermatomyositis	patients	synthase	investigate	expression	prostaglandine	pge
type2diabetes	insulins
antibody	targeted	expressed	vessels	tumor
collapsedlung	re-oxygenation	results	products	oxygen
hiv/aids
scabies	mites	determine	tested	permethrin
virus	eradicates	standard	treatment	ribavirin
vibriocholerae	-rrb-	v.cholerae
irondeficiencyanemia	high	demands	iron
glucose	metabolism	improves	suggesting	therapy	obesity
celiac	diet	eliminate	neutralized	effect	epitopes	gluten
aids	stage	hiv
hiv/aids	living	people	followed	punishment	hiv
viralinfection	enhancer	sevi	termed	forming	contains	fragments	phosphatase	pap
alcoholabuse	related	understand	sought	research	abusing	alcohol
transmissiblespongiformencephalopathies	risk	reduce	programmes	based	genotype	prionprotein
wells	drinking	bacteria
hyperglycemia	correction	immunomodulation	factor	efficacy	therapy	insulin
tuberculosis	vaccines	designed	mycobacteriumbovis	rin	bcg
vitaminand	nutritional	support	care	treat	alcoholwithdrawal
hyperglycemia	exchanged	medium	containing	glucose
uti	urinarytractinfection	treatment	assess	equivalence	ciprofloxacin
virus	binding	determine	focus	viruses
aids	program	surveys	smaller	less	surveys	behaviour	reports	numbers	condoms	shipped	describing	implementation	programmes	hiv
tb	incidence	correlation	year	introduction	rifampin
type1diabetes	adolescents	underwent	bolus	day	insertion	insulin
candidaalbicansvaginitis	model	inhibited	survival	candidaalbicans
aids	-LSB-	-RSB-	laxative
hiv/aids	knowledge	understand	conducted	provide	information	prevention	hiv
speed	turnover	adhesion
inflammation	activation	hepatic	reproduced	reduced	compared	to	hc
alcoholicfattyliver	model	axis	study	investigate	effects	exposure	alcohol
rheumatoidarthritis	treatment	approved	has	anakinra

immunoglobulin	significance	investigated	toxin	toxicshocksyndrome
viralinfection	risk	reducing	idus
uc	patients	pg/ml	pg/ml	hc
hiv/aids
venezuelanequineencephalitis	vee
scrubtyphus	patients	identified	patients	co-infected	orientiatsutsugamushi
hiv/aids
type2diabetesmellitus	with	based	insulinglargine	glargine
hypoglycemia	responsive	diazoxide
tb	inform	characterized	isolates	total	mycobacteriumtuberculosiscomplex
tumor	softtissuesarcoma	sts
cd	-RSB-	adenoma	corticotroph	pituitary
schizophrenia	patients	has	clozapine
bleeding	75	clopidogrel
hiv/aids
nsaids	reduce	inflammation
severeacuterespiratorysyndrome	outbreak	responsible	coronavirus
asthma	manifestations	aggravation	induced	treatment	followed	methacholine
schizophrenia	onset	treated	olanzapine
mrsa	usa300	s.aureus
virus	shed	failed	inoculated	shed	viruses
pain	response	modulate	capsaicin
iron-deficiencyanemia	-rrb-	resulting	-lrb-	pylori	appears	subvert	mechanism	iron
cancer	treat	cisplatin
ipv/ipb	rhinotracheitis	designated	entities	cause	bovineherpesvirustype1
hiv/aids
hivpositive	mothers	giving	ensuring	encouraging	self-disclosure	results	hiv
tuberculosis	incidence	compare	objective	vaccinated	bcg
sars	patients	confirmed	laboratory	intubation	identify	transmission	sars-cov
ifn	interferon	production	recognition	pamps	virus
pain	relieved	received	bolus	mg	pethidinehydrochloride
irondeficiency	impact	investigate	compared	content	iron
hivpositive	higher	patients	hiv
retinopathyofprematurity	model	allows	fluctuations	levels	oxygen
hypoglycaemia	bloodglucose
exenatide	effects	rosi	function	using	techniques	participants	type2diabetes
chronichepatitisc	treatment	advancement	telaprevir	combination	ribavirin
anti-hbv	antibody	antigen	hbsag
irondeficiency	causing	regulation	homeostasis	iron
hivinfection	history	aspects	factors	modes	transmission	hiv
tuberculosis	tb	caused	mycobacteriumtuberculosis
tamoxifen	deaths	compare	context	reviews	cancer
jointinfection	bone	pneumococci	antibiotic
anti-inflammatory	cancer
hand	footandmouthdisease
oic-hivpositives	%	agreement	oic-hiv
antihypertensive	medications	hypertension
flush	response	shown	revealed	using	concentration	niacin
myelomeningocele	mmc
cancer	hormone-dependent
melanoma	cells	melanocytes	basal	±	ifn-î
insulin	doses	skipping	fasting	using	aids	-LSB-	-RSB-	vomiting
breasttumours	bisphosphonates
pain	alleviating	effective	combination	remifentanil
oa	okadaicacid	targeted	palytoxin	ptx
hyperglycemia	prevent	care	provision	drips	insulin
hbv	markers	markers	antibody
rubella	screening	antibody
adhesion	molecule-1	kinase-1	tyrosine
ham/tsp	leukemia/lymphoma	development	lead	infection	htlv-1
androgen	receptor	ar
htlv-1-associatedmyelopathy	tropicalspasticparaparesis	inflammatorydiseases	cause	i	htlv-1
ophthalmiczoster	herpete	diagnosis	counts	examine	significance	immunoassay	vzv-igg
hiv/aids	clinic	visited	patients	carried	hiv
cancer	prevention	offers	introduction	vaccines
cholesterol	levels	factors	significant	qualifying	syndrome	revascularization	history	stroke
malaria	evaluated	safety	artemether-lumefantrine
hypoglycemia	times	at	given	underwent	insulin	plus	glucagon
multiplemyeloma	patients	transplantation	stem	used	alpha	±	ifn-î
breasttumors	lacking	±	estrogen
glucose	monitoring	assessed	hypoglycemia
hivinfection	those	cough	consider	differential	patients	hiv
prostaglandine	expression	investigate	synthase	patients	polymyositis
diabeticnephropathy	rate	albumin
osteoarthritis	drug	chondroitinsulfate
dengue	igm	using	circulating	antibodies
type1diabetes	autoimmunity	target	insulin
pulmonarytb	patients	superior	suggesting	infection	mtb
paracetamol	g	reduced	anglerecessionglaucoma
virus	observed	replication	viruses
insulin	secretion	defects	caused	type2diabetes
chroniclymphocyticleukemia	treated	agent	chlorambucil
squamouscellcarcinomas	diagnosing	measuring	source	$	nm
high-fat	diet	obese
vomiting	children	ondansetron
paliperidone	er	common	aes	insomnia	congestion	tachycardia
gvhd	sirolimus
tumor	size	thrombocytopenia	yielded	prednisolone
stroke	risk	reduces	warfarin
bleeding	complications	reduction	associated	reversal	anticoagulation	protamine
tb	infection	those	quantiferon	compared	mycobacteriumtuberculosis
hbv	loads	examined	treated	adefovirdipivoxil
adhesion	receptors	modulate	lh/hcg-r	involves	mechanism	improves	lh/hcg
arthritis	analysed	labelled	signalling	18f	radioisotope
hdl-cholesterol	circulating	raised	risks	obesity	type2diabetes
obsessive-compulsivedisorder	treatment	caused	improves	combination	mg/day	fluvoxamine
mrsa	transmission	s.aureus
melanoma	cells	mediating	signaling	known	signaling	interferon
adhd	treat	used	appears	reduced	compared	amounts	d-amphetamine
acquiredimmunodeficiencysyndrome	epidemic	affected	population	status	optimize	develop	objective	studies	florida	epicenters	-RSB-	humanimmunodeficiencyvirus
hiv/aids	living	translated	adapted	survey	mos-hiv
perniciousanaemia	associated	unclear	association	concentrations	vitaminb12
alcoholdependence	questionnaire	severity	use	alcohol
influenza	battle	advance	vaccine	protects	influenzaviruses
chronichepatitisc	treatment	ifn
hiv/aids	delivery	achievements	been	back	workload	hiv
tropicalspasticparaparesis	inflammatorydiseases	cause	i	htlv-1
cjd	seen	that	similar	suggesting	showed	evidence	colonization	prion
pneumonia	risk	effect	uniformity	tested	adding	allow	effect	vitamine
hiv/aids
type2diabetes	examined	effects	rosiglitazone
pb	preoperatively	drawn	undergoing	patients	patients	pancreatitis
hyperglycaemia	induced	supply	glucose
tumour	growth	investigate	effects	bisphosphonates
schizophrenia	effective	aripiprazole
bartonellosis	bartonellabacilliformis
anemia	irondeficiency
bowelperforation	signs	one	obscuring	fill	gas
anti-hav	igm	detect	serum	patients	infected	hav
ovariantumors	ocf	present	demonstrated	using	chromatography-mass	gas
asthma	symptoms	intercurrent	showed	smokers	treated	budesonide/formoterol
pain	reduce	dose	lidocaine
hivinfections	averted	type	intervention	hiv
disseminatedintravascularcoagulation	disorders	patients	drug	used	inhibitor	trypsin
hiv/aids	living	prevalence	hiv
asthmatics	intolerance	aspirin
obese	subjects	fattyacid
hantaviruspulmonarysyndrome	syndromes	cause	hantaviruses
cancer	lines	investigated	after	activation	induced	estradiol
type2diabetes	improve	used	insulin
brucellosis	zoonosis	caused	genusbrucella
mrsa	those	associated	staphylococcusaureus
rheumatoidarthritis	indications	years	used	etanercept
nitricoxide	inflammation
tuberculous	encephalitis	year	been	drugs	isoniazid	rifampin
di-nucleotide	-rrb-	flavin-adenosine
type2diabetes	t2d	combined	objective	compare	costs	insulinglargine
bcelllymphoma	history	aih	treated	rituximab
irondeficiencyanaemia	supplementation	iron
hypoglycemia	augments	administration	fluoxetine
virgin-infertile	queens	gynes	shiny	covers	coat	hydrocarbon
bacterialinfections	formulations	containing	concentrations	norfloxacin
type2diabetes	naive	insulin
irondeficiency	effects	determine	fed	deficient	iron
collagen	xviii	fragments	endostatin	belong	family	inhibitors	angiogenesis	inhibit	growth	tumor
tineanigra	mycosis	caused	hortaeawerneckii
mrsa	antibiotics
schizophrenia	criteria	fulfilling	patients	evaluate	index	olanzapine
pain	compare	ketamine
tb	candidates	pls	bcg
zn	atom	tetraâhedrally	coordinated
myocardialinfarction	patients	requirements	associated	cyp4f2	investigate	study	warfarin
pain	intensity	children	treated	paracetamol
tb	coinfection	studied	recipients	rifampicin
asthma	control	components	budesonide
ulcerativecolitis	treatment	medication	used	mesalamine
heparin	reduced	deficit	infarct
asthma	control	function	association	formoterol
antiplateletdrugs	registered	medication	used	hyperlipidemia
pilocarpine	adenosine5	induced	statusepilepticus
obesity	induced	$	high-fat
pain	causes	injection	propofol
vaccinia	plaques	fpv	non-permissive	plaquing	identified	vv
malaria	adopted	artemether/lumefantrine
hypoglycemic	events	gain	factors	impact	examined	ts
myocardialinfarctions	were	mg	rates	bleeding	75	clopidogrel
type2diabetes	sdisease	demonstrate	sensitivity	degradation	insulin
spongiformencephalopathy	affected	species	kidney	deposition	prionprotein
flu-na-diii	vaccinated	mice	developed	titers	influenzavirus-specific
type1diabetes	youth	performed	clamps	glucose
meningococcaldisease	cases	obtained	neisseriameningitidis
pupillarydilation	inducing	effective	showed	effective	combination	phenylephrine
tuberculosis	threat	requires	dissected	response	mycobacteriumtuberculosis	mtb
cancer	represent	facilitating	understanding	mechanisms	basic
hivpositive	negative	hiv
hepatitis	vaccination	receive	msm	sampled	pride	reported	used	stimulant	methamphetamine
insulin-like	factor	protease	upregulated	pregnancies	complicated	pre-eclampsia
tuberculosis	isoniazid
cholesterol	panel	syndrome	prevalence	measured	men	aged	delhi
hiv/aids
bradycardiaâ	$	significant	signals	propranolol
asthma	rats	treated	rn	dexamethasone
hivinfections	averted	type	intervention	hiv
systemiclupuserythematosus	dna	cluster	11a	cd
schizophrenia	patients	plurality	treated	followed	chlorpromazine
tularemia	caused	francisellatularensis
alcohol	abusive	analyzed	virusinfection	hepatitis
hbv	patients	load	decline	correlation	established	treatment	adefovirdipivoxil
tb	identify	assessment	plasmablasts	bcg-specific
speed	identifying	recordings	patients	als
cll	cells	effect	terms	$	$	cladribineâ
dengueshocksyndrome	agent	denguevirus
diabetesmellitustype2	non-insulin
antibodies	metastases
salmonellainfection	mechanism	blocking	adhesion	salmonella
hypothyroidism	overt	patients	syndrome	unresponsiveness	tsh
anti-tb	drugs	report	uae	first	are	%	drugs	isoniazid
metastases	shrinkage	showed	revealed	cycles	chemotherapy	oxaliplatin-capecitabine
iron	undergoing	iv	patients	iiib	type2diabetes
antibodies	anti-h5n1
rise	giving	tumors
pain	control	favoured	mitoxantrone
h5n1	avianinfluenzavirus	influenzaviruses
aids	program	surveys	smaller	less	surveys	behaviour	reports	numbers	condoms	shipped	describing	implementation	programmes	hiv
insulin	analogs	decrease	risk	diabeticketoacidosis	individuals	type1diabetes
alcohol	drinking	found	association	acuteinfection
schizophrenia	pamoate	olanzapine
pain	hypersensitivity	metal
hbv	reactivation	prevent	lamivudine
schizophrenia	patients	shows	aripiprazole
ham/tsp	called	presentation	contributing	mechanisms	elucidate	investigated	cohort	patients	htlv-1
bipolaraffectivedisorder	treated	carbamazepine
cross-habituation	contributed	chemicals
cancer	cells	using	study	cisplatin
tg	rats	±	greater	volume	infarct
mono	porphyrin	formed	showed	mediated	wavelength	nm
varicella	zoster	vzv
cll	treat	therapy	fludarabine
zinc	ors	treatment	having	prescriptions	domperidone	vomiting
hbv-dna	undetectable	cases	normal	hbsag
buruliulcer	agent	mycobacteriumulcerans
fatigue	treat	drugs	phenidate	modafinil
mdr-tb	tuberculosis	resistance	rifampin

hiv/aids
virus	activator	observed	destructor	acting	disseminator	viruses
cancer	treatment	understanding	revolutionized	discovery	regimens	platinum
pneumonia	risk	effect	uniformity	tested	adding	allow	effect	vitamine
vibriocholerae	caused	known	recognized	non-vibriocholera
silicosis	those	diagnosed	duration	exposure	silica
b-celllymphoma	patients	improved	rituximab
ezetimibe	10	performed	triglyceride	plasma	subjects	$	obese
pain	associated	lidocaine
mrsa	s.aureus
hiv/aids	prevalence	stably	tip	engineered	properties	based	trial	hiv
sugar	ointment	nausea
insulinresistance	leads	hypothesized	increased	retain	glucose
hiv/aids
rheumatoidarthritis	drugs	available	leflunomide
schizophrenia	treatments	provides	clozapine
type1diabetes	individuals	stabilizes	reduction	doses	insulin
tetraâhedrally	coordinated
asthmatic	groupbut	that	less	ratâ	mrna	group	budesonide
obesity	diet	high-fat
type2diabetes	had	metformin
hiv/aids
dysmenorrhea	types	consumption	ibuprofen
cancer	malignancies	are	studies	explore	effect	anticoagulants
cancer	cells	her2	blocks	inhibitor	tyrosine
hsv	therapy	trial	enrolled	aciclovir
virus	efforts	contributed	analysis	sequences	rubellaviruses
pain	adding	ketamine
alcoholdependence	data	severity	questionnaire	evaluated	assessment	scale	alcohol
formalin-ether	katz	techniques	harada
hbv	dna	groups	included	defined	presence	hbsag
epilepsy	syndromes	efficacy	aed	lamotrigine
alcohol	case	psychosis
post-fivinfection	fiv-c36
virus-induced	respiratorydisease	aspirin-exacerbated
nephropathy	contributes	calcineurininhibitor
cancers	treatment	chemotherapeuticagents
aids	centre	hiv
myeloma	cells	signaling	identified	advanced	understanding	action	bortezomib
tb	infection	efficacy	>	bcg
lipids	insulinresistance
adiposity	metabolism	glucose
ziprasidone	mg/day	2â	antipsychotic	assigned	patients	schizoaffectivedisorder	schizophrenia
hiv/aids
cancer	related	seropositivity	hepatitisbvirussurfaceantigen
syphilis	multi-stage	disease	caused	treponemapallidum	bacterium
ifn-î	±	ifit2	oas-1

pain	hypersensitivity	metal
chickenpox	prevention	lead	virus	replication	gives	profiling	genome	vzv
tannin-containing	plants	use	explain	rheumatoidarthritis
n-3fattyacids	levels	's	contained	found	's	decreases	fa
bleeding	episodes	supplementation	plasma	mainstay	administration	vitamink
necrotizingfasciitis	groupastreptococcus
aids	hiv
hypertension	controlled	furosemide
celiacdisease	enteropathy	triggered	ingestion	gluten
thromboembolism	patients	treated	experience	number	warfarin
hiv/aids
tick-borneencephalitis	contribute	viruses
t4-l1	level	epiduralabscess
aids	monitor	receiving	therapy	3tc
tb	candidates	pls	bcg
antibody	bevacizumab	shown	activity	rcc
ccl4-induced	models	tissues	cirrhosis
adhd	hyperactivitydisorder	treated	immediate-release	methylphenidatehcl
rheumatoidarthritis	patients	increase	ie	anakinra
secondary	cultures	performed	using	cells	cultured	confirm	effect	alemtuzumab
nicotineaddiction	use	treatment	tools	therapies	nicotine
type2diabetes	participants	techniques	insulin
tumor	starting	necrosis	rituximab
adiposity	accumulation	lipids
chronichepatitisc	patients	replication	hcv
malaria	incidence	reduced	reduced	reduced	sulphadoxine-pyrimethamine
tumor	improving	reduce	toxicity	cisplatin
abdominalpain	ranging	documented	effects	treatment	nsaid
melanoma	cells	dots	co-localizes	f-actin
bacterialinfection	caused	symptoms	treat	used	plants	extracts	show	effective	bacteria
schizophrenia	assigned	lai	high	olanzapine
impairedglucosetolerance	glucose	$	â	followed	measurements	albumin
apl	acutepromyelocyticleukemia	beneficial	anthracycline	all	transretinoicacid
gold	standard	assessing	fibrosis
diabeticretinopathy	complication	diabetesmellitus
inflammation	roles	has	activation	inhibits	enzyme
mycosis	forms	treat	used	agent	itraconazole
sts	patients	factor	level	extracts	tumor
tb	tuberculosis	control	requires	mycobacteriumbovis	guerin	bcg
leukopenia	episodes	cyclophosphamide	equivalent	has	azathioprine
vitaminadeficiency	levels	associated	levels	being	awareness	vitamina
cancer	risk	estrogens
hiv/aids
cancer	cells	inhibition	cooperated	cisplatin
statin	use	parameters	associated	severity	coronaryatherosclerosis
hypothyroid	patients	therapy	report	continue	dissatisfied	outcome	monotherapy	levothyroxine
t2d	diabetes	beta-cells	function	contributing	variation	gene	postulated	kv2	modulating	secretion	insulin
gemcitabine	combinations	proven	treatment	non-smallcelllungcancer
leukemia	cells	mtx
hiv/aids	member	had	hiv-infected
base	address	tumor
anti-tb	drugs	report	uae	first	are	%	drugs	pyrazinamide
newcastledisease	virus	ndv
fungalinfections	treatment	drug	ablc
obesity	pharmacotherapy	changed	withdrawal	rejection	sibutramine
ion	concentration	modulation	involved	examined	systems	islets	cells	insulinoma
virus	sequences	derived	library	testing	utilizing	pin-pointed	motif	shared	group	viruses
acnevulgaris	choice	drug	isotretinoin
hypothyroid	had	concentration	t3
epi	mechanisms	correlated	cells	adenocarcinoma
hiv/aids
ptfe	polytetrafluoroethylene	stenting	covered	led	complete	resolution	jaundice
mycosisfungoides	developed	manifestation	toxicity	methotrexate
h5n1	avianinfluenzavirus
rabies	enzootics	associated	rvs	studied	identify	relatives	rabiesviruses
tularemia	causing	bacterium	francisellatularensis
glucose	delivery	limiting	predispose	type2diabetesmellitus
allergies
uc	patients	assigned	66	receive	formulation	mesalamine
b-celllymphoma	rituximab
hg-u133	using	evaluated	profiling	set	tumors
hiv/aids	care	associated	plha	live	-LSB-	spent	diagnosis	hiv
m.tb	rifampin-resistant
aids-acquiredimmunodeficiencysyndrome	env	humanimmunodeficiencyvirus	hiv-1	trial	hiv
cr	rates	had	patients	metastaticcancer	sites	primarycancer
gamma-herpesvirusinfection	transferred	tested	using	herpesvirus-4
tuberculosis	exposure	data	calmetteâ	obtained	$	bcg
hypoglycemia	algorithm	combines	algorithms	all	based	data	glucose
anthrax	toxin	expression	requires	bacillusanthracis
cmv	infection	humancytomegalovirus
ar	receptor	performed	block	antibodies
aids	align	nhas	reports	applying	definition	expenditures	hiv
cancer	factor	conferred	role	formation	estrogen
tb	programs	burden	worsening	noted	strains	m.tuberculosis
fibrosis	inhibited	benazepril
melioidosis	agent	burkholderiapseudomallei
type2diabetes	received	metformin
hiv/aids
tacrolimus	immunomodulator	effective	treatment	inflammatoryboweldisease	ibd
epilepsy	patients	seizures	¥	include	populations	approved	drug	levetiracetam
tumor	progression	regulators	emerging	gonadotropins	lh/hcg
domperidone	vomiting
teicoplanin	treated	osteomyelitis
hbv	infection	hepatitisbvirus
murinetyphus	scrubtyphus	rickettsiatyphi
tia	patients	prescribed	therapy	statin
hivpositive/ks	negative	negative/ks	positive	negative/ks	hiv
tuberculosis	treatment	reduced	use	test	mtb/rif
tb	efficacy	©	vaccine	bcg
hyperglycemia	levels	glucose
insulin	hypoglycemia
pain	prevent	strategy	develop	evaluated	factors	affect	injection	propofol
antiviral	resistance	lower	potent	¯	hbeag	chronichepatitisb
nausea	treat	effectiveness	ondansetron
type2diabetes	treating	approved	was	examine	safety	bid	exenatide
hivpositive	stigmatization	prostitution	include	risks	spread	hiv/aids
bronchitis	exacerbation	patients	receive	mg	cefditoren
low-fat	diets	effects	evaluate	differing	outcomes	cardiovasculardisease	cvd
type2diabetes	precedes	impairedglucosetolerance	associated	alterations	tissues	insulin
schizophrenia	demonstrated	efficacious	risperidone
hivinfection	acquired	enrolled	transmission	$	breast-milk	of	trial	nvp
esophagealcancer	patients	well-tolerated	crt	cisplatin
hiv/aids
estradiol	levels	collected	associated	risk	cancer
cross-protective	antibodies	results	vaccines
tb	cases	resistance	presence	inh
tumor-bearing	mice	injected	containing	transposon	encoding	gene	amounts	plasmid	sb
chlamydialinfection	monitored	distributions	azithromycin
corticosteroids	respond	patients	safe	patients	focalsegmentalglomerulosclerosis	fsgs
humanalbuminsolution	reported	history	allergy
dacarbazine	receiving	chemotherapy	melanoma
h1n1influenzavirus	spread	suggests	have	antibodies
virus	showed	antisera	raised	virus	reacted	viruses
hypertension	prevalence	glucose
infectiousmononucleosis	examined	expression	cells	pd-1	+	ebv
severeacuterespiratorysyndrome	associated	coronaviruses
hivpositive	abusers	implying	subjected	co-exposure	tat	hiv
pain	incidence	necessitated	p	treatment	group	propofol
obesity	stress	accompanies	contribute	feeding	is	ingestion	macronutrients	fat
tb	reflect	primates	infected	mtb

ironoverload	degree	appropriate	export	iron
vitaminadeficiency	levels	associated	levels	being	awareness	vitamina
malaria	parasites	drug	use	pyrimethamine
sars-coronavirus
hiv/aids	impacts	effectiveness	programs	hiv
antivirals	develop	efforts	have	divergence	virus
hiv/aids
type1diabetes	patients	receive	insulinaspart
vincristine	mg/m2/day	epoch	course	receive	went	treatment	viremia	cytomegalovirus
hypercholesterolemia	prevalent	lower	levels	cholesterol
allergicdisorders	leading	bloodworms	hypersensitivity
tuberculosis	vaccines	designed	mycobacteriumbovis	rin	bcg
inflammation	observed	observed	tissue	adjacent	particles	metal
kd	kd	showed	frequency	antibodies
kidneydisease	course	increases	level	calcium
tb	trial	entering	cells/mm3	‰	â	subjects	scars	bcg
neuroblastomas	growth	mechanisms	etoposide
hivpositive	hiv
mdr-tb	tuberculosis	is	rifampicin
pain	experienced	day	day	%	vs	%	tramadol/paracetamol
hypertension	aged	patients	option	comparing	association	amiloride
hydralazine-induced	vasculitis	woman	presented	syndrome	sorethroat
cholesterol	levels	have	weight	likely	children	obese
eclampsia	considered	prevents	initiation	medication	magnesiumsulphate
open-angleglaucoma	treated	latanoprost
inflammation	suppress	prevent	inflammation	fattyacid-induced
malaria	prevalence	measure	screening	mass	conducted	inform
hivpositive	women	%	completed	follow	testing	hiv
hpvvaccines	prevent	cancers
mrsa	endocarditis	%	%	%	rates	daptomycin	vancomycin/gentamicin
hiv/aids
peripheralneuropathy	bortezomib-associated
hyperglycemia	induced	g/kg	solution	dextrose

cholesterol	two	hypertension
malaria	changed	cq	artemisinin	therapies	sulphadoxine/pyrimethamine
n-3fattyacids	levels	's	contained	found	's	decreases	fa
rabies	burden	falls	accessible	rabiesvaccines
tb	infection	protect	-rrb-	bcg
hyperglycemia	¥	mmol/l	treated	insulin
olanzapine	divided	patients	psychoticdisorder
plague	model	challenge	showed	y
varicella	vaccines	stability	increasing	useful	suggests	ability	ride	enhance	infectivity	vzv
hivpositive/ks	negative	negative/ks	positive	negative/ks	hiv
bipolardisorder	patients	augmentation	olanzapine
malaria	treatment	artemether-lumefantrine
gaucherdisease	models	responsible	lipid
plague	diagnostics	detection	y.pestis
cll	patients	resistant	fludarabine
amlodipine	olmesartanmedoxomil	combination	provides	option	treatment	hypertension
irritablebowelsyndrome	treatment	used	tegaserod
tuberculosis	containing	isoniazid
antispasmodics	effective	treatment	irritablebowelsyndrome
nicotinedependence	diagnosing	determining	nicotine
pain	enhanced	capsaicin
alzheimerdisease	studies	includes	beginning	2013	â	$	œantibodies
asymptomaticinfections	gastrointestinaldisease	associated	reported	aminoacid
type2diabetes	subjects	investigate	metformin
asthmatics	number	cause	clear	have	patients	acetylsalicylicacid
myelopathy/tropicalspasticparaparesis	ham/tsp	called	presentation	contributing	mechanisms	elucidate	investigated	cohort	patients	htlv-1
bipolardisorder	patients	treatment	injection	risperidone
sepsis	volume	associated	conditions	used	doses	amikacin
pain	management	programme	practice	tread	days	ether
asthma	aspirin-intolerant
type2diabetesmellitus	patients	effective	demonstrate	stimulate	release	insulin
cancer	invasion	inhibitor	value	antibody
zoster	vzv
opticdiscedema	presented	had	features	intracranialhypertension
seizures	bupropion-induced
hbv-dna	disappearance	effect	had	therapy	lamivudine
type2diabetesmellitus	patients	treatment	glimepiride
nausea	treat	effectiveness	prochlorperazine
depressivedisorder	comparing	sertraline
influenza	pandemic	prevent	way	eradication	avianinfluenzaviruses
restlessness	age	-LSB-	sex	characteristics	associated	use	psychotropic
cancer	patients	accuracy	predict	chemotherapy	paclitaxel
hivinfection	influencing	complex	role	patients	hiv
alcohol	dependent	likely	increased	hivinfection
cvd	risk	levels	reported	association	igm-antibodies
arrest	dependent	cells	activity	inhibited	5-fu
gastroparesis	recalcitrant	therapies	metoclopramide
ham/tsp	samples	mrna	htlv-1
upa	overexpression	suppress	growth	tumor
diabeticretinopathy	risk	candidate	inhibitor-1	plasminogenactivator
jia	juvenileidiopathicarthritis	methotrexate	mtx
iron-deficiencyanemia	-rrb-	resulting	-lrb-	pylori	appears	subvert	mechanism	iron
typeiidiabetes	treatment	indicated	inhibitor	sitagliptin
lymeborreliosis	agent	lato	borreliaburgdorferi
h5n1	influenzaviruses
denguefever	causing	pathogen	denguevirus
ifn-î	production	increased	î	injections	tgf-î	<	production	microenvironment	tumor
infectiousmononucleosis	associated	infections	epstein-barrvirus
hbv	hepatitisbvirus
malaria	countries	implemented	treatment	sulphadoxine-pyrimethamine
constipation	loperamide-induced
type2diabetes	patients	derive	metformin
hand	foot
malaria	strains	therapies	development	implications	have	results	shedding	mechanism	resistance	chloroquine
tb	taken	part	study	infection	mtb
enzymes	expressed	lines	cancer
hypothyroid	state	provoke	increase	t3/t4
bronchialasthma	patients	evaluated	levels	treated	theophylline
malaria	treatment	drug	chloroquine
fungalinfections	teatment	role	focusing	reviews	available	data	posaconazole
gonorrhoea	therapy	used	pakistan	be	ciprofloxacin	erythromycin
phobias	represent	identifying	factors	underlying	studying	pharmacotherapies	anxiolytic
bisphosphonate	research	strand	focussed	elucidating	cells	microenvironment	tumour
asthma	acetylsalicylicacid	patients	have	seen	challenge	asa
h5n1	influenzavirus
hiv/aids-affected
type1diabetes	diagnosis	investigated	requirements	insulin
atherosclerosis	extent	alter	levels	lipid
lys-7	$	$	number	expression	associated	bacterialinfection	susceptibility	result	deficiencies	gla
utis	women	receive	mg	trimethoprim
rheumatoidarthritis	treatment	clinic	used	drug	leflunomide
astrocytomas	treatment	established	role	tmz
multiplemyeloma	treatment	exemplified	approval	inhibitor	bortezomib
cross	section	cutting	goal	transferring	bedside	principles	basic
type2diabetes	receiving	mg/day	sitagliptin
tuberculosis	vaccines	development	hope	represent	regimens	utilizing	bcg
aids	stage	hiv
tb	disease	confirmed	lack	infection	mtb
acne	treatment	used	derivative	minocycline
anaemia	treatment	chelatingagents
chronichepatitisc	infection	hcv
hepatitisb	antibody	markers	tested	hbsag
cancer	patients	accuracy	predict	atp-cra
diabeticneuropathy	complication	diabetesmellitus
enzymes	feeding	improved	cholestasis
cancer	mortality	receptor-positive	hormone
cancer	used	therapy	trastuzumab
enzyme	activity	gla
type2diabetes	added	demonstrates	options	insulin
pancreatitis	risk	increase	sitagliptin
hiv/aids
glioblastoma	$	59â	therapy	weeks	followed	surgery	using	implantation	wafers	carmustine
pain	control	term	nsaids
non-alcoholicfattyliverdisease
rsvinfection	associated	bronchiolitis	infants	function	data	collected	involve	manifestations	infection	respiratorysyncytialvirus
ds	double-stranded	degraded	degraded	indicating	free	protein	virus
hypertension	patients	used	small	effect	candesartan
tobacco-smoke	exposure	contribute	risk	cancer
antitubercular	mdr	used	drugs	resistant	strains	increase	complicated	develop	tb
mycobacterialinfection	implicated	events	recapitulate	designed	model	using	demonstrated	recovery	mycobacteria
bipolardisorder	divalproex
hypothyroid	group	treated	%	methimazole	drinking	group	mice	received	injection	î	g	l-t4
aids	syndrome	acquired	humanimmunodeficiencyvirus	hiv
obesity	models	control	improves	supplementation	leucine
type2diabetes	glucose
stroke	risk	patients	anticoagulation	warfarin
nac	accumbens	discovered	facet	anorexia
hc-030031	reversed	hypersensitivity
type2diabetes	added	monotherapy	metformin
tropicalspasticparaparesis	carriers	htlv-1
aids	used	ascertain	addressed	serving	women	affected	hiv
pain	intensity	anesthetics	desflurane
schistosomiasis	strategy	chemotherapy	praziquantel
peanutallergy
tb	programs	burden	worsening	noted	strains	m.tuberculosis
thromboembolism	patients	treated	experience	number	warfarin
celiacdisease	patients	remaining	exhibit	cereals	design	genes	gluten
anthrax	agent	bacillusanthracis
malaria	treatment	derivatives	quinine
aids	patients	survivors	hiv
hypertension	patients	artistâ	tablets	carvedilol
agitation	incidence	decreasing	effective	administration	dose	propofol
ar	receptor	estrogen
over-the-counter	medications	taken	excluded	causes	nephroticsyndrome
retinol-binding	protein	skeletogenesis	rars	genes	encoding	proteins	protein	gla
septic-shock	patients	mortality	predictors	remain	>	hazard	ratio	dose	norepinephrine
norepinephrine	concentrations	measurement	microneurography	measured	patients	patients	chf
breasttumours	bisphosphonates
uc	using	sample	users	mesalamine
jia	patients	received	mg/kg	mtx
nonsteroidalanti-inflammatorydrugs	-RSB-	associated	events	risks	risks	complications	ulcer
attentiondeficithyperactivitydisorder	children	medication	atomoxetine
depressivedisorder	diagnosis	comprised	receiving	one	escitalopram
type2diabetes	those	decrease	lower	function	relative	sensitivity	insulin
pioglitazone	therapy	plus	q.d.	monotherapy	type2diabetes
celiacdisease	patients	toxicity	gluten
thromboembolism	conclusions	contribute	evidence	carries	oralcontraceptive	containing	drospirenone
hit	offer	thrombocytopaenia	heparin-induced
antibacterial	strategies	development	target	stands	trait	gbs
mrsa	sequence	isolate	genomes	s.aureus
hbv-dna	suppression	adefovir
obese	subjects	loss	intake	treatment	orlistat
mrsa	infections	increasing	-lrb-	prevalence	s.aureus
hiv/aids	delivery	achievements	been	back	workload	hiv
hypothyroidism	that	higher	t3	t4
interferon-alpha	basal	melanocytes	cells	melanoma
schizophrenia	using	meta-analysis	trials	haloperidol
softtissueinfections	causes	become	strains	methicillin-resistantstaphylococcusaureus
ctx	collagen	telopeptides	alkaline	concentrations	markers	osteoporosis
h5n1	avianinfluenzavirus
cavity	bacteria-specific
chronichepatitisc	infection	hcv
cancer	hormone-sensitive
gabapentin	effects	expression	model	neuropathicpain
pain	cause	replacements	metal-on-metal
type2diabetes	patients	use	metformin
acquiredimmunodeficiencysyndrome	aids	humanimmunodeficiencyvirus
adjuvant	models	reversed	hypersensitivity
aids	use	non-efavirenz
hypertension	prevalence	glucose
hbv	relationship	expression	serumhepatitisbvirus
sorethroat	syndrome	presented	woman	vasculitis	antibody-associated
ischemia-reperfusion	injury	mediating	investigated	role	dehydrogenase	sorbitol
allergen	provocation	induces	expansion	population	lungs	protection	manifestation	allergicasthma
ethyleneglycol	metabolized	resolve	features	acidosis
amnesia	scopolamine-induced
hiv/aids
urticaria	patients	mandated	desloratadine	cetirizine
tuberculosisinfection	-rrb-	have	u.s.a.	people	%	develop	part	bcg

psychoticdisorder	patients	divided	olanzapine	antipsychotic
type2diabetes	involving	insulin
cancer	cells	induced	mechanism	chemotherapeuticagents
psychotic	depression	aged	individuals	receive	weeks	treatment	olanzapine
alcoholaddiction	treated	subjects	incorporating	predictors	change	consumption	alcohol
cough	types	investigated	unlike	codeine
lymeborreliosis	agent	lato	borreliaburgdorferi
retinoicacid	cis	all	retinoicacid	play	roles	in	inflammation
melanoma	cells	secreted	²	ifn-î
paclitaxel	sensitive	making	target	non-smallcelllungcancer
hiv/aids
myeloma	treatment	efficacy	shown	bortezomib
diabeticretinopathy	defined	microvasculopathy	affects	complication	diabetesmellitus
intracranialtuberculomas	complication	tuberculosis
influenza	subunit	regions	motifs	correspondence	suggests	pa-pb1-pb2	subunits	equivalent	concatemer	orthomyxovirus
bacterialinfection	elevated	load	bacterial
autoimmunediseases	contribute	interferon
autistic	children	screen	assay	antibody
fluoxetine	use	amplify	type1diabetes
ion	spectrometry	with	combined	using	analysis	identified	number	modulated	snail1	cells	cancer
nsclc	patients	shown	controversial	efficacy	chemotherapy	docetaxel
pneumonia	$	group	group	min	consumption	o2
ebvinfection	diseases	the	correlates	genotypes	ebv
hereditarydisease	causes	due	alterations	receptor	glucocorticoid
mrsa	carriers	increased	carriers	s.aureus
cholesterol	levels	alters	risk	cardiovasculardisease	cvd
type2diabetesmellitus	treatment	choice	agent	recommend	metformin
cross-protective	antibodies
abscess	therapy	antibiotic
pain	incidence	lower	k	injection	mg	propofol
osteoarthritis	model	evaluate	effects	injection	celecoxib
abciximab	therapy	received	had	administration	stenting	infarct
cefixime	used	therapy	gonorrhoea
oa	treated	chondroitinsulfate
steroidmyopathy	occurs	therapy	using	corticosteroids
hypoglycemia	stimulates	suppresses	increase	insulin	se	absence	zinc
pain	100	pain	=	scale	using	stopping	infusion	remifentanil
cancer	response	was	administration	chemotherapy	selected	atp-cra
antibody-positive	vasculitis
hivinfection	acquired	enrolled	transmission	$	breast-milk	of	trial	nvp
pain	reducing	effective	drugs	added	lidocaine
gold	therapy	patients	chronichepatitisc
liverdiseases	history	woman	treated	mg	ticlopidine
pain	resolved	injection	antibiotics
virus	particles	interactions	reflecting	cause	cultured	viruses
allergy
hbv	dna	group	entecavir
mrsa	caused	bacteraemia	outcomes	worse	observed	s	methicillin-susceptible
multiplemyeloma	treatment	approved	target	bortezomib
alcoholism	increase	onset	use	alcohol
interferon-gamma	effect	interleukin-17	growth	evoked	water-extracts	prepared	leaves	tissues	mice	meth-a-fibrosarcoma
aml	leukemia	transplantation	stem	conducted	cyclophosphamide
lymphomas	mantle	combinations	bendamustine	mitoxantrone
transmissiblespongiformencephalopathies	agent	prions
h5n1	influenzaviruses
cancer	patients	treated	carboplatin	adjuvant
oxaliplatin-containing	chemotherapy	era	delirium	case	â	$	seizures
bosentan	addition	had	receiving	chemotherapy	melanoma
hypoglycemia	prevent	possible	using	shut	pump	insulin
impacted	increased	output	glucose
scd	cd36	synthesis	fat
cd	-rrb-	ibd
rickets	diagnosis	based	course	therapy	vitamind
aids	hiv
rickets	vitamind
humanimmunodeficiencyvirus/acquiredimmunodeficiencysyndrome
mrsa	methicillinresistantstaphylococcusaureus	strains	showed	activity	antibacterial
bisphosphonates	effects	evidence	increasing	supporting	use	treatment	bonedisease	cancer-induced
hbv	-rrb-	transcriptase	virus	occurring	mutations	treatment	administration	approved	analogue	adefovir
tuberculosis	control	requires	mycobacteriumbovis	guerin	bcg
hiv/aids
bloodglucose	levels	avoid	hypoglycaemia
hiv/aids
chf	suffer	patients	receive	dox
ebvinfection	promotes	cns	have	damage	ms.	isolates	ebv
tacrolimus	treatment	effective	subgroup	patients	proctitis
bisphosphonates	activity	limited	demonstrated	reductions	metastases
irondeficiencyanemia	evaluated	depletion	lack	stores	iron
severeacuterespiratorysyndrome	epidemic	caused	coronavirus
chickenpox	epidemiology	investigate	studied	population	bissau	has	age	infection	vzv
abciximab	therapy	stenting	artery	used	patients	acutemyocardialinfarction	ami
hyperglycemia	activity	increased	incorporation	glucose
insulinresistance	wasting	control	glucose
commoncold	symptoms	recorded	determined	load	viruses
obstructivepulmonarydisease	survival	improve	proven	treatment	therapy	oxygen
hbv	hepatitisbvirus
schizophrenia	psychosis	treatment	approved	ziprasidone
insulin	hyperglycemia
cr	share	ameliorating	insulinresistance
oa	cartilage	investigated	effects	salmoncalcitonin
oa	osteoarthritis	drugs	sulfate	glucosamine
tb	vaccine	calmette-guerin	bcg
opticneuritis	control	therapies	using	biologicals
metal	hypersensitivity
tb	therapy	discovery	targeting	topoisomerase	relaxation	m.tuberculosis
dronedarone	reduce	atrialfibrillation
hivinfection	represents	domain	hiv
triglycerides	hypertension	determined	assessment	insulinresistance
caries	involved	bacteria
virus	give	mutate	viruses
ammonia	pretreated	showed	astrocyte	swelling
hbv	hepatitisbvirus
candidaemia	cases	caused	dubliniensis	prevalent	tropicalis	candida
hivinfection	frequency	evaluate	using	test	hiv
virus	replication	correlates	infection	viruses
neuroblastoma	cells	obtained	cisplatin
type2diabetes	patients	assigned	days	doses	insulinlispro
hepatitisc	viruses	%	ribavirin	respond	interferon
5-aza-2	agent	lines	treated	identify	genes	regulated	tumors
post-fivinfection	fiv-c36
hyperglycaemia	hallmarks	include	insulinresistance	associated	increase	output	glucose
i-lvd	that	correlated	carcinoma
hiv/aids	reporting	testing	hiv
postpartumhaemorrhage	and	medline	ergonovine
onychomycosis	effective	terbinafine
rotavirusinfection	control	involved	mechanisms	known	characterized	responses	rotavirus-induced
type1diabetesmellitus	autoimmunedisease	characterized	and/or	action	insulin
nausea	abdominalpain	presented	woman	history	use	oralcontraceptive
hivpositive	person	sit	them	tested	hiv
multiplemyeloma	improved	bortezomib
allergen	sensitivity	compare	facilitate	pollenallergy
rise	give	oncogene	tumour
tropicalspasticparaparesis	carriers	htlv-1
alkanes	di
seizure	episodes	number	resulted	treatment	phenobarbital
tumors	showed	suggesting	suggesting	development	sts
fattyacid	metabolism	inflammatorydisease
interferon	failed	patients	agent	shown	activity	rcc
malaria	morbidity	reduces	treatment	infants	sulphadoxine-pyrimethamine
hiv/aids
obstructivepulmonarydisease	likelihood	recommend	use	treatment	oxygen
ironoverload	irondeficiency	disorders	develop	help	understanding	interplay	factors	involved	regulation	metabolism	iron
hypoglycemia	gain	risk	increasing	improves	control	based	levels	glucose
hypertension	compared	monotherapy	valsartan
insulin	birth	factors	predict	assess	examine	influence	type1diabetes
insecticides	resistance	receiving	increasing	threatens	sustainability	programs	malaria
hbv	loads	serumhepatitisbsurfaceantigen
wasting	determine	prevalence	infection	sth
interferon-alpha	combination	started	chronichepatitisc
herpeszoster	vaccination	varicellazostervirus
denguehemorrhagicfever	complications	infection	one	serotypes	denguevirus
glucose	tolerance	examine	influence	type1diabetes
rsvinfection	treatment	limited	critical	reduce	transmission	rsv
myocardialinfarction	patients	eptifibatide
melioidosis	agent	burkholderiapseudomallei
tb	-rrb-	distinction	permit	treated	m.tuberculosisinfection
type2diabetes	patients	received	units	insulin
aids	hiv
pulmonaryaspergillosis	confirmed	culture	fluid	test	antigen	aspergillus
cross-link	leading	iron
tha	metal-polyethylene	associated	osteolysis
hbv	kits	detection	hepatitisbvirus
il-2	±	effects	anti-tumor
aids	defined	individuals	samples	patients	hiv
hiv/aids
mh	condition	occurs	subjects	neuromuscular	blocking	succinylcholine
hbv	hepatitisbvirus
hivpositive	hiv
anti-tuberculosis	drugs	isoniazid
enzyme	develop	hyperhomocysteinemia	factor	thromboembolism
hiv/aids-related
pain	insertion	ease	relation	designed	investigate	alternative	propofol
vitaminadeficiency	continue	vitamina
hivinfections	combating	intervention	prevention	transmission	hiv
hivinfection	acquiring	predispose	sexuallytransmittedinfections	virus	hiv
virus	titres	post-infection	reduced	reduced	viruses
chronichepatitisc	assess	define	cells	hcv-specific
hivinfection
hbv-seropositive	-RSB-	hbsag
hiv/aids
piedra	dermatophytes
tuberculosis	granulomas	collections	cells	comprised	cells	form	infection	mtb
hepatitis	vaccination	receive	msm	sampled	pride	reported	used	stimulant
pain	compare	ketamine
alcohol	use	cut	predictors	womanabuse
obese	patients	levels	antibodies
septicshock	diagnosis	measured	epinephrine
bosentan	effects	receiving	therapy	cutaneousmelanoma
bacteraemia	clearance	improvement	defined	patients	received	antibiotics
sda	acid	fat-3
type2diabetes	assigned	treatment	pioglitazone
dr	appears	required	avoid	patients	diabetesmellitus
vancomycin/gentamicin	daptomycin	rates	%	%	%	endocarditis
chf	patients	outflow	inhibits	therapy	statin
fibrosis	decreasing	modulating	metabolism	lipid
tb-complex	bcg
d3	expression	observed	nevi
adhesion	kinase	kinase	tyrosine
cancer	lines	expression	downregulation	affects	show	using	approach	tetracycline-inducible
tb	trials	bcg-based
chronichepatitisc	treatment	advancement	telaprevir	combination	peginterferon
cancer	remains	consisting	chemotherapy	platinum-based
hbv	variants	hepatitisbvirus
œdiabeticmaculopathyâ	$	$	â	$	œdiabetesmellitusâ
tb	vaccines	development	hope	represent	regimens	utilizing	bcg
irondeficiency	effects	determine	fed	control	id	fe
vehicles	able	eradicate	tickinfestation
anti-sars	abs	coronavirus
hypothyroidism	patients	replacement	accomplished	monotherapy	levothyroxine
aids	agent	reported	retrovirus	humanimmunodeficiencyvirus	hiv
rheumatoidarthritis	treated	adalimumab
genitalwarts	simulating	infection	hpv
hbv	dna	adefovir	superior	used	adefovir
hbv-dna	suppression	adefovir
aids	hiv/acquiredimmunodeficiencysyndrome
malaria	intermittent-preventive-therapy	sulfadoxine-pyrimethamine
virus	genes	usage	variations	observed	viruses
osteoarthritis	treatment	analgesic
type2diabetes	predisposition	individuals	underwent	measure	sensitivity	insulin
type2diabetes	patients	remained	had	effects	levels	requirement	insulin
steroids	therapy	received	patients	lupusnephritis
asthma	trials	meta-analysis	have	budesonide/formoterol
insulin	delivery	predicted	hypoglycemia
breasttumor	samples	patients	relapse	treatment	tamoxifen
high-fat	diet	express	used	virus
mrsa	antibiotics	accumulation	related	vivo	in	enhanced	effect	antibacterial
hbv	hepatitisbvirus
hiv/aids
collagen	depots	due	replacement	tissue	tumor
schizophrenia	treating	approved	paliperidone	metabolite	risperidone
melioidosis	agent	burkholderiapseudomallei
triglycerides	accumulation	prevented	diet	chf
painful	part	applied	patches	lidocaine
alcoholdependence	development	lead	exposure	alcohol
hivinfection	risk	population	hiv-infected
asthmatic	patients	number	responded	challenge	aspirin
18-carbon	productsâ	fat-3	$	gla
oxygen	secure	proliferate	metastasize
visceralleishmaniasis	treat	increasing	used	liposomalamphotericinb
glucose	delivery	limiting	predispose	insulinresistance
perniciousanaemia	associated	vitaminb12deficiency
aaa	development	associated	mismatch	allotypes	adalimumab
hypertension	patients	proved	superior	antihypertensiveagents	valsartan
meth-a	mice	fibrosarcoma-bearing
hiv/aids/art
transmissiblespongiformencephalopathies	diseases	associated	prionprotein
celiacdisease	mediated-inflammatory	caused	ingestion	gluten
thiazolidinediones	class	agonists	reduce	insulinresistance
colibacillosis	diagnosed	chickens	recovered	characterized	isolates	escherichiacoli
cr	remission	+	patients	acutemyeloidleukaemia
hepatitisc	hcv
virus	particles	self-aggregate	na	resistant	reduced	viruses
musculardystrophy	cardiomyopathy	elevated	known	assess	resonance	manganese-enhanced
inflammation	history	studies	help	mechanisms	basic
tpa	plasminogenactivator	development	produce	translation	agents	ischemicstroke
rabies	deaths	thousands	occur	availability	vaccines
cholera	pandemic	beginning	tor	epidemic/endemic	seems	determined	multidrug	resistant	strains	v.cholerae
aids	initiative	carried	review	links	$	œhiv
listeriosis	causes	listeriamonocytogenes
pneumonia	%	prescribed	antibiotics
type2diabetes	inhibition	patients	impaired	inhibited	insulin
hiv/aids
chronichepatitisc	patients	respond	therapies	interferon-based
anemia	irondeficiency
tumor	xenografts	using	study	cisplatin
swelling	showed	cell	increased	cytokines	-lrb-	co-treatment	ammonia
hiv/aids
hiv/aids
malaria	diagnosed	recommends	use	rdt	treat	cq	chloroquine
tha	arthroplasty	offer	osteoarthritis
sars	patient	revealed	presence	coronavirus
pain	incidence	necessitated	use	fentanyl
hiv/aids
h5n1	surveillance	need	highlight	findings	possess	implications	influenzavirus
denguehemorrhagicfever	lead	denguevirusinfection
rise	giving	cause	metastasis
granulomas	analysis	confirmed	biochemical	analysis	species	lipid
rotavirusdisease	resolution	correlate	demonstrated	strains	rotavirus
staphylococcalinfection	decrease	associated	catheters	antibiotic-impregnated
pain	preventing	injection	propofol
hbv	viruses
pain	recorded	started	infusion	propofol
tb	control	therapy	isoniazid
aids	synthesis	interâmediate	drug	c14h17clo7s	zidovudine
fitted	assess	glucose
insulin	association	examined	studies	cross-sectional
humaninfluenza	that	resembles	susceptible	infection	humaninfluenzaviruses
cp	enzymes
cystinosis	patients	functioning	improve	treatment	cysteamine
iron	effect	examine	control	patients	kidneydisease
hiv/aids
asthma	aspirin-tolerant
thromboembolism	women	receiving	oralcontraceptives	containing	that	women	receiving	oralcontraceptives	containing	levonorgestrel
ca-mrsa	infected	patients	hospitals	obtained	reviewed	isolates	staphylococcusaureus
dr	microalbuminuria	patients	characterized	is	essence
bacterialmeningitis	patients	analyzed	indices	immunoglobulin
hyperglycemia	accumulation	fat
aml	patients	cells	chemosensitivity	bases
hdl-cholesterol	circulating	raised	increases	risk	type2diabetes
obese	mice	weight	doses	lower	fattyacids
enzyme	activity	affect	cofactors	-rrb-	di-nucleotide
aids	hiv
hiv/aids
hbv	genotypes	had	hbsag
neutropenia	schedules	cancer	treatment	regimens	ac	pegfilgrastim
hypersensitivityreaction
neuroblastoma	growth	compounds	etoposide
malaria	treatment	six-dose	three-dose	suspension	artemether-lumefantrine
malaria	treatment	sp	sulphadoxine-pyrimethamine
hyaluronicacid	evaluated	model	osteoarthritis
oil	groups	times	ten
hiv/aids
hypertension	controlling	drug	telmisartan
schizophrenia	treated	risperidone
malaria	parasites	drug	use	pyrimethamine
avianinfluenza	cases	isolated	influenzaviruses
type2diabetes	patients	using	insulin
viremia	treatment	went	receive	course	epoch	mg/m2/day	cyclophosphamide
adrenocorticotropin	hormone	secretion	caused	adenoma	corticotroph	pituitary
enzyme	analyzed	samples	tumour
prion	prions	kuru
psoriasis	studies	concentrated	lipids	lipids
angleclosureglaucoma	associated	methazolamide
rheumatoidarthritis	patients	opportunity	window	notion	reached	recognition	methotrexate
gluten	epitopes	effect	neutralized	eliminate	diet	celiac
hivinfection	preventing	value	considered	risk	resistance	associated	prophylaxis	nvp
alcoholdependence	problems	range	treatment	services	uncovered	women	group	leaving	designed	considered	contribution	use	alcohol
allergicreactions	reported	use	neostigminebromide
tb-antigens	boost	increased	compared	to	animals	primed	bcg
virus	abundance	ranged	viruses/cm3
psoriaticarthritis	treatment	available	agents	infliximab	etanercept
tumor	load	affect	co-injection	plasmid	sb
statin	transposon	dose	injected	animals	affect	load	tumor
postoperativenauseaandvomiting	prevention	dexamethasone	metoclopramide
rheumatoidarthritis	criteria	rf	provides	status	antibody
kuru	given	endocannibalism	thought	transmitted	exposure	prion
denguefever	agent	denguevirus
melanoma	cells	mediating	signaling	known	signaling	interferon
onychomycosis	cure	achieving	effective	analysis	terbinafine
rcc	renalcellcarcinoma	ve	approved	bevacizumab	combination	alfa	interferon
highbloodpressure	normalization	option	represent	clonidine
chytridiomycosis	causes	fungus
hiv/aids
respiratoryacidosis	hypercapnia	difference	pressure	carbondioxide
mrsa	s.aureus

aids	presenting	decreased	increased	illness	hiv
chronichepatitisc	patients	genotype	hepatitiscvirus
hyperglycemia	subjects	performed	measured	fasting	levels	glucose
bipolarmooddisorder	treatment	lithium
tb	contraindication	vaccine	bacilluscalmette-guerin
vitamins	use	considered	conclude	needed	develop	methods	prevention	preeclampsia
type1diabetes	adults	reduce	conclusion	closed	delivery	insulin
tb	mycobacteriumtuberculosis
hivinfections	rate	estimate	africa	using	data	hiv
hivinfection	protection	provide	showed	trial	hiv
tuberculosis	detect	test	mtb/rif
tuberculosis	caused	mycobacteriumtuberculosis
sts	softtissuesarcomas
ulcerativecolitis	treatment	drug	mesalamine
pml	complication	highlighting	neurotropism	polyomaviruses
obesity	therapy	supplementation	leucine
cholera	areas	collected	samples	detected	species	v.cholerae
type2diabetes	involving	insulin
syphilis	tested	specimens	conformed	agglutination	treponemapallidum
mrsa	-rrb-	-lrb-	s.aureus
cocaineabusers	exposures	model	fatigue
heroinaddiction	patients	symptoms	considered	raising	doubts	possess	patients	abuse	opioids
virus	attachment	regulates	studying	present	viruses
promyelocyticleukemia	line	using	performed	experiments	led	treatments	duration	all-trans-retinoicacid	atra
malaria	cases	treatment	prophylaxis	used	drug	atovaquone-proguanil
pain	compare	ketamine
mtbdr	plus	had	resistance	rif
falciparummalaria	treatment	update	programme	mali	efficacy	chloroquine
thromboembolism	prevention	heparins
type2diabetes	insulins	experienced	switching	regimen	insulin
virus	protected	vaccinated	protected	viruses
exenatide	injection	examined	individuals	type2diabetes	impairedglucosetolerance
fat	loss	correlated	fibrosis
cancer	cells	spread	facilitated	enhanced	model	chemically
rubella	agent	rubellavirus

epiduralabscess	association	indication	cement	antibiotic-bone
hiv/aids
multiplemyeloma	cells	8226-lr5	melphalan-resistant
triglyceride	high	-RSB-	participants	obesity
single-crystal	crystallography	characterized	investigated	series	lines	cancer
ham/tsp	samples	proteins	htlv-i
rabies	lyssavirus	rabiesvaccine
antihypertensive	medication	on	not	were	mmhg	lower	diagnosis	cardiovasculardisease
hypercholesterolemia
schizophrenia	those	in	exist	composition	fattyacids
pml	leukocoencephalopathy	dementia	form	agent	humanpolyomavirusjc
impairedglucosetolerance	pressure	glucose
hivinfection	people	percentage	associations	controlling	prevalence	hiv
schizophrenia	keep	risperidone	switching	risperidone
chf	patients	assessed	effects	statin
fluoxetine	effects	regarding	hypoglycemia	type1diabetes
nicotineaddiction	cessation	reports	nicotine
pain	treatment	drug	acetylsalicylicacid
type1diabetes	type2diabetes	insulin
cholesterol	levels	individuals	risk	cvd
adenocarcinoma	cells	assess	acid	eicosapentaenoic	n-3fattyacid
asthma	patients	aspirin-tolerant
asthma	patients	inhibited	dexamethasone
relapsingremittingmultiplesclerosis	treatment	approved	conducted	evaluate	efficacy	glatirameracetate
cancer	reviews	context	compare	deaths	tamoxifen	minimizing	occurrence	dm
arthritis	analysed	labelled	injected	fluorodeoxyglucose
polio	eradication	prospects	look	host	polioviruses
obese	patients	glucose
insulin	therapy	drugs	treated	critical	diagnosis	diabetesmellitus
myeloma	bortezomib
type2diabetes	individuals	comparison	received	insulin
vitaminadeficiency	levels	associated	levels	being	awareness	vitamina
nsclc	patients	received	docetaxel
melanoma	interferonalpha-2b	adjuvant
pain	modalities	relief	confirmed	response	resulted	treatment	strontium-89chloride
hivinfection	enhancement	deposited	surface	virions	hiv
tb	programs	undermines	emergence	resistance	m.tuberculosis
chronichepatitisc	patients	frequency	genotype	genotype	hcv
anemia	pathophysiology	related	factors	hemodilution	losses	erythropoietin
vomiting	found	groups	dexamethasone
cancer	estrogen
melanoma	treatment	changed	introduction	interferon
silicosis	defined	disease	resulting	silicadust
pain	incidence	scores	need	boluses	dose	bupivacaine
jia	patients	received	mg/kg	mtx
picornavirusinfection	review	discuss	replication	picornavirus
vibriocholerae	isolates	multidrug	responsible	unraveling	help	evolution	bacteria
bacterialinfections	formulations	containing	concentrations	norfloxacin
enuresis	case	alcohol
asbestosis	features	show	fibrosis	suggest	cause	asbestosfibers
anti-cmv	therapy	valganciclovir
diarrhea	onset	time	reduced	extract	methanol
tam	promote	progression	lymphomas
hbv	expression	screened	sites	hepatitisbvirus
chronichepatitisc	chc	patients	pbmcs	individuals	injection	ifn
stroke	calculated	determine	rhythms	secretion	melatonin
hemochromatosis	study	y	¥	controls	replete	iron
melphalan	infusion	option	cases	retinoblastoma
hiv/aids
collagen-induced	arthritis
hbv	replication	suppression	entecavir-induced
shingles	prevention	lead	virus	replication	gives	profiling	genome	vzv
blepharospasm	neurologicdisorders	treatment	used	preparations	substance	botulinumneurotoxintypea
hivinfection	play	examining	suggests	role	pathway	integration	hiv
ammonia	co-treatment	-lrb-	cytokines	increased	cell	showed	swelling
hbv	virus	selection	give	determinant	hbsag
hbv	genotype	carriers	hbsag
rheumatoidarthritis	developed	starting	therapy	adalimumab
oa	mild	confirmed	studies	comparing	gel	diclofenacsodium
carcinoma	cells	chemotherapeuticagents
triglycerides	dr	loss	speed	level	acuity	amd	age-relatedmaculardegeneration
type1diabetes	phenotype	has	mean	years	bmi	dose	insulin
listeriosis	clusters	caused	subtype	listeriamonocytogenes
dentalplaque	education	dying	toothbrushing	dentifrice	fluoride
bleeding	risk	associated	demonstrated	clopidogrel
tb	drug	treatment	regimen	components	rifampicin
tacrolimus	immunomodulator	effective	treatment	inflammatoryboweldisease
salmonellainfection	controlling	essential	antibodies
virus	then	neurovirulent	some	viruses
collagen	types	fibrosis
htlv-1infection	associated	indicate	factor	acquiring	htlv-1
giardiasis	treatment	metronidazole	effective	albendazole
cancer	causes	metalloid	cysteine	property	infer	responsiveness	arsenic
cystinuria	treatment	useful	d-penicillamine
hivpositive	had	had	status	hiv
hbv	difference	hepatitisbvirus
melanoma	patients	levels	measuring	explore	mechanism	action	2b	ifn-î
m.tuberculosis	infection	mtb
alzheimerâ	patients	benefits	donepezil
infectiveendocarditis	cases	number	number	prescriptions	prophylaxis	consisting	dose	amoxicillin
viremia	decrease	observed	treatment	adefovir
hereditarydisease	causes	due	alterations	receptor	glucocorticoid
type2diabetes	patients	options	provides	analog	insulin
hbv	infection	data	lamivudine
insulin-like	protein	osteopontin	l6	tumor-associated
hypertension	inhibited	ea
pain	rated	intensity	reduced	comparable	groups	%	tramadol
seizure	models	has	affinity	carbamazepine
tumors	growth	suppressed	potently	capsaicin
papilloedema	active	intracranialhypertension
hypercholesterolemia	treatment	used	suggesting	observed	reduction	cholesterol
humaninfluenzaviruses	related	influenzaviruses
pain	propofol-induced
hyperglycemia	duration	delayed	results	insulin
hiv/aids
chronicrenalfailure	rats	received	calciumcarbonate
tuberculosis	have	received	bcg
hbv	infection	hepatitisbvirus
collagen	connectivetissuedisorder
cancer	patients	accepted	regimens	fluorouracil-based
psoriasis	studies	concentrated	lipids	lipids
antibiotic	bacteria	caused	bone	jointinfection
pre-eclampsia	complicated	pregnancies	upregulated	protease	factor	a2	plasmaprotein
overweight/obese	patients	outcomes	differing	ratio	carbohydrate-to-protein
vasculitis	hydralazine-induced
interferons	characterized	autoimmunedisease
ebvinfection	occurs	infection	titers	ebv
hbv	hepatitisbvirus
formaldehyde	induces	pain	cancer
hiv/acquiredimmunedeficiencysyndrome
tuberculosis	incidence	has	necessary	studies	mycobacteriumtuberculosiscomplex
progressivemultifocalleukoencephalopathy	jcvirusinfection
subacutecombineddegeneration	anaemia	present	vitaminb12deficiency
ethanol	exposed	understand	mechanisms	fetalalcoholspectrumdisorder
neurosyphilis	form	infection	caused	treponemapallidum	bacterium

pioglitazone	12,14-prostaglandin	j2	ligands	injury	ischemia-reperfusion
gerd	treatment	observed	review	emphasis	protonpumpinhibitors
obesity-related	conditions	factors	produces	remains	loss	orlistat-induced
pml	sequences	found	aminoacids	subset	acquired	found	performed	analysis	sequences	jcvirus
gonococcalinfections	symptoms	genotypes	type	neisseriagonorrhoeae
hivpositive	tested	hiv
oxytocin	iol	require	likely	felt	pain
lymedisease	caused	species	borrelia
crystal	deposits	occur	type	renaltubularacidosis	rta
oa	osteoarthritis	drugs	chondroitinsulfate
denguefever	range	infection	denguevirus
abnormalcoagulation	profile	were	aspirin	clopidogrel
mrsa	bacteraemia	vancomycin/gentamicin	alternative	daptomycin
influenzavirus
bradycardia	cause	potent	found	signal	bradycardia	associated	propranololhydrochloride
oa	evidence	presence	associated	use	nonsteroidalantiinflammatorydrugs	nsaids
hyperglycemia	control	age	need	therapy	insulin
gastroesophagealrefluxdisease	treatment	used	drug	lansoprazole
atherosclerosis	suppress	prevent	inflammation	fattyacid-induced
inflammation	brought	relationship	obesity/fat
hiv/aids
interferon	protein	molecule-1	adhesion
gerd	patients	compare	that	mg	esomeprazole
tuberculosisinfection	diagnosed	received	rifampicin	rif
hiv/aids
humanimmunodeficiencyvirusinfection/acquired	epidemic	hiv/aids
antibiotic	use	co-infection
virusisolation	detected	viruses
malaria	diagnosed	recommends	use	rdt	treat	cq	chloroquine
type2diabetes	representative	randomized	metformin
hiv/aids
hypertension	treatment	drug	conclusions	confirmed	carvedilol
androgen	therapy	cancer
impairedglucosetolerance	ratio	glucose
hypoglycemia	insulin	decrease	increased	remained	levels	glucagon
mrsa	-rrb-	caused	proportion	decreased	increased	proportion	infections	s.aureus
antibody-impregnated	filters	use	way	prevent	transmission	h5n1
irondeficiency	had	suggesting	constitute	deficiencies	folicacid
vcjd	pathogenesis	determined	type	prion
hiv/aids	epidemic	dynamics	understanding	contributing	described	seroconversion	infection	hiv-1
influenza	strains	raised	emergence	influenzavirus
dengue	outbreaks	prediction	goals	included	share	expertise	tests	identify	used	denguevirus
inflammation	treatment	vehicle	compare	safety	ointment	loteprednoletabonate
tick-borneencephalitis	virus	tbev
antibiotics	co-infection
flush	response	rated	applied	patches	niacin
clarithromycin	penicilling	antibiotics	contained	observed	isolates	mrsa
hypoglycaemia	avoid	levels	bloodglucose
hbv	dna	hepatitisbvirus
type2diabetes	treatment	available	agent	pioglitazone
malaria	transmission	area	children	investigated	effect	treatment	sulphadoxine-pyrimethamine
qfever	caused	coxiellaburnetii
virus	transmission	use	idu
insulin	antidiabetics	therapy	controlled	age	was	incidence	patients	diabeticfoot
influenza	infection	suggest	avianinfluenzaviruses
pain	preventing	effective	mg	ketamine
h5n1	influenzaviruses
asthma	outcomes	achieves	monotherapy	budesonide
hypertension	treatment	option	provides	combination	olmesartanmedoxomil	amlodipine
vaginalthrush	patients	isolated	stellatoida	investigated	candidaalbicans
antibodies	1.32	=	â	absence	toilet	flush
oa	knees	trial	findings	show	equivalence	celecoxib
diarrhea	onset	time	reduced	extract	aurea	drug	loperamide
dobutamine	cmr	literature	summaries	is	use	cmr	diagnosis	coronaryarterydisease
hbv	-rrb-	isolates	hepatitisbvirus
vitamind	levels	associated	and/or	factor	development	multiplesclerosis
pain	preventing	effective	mg	ketamine
dermatomyositis	secretion	hormone
oa	osteoarthritis	patients	lesions	determine	effect	treatment	chondroitinsulphate
hypoglycemia	protect	enhancing	counterregulation	glucagon
mtb	assessed	mtb
escitalopram	treated	individuals	depressivedisorder
type2diabetes	treatment	insulin-independent
hyperglycaemia	occurs	consequences	related	glucose
gan	grown	wells
melanoma	therapy	remains	treatment	temozolomide
depressivedisorder	diagnosed	study	sought	compare	safety	capsules	sertralinehydrochloride
osteoarthritis	determine	effect	chondroitin
r-tpa	target	clot	hemorrhage
tb	cases	resistance	presence	inh	isoniazid
pvcs	reduced	lidocaine
hiv/acquiredimmunodeficiencysyndrome
type2diabetes	therapy	insulin
viremia	treatment	went	receive	course	epoch	mg/m2/day	etoposide
hivinfection
urinarytractinfections	pyelonephritis	treatment	evaluating	levofloxacin
liverabscess	arise	insult	gut	allowing	drainage	bacteria
tb	incidence	reduce	needed	protect	rin	bcg
dengue	infections	has	hypothesize	leading	revealed	cells	denguevirus-infected
œasthmaticâ	$	improves	produces	enhancement	activity	albuterol
hyperglycemia	exceeds	threshold	glucose
meningococcaldisease	fight	strategy	involves	meningococcus
cancer	patients	accuracy	predict	chemotherapy	cisplatin
apl	treatment	approved	use	ato	arsenictrioxide
type2diabetes	those	decrease	lower	function	relative	sensitivity	insulin
coeliacdisease	patients	age	years	1.0	â	$	$	mononuclear	blood	years	$	on	diet	gluten-free
vitamins	use	considered	conclude	needed	develop	methods	prevention	preeclampsia
aids	agent	humanimmunodeficiencyvirus	hiv
influenza	modification	assessed	documented	influenzaviruses
hbv	hepatitisbvirus
hivinfections	eliminate	opportunity	is	argues	high	visit	region	hiv
vomiting	episode	tolerate	patients	offer	bioequivalent	aprepitant
immunodeficiencies	deficiencies	immunoglobulin
interleukin-2	±	gene	il2ra/cd25	emerging	gene	autoimmunediseases
asthma	trials	meta-analysis	have	budesonide/formoterol
hiv/aids
cholesterol	levels	dyslipidemia	impairedglucosetolerance

bleeding	complications	occurrence	reduction	associated	undergoing	stenting	safe	reversal	anticoagulation	protamine
acutepromyelocyticleukemia	fused	alpha	retinoicacid
pain	specialists	attended	discuss	predicting	plaster	lidocaine
rabies	diagnosed	animals	collected	subjected	isolates	glycoprotein	rabiesvirus
leptomeningealmetastases	patients	analyzed	indices	immunoglobulin
hiv/aids
ocd	efficacy	clomipramine
hivinfection	providers	asking	willingness	testing	hiv
asthmatics	hyperpnea	induced	inflammation	was	compare	effects	montelukast
adhd	treatment	used	methylphenidate
type2diabetes	individuals	administered	determine	effects	insulinglargine
fattyacids	saturated	subjects	type2diabetes
atherosclerosis	associated	speed
gvhd	sirolimus	tacrolimus
type1diabetes	sitagliptin	therapy	insulin
ds	children	found	characteristics	tb
astrocytomas	management	review	role	tmz
pain	tourniquet	lidocaine
atorvastatin	mg	showed	levels	reduction	prevention	reduced	incidence	stroke
tuberculosis	test	mtb/rif
testosterone	associated	risk	cancer
pain	treatment	drug	acetylsalicylicacid	-RSB-	aspirin
ranibizumab	demonstrated	neovascularization	age-relatedmaculardegeneration
insulin-stimulated	transport	have	implications	transport	pregnancycomplications
carotene	-RSB-	²	showed	exhibited	showed	sites	stratified	type	carcinoma
gout	treated	allopurinol
cmv	humancytomegalovirus
ecthymagangrenosum	associated	pseudomonasaeruginosa
malaria	therapy	recommended	artemether-lumefantrine
hivpositive	women	experiences	based	study	linked	transmission	programs	hiv
infectiousmononucleosis	patients	ebv
non-smallcelllungcancer	activity	has	oxaliplatin/docetaxel
type2diabetes	assigned	treatment	metformin
enzymes	molecules	adhesion
esophagitis	effective	shown	has	ability	inhibit	omeprazole
pulmonarytb	patients	collected	tested	susceptibility	ethambutol
hypoglycemia	preceded	ingestion	glucose
tuberculosisinfection	-rrb-	have	u.s.a.	people	%	develop	part	bcg
cocaineabuse	complication	occur	insufflated	cocaine
cholesterol	hdl	obesity
hiv/aids
cancer	therapy	adjuvant
hyperglycemia	¥	‰	bloodglucose
pulmonarysarcoidosis	patients	group	group	associated	disorders	collagen
sz	found	compared	with	hc
hiv/aids
strep-tococcal	infections	use	antibiotic
psoriasis	improvement	result	alefacept
painful	chest	patient	involvement	treated	regimen	paclitaxel
pain	group	patients	received	combined	with	mg/kg	paracetamol
bloodglucose	parameters	lipoprotein	high-density
hiv/aids
coeliacdisease	enteropathy	characterized	proteins	cereal-gluten
uti	treatment	ciprofloxacin
viruses
positivehiv	results	linked	determine	proportion	infants	linked	care	hiv
type2diabetes	monotherapy	q.d.	plus	therapy	pioglitazone
inflammation	attenuating	effective	treatment	ibuprofen
virus	limited	viruses
hypoglycemia	leading	counterregulation	$	$	hypoglycemia	more	euglycemia	making	harder	driving	utilization	carbohydrate
gout	flares	frequency	occurs	required	prophylaxis	colchicine
malaria	patients	ethiopia	effectiveness	-rrb-	chloroquine
tb	patients	controls	bcg-vaccinated
hivencephalitis	hiv-1	trial	hiv
mrsa	carriers	develop	likely	than	in	carriers	s.aureus
pain-reliever	acetaminophen
hiv/aids
type2diabetes	±	%	insulin
seizures	patients	lamotrigine
hyperglycemia	weight	response	insulin
pain	incidence	disappeared	that	group	remifentanil
viruses
h5n1	avianinfluenzaviruses	influenzaviruses
type2diabetes	stages	used	sitagliptin
promyelocyticleukemia	formation	±	±	that	tenovin-6	$	promyelocyticleukemiaâ	limited	shows	transretinoicacid
pain	reduce	dose	lidocaine
aids	hiv
nausea	=	control	had	patients	receiving	prochlorperazine
hivinfection	inhibit	mechanisms	contain	women	cvl	hiv
hypogonadism	defined	level	testosterone
tuberculosis	have	vaccination	bcg
aids	monitor	is	â	d4t
hiv/aids
hbv	positive	hbsag
tb-burden	country	lineage	m.tuberculosis
trachoma	prevalence	1â	%	%	c.trachomatis
pain	procedures	modulating	using	menthol
m.tuberculosis	isolates	incidence	growing	reported	data	variation	isolates	m.tuberculosis
melanoma	patients	autoantibodies	treated	2b	ifn-î
opioidwithdrawal	analgesia	affecting	induces	laxation	patients	use	opioid
chickenpox	outbreaks	seen	used	vaccine	vzv
promyelocyticleukemia	formation	±	±	that	tenovin-6	$	promyelocyticleukemiaâ	limited	shows	transretinoicacid
aids	patients	treat	reduce	deliver	carry	understand	epidemic	hiv/aids
statin	therapy	prevention	stroke
infectiousmononucleosis	present	cells	ebv-infected
priondisease	titers	prion
hepatitis	albendazole-induced
hiv/aids	living	people	stigmatization	perpetuate	focused	are	number	studies	stigma	hiv-related
hepatitisb	seropositive	received	analyzed	monotherapy	entecavir
chronichepatitisc	virusinfection	patients	cases	developing	anemia	associated	treatment	alpha	interferon
h5n1	influenzavirus
hbv	-rrb-	hepatitisbvirus
allergicreactions	history	referred	challenged	doses	penicilling	benzylpenicillin
kd	â	log	negligible	higher	expected	sertraline
malaria	recommendations	promoting	accompanied	change	policy	malaria	sulfadoxine-pyrime-thamine	artemether-lumefantrine
lipid	droplets	arise	mr	indicating	estimated	mr	observed	carcinomas
ca	carcinomas	carcinomas
growthhormone	syndrome	ts
nsaids	increase	risk	that	4-fold	gibleeding
pcos	received	metformin
tb	cases	controls	bcg
malaria	treatment	sp	sulphadoxine-pyrimethamine
humaninfluenzaviruses
omega-3fattyacid	supplementation	promoting	hypothesized	intervention	ptsd
priondisease	susceptibility	determinant	polymorphism	codon	gene	prion
malaria	exposure	-rrb-	trial	doxycycline
autoimmunediseases	focusing	association	genes	involved	pathways	interferon
necrotizingfasciitis	s.pyogenes
gbs	incubation	reduced	revealed	investigation	role	antibodies
uti	recurrence	time	days	days	group	trimethoprim
tuberculosis	medicines	introduced	1940s	documented	resistance	drugs	antituberculosis
anti-tb	drugs	report	uae	first	are	%	drugs	isoniazid
allergy
flu	141	influenzaviruses
adhd	patients	methylphenidate
uc	maintenance	compliance	improving	role	discuss	examine	data	mesalamine
bacterialinfections	associated	known	those	dissimilar	bacteria
oa	osteoarthritis	progression	determine	chondroitinsulfate
nitricoxide	upregulated	m.tuberculosisinfection
chronichepatitisc	virus	hcv
bipolardisorder	presentation	mechanism	action	divalproex
hivinfection	babies	regimen	nevirapine
malaria	treatment	observed	use	chloroquine
mcp-1	âˆ	variant	associated	findings	patients	sle
histoplasmosis	fungaldisease	caused	histoplasmacapsulatum
hiv/aids	knowledge	preponderance	characterized	hiv
obese	patients	osa	sibutramine
mycoplasmainfection	history	have	patients	igg	mycoplasma
influenza	pandemic	is	spreading	influenzavirus
hivseropositivity	factors	modes	transmission	hiv
thromboembolism	users	oralcontraceptive	containing	containing	levonorgestrel
cancer	sections	%	staining	receptor	estrogen
hbv	hepatitisbvirus
relapsing-remittingmultiplesclerosis	treatment	glatirameracetate
enoxaparin	obtained	reduction	complications	bleeding
heparinâ	$	targets	$	endpoint	$	$	metastases
tuberculosis	patients	isolates	levels	mycobacteriumtuberculosis
hiv/aids
b-celllymphoma	therapy	target	considering	conferred	treatment	rituximab
tb	laboratory	isolates	compared	specimens	assay	tube	testing	resistance	inh

onychomycosis	treatment	compare	efficacy	terbinafine
essentialoil	properties	investigated	strains	paratuberculosis
cr	share	ameliorating	obesity
tumor	cyld	enzyme
hiv/aids
delirium	case	â	fu
graft-versus-hostdisease	cause	mycophenolatemofetil
dcm	coronaryarterydisease	dilatedcardiomyopathy
malaria	recommendations	promoting	accompanied	change	policy	malaria	sulfadoxine-pyrime-thamine	artemether-lumefantrine
zinc-free	insulin	decrease	suppressed	increased	decrease	insulin	hypoglycemia
psychotic	features	bpd	treated	dose	clozapine
virus	caused	losses	decrease	vaccines
type1diabetes	subjects	minimize	delivery	system	insulin
schizophrenia	research	used	model	in	namely	risperidone
melanoma	lines	death	mode	determined	tmz
cancer	invasion	regulation	investigated	role	melatonin

hiv/aids
thyrotoxicosis	unit	admitted	containing	levels	thyroxin
hypoxia-evoked	species	oxygen
pain	prevent	strategy	develop	evaluated	factors	affect	injection	propofol
pain	associated	propofol
pulmonaryhypertension	model	lungs	mmp-2	treatment	bosentan
hypercholesterolemia	defined	‰	¥	100â	cholesterol
osteoarthritis	treatment	administered	glucosamine
dyspnea	bode	test	gas
malaria	intermittent-preventive-therapy	sulfadoxine-pyrimethamine
epilepsy	members	impairments	topiramate-induced
h5n1	avianinfluenzavirus
asthmatic	rats	asmcs	downregulate	budesonide
sars-coronavirus	sars-cov
atrialfibrillation	patients	%	receive	warfarin
tuberculosis	progressing	ranging	outcomes	results	infection	mycobacteriumtuberculosis
vitamind	multiplesclerosis
hiv/aids
atopicasthma	associated	³	ifn-î
aspirin-intolerant	cu	prevalences	differences	focusing	investigated	patients	urticaria
asthmatic	patients	underwent	aspirin
schizophrenia	patients	compare	retrieved	search	trials	injectables	fluphenazinedecanoate
type2diabetes	action	insulin
cancer	ve	patients	enrolled	obtaining	atp-cra
ventriculartachycardia	reduced	quinidine
rickets	-RSB-	form	vitamind
vasculitis	antibody-associated
cross-neutralizing	antibodies
bipolardisorder	episodes	patients	assess	effect	sodiumvalproate
urinarytractinfection	treatment	assess	equivalence	ciprofloxacin
influenza	immunity	contribute	production	antibodies	anti-influenzavirus
edema	mechanism	involved	levels	ammonia
aki	injury	patients	prescribed	furosemide
gvhd	sirolimus	tacrolimus
i-ii	trial	blinded	evaluates	prophylaxis	adhesion
arthritis	drugs	anti-inflammatorydrugs
tumors	delivered	antibodies
leucine	neuronals	neurexins	series	link	ts
pain	propofol-induced
fluvoxamine	activity	onset	observed	associated	depressivedisorder
type2diabetes	impaired	preserved	effect	peptide-1	glucagon-like
viralinfection	stage	mechanism	response	activate	infections	viruses
chroniclymphocyticleukemia	treatment	agents	one	is	fludarabine
hypertension	established	use	diuretic
hivpositive	frequently	rejected	hiv
hiv/aids	crisis	responds	critical	research	prevalence	acceptance	hiv-related
aids	relief	plan	fight	fund	policies	hiv/aids
acquiredimmunodeficiencysyndrome	hiv
silicosis	lungdisease	characterized	lesions	occurs	due	accumulation	particles	silica
severeacuterespiratorysyndrome-associated	coronavirus	sars-cov
influenzavirusinfection	determine	focus	viruses
hiv/aids	member	had	hiv-infected
streptomycin	susceptibility	tested	collected	patients	pulmonarytb
transmissiblespongiformencephalopathy	originating	reported	infectivity	prion
malaria	treatment	sp	sulphadoxine-pyrimethamine
insulin	sensitivity	modulate	exacerbate	glucoseintolerance
virus	xinjiang	known	viruses
pain	severity	lower	groups	received	remifentanil
prionprotein	conversion	associated	diseases	priondiseases
hypocalcemia	had	subjects	proportions	%	calciumacetate
malaria	exposure	-rrb-	trial	doxycycline	chloroquine
high-fat	meals	induced	present	individuals	insulinresistance
anaphylaxis	diagnosed	patients	facilitate	administration	adrenaline
tb	regimen	treatment	rifampin	pyrazinamide
clls	after	mono-therapy	fludarabine
bacterialinfection	children	%	prescribed	antibiotics
hbv	hepatitisbvirus
dcm	cad
vitamins	was	diagnosis	cancer
hbv	infections	hepatitisbvirus
smallpox	agent	variolavirus
tb	tuberculosis	agent	mycobacteriumtuberculosis	mtb
chronichepatitis	patients	studied	level	triglyceride
hivpositive
hypoglycemia	increase	greater	fourfold	response	glucagon
hbv	-rrb-	-lrb-	hepatitisbvirus
œvirus	$	build-up	factoriesâ	$	infected	viruses
hypertension	pathogenesis	complex	induces	loss	estrogens
insulin	analogs	decrease	risk	diabeticketoacidosis	dka
type2diabetesmellitus	t2d	therapy	insulin
rickets	prevention	role	vitamind
virus	viruses
insulin	delivery	limiting	predispose	type2diabetesmellitus
ptsd	examined	ptg	focusing	each	factors	ptg
atopicdermatitis	undertook	gain	signatures	distinguish	atopicdermatitis
tuberculosis	diagnosis	standard	serves	ability	mycobacteriumtuberculosis
atrialfibrillation	patients	reduce	drug	warfarin
tb	cases	infected	increased	those	infected	m.tuberculosis
mrsainfection	treatments	source	antibacterialagents
spottedfever	cases	cause	determine	screened	ticks	collected	arkansas	rickettsiae
hbv	dna	hbsag
scrubtyphus	orientiatsutsugamushi
immune-mediatedthrombocytopenia	hypersensitivityreaction
indomethacin	ischemia-reperfusion
mcp-1	âˆ	variants	patients	individuals	sle
sulfurmustard	poisoning	complications	one	obstructivepulmonarydisease
aids	potentiate	ad5-10	eradication	macrophage	hiv-infected
hiv/aids
mono-drug	resistance	proportions	%	%	streptomycin
pain	reduce	conclusions	ompared	chondroitin
malaria	strains	chloroquine	resistance	associated	protein	named	pfcrt	form	able	reduce	accumulation	chloroquine
nausea	terms	comparable	groups	ondansetron
falciparummalaria	treatment	update	programme	mali	efficacy	sulphadoxine-pyrimethamine
oroyafever	cause	bartonellabacilliformis
hiv/aids
cancer	women	treatment	promising	capecitabine
granulomas	analysis	confirmed	biochemical	caseum	identified	cholesterol
malaria	vector	available	control	one	investigate	that	pyrethroids
silver	na	combined	specificity	holds	promise	pneumoniae
lymphoma	consisting	cytarabine

musclerelaxant	suxamethonium
type1diabetes	with	doses	injection	assessing	established	pharmacokinetics	analogs	insulin
osteosarcoma	patients	excretion	mtx
hereditaryhemochromatosisâ	$	drawn	present	suggesting	exerts	circulating	stores	iron
type1diabetes	infused	glulisine	zinc-free
aids	declaration	led	pandemic	hiv
hc-030031	reversed	models	model	neuropathicpain
type2diabetes	model	evaluate	sitagliptin
mrsa	-rrb-	emerged	isolates	s.aureus
hiv/aids
hbv	hepatitisbvirus
avianinfluenzaviruses	influenzaviruses
seizures	approved	formulation	lamotrigine
type2diabetes	patients	treatment	agents	class	first	sitagliptin
tb	contraindication	vaccine	bacilluscalmette-guerin
high-fat	meal	given	injection	examined	individuals	type2diabetes	impairedglucosetolerance
tuberculosis	treatment	course	phase	dying	patients	%	infected	resistant	isoniazid
uc	associated	localization	showed	therapy	sulfasalazine
hypercholesterolemia	triglycerides	hdl-cholesterol
tb	model	disrupted	relationship	m.tuberculosis
trypsin	inhibitor	used	drug	patients	disorders	pancreatitis
polymyositis	patients	evaluated	treatment	immunosuppressive
rheumatoidarthritis	reduced	immunomodulators	form	methotrexate
mrsa	infections	s.aureus
fondaparinux	associated	reduction	complications	bleeding
antibodies	ama	profile	established	diagnosis	pbc
hyperglycemia	protected	reduced	concentrations	insulin
typhoidfever	diagnosis	aid	report	development	kit	detection	antibodies	salmonellatyphiâ
schizophrenia	symptoms	effective	haloperidol
hbv	detection	seroreversion	hbsag
chronichepatitisc	virus	therapy	interferon
glargine	youth	type1diabetes
insulin	users	risk	cancer
ibs	fulfilling	patients	received	mg	tegaserod
vomiting	treating	supporting	authorized	used	ondansetron
varicella	infected	reported	receiving	vaccination	vzv
hyperglycemia	accumulation	fat
zoster	vaccines	stability	increasing	useful	suggests	ability	ride	enhance	infectivity	vzv
tuberculosis	treatment	efficacy	undermines	emergence	resistance	m.tuberculosis
measles	elimination	goal	view	is	assess	circulation	measlesvirus
hypersensitivityreactions	factors	allergies
alcohol	use	reasons	included	avoid	suppress	pain
omega-3fattyacids	enriched	emulsion	safe	patients	ards
hmd	maculardystrophy
antipyretics	received	patients	characteristics	compare	evaluate	children	upperrespiratorytractinfections
cll	patients	resistant	fludarabine
hantavirusinfection	respond	confirming	involved	recognition	hantavirus
thromboembolism	complication	patients	admitted	heparin
type2diabetes	30	underwent	evaluation	production	secretion	insulin
shortstature	deficiency	gh	treated	children	review	safety	growthhormone
tb	-rrb-	detect	m.tuberculosis
hypercholesterolemia
acquiredimmunodeficiencysyndrome	treating	agent	activity	anti-hiv
hepatitisb	patients	%	achieved	transition	hbsag
pupillarydilation	inducing	effective	showed	effective	combination	tropicamide
hiv/aids	information	neglected	hiv
h5n1	avianinfluenzaviruses
insulin	production	glucoseintolerance
typhoidfever	caused	salmonellatyphi
pain	enhanced	capsaicin
tb	used	vaccine	bacillus	matter	efficacy	bcg
pain	specialists	attended	discuss	predicting	plaster	lidocaine
hydralazine	cessation	commenced	commenced	lincomycin	bloodstreaminfection
cancer	equivalent	tegafur/leucovorin
tuberculosis	agent	mycobacteriumtuberculosis	mtb
asbestosis	diseases	causes	knowledge	people	handled	handle	asbestos
hypovitaminosisd	insufficiency	vitamind
rheumatoidarthritis	role	risk	examined	antibody
hypercalcemia	reduce	used	calcitonin
i-lvd	lvd	studied	analyzed	tissues	carcinoma
strokes	promote	reported	levels	arginine
transmissiblespongiformencephalopathies	cause	agents	prions
tuberculoid	borderline
pimecrolimus	calcineurininhibitors	treat	lupus
pain	model	breast	marrow	increased	concentration	formaldehyde
ponv	prevent	way	treatment	combination	metoclopramide
anthrax	outbreak	animals	b.anthracis
blackdeath	caused	y.pestis
rotavirusinfection	known	have	rotaviruses
antiviral	therapy	responses	associated	liverfailure
virus	viruses
epileptic	activity	model	induced	injection	pentylenetetrazol
androgens	occurs	patients	obese
pain	prevention	ketorolac	surgery	represent	paracetamol
fungaldiseases	answer	necessary	proteins	fungi
hivinfection
cancer	involvement	treated	carboplatin
hepatitisc	spread	deal	contributing	lack	awareness	transmission	screening	hcv
cr	exercise	combination	reduced	insulinresistance
hiv/aids
h5n1	avianinfluenzaviruses
humanimmunodeficiencyvirus/acquiredimmunodeficiencysyndrome	epidemic	hiv/aids
tumor	load	affect	animals	injected	dose	transposon	statin
ion	channels	biology	discusses	cp
reflux	dysphonia	quality	omeprazole
virusinfection	avoidance	improved	combination	ribavirin
dyskinesia	system	dopaminergic
thromboembolism	prophylaxis	licensed	heparin	enoxaparin
lymphomas	therapy	studied	has	activity	toxicity	r-chop	-LSB-	hydroxydaunorubicin
adjuvant	5-fluorouracil	treatment	cancer
hiv/aids
insulin	has	factor	cancer
l-asparaginase	immediately	features	headache
melatonin	timing	demonstrated	stroke
plasmodiumfalciparummalaria	cases	therapy	recommended	quinine
aminoacid	insertion	variety	domain	impacted
antiviral	prescription	intensity	pain
alcohol	consumption	established	factors	development	gout
nsaid	prescription	predicted	was	association	intensity	prescription	pain
type2diabetes	part	relationship	disconnected	sensitivity	insulin
chronichepatitisb	hbeag	¯	lamivudine
hbv	gene	hbsag
silicosis	risk	exposed	silica
cll	patients	resistant	fludarabine
androgen	cells	cancer
cholesterol	levels	showed	patients	stroke	tia
acquiredimmunedeficiencysyndrome	hiv
hiv/aids
alcoholism	field	used	problems	alcohol
hypothyroidism	overt	patients	syndrome	unresponsiveness	tsh
aids	patients	hiv-positive
influenza	season	compared	influenzaviruses
tuberculosis	vaccine	employed	japan	mycobacteriumtuberculosis
tuberculosis	vaccine	provide	bcgvaccine
mrsa	carriage	associated	-lrb-	s.aureus
hyperglycemia	reduce	used	greater	appears	plays	role	administered	doses	insulin
cancer	equivalent	regimen	setting	adjuvant
juvenileidiopathicarthritis	treatment	methotrexate	mtx
tuberculosis	agent	mycobacteriumtuberculosis	mtb
nac-5-htr4	overexpression	upregulated	nac-cart	provoked	anorexia
type1diabetes	history	woman	came	discontinuing	therapy	insulin
pain	sensitization	propofol
apl	patients	monitoring	species	arsenic
abciximab	therapy	stenting	artery	infarct
rotavirusgastroenteritis	case	associated	factors	importance	rank	asking	test	assess	impact	rotavirusgastroenteritis
sodiumvalproate	effect	assess	patients	episodes	bipolardisorder
cd	y	33.4	y	uc
malaria	evaluated	safety	artemether-lumefantrine
type2diabetes	treatment	approved	agonists	exenatide
melanoma	enrolled	trial	treated	dacarbazine
melanoma	patients	therapy	trial	ifn
tuberculosis	augment	strategy	represents	vaccination	bcg
anti-hbv	antibody	hepatitisbvirussurfaceantigen
erythropoietin	analogue	treatment	evaluate	patients	acutemyocardialinfarction
hypothyroidism	revealed	patients	introduced	substitution	l-t4
commoncold	suffering	patients	treatment	mg	ginseng	mg	vitaminc
antiviral	treatment	male	infection	hbv
pain	assessment	measuring	demonstrated	efficacy	iv-ibuprofen
salivaryhypersecretion	congestion	insomnia	aes	common	er	paliperidone
hivinfections	increase	prevent	continue	need	incidence	hiv
nausea	found	groups	dexamethasone
alcohol	financing	programme	cvd
tb	incidence	correlation	year	introduction	rifampin
onchocerciasis	infected	individuals	events	risk	assess	important	use	combination	ivermectin
t2d	subjects	determined	intake	achieve	infusion	insulin
thromboembolism	users	oralcontraceptive	containing	drospirenone

type2diabetes	action	retain	doses	glargine
hiv/aids
glaucoma	evaluate	efficacy	mmc
hiv/aids	clinic	visited	patients	carried	hiv
pain	rated	intensity	reduced	comparable	groups	%	tramadol
cancers	ablation	candidates	nanoparticles	platinum
pain	incidence	lower	that	remifentanil
hbv	hepatitisbvirus
acne	patients	have	treatment	isotretinoin
hivinfection	inhibit	mechanisms	contain	women	cvl	hiv
methicillin-resistantstaphylococcusaureus	oxacillin
pain	combination	determine	effect	chondroitin
melanoma	protect	provide	rationale	use	vaccines
insulin	infused	type	obese
enzymes	study	necessary	have	type	neoplasm
dehydrated	state	relative	occurred	resulted	replenishment	contains	glucose
type2diabetes	lower	insulin
ar	selectivity	was	preserved	attachment	chains	amide-linked
bacterialinfection	likelihood	underestimate	children	leading	undertreatment	antibiotics
type2diabetes	monotherapy	q.d.	plus	therapy	pioglitazone

mrsa	-rrb-	-lrb-	s.aureus
pupillarydilation	inducing	effective	showed	effective	combination	tropicamide
triglycerides	insulin	insulinresistance
anthrax	cause	pathogens	bacillusanthracis
cmv	humancytomegalovirus
hbv	period	hbig	suggest	shown	globulin	populations	result	acquisition	hepatitisbvirus
granuloma	development	caseation	dysregulation	metabolism	lipid
tb	regimen	treatment	rifampin	isoniazid
sars	severeacuterespiratorysyndrome	illness	caused	virus	sarscoronavirus	sars-cov
coccidioidomycosis	results	had	proportion	determined	tested	spp.	coccidioides
hivinfection	onset	age	estimates	using	used	calculate	cost	disability	adjusted	year	saved	measure	cost-effectiveness	type	intervention	hiv
thiamine	concentrations	linked	sensitivity	humans	thiaminedeficiency
poliomyelitis	eradication	challenges	include	reinfection	areas	outbreaks	circulating	polioviruses
constipated	appeared	subjected	diarrhoea	castoroil
hemophiliaa	form	report	<	factorviii
hypertension	history	had	excluded	subjects	receiving	thyroxine
vitamind	role	implicates	autoimmunediseases	multiplesclerosis
b-celllymphoma	cells	rituximab
ptc	cancers
poliomyelitis	agent	poliovirus
lipid	droplets	arise	mr	indicating	estimated	mr	observed	carcinomas
gaucherdisease	models	responsible	lipid
interleukin-2	±	gene	il2ra/cd25	emerging	gene	rheumatoidarthritis
diarrhoea	castoroil
hepatitisb	patients	lamivudine-resistant
hivinfection	facilitating	involved	disrupt	independence	hiv
tumor	proliferation	responsible	levels	estrogen	hormone
toxin	disposition	mechanism	elucidating	state	renaldisease
hbv-dna	suppression	adefovir	tenofovir
cancer	signatures	outperforms	signature	dm
aids	idus	proportion	estimate	determine	factors	associated	diagnosis	hiv
hbv	hepatitisbvirus
non-smallcelllungcancer	patients	shown	controversial	efficacy	chemotherapy	docetaxel
tuberculosis	progressing	ranging	outcomes	results	infection	mycobacteriumtuberculosis	mtb
kpd	period	insulin-free
pain	compare	lidocaine
allergy
pain	capsaicin-induced
fishoil-supplemented	diet	feeding	reduces	inhibition	proliferation	cancer
hiv/aids
lymedisease	disease	caused	lato	borreliaburgdorferi
mycobacteriumtuberculosis
constipation	antagonists	activator	promising	appear	remain	laxatives	polyethyleneglycol
hotflashes	treatment	explored	therapies	blackcohosh
dengue	outbreaks	prediction	goals	included	share	expertise	tests	identify	used	denguevirus
hivinfection
il-2	expression	stimulated	correlation	observed	donors	vaccinated	virus	hbv
cross-species	differences	contribute	transcriptomes	metabolism	related	lipid
myocardialinfarction	anticoagulant
mdr-tb	8.8	%	prevalence	%	prevalence	isoniazid-resistance
stroke	rates	embolism	similar	those	associated	warfarin
lactamantibiotics	effect	enhanced	in	vivo	related	accumulation	antibiotics	mrsa
hbv	reactivation	preventing	investigate	outcome	lamivudine
vitaminadeficiency	levels	associated	levels	being	awareness	vitamina
cancer	specimens	technique	remains	fixation	formaldehyde
pain	incidence	scores	need	boluses	dose	bupivacaine
tumors	provides	estimate	metabolism	glucose
osteosarcoma	derived	demonstrated	nitrite
amebicliverabscess	treated	metronidazole
sepsis	p	270	=	0.22	$	5â	range	median	had	arm	ciprofloxacin
hyperglycemia	treatment	achieved	inhibiting	±	absorption	glucose
atp	upregulated	tumors
chemical	agents	due	holding	$	cariesâ
hbv	hepatitisbvirus
inflammation	inhibited	acid	asa
melanoma	patients	therapy	trial	ifn
bacterialinfection	elevated	animals	infected	bacteria
breasttumors	receptor-positive	estrogen
asthma	exacerbations	definitions	aligned	metric	bud	effect	inhaler	pressurized	budesonide/formoterol
virus	resistant	plants	expressing	amirnas	designed	target	genome	viruses
dyskinesia	patients	ability	measured	we
virusinfection	transcribed	present	45	viruses
stz	trail	co-injected	mice	characterized	expression	markers	pancreatic	molecule	adhesion
type2diabetes	function	interfere	therapy	insulin
co-trimoxazole	prophylaxis	reduce	hivinfection
tick-borneencephalitis	contribute	viruses
osteoarthritis	treatment	used	injection	celecoxib
tuberculosis	cases	resistance	presence	rifampicin
mono	alkanes	alkanes
hivpositive	females	prevalence	higher	females	hiv
chlamydiainfection	advance	used	establish	making	pdi	protein	identified	attachment	species	chlamydia
cat-scratchdisease	patients	cats	analyzed	relatedness	isolates	bartonellahenselae
evans	dye	elicits	excitation	345-nm
cd	-RSB-	adenoma	caused	endocrinedisease	cushingsyndrome
congenitalshortbowelsyndrome	condition	sbs
gvhd	graft-versus-hostdisease	cause	mycophenolatemofetil
excessiron	removal	protein	characteristics	source	iron	starvation	iron
hemophiliaa	diagnosed	level	factorviii
domperidone	evaluation	lacking	shows	evidence	treatment	vomiting
infectiveendocarditis	cases	number	number	prescriptions	prophylaxis	consisting	dose	amoxicillin
lymeborreliosis	agent	borreliaburgdorferi
pulmonaryembolism	risk	reducing	prescribed	warfarin
colonystimulatingfactor	necrosis	tumor
tumor	$	$	tumors	patients	similar	those	patients	therapy	adjuvant
glaucoma	patients	trabeculectomy	revive	method	revision	mmc
hbv-dna	hepatitisbsurfaceantigen
non-vldl-tg	levels	increased	observed	livercirrhosis
problemdrinking	promote	numbers	outlets	alcohol
onchocerciasis	relied	donation	ivermectin
fungalinfections	preventing	delivery	use	evidence	limited	products	amphotericinb
h5n1-vlp	uptake	neutralization	exhibited	five	antibodies
pneumococcalinfections	models	confer	antigens	pneumococcal
oa	people	participation	evaluated	effects	intake	glucosamine
coronavirusinfection	associated	showed	identification	coronavirus
tb	patients	isolated	strains	m.tuberculosis
virus	use	exposure/release	concerns	alleviating	antibodies
aldehyde	dehydrogenase	activity	expression	chemoresistance	b-celllymphoma-2
coeliacdisease	patients	intake	gluten
hyperglycemia	reduction	giving	reaches	insulin
softtissuesarcoma	ifosfamide
malaria	treatment	artemether-lumefantrine
hivinfections	majority	diagnosed	idus	potential	transmission	hiv
cancer	patients	provides	lapatinib	combination	capecitabine
scabies	treated	ivermectin
malaria	preventing	means	therapy	sulfadoxine/pyrimethamine
adhd	options	increased	introduction	formulations	atomoxetine
carbohydrate	diet	assigned	total	men	type2diabetes
aids	hiv
h5n1	avianinfluenzavirus
type1diabetes	adolescents	underwent	bolus	day	insertion	insulin
vomiting	motivated	efficacy	ondansetron
hbv	carriers	hepatitisbvirus
tuberculosis	treatment	require	regimen	rifampicin
systemiclupuserythematosus	patients	undergoing	therapy	glucocorticoid
avianinfluenzavirus	influenzavirus
il-2	±	ability	reversed	reduce	metastases
alcoholism	pharmacotherapy	represent	indicate	disrupted	reconsolidation	memories	alcohol-related
hiv/aids
glucose	metabolism	improves	mice	obese
viralinfections	cited	examines	related	role	viruses
hbv	infection	chronichepatitisbvirus
cancer	compelled	seek	alternatives	blackcohoshextract
aids	affected	workers	prevalence	hiv
influenza	pandemic	result	gain	influenzavirus
adhd	children	have	response	dexamphetamine	methylphenidate
obesity	reduce	electroacupuncture	ea
hyperglycemia	hypersecretion	insulin
hypertension	patients	received	monotherapy	mg	candesartancilexetil
virus	titres	post-infection	reduced	reduced	viruses
pain	resulted	block	lidocaine
diarrhea	onset	time	reduced	model	castoroil
pneumonia	patients	induction	indicator	production	colony-stimulatingfactor
plague	caused	yersiniapestis
aids	hiv
pain	conditions	efficacious	medicated	lidocaine
hyperglycemia	activity	increased	incorporation	glucose
infectiveendocarditis	cases	number	measures	dose	clindamycin
heat-shock	protein	adsorption	albumin
varicellainfection	students	assess	screening	antibodies	varicellavirus
fmn	cofactors	mono-nucleotide
insulin-resistant	patients	identified	hyperglycemia
hbv	antigen	hbsag
cancer	patients	individuals	adjuvant
infectiousmononucleosis	copies/ml	ã	loads	ebv
iron	accumulation	characterized	cause	hereditaryferritinopathy
ifn	responses	induction	uncoupled	discovery	suggests	intervention	inflammations
pain	decreased	application	capsaicin
tumor	vaccines
chronichepatitisc	infection	hcv
malaria	incidence	reduced	reduced	reduced	sulphadoxine-pyrimethamine
inflammation	onset	metabolism	lipid
anthrax-causing	bacillusanthracis
type2diabetes	effect	known	blunt	rise
diarrhea	castoroil-induced
asthma	brushings	cells	treated	formoterol
type2diabetes	obesity	risks	raised	circulating	insulin
nicotinedependence	aspects	treatment	therapeutics	facilitating	intake	nicotine
hivinfection	monitoring	frequency	guide	starting	therapy	validated	patients	study	hiv
problemdrinking	interventions	expectancies	participantsâ	designated	predictors	response	gender	education	use	sociodemographics	consumption	help	problems	alcohol
insulin-stimulated	uptake	had	patients	type2diabetes-low
thromboembolism	patients	treated	experience	number	warfarin
insecticide	nets	used	inconsistent	evidence	confer	malaria
allergicreaction	dicloxacillin	history	hypersensitivity
type2diabetes	risk	reducing	pursuit	option	represents	fdc	repaglinide/metformin
cholera	areas	samples	detect	species	v.cholerae
asbestos	burden	hazard	view	origins	mesothelioma
virus	model	context	hiv-1	evolution	sequencing	made	time	identification	viruses
melanoma	patients	responses	demonstrating	advantage	dacarbazine
brucellosis	agents	species	brucella
hypertension	treatment	used	drug	torasemide
strokes	prevents	receive	warfarin
tb	resistant	inh
aids	epidemic	driving	variants	hiv
cardiovasculardisease	individuals	identification	contribute	comprehension	intercorrelation	glucose
hepatitisb	members	viruses
chickenpox	cause	varicella-zostervirus
œneurologicallymediseaseâ	$	$	evidenced	2	patients	submitted	employing	detect	borreliaburgdorferi
bacterialinfections	diversity	occurrence	known	recognised	infections	caused	combinations	bacteria
stroke	having	taking	medication	warfarin
pain	decrease	considered	treatment	gabapentin
cross	lack	ca
post-antineoplastic	therapy	patients	index	plaque
ulcerativecolitis	remission	maintenance	considered	aminosalicylates	5-asa
anti-tuberculosis	drugs	pyrazinamide
fits	consequence	considered	co-exist	suggested	series	pyridoxine
cd	uc
sepsis	patients	have	¥	required	mg/kg	amikacin
hyperglycaemia	excursions	glucose
insulinresistance	onset	pref-1	role	gain	measured	metabolism	glucose
promyelocyticleukemia	formation	±	±	retinoicacid
hyperglycemia	ameliorating	possess	property	insulin-like
diarrhoea	effects	frequency	using	frequency	intake	bisacodyl
type2diabetes	p	secretion	correlations	showed	supporting	influence	affecting	secretion	insulin
pain	incidence	is	propofol
malaria	treatment	six-dose	three-dose	suspension	artemether-lumefantrine
h5n1	avianinfluenzavirus
bloodglucose	control	strategies	used	increased	contribution	end-stagekidneydisease
vitaminb12deficiency	related	symptoms	developing	risk	have	expected	categorised	deficient	vitaminb12
tar	dna	redistribution	binding	characteristic	amyotrophiclateralsclerosis	als
inflammation	pathology	leading	negotiate	site	retention	fibres
nicotineaddiction	comorbidity	model	created	injecting	nicotine
mouthulcers	syndrome	presented	woman	vasculitis	antibody-associated
virus	xinjiang	known	viruses
bladdertumor	mice	bcg
hbv	genotypes	expression	rna	antigen	hbsag
chf	f	concentrate	replaced	lipids
pain	recorded	started	infusion	propofol
uti	coli	resistant	ciprofloxacin
chemotherapeuticagents	promote	death	tumor
hyperglycemia	response	load	glucose
cavity	reside	bacteria
carcinoidsyndrome	control	hormone
hiv/aids
ulcer	complications	risks	propose	anti-inflammatoryagents
obese	patients	glucose
terbutaline	mg	administration	causes	type1diabetes
epsteinbarrvirusinfection	consistent	epsteinbarrvirus
vitamine	decreased	risk	pneumonia
virus	activator	observed	destructor	acting	disseminator	viruses

hiv/aids
lymphomas	mantle	combinations	bendamustine	mitoxantrone
metastasis	factor	investigate	studied	analyzed	antibody
prostaglandine	expression	investigate	synthase	patients	dermatomyositis
oflungabscess	paucity	recommended	combination	drainage	therapy	antibiotic
pancreatitis	sitagliptin
hemophiliaa	requires	prophylaxis	factorviii
rheumatism	analgesic
schizophrenia	depressivedisorder	disorders	treatment	approved	antipsychoticdrug
autoimmunediseases	treat	hyperactivated	ifn
cardiopathy-related	disorders	diabetic	disorders	ic	dm
hivpositive	patients	manifest	characterized	non-disclosure	status	hiv
pain	intensity	correlated	mediation	consistent	produced	affected	capsaicin
pain	intensity	average	â	used	opium
chromium	determine	>	stress	type2diabetes
uc	cd
autism	syndrome	children	received	months	bumetanide
malnutrition	estimated	thickness	tsf
melanoma	treatment	accepted	dacarbazine
aids	patients	hiv-negative
hivinfection	inhibit	cvl	hiv
mrsa	-rrb-	s.aureus
adhd	attention-deficit/hyperactivitydisorder	diagnosed	children	evaluate	methylphenidate
campylobacterinfections	proportion	miss	used	found	considered	testing	campylobacter
obese	$	subjects	plasma	triglyceride	performed	trial	diet	low-fat
tb	infection	those	quantiferon	compared	mycobacteriumtuberculosis	mtb
lowbackpain	activity	treatment	patches	lidocaine
mrsa	pattern	extent	different	samples	s.aureus
anti-melanoma	drugs	dacarbazine
type2diabetes	cancer	attributable	mortality	overshadowed	suggest	confer	therapy	insulin
gan	epilayers	formed	scratches	sides	occurred	phenomena	pile-up
chronichepatitisc	virus	hcv
livercirrhosis	rats	received	furosemide
malaria	co-exist	interesting	investigate	has	mefloquine
ham/tsp	correlated	antibodies
intellectualdisability	people	services	development	ensuring	care	set	interventions	combining	inform
hbv	infection	chronichepatitisbvirus
schizophrenia	those	in	exist	acid	one	fas	omega-3
cholera	cause	v.cholerae
aids	acquiredimmunodeficiencysyndrome	infected	people	number	estimates	used	constructed	take	hiv
olanzapine	treated	onset	schizophrenia
aml	cells	daunorubicin
type1diabetes	excursions	assess	effect	timings	insulin
atorvastatin	mg	showed	levels	reduction	prevention	reduced	incidence	stroke
malaria	prevent	fails	areas	resistance	sulfadoxine-pyrimethamine
tyrosine	receptor	play	metastasis
pain	relief	morphine	efficacy	paracetamol

cholera	patients	similar	bowel	abnormalities	had	stools	concentrations	had	found	series	studies	patients	non-vibriocholera
utis	urinarytractinfections	compare	extract	trimethoprim
hg	$	â	â	hbp
hypercholesterolemia	effects	rabbits	feed	cholesterol

ironoverload	complications	management	transfusions	chelation	iron
5-fu	associated	responses	observed	differences	comparable	the	activities	tumor
acutehepatitisc	observed	circulating	cells	hcv-specific
agitation	prevented	midazolam
open-angleglaucoma	patients	haemodynamics	bimatoprost
non-a	non-bhepatitis
asthmatics	intolerance	aspirin
h5n1	avianinfluenzavirus
type1diabetes	counting	carbohydrate	efficacy	assessed	validated	patients	treated	infusion	insulin
zinc	associated	episodes	diarrhea
ingan/gan	wells	growth	relaxed	improves	%	wells
hivinfection	vulnerability	have	expressed	doubts	transmission	hiv
falciparummalaria	therapy	mefloquine-artesunate
dic	disseminatedintravascularcoagulation	pancreatitis
aids	organisation	organisation	counselling	living	hiv
seizure	oxcarbazepine
insulin	sensitivity	modulated	activity	daughters	patients	type2diabetes
atopicdermatitis
atherosclerosis	factor	hyperglycemia	characterized	disease	diabetesmellitus	dm
thromboembolism	do	formulations	containing	levonorgestrel
hyperglycemia	cause	failure	conspicuous	harbinger	disposal	insulin-dependent
cryptococcusneoformans/cryptococcus
apl	leukemia	treat	used	drug	arsenictrioxide
gastritis	reduces	-rrb-	enzyme
hypercholesterolemia	defined	‰	¥	100â	cholesterol
hiv/aids
hiv/aids
painful	sensation	mediate	capsaicin
non-alcoholicfattyliverdisease	incidence	present	patients	treated	valproicacid
malaria	transmission	area	children	investigated	effect	treatment	sulphadoxine-pyrimethamine
tick-borneencephalitis	contribute	viruses
oa	pain	reducing	effective	naproxen
pulmonarytuberculosis	analyzed	presenting	isolated	strains	m.tuberculosis
malaria	exposure	-rrb-	trial	doxycycline
thromboembolism	warfarin
hepatitisc	viruses
leprosy	disease	caused	mycobacteriumleprae
rheumaticfever	causes	humans	pathogen	streptococcuspyogenes
mrsa-related	hospitalizations	number	more	doubled	$	â	number	s.aureus
rise	gives	swelling
t2d	snp	linkage	investigated	comparing	sensitivity	insulin
ulcerativecolitis	remission	maintenance	considered	aminosalicylates	5-asa	referred	agents	mesalamine-based
insulin	users	risk	cancer
epiduralabscess	treatment	beads	antibiotic-cement
mtbdr	plus	had	resistance	inh
influenza	antibodies
immunodeficient	nih	caused	mice	doses	photosensitizer
hbv	reactivation	incidence	reducing	assess	efficacy	lamivudine
ami	make	heparin
insulin	substrate	level	signaling	impaired	insulinresistance
dengueshocksyndrome	complications	borne	arthropod	affects	denguevirus
basalcellcarcinomas	diagnosing	measuring	source	$	nm
transmissiblespongiformencephalopathies	diseases	associated	prionprotein
sz	found	compared	with	hc
aids	progressed	tb	inmates	hiv-negative
nsclc	treatment	provides	therapy	docetaxel
chronichepatitisc	virus	therapy	ribavirin
irondeficiency	associated	risk	deficient	iron
lymedisease	species	borrelia
denguehemorrhagicfever	causing	pathogen	denguevirus
enzyme	develop	hyperhomocysteinemia	factor	vasculardisease
allergies	heredity	children	had	odds	developing	allergy
pain	occasions	associated	use	nonsteroidalantiinflammatorydrugs	nsaids
hiv/aids
pain	capsaicin
antibody	factor	anti-tumor
malaria	exposure	-rrb-	trial	doxycycline	chloroquine
ampicillinsodium	case	endophthalmitis
pain	preventing	effective	mg	lidocaine
hiv/aids	living	associated	perceptions	treatment	hiv
hiv/aids
bleeding	complications	risk	reduces	beneficial	aprotinin
diarrhoea	castoroil
cancer	examined	study	alpha-tocopherol
h5n1	influenzavirus
hiv/aids
carcinoma	androgen-independent
hbv	hepatitisbvirus
colorectaltumors	growth	metastatic	inhibit	used	beauty	sb
severeacuterespiratorysyndrome-coronavirus	coronaviruses
hypertension	-LSB-	â	subjects	‰	diuretic	defined	â	15	had	added	spironolactone
cataract	surgery	vehicle	compare	safety	ointment	loteprednoletabonate
malaria	strategy	launch	sp	sulphadoxine-pyrimethamine
hiv/aids
cancer	patients	tissues	breast	marrow	increased	concentration	formaldehyde
anti-malaria	drug	prophylaxis	mefloquine
obesity	insulinresistance	the	appears	freet4.tsh
hivpositive	tested	hiv
aids	relief	plan	fight	fund	policies	hiv/aids
chemical	signals	gate	development	step	design	diagnosis	priondiseases
cross-over	placebo	separated	5weeks	consumed	pufa	fishoil
dr	microalbuminuria	patients	characterized	is	essence
utis	prevention	had	trimethoprim
infectiousbursaldisease	virus	ibdv
cd	ulcerativecolitis
anti-tuberculous	treatment	starting	measured	responses	mtb
pain	=	scale	measured	seconds	injection	propofol
cmv	humancytomegalovirus
cardiopathy-related	disorders	diabetic	disorders	ic	dm
acquiredimmunedeficiencysyndrome	recognized	investigate	tested	women	participated	1959-1964	hiv
t2d	-rrb-	patients	beginning	insulin
acquiredimmunedeficiencysyndrome	hiv
chronichepatitisc	genotype	treated	ribavirin
speed	loss	dr	cataract
neutropenia	associated	oxaliplatin/docetaxel
interferon	influenzavirusinfection
malaria	changed	disease	causing	resistance	chloroquine
type2diabetes	%	documented	%	glucose
rheumatoidarthritis	type1diabetesmellitus	dm
hypothyroid	group	groups	divided	symptoms	hormone	t4
melatonin	rhythms	timing	impacts	infarction
aids	epidemic	drivers	conclude	led	strength	evidence	linking	hiv
hbv	dna	adefovir	superior	used	adefovir
hiv	humanimmunodeficiencyvirus
type2diabetes	associated	â	one	tissues	insulin
tb-antigens	boost	increased	compared	to	animals	primed	bcg
paratyphoidfever	cause	serotype	salmonellaenterica
swelling	showed	cell	increased	cytokines	-lrb-	co-treatment	ammonia
meningococcalinfections	factor	form	vaccines
fluorescein	bp	bullouspemphigoid
hivdisease	progression	types	susceptibility	impose	candidate	humanimmunodeficiencyvirus	hiv
chemically	engineering	cavities
hivinfection	developed	commencing	zidovudine
hypoglycaemia	numerically	trial	comprising	glucose
obese	individuals	samples	adults	children	undergoing	testing	glucose
cardiovasculardisease	outcomes	differing	evaluate	effects	diets	low-fat
dronedarone	mg	decrease	recurrence	atrialfibrillation
aids	patients	presentation	acquired	manifestations	occur	%	humanimmunodeficiencyvirus	hiv
interferon-alpha	basal	melanocytes	cells	melanoma
rise	giving	cause	suggests	stem	cancer
shock	baseline	cortisol
onchocerciasis-endemic	states	evolved	treatment	ivermectin
hbv	reactivation	withdrawal	lamivudine
alcohol	intake	vary	history	benignbreastdisease
vitamind	status	gain	assessed	study	pneumonia
fat	accumulation	hyperglycemia
5-fu	effect	anti-cancer
streptococcalinfections	interfering	antibodies
carbohydrate	status	divided	individuals	-RSB-	type2diabetes
pain	enhanced	capsaicin
hbv	proteome	hepatitisbvirus
malaria	case-management	describe	replaced	pyrimethamine
hypertension	patients	proved	telmisartan
cholera	results	expulsion	bacteria
hbv	was	group	lamivudine
epilepticseizures	adults	demonstrated	safety	lacosamide
fibre	effect	determine	objective	peppermintoil	treatment	irritablebowelsyndrome
obesity	microbiota	interaction	data	brought	relationship	obesity/fat
tb	diagnosis	improve	plasmablasts	bcg-specific
melanoma	cells	expression	inhibition	enhanced	stimulation	interferon
non-smallcelllungcancer	patients	regimen	compare	regimen	cisplatin-plus-vinorelbine
lymphoplasmacytoidlymphoma	treated	using	rituximab
tb	ltbi	with	-rrb-	risk	identify	tests	detection	antigens	m.tuberculosis
open-angleglaucoma	patients	preference	brinzolamide/timolol
viralhaemorrhagicfever	viruses
tb	infection	those	quantiferon	compared	mycobacteriumtuberculosis
priondiseases	diseases	associated	conversion	prionprotein
ami	pci	become	abciximab	aspirin
hiv/aids	-rrb-	center	program	hiv
hl-60	cells	all-transretinoicacid-resistant
tb	develop	complicated	increase	strains	resistant	drugs	used	mdr	antitubercular
cholera	pandemics	contribute	factors	strains	vibriocholeraeo1
melanoma	protein	mda5	known	ifih1	interferon
sepsis	intervention	suggests	discovery	uncoupled	induction	responses	ifn
jia	juvenileidiopathicarthritis	presentation	describes	antibodies
vomiting	incidence	dexamethasone
tuberculosis	cases	resistance	presence	rif
insulin-resistant	evident	differences	insulinresistance
pain	causes	injection	propofol
type2diabetesmellitus	levels	insulin
deficit	conditions	increased	oil	estimated	phenolics
type2diabetes	insulinglargine	men	response	+	$	metformin	5â	exe	exenatide
virus-specific	assays	establish	determine	viruses
tuberculosis	exposure	history	tst	tst	combination	vaccination	bcg
hypercholesterolemia	patients	therapy	goal	reducing	cholesterol
hyperglycemia	testing	glucose
tb	contraindication	vaccine	bacilluscalmette-guerin
insulin	signaling	versus	insulinresistance
tb	tuberculosis	augment	strategy	represents	vaccination	bcg
melanoma	patients	levels	measuring	explore	mechanism	action	2b	ifn-î
pioglitazone	has	unclear	induces	promotion	obesity
pain	effect	had	study	mg	gabapentin
hormone	secretion	caused	endocrinedisease	cushingsyndrome
type2diabetes	population	characteristics	cardâ	education	insulin
asthmatic	children	%	seen	challenge	asa
autoimmunediseases	patients	estimated	levels	interferon-alpha	ifn
cd	0.69	100,000	uc
alcohol	consumption	hyperuricaemia
falciparummalaria	treatment	artemisinin	primaquine
commoncold	suffering	patients	treatment	mg	study	containing	mg	echinaceaextract
rsvinfection	inhibition	observed	lines	charged	cells	known	binding	rsv
high-fat	diet	contained	found	's	decreases	fa
mdr-tb	resistance	rifampin
hydrogensulfide	have	sdisease	effects	models	ischemia/reperfusion
malaria	treatment	derivatives	quinine
astrocytoma	patients	treatment	temozolomide
albino	mice	toxicity	nitrate
malaria	death	effect	quinine
bacterialmeningitis	viralmeningoencephalitis
ebvinfection	associated	infections	epstein-barrvirus
malaria	morbidity	reduces	treatment	infants	sulphadoxine-pyrimethamine
asthma	control	function	association	budesonide
ion	dose	evaluating	control	tumor
insulin	pump	shut	using	possible	prevent	hypoglycemia
hiv/aids
pain	propofol
cerebralischemia	vulnerable	reductions	delivery	oxygen
pain	treatment	asa
influenza	continues	availability	antiviraldrugs
oestrogen	receptor	status	size	tumour
rotavirusinfections	prevalence	show	children	admitted	gastroenteritis	caused	strains	rotavirus
insulin	dose	remained	risk	dka
hbv	dna	hbsag
virus	lineages	shuffling	recombination	ranged	number	viruses
influenza	patients	shedding	aerosol	facemasks	impact	none	data	aerosol	influenzavirus
type2diabetes	patients	received	therapy	antihypertensive
toxin-1	toxicshocksyndrome
tuberculosis	isoniazid
hypothyroid	group	groups	divided	symptoms	hormone	t4
type2diabetesmellitus	agonist	exenatide
malaria	treatment	sp	sulphadoxine-pyrimethamine
hbv	reactivation	incidence	reduced	lamivudine
oa	okadaicacid
pain	produces	injection	propofol
pain	incidence	reducing	effective	pretreatment	remifentanil
collagen	elisa	pro-peptides	formation	quantification	activation	camp	signaling	eia
vehicle	-lrb-	received	group	-lrb-	groups	divided	mice	albino
hiv/aids	knowledge	association	testing	hiv
obese	subjects	associated	fasting	triglycerides
hl	documented	effect	bleomycin
cancer	tissue	expression	plasminogenactivator	associated	suggests	prolong	overexpression	upa
adenosine	cmr	reproducibility	determine	risk	cad
anthrax	infection	associated	suggesting	effects	toxins	originated	bacillusanthracis
type2diabetes	30	underwent	evaluation	production	secretion	insulin
histoplasmosis	diagnosis	made	performed	revealed	consistent	histoplasmacapsulatum
hbv	vaccination	lack	procedures	contact	carriers	hepatitisbvirus
thromboembolism	prevention	indications	agents	include	heparins
hbv	infection	patients	found	comparison	status	viruses
type2diabetesmellitus	tolerated	results	coverage	concentrations	exenatide
sugar	amounts	incorporate	deregulated	cells	cancer
hivpositive	patients	obtained	results	hiv
pain	resulted	was	association	strength	analgesic
shingles	varicella-zostervirus
statin	use	persistence	‰	proportion	include	outcomes	secondary
cll	cells	effect	terms	$	$	fludarabine
type2diabetes	model	characterized	secretion	insulin
malaria	pregnancy	sulphadoxine-pyrimethamine
maleinfertility	phenotypes	resulting	induced	mito-mice
celiac	diet	eliminate	neutralized	effect	epitopes	gluten
pain	incidence	associated	use	propofol
asthma	quality	questionnaire	twice	âµg	evaluated	effects	therapy	âµg	formoterol
chemicals	use	relies	reduce	number	vectors	malaria
thromboembolism	complication	patients	admitted	heparin
influenza-like	illness	years	younger	total	tested	influenzaviruses
prionprotein	plays	disease	disease	scrapie
cancer	risk	decreases	use	insulin
schizophrenia	diagnosis	participants	trial	risperidone	medication	antipsychotic
hivinfection	induced	ifn	inhibited	replication	hiv
thromboembolism	factor	hyperhomocysteinemia	develop	enzyme	transferase	alanine
ten	benzenoids	lignans	steroids
b-cellcll/lymphoma	2	these	three	associated	suggests	m	cpm
anaphylaxis	mechanism	indicated	prick	testing	up	dilution	enoxaparin
hbv	infection	diagnosed	treated	lamivudine
virus	hepatitis	inactivate	required	levels	defined	viruses
hbv	loads	examined	treated	adefovirdipivoxil
tuberculosis	restrict	recognizing	antigens	mtb-derived
pain	pain	consumption	fentanyl
tb	induced	bcg
cholesterol	²	participation	csf	find	biomarkers	effects	hypertension
xanthine	oxidase	implicated	pathogenesis	cardiovasculardisease
malaria	season	spanning	placebo	given	bimonthly	sulphadoxine-pyrimethamine
pneumonia	susceptibility	warrants	vitamine
rheumatoidarthritis	present	necrosis	therapy	adalimumab
type1diabetes	dose	insulin
pain	assessed	injection	propofol
virus	cycle	role	suggest	conservation	properties	viruses
hiv/aids
ventricularfibrillation	predictors	arrhythmias	reliability	has	substantiated	efficacy	lidocaine
steroid-independent	expression	center	arc
type2diabetes	individuals	comparison	prevalent	all	need	insulin
fetalcirculation	replicated	maternal	milieu	fattyacid
oa	progression	slow	sulphate	glucosamine
tumor	cytokines	necrosis	showed	inhibited	mediators	nitricoxide
irondeficiency	limit	availability	iron
hiv/aids
aids	relief	plan	fight	fund	policies	hiv/aids
painful	part	applied	patches	lidocaine
smallpox	disease	caused	variolavirus
cobalamin	injection	resolved	symptoms	anemia-associated
cmv	disrupted	disrupted	hcmv
cross-sectionally	mdd	ca
commoncold	caused	variety	viruses
hypertension	patients	carvedilol
pneumoniae	infection	treatment	used	macrolides
cholesterol	levels	observed	decrease	risk	cvd
nitricoxide	production	underlie	dysfunction	failure	characterize	endotoxicshock
impairedglucosetolerance	glucose
h5n1	²	neutralization	increased	tgf-î	²	mortality	$	influenzavirusâ
collagen	genes	silencing	approach	oi
hyperglycemia	diabetics	group	group	group	control	glucose
psoriasis	studies	concentrated	lipids	lipids
sle	increased	triglycerides
mycobacteriumtuberculosis	resistant	drugs	ethionamide
hivinfection	either	effects	occur	common	course	infection	humanimmunodeficiencyvirus
hiv/aids	improve	access	services	basic
psychosis	genes	variation	ice
methemoglobinemia	treatment	clinically	used	methyleneblue
malaria	evaluated	safety	artemether-lumefantrine
stroke	recurrence	reduce	pioglitazone	benefit	warfarin
schizophrenia	patients	atypical	therapy	antipsychotic
pain	treatment	become	opioid	formulation	oxymorphone
cd	histopathology	resembles	model	glutensensitivity
non-tuberculous	mycobacteriumtuberculosiscomplex
impairedglucosetolerance	pressure	glucose
ion	chromatography	using	quantified	collected	38	46	asthma
tobacco	dyslipidemia	hypertension
plaquepsoriasis	treatment	evaluated	efficacy	safety	ustekinumabâ	study	failed	medications	methotrexate
pml	patients	isolated	sequences	display	capsid	aminoacids	surface	jcvirus
atherosclerosis	cause	hyperinsulinemia	prevent	added	type2diabetes	receiving	insulin
h5n1	a/ck/malaysia	cloned	develop	nonviral	system	avianinfluenzavirus
hypoglycemia	mg/dl	<	glucose
ventriculartachycardia	abolished	therapy	levothyroxine
cholesterol	diet	kept	investigate	affects	atherosclerosis
cross-protection	offered	taken	forming	basic
infectiousmononucleosis	patients	carried	epstein-barrvirus
virus	incapable	render	denaturation	viruses
kd	kd	showed	frequency	antibodies
type1diabetes	therapy	insulin
pain	induction	inhibited	maprotiline
alcoholism	prevent	antagonist	naltrexone	effects	mediated	level	effects	ethanol-induced
malaria	therapy	recommended	artemether-lumefantrine
hemochromatosis	-LSB-	polymorphisms	genes	iron
magnesiumdeficiency	occurs	intake	magnesium
5-fu	inhibitors	predict	gauge	provides	signature	cells	cancer
urokinase-typeplasminogenactivator	expression	associated	increased	suggests	suppress	growth	tumor
asthma	symptoms	intercurrent	showed	smokers	treated	budesonide/formoterol
anti-seizure	lamotrigine
tumor	environment	induces	formaldehyde
atopiceczema	symptoms	cream	pimecrolimus
type2diabetes	patients	therapy	assessed	metformin
autoimmunethyroiditis	represented	thought	mutations	proteins	involved	tsh
septic-shock	patients	achieving	aimed	norepinephrine
o3	correlation	show	results	uri
osteoarthritis	progression	determine	glucosamine
hiv/aids
cll	patients	isolated	cells	death	fludarabine-induced
lymedisease	causes	bacterium	borreliaburgdorferi
tuberculosis	exposure	history	tst	tst	combination	vaccination	bcg
poliomyelitis	eradication	challenges	include	reinfection	areas	outbreaks	circulating	polioviruses
coagulopathy	induce	hydroxyethylstarch	hes
diarrhea	onset	time	reduced	extract	aurea	drug	loperamide
tuberculosis	cases	933	detected	testing	mtb/rif
hiv/aids
nephropathy	added	losartan
hbv	infection	donations	hbsag
irondeficiency	effects	determine	fed	deficient	iron
multiplemyeloma	improved	bortezomib
pneumococcalmeningitis	patients	lesion	evidence	recognition	important	aggressive	evolution	endocarditis	pneumococcal
tannin-containing	plants	use	explain	inflammatoryboweldisease
excessiron	stored	transported	iron
hypertension	had	carvedilol-naive
virus	depositing	transmitted	viruses
allergies	factors	hypersensitivityreactions
epilepsy	population	levetiracetam
hypertension	patients	reduced	conclusions	regimen	olmesartanmedoxomilâ
tb	disease	those	control	replication	mtb
tb	cases	resistance	presence	rif
irondeficiencyanemia	marker	used	owing	complexity	metabolism	iron
tb	programs	burden	worsening	noted	strains	inh
collagen	integrin	uptake	inhibited	prevented	formation	virusinfection
anteriorpituitary	function	analyzed	rates	tumor
ham/tsp	tropicalspasticparaparesis	carriers	htlv-1
insulin-sensitizing	properties	mediates	protein	related	obesity
pain	incidence	is	propofol
asthma	trials	meta-analysis	have	fluticasone/salmeterol
antibody	lupuserythematosus	sle
jia	cases	genotyping	selected	snps	showed	dm
chronichepatitisc	progress	therapies	ifn
cancer	patients	treated	carboplatin
virus	variation	investigated	duck	isolated	viruses
commoncold	suffering	patients	treatment	mg	study	containing	mg	echinaceaextract
irondeficiency
multiplemyeloma	lymphoma	treatment	approved	homeostasis	results	stress	cause	death	cells	exposed	bortezomib

hbv	replication	suppression	entecavir-induced
tumors	enhance	efficacy	antibodies
virusisolation	time	suffering	respiratorydisease
metastases	improving	reduce	toxicity	cisplatin
type2diabetes	associated	insulin
viremia	associated	outcomes	disease	cause	viruses
antibiotics	prescribed	%	bacteraemia
thrombosis	differences	were	stay	heparin
hbv	reactivation	withdrawal	lamivudine
uti	escherichiacoli	resistant	ciprofloxacin
hypertension	patients	reducing	demonstrated	combination	olmesartan/amlodipine
meth-a	fibrosarcoma	microenvironment	tumor
rickets	findings	disorder	i	referred	±	vitamind
type1diabetes	adolescents	underwent	bolus	lispro
t2d	gene	attracted	regulates	secretion	insulin
hivpositive	subjects	higher	high	warrant	recommendation	screen	status	hiv
antibody	titers	higher	ham/tsp
insulin	association	examined	common	sleepapnea
trenchfever	cause	bartonellabacilliformis	bartonellaquintana
œvirus	$	build-up	factoriesâ	$	infected	viruses
cancer	patients	patients	develop	trastuzumab
enzymes	retained	uses	ten
hepatitisb	seropositive	received	analyzed	monotherapy	entecavir
arthritis	model	investigate	role	mmp-8	collagenase-2
anti-hbv	antibody	hepatitisbvirussurfaceantigen
pain	reduce	dose	lidocaine
antibiotic	treatment	unresponsive	cornealabscess
astrocytoma	paradigms	part	become	agent	alkylating	dna	temozolomide	tmz
acutehivinfection	detection	testing	testing	hiv
hivpositive	mothers	interpreted	risk	transmission	hiv
bacterialpneumonia	clearing	bacteria
calcium	gluconate	resolved	preparation	hypocalcemia
chemotherapeuticagent	irrespective	produce	indicate	depend	agent	carcinoma
hbv	infections	hbsag
tb	tuberculosis	control	requires	mycobacteriumbovis	guerin	bcg
hes-induced	cells	suppressed	inflammation
scabies	mites	determine	tested	pbo	piperonylbutoxide
malaria	incidence	high	low	recommended	treatment	infants	sulfadoxine-pyrimethamine
type2diabetes	diagnosed	taking	insulin
ebvinfection
type2diabetes	subjects	delayed	action	dosages	lispro
calcium	inhibitors	rates	terms	models	differences	are	exhibiting	stage	development	cardiomyopathy
asthmatic	patients	number	responded	challenge	aspirin
psoriasis	treatment	cyclosporine
hivinfection	course	change	level	diversity	individual	hiv-infected
oa	treated	chondroitinsulfate	glucosamine
sars	coronavirus
type2diabetes	therapy	insulin
malaria	patients	treating	sulphadoxine-pyrimethamine
atrialfibrillation	patients	%	receive	warfarin
shigellainfections	manage	reduce	excretion	dominance	bacteria
mrsa	-rrb-	prescribed	antibiotics	activity	investigate	methicillin	infections	s.aureus
cancer	cells	target	agents	used	effective	bisphosphonates
cancer	behavior	associated	american	ca
hbv	reactivation	hepatitisbvirus
breasttumors	%	express	receptor	estrogen
type2diabetesmellitus	sdisease	linked	degrades	²	insulin
acuterheumaticfever	sequelae	infections	streptococcuspyogenes
chronichepatitisc	therapy	interferon
cancers	treatment	chemotherapeuticagents	one	5-fluorouracil
virus	suppressed	forskolin	resulted	reactivation	viruses
hyperglycemia	indexes	using	measures	glucose
tuberculosis	therapy	component	rifampicin
apl	patients	specimens	metabolites	arsenic
avianinfluenzaviruses
tumour	correlate	has	hazard	burden	fibre
apl	acutepromyelocyticleukemia	treatment	therapeutic	used	arsenictrioxide
b-celllymphoma	patients	had	treatment	rituximab
cardiacarrest	patients	groups	compared	patients	followed	mg	epinephrine
msa	atrophy	pathologies	ataxia	sca
multiplemyeloma	/	interferon
ca-mrsa
type2diabetes	presumably	glucose
strokes	prevent	explain	utilization	warfarin
pain	shortens	addition	acetaminophen	lidocaine
pml	progressivemultifocalleukoencephalopathy	ranging	reported	prevalence	polyomaviruses
influenza	evidence	seems	has	effect	evolution	influenzavirus
malaria	adopted	artemether/lumefantrine
glucocorticoid	revealed	adrenalhyperplasia
qfever	zoonosis	caused	coxiellaburnetii
h5n1	influenzaviruses
type1diabetes	demonstrated	lowered	doses	insulin
pain	injection	propofol
chronichepatitisc	treatment	interferon
aids-related	diseases	presence	increases	shown	hiv
apl	patients	undergoing	treatment	arsenic
malaria	programmes	context	approaches	inform	screening	administered	needed	safety	primaquine
ion	chromatography	using	quantified	collected	38	46	asthma
t2d	patients	plasma	levels	cholesterol
pain	stimulation	observed	changes	activation	-rrb-	c-amp-responsive
aids	women	higher	is	participate	women	hiv-positive
mrsa	transmission	prevent	reduce	define	burden	disease	s.aureus
cancer	ve	patients	treated	chemotherapy	mg/m2	paclitaxel
astrocytomas	management	review	role	tmz
cancer	women	options	better	tool	addition	bisphosphonates	therapy	adjuvant
influenza	epidemic	pre/post	%	positive	influenzavirus
type2diabetes	genes	studies	confirmed	associated	variant	mass	fat
tularaemia	consistent	showed	found	dna	francisellatularensis
enterovirus	enteroviruses
osteoarthritis	determine	effect	glucosamine
anthrax	factor	toxin	bacillusanthracis
amnesia	induced	scopolamine
asthma	control	function	association	budesonide
type2diabetesmellitus	characterized	defects	secretion	insulin
pulmonaryembolism	event	receiving	phenprocoumon
tb	drug	resistant	important	identification	isolates	belonging	-rrb-	mycobacteriumtuberculosiscomplex
irondeficiency	screening	supplementation	iron
type2diabetes	naive	insulin
dyspepsia	risk	events	nsaid-related
glucose	metabolism	improves	suggesting	therapy	type2diabetes
shigella	validated	bacteria
hyperglycemia	characterized	secretion	insulin
humaninfluenza	that	resembles	used	study	pathogenesis	influenzavirus
chikungunya	bunyaviridae
zona	incerta	septum	labeled	antibodies
insulin-induced	stimulation	reduced	presumably	type2diabetes
cancer	patients	treating	improve	effects	therapy	adjuvant
inflammation	reduction	%	indomethacin
osteoarthritis	patients	lesions	determine	effect	treatment	chondroitinsulphate
cyclophosphamide	mg/m2/day	epoch	course	receive	went	treatment	viremia	cytomegalovirus
malaria	risk	reducing	recommended	treatment	ulphadoxine-pyrimethamine
bleeding	provide	bivalirudin	inhibitor	thrombin
tb	incidence	reduce	needed	protect	rin	bcg
progressivemultifocalleukoencephalopathy	ranging	reported	prevalence	polyomaviruses
hiv/aids
hiv/aids
type2diabetes	improve	insensitivity	insulin
cancer	women	treatment	promising	docetaxel
methicillin-resistantstaphylococcusaureus	infection	length	predictor	bacteriuria	s.aureus
chloroquine	cq	treat	rdt	use	recommends	diagnosed	malaria
type2diabetes	improve	used	metformin
hit	risk	characterized	complication	therapy	heparin
ebvinfection	contribute	suggests	dhs	ebv-associated
ventricularfibrillation	preceded	avoid	suppression	arrhythmias	lidocaine
anthrax	toxin	toxin	determinant	bacillusanthracis
empyema	created	injection	bacteria
psoriasis	severity	reduces	treatment	cyclosporine
cancer	biomarkers	form	vary	products	chemical
systemiclupuserythematosus	antibody
hbv	infection	diagnosed	treated	lamivudine
carcinoma	lines	used	ovarian	a2780cis	cisplatin-resistant
hbv	protein	x	leading	protein	hepatitisbvirus
malaria	patients	ethiopia	effectiveness	-rrb-	chloroquine
hbv	resulting	liverdiseases	remains	advances	treatment	infection	chronichepatitisbvirus
aids	hiv
melanoma	treated	2b	ifn-î
inflammation	pathology	initiation	leading	retention	hypothesis	behaviour	fibres
denguehaemorrhagicfever	agents	dengueviruses
chf	f	concentrate	replaced	lipids	diet	chow	low-fat
basic	parameters	patients	leptomeningealmetastases
colony-stimulatingfactor	treatment	evaluate	patients	acutemyocardialinfarction
geminiviruses	exhibit	shown	replicated	viruses
arthritis	characterized	children	syndrome	immunoglobulin
mycosisfungoides	patients	reported	ulceration	methotrexate-induced
hbv	reverse-transcription	±	eradicate	hepatitisbvirus
retropharyngealabscesses	caused	invasion	bacteria
lymedisease	risks	increasing	infected	increases	presence	genotypes	borrelia
hbv	transmission	safety	achieved	hbsag
anaphylaxis	choice	drug	epinephrine
hiv/aids
hiv/aids	clinics	worked	are	%	patients	hiv
enzyme	loading	optimized	proportions	enzymes	²	glucosidase	xylosidase	1,4-xylanase	endo-î
dacarbazine	receiving	had	progression	tumor
cobalt	display	hypoxia
adhd	symptoms	reducing	demonstrated	efficacy	tablets	modafinil
ddt	performed	adults	collected	assess	susceptibility	vectors	malaria
htlv-1-associatedmyelopathy	tropicalspasticparaparesis	disorder	agent	type	htlv-1
hiv/aids
falciparummalaria	treatment	recommended	unknown	added	dose	primaquine
pre-eclampsia	management	focuses	management	seizures	using	magnesiumsulfate
ironoverload	degree	corresponding	brain	increased	expression	hepcidin	iron
tumor	necrosis	fattyacids
anti-malarials	consumption	reduce	confirmed	malaria
hiv/aids
fats	financing	programme	cvd
type2diabetes	objectives	study	effects	metformin
h5n1	viruses	pandemic	developed	option	provide	potential	has	identification	neutralizing	antibodies
schizophrenia	trial	-RSB-	aripiprazole
bleedingdisorder	anticoagulants
hbv	infection	endemicity	level	indicate	higher	prevalence	members	individuals	hbsag

septicemia	fulminant	due	died	combination	ceftazidime
worms	recovered	found	praziquantel
malaria	treatment	drug	remains	quinine
tropicalspasticparaparesis	development	lead	infection	humantcelllymphotropicvirustype1
nsclc	patients	shown	controversial	efficacy	chemotherapy	docetaxel
porcinecontagiouspleuropneumonia	disease	caused	actinobacilluspleuropneumoniae
chronichepatitisc	patients	administered	interferon-alfa
aspergillosis	monotherapy	caspofungin
tb	disease	culture-positive	mtb
cutaneouslupuserythematosus	encompasses	variety	lesions	refractory	topicalagents
htlv-1infection
glucose	monitoring	assessed	hypoglycemia
rigidity	increased	positivity	increased	p	208	ã	nm
obesity	investigate	effects	feeding	high-fat
breasttumors	observed	genotyping	polymorphisms	enzymes	tamoxifen-metabolizing
alcohol	$	obsessiveâ	schizophrenia	anxietydisorders
pain	scores	similar	required	patients	group	fentanyl
hbv	replication	action	analog	lamivudine
hyperglycemia	insulin
non-hiv/aids
cavity	shealth	fluoride
methicillin-resistantstaphylococcusaureus	oxacillin	effect	antibacterial
asthma	exacerbations	definitions	aligned	metric	bud	effect	inhaler	pressurized	budesonide/formoterol
ponv	postoperativenauseaandvomiting	prevention	dexamethasone	metoclopramide
pde5inhibitors	enhance	efficacy	antibodies	metastases
cancer	tissue	expression	plasminogenactivator	associated	suggests	prolong	overexpression	upa
irondeficiency	had	suggesting	constitute	deficiencies	iron
opioiddependence	treatment	recommended	agonist	âµ-opioid
virus	schemes	advance	required	breadth	limited	produce	viruses
hiv/tb	adults	rifampicin
antiviral	responses	induce	phagocytose	cells	enterovirus-infected
tumor	necrosis	fattyacids	increases	injection	induced	increase	concentrations	nitrite
cholesterol	synthesis	inhibition	inhibited	uptake	integrin	virus
cystinosis	patients	treated	cysteamine
type2diabetes	develop	risk	indicates	decline	sensitivity	insulin
obese	mice	improves	suggesting	therapy	supplementation	leucine
cancer	cells	apoptosis	induce	dha
caspofungin	effective	groups	those	malignancies	neutropenia
virus	studies	borne	idus
hyperglycemia	disposal	glucose
anti-cmv	therapy	cidofovir
delhi	aged	men	measured	concentrations	lipid
malaria	changed	disease	causing	resistance	chloroquine
type1diabetes	patients	number	approach	î	possibility	suggests	demonstration	persistence	cells	insulin-producing
goitre	rate	thyroxine	t4
h5n1	subtype	avianinfluenzavirus
malaria	treatment	intramuscular	artemether
astrocytoma	iii	temozolomide
virus	monitoring	assessed	introduced	mallards	infected	viruses
multiplemyeloma	lesions	increased	inhibited	suggesting	result	bortezomib
hbv	carriers	increased	decreased	carriers	hbsag
hivinfection	control	correlate	defines	capability	t-cells	hiv-specific
hbv	reactivation	prevent	considered	chemotherapy	patients	hbsag-positive
malaria	treatment	six-dose	three-dose	suspension	artemether-lumefantrine
tuberculous	encephalitis	year	been	drugs	isoniazid
ingan/gan	wells	comprising	emitting	nanostructures	incorporated	emitting	wells
pain	scores	ml/h	appears	bupivacaine
hodgkinlymphoma	patients	documented	effect	dacarbazine
thromboembolism	users	oralcontraceptives	containing	drospirenone
vivaxmalaria	reappearance	related	factors	included	dosage	primaquine
pain	alleviate	make	agents	chondroitinsulfate
bacterialmeningitis	patients	analyzed	quotient	glucose
pain	associated	injection	propofol
hfrs	foci	located	occurred	presenting	transmission	characteristic	hantaanvirus
valproicacid	model	autism
cross-sectional	study	using	recorded	factors	development	bp-onj	patients	therapy	bisphosphonates
irritablebowelsyndrome	treatment	effective	fibre
cancer	response	started	therapy	administration	weight	dexamethasone
antiviral	treatment	including	countered	halve	proportion	ulcers
asthma	quality	questionnaire	twice	âµg	budesonide
hbv	infection	called	replication	genome	liver	absence	markers	hepatitisbvirus
alcoholdependency	disorders	alcohol
cancer	specimens	formalin-fixed
severeacuterespiratorysyndrome	coronaviruses
cu	patients	prevalences	differences	focusing	investigated	patients	urticaria
schizophrenia	patients	plurality	treated	followed	perphenazine
virus	that	equivalent	growth	viruses
ifn-î	production	increased	î	injections	tgf-î	<	production	microenvironment	fibrosarcoma
shortstature	etiology	identified	have	deficiency	growthhormone
collagen	components	affect	adhesion
malaria	treatment	investigated	sulphadoxine-pyrimethamine
iron	function	result	pathogenesis	hereditaryferritinopathy
malaria	chloroquine-resistant
type2diabetes	received	sitagliptin
stroke	induces	indicating	impacts	timing	rhythms	melatonin
hiv/aids	populations	tb	screening	attached	indicated	deserves	prevalence	co-infection	hiv/tb
tumors	bearing	mice	showed	dox
hivpositive	tested	hiv
cancer	patients	provides	lapatinib	combination	chemotherapeuticagents
bradycardia	attenuate	independent	capacity	atropineâ
malaria	parasites	resistance	quinine
prions	distinct	cjd
cancer	survival	counterparts	ca
tor	vergata	hospital	seen	patients	ischemia
epileptic	patients	those	assessment	influence	phase	pharmacokinetics	vpa	valproicacid
pain	alleviating	effective	mixture	lidocaine
adrenergicblocker	suggests	administered	patients	have	tachycardia
hyperglycemia	effects	review	provide	ward	formulating	guidelines	administration	monitoring	glucose
fungalinfections	prophylaxis	approved	posaconazole
malaria	parasites	examined	recorded	use	sulfadoxine-pyrimethamine
immunosuppressive	therapies	respond	patients	safe	patients	focalsegmentalglomerulosclerosis
hivinfection
hivpositive	mothers	developed	wake	epidemic	hiv
pain	reduce	dose	determine	sought	induced	injection	propofol
malaria	treatment	consists	administration	dose	sp	sulphadoxine-pyrimethamine
tumors	therapy	adjuvant
hemorrhagicfeverwithrenalsyndrome	caused	puumalahantavirus
type2diabetes	risk	increase	raise	fasting	levels	insulin
hivinfection	effect	assess	hcv/hiv
type2diabetes	treatment	developed	inhibitor	dpp4	sitagliptin
h5n1	avianinfluenzavirus
tuberculosis	agent	mycobacteriumtuberculosis
cholesterol	levels	adults	be	risk	cognitivedecline
ddt	methyl	irs	allow	predicted	impact	transmission	malaria
irondeficiency	disorders	develop	help	understanding	interplay	factors	involved	regulation	metabolism	iron

schizophrenia	injection	olanzapine
aids	epidemic	early	lesion	hivan
hbv	recurrence	prevention	effective	prophylaxis	lamivudine
zn	explain	strategy	executed	engineering	cavities
deficiencyoffolicacid	anaemia	had	suggesting	constitute	deficiencies	folicacid
antibody	lupuserythematosus	sle
paraffin	samples	allow	help	studies	history	inflammation
h5n1	sources	outbreaks	avianinfluenzavirus
bullouspemphigoid	lotion	cream	dipropionate	treated	mg	methylprednisolone
hyperglycemia	weight	response	load	glucose
hypoglycemia	regarding	effects	fluoxetine
pain	perception	loss	determines	leading	r100w	aminoacid
cryptococcosis	patients	isolated	genotype	strains	cryptococcus
cholera	outbreaks	causing	strains	known	variants	biotype	vibriocholeraeo1
mrsa	cases	with	infection	s.aureus
hg	$	mmâ	â	proportions	included	endpoints	secondary
aids	hiv
acne	used	retinoid	isotretinoin
hivinfection	increases	one	infections	patients	hiv
type1diabetes	patients	decrease	increased	use	insulin

ion	channels	biology	discusses	cp
heparin	contaminants	attributed	cases	anaphylaxis
epileptic	subjects	fosphenytoinsodium	administration	performed	analysis	phenytoin
coronaryarterydisease	suffering	patients	represent	seems	associated	pre/postconditioning	mechanisms	anti-inflammatory
sarcoma	homolog	patients	approved	updated	basis	results	trial	comparing	therapy	adjuvant
type2diabetes	adults	±	randomized	exenatide
scabies	treatment	increased	mediate	resistance	ivermectin
tyrosine	kinase	met	involved	metastasis
leucine	supplementation	effects	investigated	multifold	cause	type2diabetes
melanoma	cells	protrusions	tips	co-localized	f-actin
breasttumors	chemotherapy	implicated	development	independence	estrogen
hiv/aids
htlv-1-associatedmyelopathy	tropicalspasticparaparesis	carriers	htlv-1
type2diabetes	associated	abnormalities	many	sensitivity	insulin
chronichepatitisc	started	combination	interferon-alpha
obstructivepulmonarydisease	objectives	compare	treatment	oxygen
bacterialinfections	treatment	problem	appearance	bacteria
hotflushes	effect	improvement	obtain	modulator	estrogen
tb	cases	higher	circulating	secretion	antibodies	bcg-specific
asthma	worsening	demonstrated	â	‰	long-acting-beta2-agonists	+	beclomethasone
infectiousmononucleosis	recovered	epstein-barrvirus	ebv
tuberculosis	incidence	bcgvaccine
cancer	cells	development	anti-cancerdrug
type2diabetes	t2d	gene	attracted	regulates	secretion	insulin
hbv	infection	occurs	reduced	introduction	screening	antigen	hbsag
tb	tuberculosis	agent	mycobacteriumtuberculosis
fluorescein	avoid	premedicate	antihistamines	patients	albuminsolutionallergy
pge2	mediated	cells	hyporesponsiveness	uc-mscs
uveitis	option	implant	dexamethasone
insulin	secretion	type2diabetes
pain	induces	formaldehyde
vomiting	treating	effective	ondansetron
cancer	genomes	profiling	utilized	enzyme
virus	groups	viruses
virus	strains	viruses
coeliacdisease	patients	intake	gluten
glucose	investigated	type2diabetes
polytetrafluoroethylene	stenting	covered	led	complete	resolution	jaundice
asthma	cells	levels	mp	formoterol
aids	progressed	tb	inmates	hiv-negative
hivinfection	acquired	enrolled	transmission	$	breast-milk	of	trial	nvp
fat	percentage	related	humans	bat	prevalence	shown	suggesting	associated	obesity
virus-infected	cells	added	manner	inhibited	showed	affected	pretreated	viruses
scrubtyphus	cases	caused	strain	-rrb-	orientiatsutsugamushi
haloperidol	treatment	correlated	parkinsonism
anti-tb	vaccines	development	increase	way	investigated	treatment	bcgvaccines
vasculitis	antibody-associated
entericfever	ciprofloxacin-resistant
polyuria	symptoms	basis	level	bloodglucose
insecticides	classes	investigate	one	control	available	vector	malaria
ppi	data	compiling	cryptococcusneoformans
statin	transposon	dose	injected	animals	affect	load	tumor
pain	treatment	drug	acetylsalicylicacid
tuberculosis	tb	mtb
staph	system	agar	culturing	reidentified	isolates	methicillin	using	test	cefoxitin
dengue	outbreaks	prediction	goals	included	share	expertise	tests	identify	used	denguevirus
antibodies	efficacy	enhance	tumors	metastasized
whoopingcough	pertussis
rockymountainspottedfever	agent	rickettsiarickettsii
type2diabetes	those	need	treatment	insulin
mdr-tb	classified	rifampicin
type2diabetes	use	insulin
allergicasthma	occurs	hypersensitivityreaction
inflammation	control	genes	expression	showed	treated	prednisone
candidiasis	infection	treatment	agents	use	patientâ	spectrum	species	candida
cancer	cells	controls	lh/hcg
m.tb	mycobacteriumtuberculosis

tb	trials	bcg-based
shortstature	etiology	identified	have	deficiency	growthhormone
aspergillosis	limit	likely	choice	amphotericinb
sars-coronavirus	sars-cov
ingan/gan	wells	comprising	emitting	nanostructures	incorporated	emitting	wells
insulinglargine	n	using	patients	had	incidence	dka
convulsions	severity	rates	dose50	bupropionhcl
cross	reacts	antibody
cancer	line	association	cxcr4	transactivate	plays	role	migration	igf-i-induced
tb	progression	involves	development	granuloma	cavitates	bacilli	mycobacteriumtuberculosis
antiviral	responses	reduced	hantavirusinfection
virus	induction	encoded	ns1	viruses
collagen-induced	model	arthritis
oa	effects	treatment	patches	lidocaine
hivinfections	upstream	consider	evaluate	effectiveness	prevention	hiv
multiplesclerosis	type1diabetesmellitus	dm
insulin	decrease	stimulates	hypoglycemia
m.tb	mycobacteriumtuberculosis
sugar-binding	sites	crds	unit	rigid
breasttumors	status	double	progesterone
sarcomas	etoposide	doxorubicin	cyclophosphamide	alternating	ifosfamide
schizophrenia	history	have	those	clozapine-user
tb	programs	undermines	emergence	resistance	m.tuberculosis
irondeficiency	treatment	iron
type2diabetes	those	secretion	investigate	sensitivity	insulin
malaria	shown	combination	artemether-lumefantrine
viruses
hbv	reactivation	developed	developed	therapy	lamivudine
obese	rats	show	levels	choline
asthma	outcomes	achieves	monotherapy	budesonide
tuberculosis	vaccine	employed	japan	bcg
breasttumor	formation	estrogen-induced
mdr-tb	isoniazid
type2diabetesmellitus	assists	sitagliptin
nm	precursor	injection	sufficient	confirmed	amelioration	fibrosis
acidosis	encephalopathy	melas	treat	supplementation	l	arginine
v.cholerae
hypoglycemia	stimulates	secretion	glucagon
cancer	examined	effects	carotene
hbv	infections	hbsag
anti-tuberculosis	drugs	isoniazid
photosensitizer	doses	mice	caused	suppression	growth	tumour
aids	hiv
ventriculartachycardia	exacerbated	flecainide
malaria	control	issue	development	known	performed	efficacy	arthemeter-lumefantrine
cd	-RSB-	cushingdisease
type2diabetes	provide	detemir	insulin
tb	stages	individuals	produced	mtb
nitricoxide	metabolites	concentrations	increase	induced	injection	increases	fattyacids	necrosis	tumor
type2diabetes	patients	options	provides	analog	insulin
hl	documented	effect	vinblastine
high-fat	mice	obese
oa	management	be	use	glucosamine
asthma	symptoms	relief	used	combination	budesonide/formoterol
autism	treat	agent	bumetanide
tularemia	agent	bacterium	francisellatularensis
tularemia	agent	francisellatularensis
esophagealcancer	radiotherapy	combined	result	cisplatin
hypertension	type2diabetes	patients	stage	independent	tolerated	added	losartan
cmv	reduced	tagged	ie2	homologue	hcmv
pill	burden	complicated	treatment	tb
adenocarcinoma	woman	developed	caused	cycles	chemotherapy	paclitaxel
hiv/aids
glucose-6-phosphate	dehydrogenase	enzyme	worldwide	enzymopathy
interferon-alpha	basal	melanocytes	cells	melanoma
hiv/aids	heard	those	reported	said	healthy	looking	spread	hiv
tuberculosis	vaccine	employed	japan	mycobacteriumtuberculosis	isolate	mtb
type1diabetes	patients	control	glucose
myocardialinfarction	endpoint	reduced	%	%	clopidogrel
meningococcalsepticaemia	model	-rrb-	n.meningitidis
rmg-i	cells	adhesion
virus	infectivity	quantification	determination	quantification	performing	compared	characteristics	viruses
hivdisease	course	clinics	associated	access	care	hiv
ezetimibe	diet	addition	improve	inflammation
bleedingdisorder	hereditary	deficiency	vitamink-dependent
tuberculosis	control	tool	genotyping	mycobacteriumtuberculosis
hivinfection	therapy	exhibit	range	dysfunctions	contribute	pathogenesis	hiv
hivinfections	survey	linkage	diagnosed	categorized	uklfu	record	attendance	clinic	hiv
ptsd	relate	relate	factors	ptg
granulomas	resulted	improved	treatment	inh
rickettsiosis	cause	identified	monacensis	rickettsia
viruses
pain	perception	loss	determines	leading	r100w	aminoacid
melanoma	sensitized	dtic
lvh	regression	favor	concluded	considered	employing	nitrates
type2diabetes	metformin
antipsychoticdrug	approved	treatment	disorders	depressivedisorder
timololmaleate	patients	ocularhypertension
hiv/aids
cancer	ebrt	combination	provides	option	brachytherapy	adjuvant
epinephrine	ans	responses	increased	hypoglycemia
inflammation	diabetes	test	glucose
hyperglycemia	reanalysis	outcomes	assess	effect	variability	glucose
hiv/aids
hiv/aids
g6pddeficiency	showed	cases	assay	enzyme

cross-protective	antibodies
otalgia	syndrome	presented	woman	vasculitis	antibody-associated
rheumatoidarthritis	patients	reveal	increase	doses	anakinra
ranolazine	reduced	incidence	supraventriculartachycardia
high-carbohydrate	meals	induced	present	individuals	insulinresistance
africantrypanosomiasis	treatment	used	eflornithine
sugar	bait	methods	decimate	based	determined	control	district	mali	africa	west
infectiousmononucleosis	increased	ebv
cancer	lines	subset	compounds	platinum
lungtumor	line	caspase-3	sensitivity	role	investigated	paclitaxel
pain	tolerable	hr	patches	fentanyl
precociouspuberty	diagnosis	test	gonadotropin-releasinghormone
obstructivepulmonarydisease	progression	factors	recognized	tension	delivery	oxygen
hypoglycaemia	incidence	associated	colesevelam	combined	range	agents	glucose-lowering
mycobacterialinfection	implicated	events	recapitulate	designed	model	using	demonstrated	recovery	mycobacteria
tb	contraindication	vaccine	bcg
adhd	treatments	result	reports	results	amphetamines	secondary	patients	using	atomoxetine
estrogens	circulating	risk	cancer
loteprednoletabonate	ointment	safety	compare	vehicle	treatment	pain
type1diabetes	autoantibodies	screening	identified	mutations	insulin
meth-a	fibrosarcoma
tumor	location	characteristics	evaluated	terms	rate	dm
type2diabetes	excursions	improves	exenatide
aids	stage	hiv
virus	triggered	antimycin	inducer	viruses
pain	reduce	dose	lidocaine
tb	regimen	pyrazinamide
pain	injection	propofol
lidocaine	patches	applied	exhibited	showed	questionnaire	oa
exenatide	group	pancreatitis
metal	hypersensitivity
hypoglycemia	assessed	monitoring	glucose
haloperidol	receiving	patients	had	dyskinesia
virus	$	/	a/swine/mn
autoimmunediseases	genetics	advances	review	attempt	understand	role	interferons
osteoporosis	treatment	grade	significance	vitamind
insulin	signaling	associated	insulinresistance
vomiting	pain	recurrences	prevent	lorazepam
hypoglycemia	responses	sensors	glucose

aids	provided	plan	fight	hiv
gardnerella	sneathia	genera	marker	identified	bacterium
hbv	hepatitisbvirus
bacterialinfections	m.tb	rifampin-resistant
gastroesophagealrefluxdisease	treatment	literature	review	emphasis	protonpumpinhibitors
chronichepatitisc	patients	therapy	pegylated	combined	with	drug	ribavirin
cannabinoids	administration	leads	phenotype	associated	model	schizophrenia
malaria	recommendations	promoting	accompanied	change	policy	malaria	sulfadoxine-pyrime-thamine	artemether-lumefantrine
pneumonicplague	agent	yersiniapestis
tuberculosis	syndrome	adherence	include	levels	antitubercular
discoidlupuserythematosus	patients	lupuserythematosus
pulmonaryembolism	risk	reducing	prescribed	warfarin
schizophrenia	patients	soc	risperidone
tumor	lrr	risk	are	survival	correlation	metastasis	dm
breasttumor	samples	estrogen-receptor
openangleglaucoma	anglerecessionglaucoma	reduced	g	paracetamol
chronichepatitisb	affects	is	remain	infection	hepatitisbvirus
h5n1	influenzavirusinfections
virus	particles	interactions	reflecting	cause	cultured	viruses
hypoglycaemia	avoid	levels	bloodglucose
irondeficiency	drawn	present	suggesting	exerts	circulating	stores	iron
epileptic	patients	treated	valproicacid
hypothyroidism	that	higher	t3
type2diabetes	patients	atherosclerosis	prevention	review	effectiveness	pioglitazone
tb	granulomas	expressed	genes	sequestration	lipid
flush	response	patch	niacin
pain	causes	injection	propofol
glucagon	levels	remained	increased	decrease	insulin	hypoglycemia
cancer	chemotherapy	adjuvant
hbv	infection	suffer	administrated	immunoprophylaxis	immunoglobulin	hbig
hypersensitivity
malaria	patients	ethiopia	effectiveness	-rrb-	chloroquine
virus	protein	analysis	provided	related	viruses
type2diabetes	manage	use	review	detemir	insulin
lipid	peroxidation	inhibition	oxidant	hyperglycemia
hiv/aids-related
malaria	shown	combination	artemether-lumefantrine
tetanus	disease	produced	clostridiumtetani
malaria	changed	cq	artemisinin	therapies	sulphadoxine/pyrimethamine
hla-dr/cd38	co-expression	markers	expression	reduced	administration	leflunomide
tuberculosis	have	received	bcg
diarrhea	onset	time	reduced	extract	aurea	drug	loperamide
malaria	treatment	sp	sulphadoxine-pyrimethamine
chickenpox	cause	vzv
leukopenia	challenge	reduce	vaccines
virus	found	viruses
dr	diabeticretinopathy	complications	associated	diabetesmellitus
tuberculosis	candidate	demonstrated	so2	mycobacteriumtuberculosis
enzyme	targets	predict	cancerdrugs
tb	disease	those	control	replication	mtb
h5n1	antibodies
problemdrinking	interventions	expectancies	participantsâ	designated	predictors	response	gender	education	use	sociodemographics	consumption	help	problems	alcohol
cryptococcosis	patients	isolated	genotype	strains	cryptococcus
rickets	vitamind-dependent
typhoid	agents	ancestries	demonstrating	placed	s.typhi
lymeborreliosis	disease	caused	bacteria	borreliaburgdorferi
ptg	factors	each	focusing	ptg	examined	posttraumaticstressdisorder
hypoglycemia	nights	percentage	%	occurred	events	hypoglycemic
congestiveheartfailure	development	complicated	treatment	patients	doxorubicin
ion	channels	biology	discusses	cp
tb	clinics	used	aid	diagnosis	mycobacteriumtuberculosis
cobalt	chloride	exposed	hypoxia
hiv/aids	linkages	pointed	need	resources	hiv
ifn-î	production	increased	î	injections	tgf-î	<	production	microenvironment	tumor
sugar	reorientation	with	fit
autoimmunehaemolyticanaemia	pathogenesis	involved	antibodies
tumors	impact	constitute	catecholamine	hormone
chronichepatitisc	1b	patients	group	evaluate	after	course	pegylated	ribavirin
calcium	homeostasis	role	attributed	effects	capacity	implicates	autoimmunediseases	multiplesclerosis
vancomycin/gentamicin	daptomycin	rates	%	%	%	bacteraemia
urinarytractinfections	pyelonephritis	treatment	approved	fluoroquinolone	levofloxacin
hiv/aids
uc	cd
hivpositive	hiv
hiv/aids	knowledge	association	testing	hiv
anorexia	ointment	povidone-iodine
seizures	$	â	fu
aids	patients	treat	reduce	deliver	carry	understand	epidemic	hiv/aids
h5n1	influenzaviruses
tb	incidence	role	plays	suggesting	p	%	%	clustered	likely	m.tuberculosis
ironoverload	damage	ironoverload	provides	overview	metabolism	iron
thromboembolism	risk	associated	use	contraceptive	drospirenone
myeloma	treatment	agent	bortezomib
peanutallergy
pain	decrease	administration	ibuprofen
tuberculosis	transmission	due	lineages	m.tuberculosis
statin	therapy	prevention	stroke
androgen	negative	pc-3	line	cancer
enzymes	mrnas	analysis	combined	utilized	cancer
abdominalpain	presented	woman	history	use	oralcontraceptive
mycobacteriumtuberculosis	resistant	drugs	isoniazid
genitalwarts	prevention	due	occur	impact	incidence	hpv-related
sda	acid	$	gamma-linolenicacid
dentalcaries	agent	effects	species	bacteria
mrsa	5	mic	detected	strains	s.aureus
aids	knowledge	hiv
type1diabetes	demonstrated	insulinglargine
hypoglycemia	spent	time	associated	monitoring	glucose
calcium-binding	protein	s100a12	associated	diseases	inflammatoryboweldisease	ibd
osteoporosis	pathophysiology	important	levels	vitamind
bovinespongiformencephalopathy	prions
tb	granulomas	collections	cells	comprised	cells	form	infection	mtb
hivpositive	women	willing	strengthen	integration	service	programmes	hiv
hivpositive	women	%	attending	%	notified	status	hiv
antipsychotics	introduction	step	treatment	psychoses	schizophrenia
type2diabetes	7.0	%	-RSB-	metformin
bloodglucose	phenotype	non-obese
stroke	risk	reducing	prescribed	warfarin
pain	tolerable	hr	patches	fentanyl
malaria	strains	chloroquine	resistance	associated	protein	named	pfcrt	form	able	reduce	accumulation	chloroquine
antipsychotics	introduction	step	treatment	psychoses
cross-neutralizing	antibodies
hiv/aids
allergen	sensitivity	compare	making	provide	alternative	painful
schizophrenia	treatment	indications	antipsychotic	olanzapine
denguehemorrhagicfever	complications	borne	arthropod	affects	denguevirus
hivinfection	represents	domain	humanimmunodeficiencyvirus
statin	use	time	model	treated	in	coronaryheartdisease
asthmatics	â	râ	ige	nitrite
psychosis	reported	drug	disulfiram
hivinfection	route	objective	improve	treatment	hiv
kd	â	log	negligible	sorption	venlafaxine
scabies	mites	becoming	tolerant	ivermectin
mrsa	misidentified	-rrb-	other	s.aureus
pain	obtained	patches	fentanyl
type2diabetesmellitus	subjects	enrolled	dose	rosiglitazone
gbs	metabolism	confirming	glucans	glucose
hypertension	improvement	shown	indicated	role	estrogen
type2diabetes	subjects	$	individuals	metabolism	glucose
bovinetuberculosis	agent	mycobacteriumbovis
octreotide	lar	lengthened	placebo	patients	tumors
tuberculosisinfection	diagnosed	received	rifampicin
ptsd	symptoms	correlated	factors	ptg
hbv	mutation	resistant	adefovirdipivoxil
bubonicplague	agent	yersiniapestis
hiv/aids
anaphylaxis	ablated	deficiency	blockage	antibody
hiv/aids
varicellar-zoster	virus	vzv
chronichepatitisc	subjected	interferonâ	therapy	$	ribavirin
hypogonadism	men	concentrations	testosterone
malaria	parasites	transmission	result	shown	parasites	resistant	chloroquine
anti-tb	drugs	report	uae	first	are	%	drugs	pyrazinamide
priondisease	titers	prion
hivseropositive	patients	hiv
infectionwithfelineimmunodeficiencyvirus	fiv
pain	management	practice	revolutionized	include	adjuvants	sufentanil
prednisolone	tacrolimus	coadministration	produce	treatment	dermatomyositis	polymyositis
tb	characterising	evaluating	kinetics	antibodies	synthesized	antigens	m.tuberculosis
paliperidone	er	common	aes	insomnia	congestion	tachycardia
malaria	treat	rely	markers	indicate	increasing	resistance	pyrimethamine/sulfadoxine
hiv/aids
cutaneouscryptococcosis	c.neoformans
priondiseases	feature	accumulation	conformers	prionprotein
hps	syndromes	cause	hantaviruses
hypercholesterolemia	received	atorvastatin
anorexia	understanding	develop	stimulants
tb	vaccines	development	approaches	one	represents	development	-lrb-	bcg
bacterialinfection	response	involved	indicated	contribute	clearance	invading	bacteria
antibiotic	treatment	free	enrolled	design	hospitalized	department	diabeticfoot
malaria	changed	disease	causing	resistance	chloroquine
uc	cd
ondansetronhydrochloride	antiemeticdrug	used	treat	nausea
malaria	strains	chloroquine	resistance	associated	protein	named	pfcrt	form	able	reduce	accumulation	chloroquine
h5n1	surveillance	need	highlight	findings	possess	implications	influenzavirus
pain	propofol
virus	faced	pressures	nature	understand	histories	viruses
adhd	treatment	approved	atomoxetine	atomoxetinehydrochloride
aspirin-intolerant	cu	prevalences	differences	focusing	investigated	toxin	toxicshocksyndrome
pain	propofol
tb	cases	resistance	presence	inh	isoniazid
cancer	patients	receive	cisplatin
melanoma	reduced	association	dtic
insulin-stimulated	glucose	assess	using	studied	men	type2diabetes
hbv	infection	suffer	administrated	neonates	antigen	hbsag
titanium	pin	mimic	arthroplasty	followed	induce	osteolysis
adhd	children	took	showed	similar	degree	improvement	speed
aids	patients	in	analyzed	individuals	hiv-infected
hiv/aids	living	associated	perceptions	treatment	hiv
falciparummalaria	admitted	after	introduction	new	quinine
denguefever	arthropod	affects	denguevirus
asthma	exacerbations	definitions	aligned	metric	bud	effect	inhaler	pressurized	budesonide/formoterol
hypoxia	signals	interferon	ifn
constipated	appeared	subjected	diarrhoea	castoroil
neutropenia	incidence	relative	that	expected	docetaxel
alcoholism	received	952	men	alcohol-dependent
schizophrenia	aripiprazole
melanoma	treated	tmz
multiplemyeloma	patients	treated	cyclophosphamide
lymedisease	borrelia
endocarditis	therapy	non-inferior	daptomycin
pain	had	required	high	use	sedation	propofol
myeloma	investigate	effect	patients	bortezomib
immunomodulators	distributed	undergoing	relapsing-remittingmultiplesclerosis
hiv/aids
visceralleishmaniasis	responsible	countries	argentipes	investigate	susceptibility	ddt
aids	hiv
st75/st883-mrsa	properties	due	strains	s.aureus
opioids	management	pain
hivinfection	implications	having	increases	pathway	replication	hiv
adenocarcinoma	woman	developed	caused	cycles	chemotherapy	carboplatin-based
hivinfection
acquiredimmunedeficiencysyndrome	diagnosis	established	undertook	humanimmunodeficiencyvirus
mrsa	-rrb-	s.aureus
t2d	combined	insulinaspart
asthma	treatment	relief	supports	use	budesonide/formoterol
wasting	fat
hivpositive	mothers	practiced	controversy	brought	knowledge	risk	transmission	humanimmunodeficiencyvirus
neuroblastoma	lines	used	plus	subline	cisplatin-resistant
hivinfection	acquired	enrolled	transmission	$	breast-milk	of	trial	nvp
carbonmonoxide	upregulated	conditions	hypoxic
irondeficiencyanemia	marker	used	owing	complexity	metabolism	iron
iothalamate	patients	obtained	values	based	$	divided	kidneydisease
bipolardisorder	with	combined	conducted	olanzapine
leptospirosis	disease	caused	strains	genusleptospira
hbv	hepatitisbvirus
irondeficiency	treatment	iron
ards	patients	fattyacids	enriched	emulsion	lipid
tuberculosis	have	received	bcg
problemdrinking	consumption	consumption	alcohol
fatigue	sustaining	suggest	involvement	midbrain	dopaminergic
type2diabetes	similar	subjects	failure	degree	treatment	insulin
malaria	season	end	receive	sulfadoxine-pyrimethamine
hiv/aids
corticosteroids	osmotherapy	epilepticseizures
hivinfection	diagnosis	having	visit	provider	hiv
glucose	investigated	association	activity	adiposity
glucocorticoids	combined	anaesthesia	generate	ratings	pain
methaemoglobinaemia	diagnosed	consisted	methyleneblue
tb	therapy	component	rifampicin
hypoglycaemia	example	zones	bloodglucose
rheumatoidarthritis	patients	effective	patients	methotrexate
cross-linked	aggregates	enzyme
cancer	treat	platform	use	conjugates	antibody-drug
atopicdermatitis	illnesses	atopy-related
juvenileidiopathicarthritis	treatment	methotrexate
plague	infection	caused	yersiniapestis
hepatitisb	hbeag	antigen	hbsag
breasttumors	±	therapy	patients	receptor	estrogen
celiacdisease	disorder	gut	induced	proteins	gluten
hereditaryhemochromatosis	derived	homeostasis	iron
dexamethasone	implant	option	patients	macularedema	resulting	diabeticretinopathy
vomiting	treatment	evidence	shows	efficacy	molecule	ondansetron
nm	$	bay-60â	-LSB-	is	treating	coronaryarterydisorders
retinopathyofprematurity	model	allows	fluctuations	levels	oxygen
pain	associated	lidocaine
htlv-1infection	discuss	propose	model	complex	htlv-1
hiv/aids
lymedisease	cases	considered	use	thirdgenerationcephalosporins
tobaccodependence	treatment	proven	therapy	nicotine
inflammation	impact	counteracts	prednisolone
vaginalthrush	patients	isolated	stellatoida	investigated	candidaalbicans
multiplemyeloma	bortezomib
amenorrhea	gynecomastia	result	inhibition	gonadotropinreleasinghormone
hyperglycemia	prevent	fetus	maintains	insulinresistance
chemical	chaperone	acid	study	mechanism	underlying	mice	mice	obese
onchocerciasis	elimination	administration	ivermectin
dermatomyositis	treatment	produce	coadministration
obesity	treat	considered	needed	decide	safety	phentermine
adiposity	accounting	insulin
hiv/aids-focused
multiplemyeloma	treatment	agent	used	bortezomib
tb	laboratory	isolates	compared	specimens	assay	tube	testing	resistance	inh
cll	patients	resistance	fludarabine
calcitonin	receptor	chondrocytes	oa
pain	incidence	lower	k	injection	mg	propofol
systemiccandidiasis	incidence	promote	colonization	candida
selenium	cultured	showed	cells	tumour
visceralleishmaniasis	$	30â	zones	climatic	temperatures	stable	formulation	amb
cholesterol	levels	abolished	cvd
methamphetaminedependence	prevalence	increases	use	methamphetamine
thromboembolism	warfarin
chronichepatitisc	virusinfection	treatment	made	introduction	interferon
type2diabetes	options	dapagliflozin	make	mechanism	insulin-independent
abciximab	administration	undergoing	safe	associated	reduction	complications	bleeding
cholera	research	principle	became	saw	v.cholerae
tuberculosis	incidence	compare	objective	vaccinated	bcg
aids-associated	ssarcoma	infection	people	living	hiv/aids
peppermintoil	comparing	adults	irritablebowelsyndrome
antidepressant	treatment	contributes	part	abnormalities	found	brains	affectivedisorder
osteoarthritis	osteoarthritis	oa	treated	chondroitinsulfate	glucosamine
neutropenia	risk	granulocyte-colonystimulatingfactors
humaninfluenzaviruses	transmitted	h1n1	transmit	showed	none	avianinfluenzaviruses
cystitis	severity	reduce	lowered	serum	inhibition	antibody
esophagealcancer	radiotherapy	combined	result	cisplatin
strokes	prevent	explain	utilization	warfarin
priondiseases	agents	propagation	prions
non-smallcelllungcancer	activity	has	oxaliplatin/docetaxel
asthma	linked	administration	antibiotic
hyperglycemia	factor	has	insulin
vomiting	treatment	evidence	shows	lacking	evaluation	drugs	antiemetics
m.tuberculosis	isolates	incidence	growing	reported	data	variation	isolates	m.tuberculosis	circulating	spectrum	occurrence	mutations	determining	drugs	isoniazid
antisera	profiles	observed	similarity	cross-species
worms	effective	drug	praziquantel
nh2-terminal	kinase	activation	insulinresistance
insulinresistance	decreased	cr
infectiveendocarditis	pathogenesis	mechanism	the	bacteria
septicshock	$	phenylephrine
estradiol	associated	cancer
denguehemorrhagicfever/dengueshocksyndrome	pathogenesis	contribute	speculated	infection	feature	denguevirus
phn	associated	prescription	antiviral
haloperidol	2â	antipsychotic	assigned	patients	schizoaffectivedisorder	schizophrenia
tuberculosis	suggestive	comprised	positivity	m.tuberculosis
breasttumour	treated	therapy	trastuzumab-based
irondeficiency	impacted	suggesting	assimilation	iron
aids	hiv
thromboembolism	use	levonorgestrel
meningealtb	genes	mtb
influenza	virus	antibody

interferons	characterized	autoimmunedisease	lupuserythematosus	sle
hypersensitivity
malaria	changed	cq	artemisinin	therapies	sulphadoxine/pyrimethamine
thromboembolicevent	matter	therapy	warfarin
mdr-tb	tuberculosis	is	isoniazid
cancer	institute	enrolled	subtypes	defined	pr	progesterone
hbv	dna	adefovir	superior	used	adefovir
lvh	prevalence	group	nitrate
tb	resistant	inh
bleedingdisorder	resulting	levels	ii	coagulationfactors
gluten	epitopes	effect	neutralized	eliminate	diet	celiac
antineoplastic	therapy	diarrhea
dacarbazine	therapy	cutaneousmelanoma
lymedisease	spirochetes	represent	species	borrelia
infectiousmononucleosis	parallel	increased	appears	shadows	epstein-barrvirus	ebv
tuberculosis	tb	especially	resistance	prevalence	worsening	noted	strains	inh
pain	moderate	control	analgesics	meperidine
scabies	mites	tolerance	permethrin
hbv	infection	leading	factors	one	contribute	clearance	infection	hepatitisbvirus
mrsa	infection	length	predictor	bacteriuria	s.aureus
cancer	risks	estimate	took	advantage	available	information	expression	receptor	progesterone
blackdeath	associated	y.pestis
hypoglycemia	induced	min	concentrations	glucose
schizophrenia	schizoaffectivedisorder	patients	assigned	antipsychotic
atherosclerosis	associated	performance	test	speed
lipid	droplets	arise	mr	indicating	estimated	mr	observed	carcinomas
pain	prevention	examined	injection	propofol
invasivecandidiasis	diagnosis	mannan	dna	candida
h5n1	influenzavirus
viruses
glucagon	levels	remained	increased	decrease	insulin	hypoglycemia
anti-hav	detection	confirmed	infection	hav
malaria	treatment	six-dose	three-dose	suspension	artemether-lumefantrine
hypertension	events	risks	propose	acetaminophen
hiv/aids	center	follow-up	conducted	patients	hiv
rise	give	likely	compartments	select	matched	stem	transcriptomes	tumors
inflammation	in	retinoicacid	retinoicacid	transretinoicacid
tuberculosis	extensively	exhibited	organisms	mycobacteriumtuberculosiscomplex
acnevulgaris	treatment	used	antibiotic	minocycline
tuberculosis	diagnosis	relies	microscopy	mycobacteriumtuberculosis
pain	treatment	drugs	capsaicin
pain	incidence	disappeared	that	group	lidocaine

fattyacids	migration	polyunsaturated	triggered	distribution	adhesions
myeloma	cells	signaling	identified	advanced	understanding	action	bortezomib
antiviral	state	resulted	cells	encountering	revealed	studies	cells	insuloma
alcoholism	increase	onset	use	alcohol
kd	â	log	negligible	sorption	carbamazepine
inflammation	factor	explored	potential	orthotopically	diclofenac
sulfide	atoms	adopting	coordinated
insulin-induced	suppression	production	observed	evolution	type2diabetes
hbv	genotypes	hepatitisbvirus
hypoglycemia	frequency	decreased	pulses	glucagon
coronaryheartdisease	patients	medication	considered	agent	antianginal
hepatitiscinfection	hcv
autism	disorders	treatment	approved	antipsychoticdrug	aripiprazole
influenza	virology	advances	based	genetics	influenzavirus
prion	strains	propagation	relate	likely	compared	properties	prions	kuru
ebvinfection
pre-eclampsia	aspirin
hypocalcemia	preparation	due	acute	bowel	sodiumphosphate
type1diabetes	model	induces	insulin
hiv/aids
retinol-binding	protein	links	type2diabetes
asthma	outcomes	achieves	therapy	budesonide/formoterol
aids-like	illnesses	associated	used	model	study	humanimmunodeficiencyvirus	hiv
mrsa	respectively	cohort	seen	determined	profiles	antibiotic
sle	group	density	different	found	exposure	glucocorticoid
diarrhea	onset	time	reduced	model	castoroil
carcinoma	model	chemically
tumor	location	gender	adjuvant
pains	begun	prescription	tramadol
androgens	insulinresistance
pituitary	outcomes	use	effects	control	hormone
open-angleglaucoma	latanoprost
mrsa	staphylococcusaureus
insulin	responses	anorectic
mh	events	occurring	those	similar	events	triggered	anestheticagents
hypertension	two	had	thickness	creatinine	albumin
atopic/non-atopicasthma
asbestos	burden	hazard	has	correlate	tumour
hyperglycemia	induced	content	mice	content	fat
hivpositive	subjects	percent	subjects	hiv
agitation	anesthesia	tested	effect	administration	midazolam
type2diabetes	effects	sensitivity	insulin
lymedisease	incidence	disparity	result	disparity	invasiveness	bacteria
echinococcosis	allow	administration	albendazole
hbv	reactivation	complication	chemotherapy	patients	non-hodgkin	hbsag-positive
tumor	necrosis	factor	synthase	nitricoxide
gout	alternative	alternative	allopurinol
prions	those	equivalent	prion	prions	kuru
oxygen	species	increase	linked	insulinresistance
pulmonaryembolism	complicated	requiring	thrombolysis	tpa
pge2	mediated	cells	hyporesponsiveness	uc-mscs
malaria	co-exist	interesting	investigate	has	mefloquine
type2diabetes	risk	increases	raised	circulating	insulin
psychosis	case	alcohol	patient	disulfiram
pain	reduce	dose	lidocaine
eczema	antibiotics
hivdisease	progression	types	susceptibility	impose	candidate	humanimmunodeficiencyvirus
hayfever	conditions	atopy-associated
dengue	vaccine	safety	evaluate	responses	denguevirus
rickets	findings	disorder	i	referred	±	vitamind
giardiasis	treatment	protocols	metronidazole
zinc	supplement	reduced	severity	diarrhea
tb	disease	reservoir	representing	estimated	infected	mycobacteriumtuberculosis
terbutaline	prevents	causing	hyperglycemia
aids	hiv
tb	ltbi	with	-rrb-	risk	identify	tests	detection	antigens	m.tuberculosis
hg	$	mmâ	19.0	â	â	hbp
ptsd	examined	ptg	focusing	each	factors	ptg
ovariantumor	growth	abrogated	completely	cisplatin
porphyria	patients	found	´	properties	studied	using	synthesis	complexes	enzyme
cll	treatment	focus	discusses	applications	alemtuzumab
pml	sequences	found	aminoacids	subset	acquired	found	performed	analysis	sequences	jcvirus
cholera	-rrb-	subunit	responses	decreased	were	differences	-rrb-	responses	v.cholerae
rsvinfections	prophylaxis	used	injection	palivizumab
hyperglycemia	fasting	prevented	improved	levels	insulin
hiv/aids
hypoglycemia	delivered	showed	amplify	response	epinephrine
pain	response	rat	induced	formaldehyde

high-fat	diet	fed	clamp	measured	gain	role	pref-1	onset	insulinresistance
tb	patients	controls	bcg-vaccinated
congestiveheartfailure	increase	reported	used	doxorubicin
tb	used	vaccine	bacillus	matter	efficacy	bcg
stroke	rates	associated	warfarin
basic	advances	led	development	target	pathways	fibrosis
tb	induced	bcg
obesity	ameliorating	share	function	anti-inflammatory
hypoxic	conditions	pre-exposed	cells	using	established	pad	fat
rheumatoidarthritis	treatment	ccii	efficacy	evaluate	conducted	mtx
hiv/aids	member	had	hiv-infected
tacrolimus	coadministration	produce	treatment	dermatomyositis
pioglitazone	therapy	plus	q.d.	monotherapy	type2diabetes
bradycardia	frequency	evaluate	extract	database	detection	propranololhydrochloride
aids	provided	plan	fight	hiv
hypoglycemia	amplify	examine	potential	sur-1â	$	opener	channel	potassium
virus	showed	antisera	raised	virus	reacted	viruses
tuberculomas	had	patients	isolated	m.tuberculosis
cardiacarrest	patients	groups	compared	patients	followed	mg	epinephrine
asthma	trials	meta-analysis	have	budesonide/formoterol
influenza	humaninfluenzaviruses
insulin	production	glucoseintolerance
hivinfection	acquiring	risks	added	babies	born	women	hiv-positive
acquiredimmunodeficiencysyndrome	measures	made	discovery	humanimmunodeficiencyvirus
atorvastatin	mg	showed	levels	reduction	prevention	reduced	incidence	stroke
type1diabetesmellitus	aged	subjects	combination	insulinaspart
neutropenia	treat	colony-stimulatingfactors	filgrastim
vitaminadeficiency	levels	associated	levels	being	awareness	vitamina
psoriasis	patients	patients	patients	allergies
vivaxmalaria	strategies	context	g6pddeficiency	consider	light	role	administration	primaquine
hypoglycemia	play	sensors	glucose
ions	transport	involved	cp
cholesterol	homeostasis	inflammation
aids	hiv
bacterialinfections	vancomycin
malaria	treatment	investigated	sulphadoxine-pyrimethamine
insulin	model	insulinresistance
virus	activator	observed	destructor	acting	disseminator	viruses
bipolardisorder	treating	agents	one	valproicacid
kidneydisease	chronic	$	1â	gfr	added	dose	losartan
vitamind	role	implicates	autoimmunediseases	multiplesclerosis
viremia	decrease	observed	displayed	replacement	lamivudine
hiv/aids	-rrb-	center	program	hiv
wasting	control	glucose
gastrointestinaldisease	associated	reported	aminoacid
infectiveendocarditis	sequelae	preventing	effective	amoxicillin
vcjd	uniformly	seen	evidence	colonization	prions
asthma	control	function	association	formoterol
scrubtyphus	cases	caused	describe	described	cases	â	rickettsia
tb	infection	diagnose	antigens	population	bcg-vaccinated
malaria	recommendations	promoting	accompanied	change	policy	malaria	sulfadoxine-pyrime-thamine	artemether-lumefantrine
tuberculosis	test	mtb/rif
corticosteroid	receptors	expression	calcyon	gene	attention-deficit/hyperactivitydisorder
obesity	insulinresistance	wasting	control	glucose
beta-adrenergicreceptorantagonist	achieved	that	comparable	way	reduced	anglerecessionglaucoma
cbd	symptoms	associated	had	virus
multiplemyeloma	treated	bortezomib
asthma	control	function	association	budesonide

malaria	season	end	receive	sulfadoxine-pyrimethamine
morphine	brought	hospice	nairobi
pcos	candidate	chosen	affects	metabolism	glucose
androgens	indices	insulinresistance
irondeficiencyanemia	high	demands	iron
recombinanthumandnase	use	due	suggest	analyses	secondary

varicella	vzv
hbv	recurrence	prevention	effective	prophylaxis	lamivudine
nsaid	prescription	predicted	was	association	intensity	prescription	pain
influenza	tool	used	specimens	detection	genes	influenzavirus
hbv	recurrence	protocol	based	milligrams	lamivudine	injections	hbig
tb	associated	have	infection	macrophages	individuals	manifestations	mycobacteriumtuberculosis	mtb
abnormalcoagulation	profile	were	aspirin
hyperglycemia	best	doses	insulin
irondeficiency	increase	iron
priondiseases	diseases	associated	prionprotein
hypertension	patients	carvedilol
schizophrenia	trial	-RSB-	aripiprazole
type2diabetes	insulinresistance
tumours	displays	dynamics	dm
obstructivepulmonarydisease	subgroup	mortality	%	arm	%	arm	oxygen
hivinfection
viremia	treatment	went	receive	course	epoch	mg/m2/day	vincristine
type2diabetes	liraglutide	subjects	â	lowered	glimepiride	had	therapy	metformin
gamma-linolenicacid	$	gla
pain	evaluate	role	methadone-lidocaine
hypoglycemia	increased	responses	ans	norepinephrine
buruliulcer	disease	caused	mycobacteriumulcerans
arthritis	collagen-induced
post-methacholine	challenge	test	investigated	bakers	suffering	asthma
h5n1	influenzaviruses
type2diabetes	individuals	study	subjects	range	sensitivity	insulin
xdr-tb	resistant	drugs	used	mdr	antitubercular
hiv/aids
stroke	risk	reducing	prescribed	warfarin

cancer	supported	patients	receiving	antibody
tuberculosis	containing	pyrazinamide
typhoid	diagnosis	allowing	developed	method	detection	salmonellatyphi
viralmeningoencephalitis	patients	analyzed	quotient	glucose
osteoporosis	-RSB-	form	vitamind
htlv-1-associatedmyelopathy	tropicalspasticparaparesis	development	lead	infection	humantcelllymphotropicvirustype1
rmg-i-h	cells	adhesion
dextrose/h	-rrb-	ml	units/h	infused	-lrb-	type	obese
hypoglycemia	assessed	monitoring	glucose
hiv/aids
hivinfection	screening	recommend	hiv
virus	questionnaire	using	use	interviewed	respondent	recruited	idus
hypertension	nisoldipine
gout	treated	allopurinol
enzyme-dtnb	complex	allowed	determination	kd
titanium	microstructures	investigate	adhesion
type2diabetes	patients	hypoglycemia	associated	access	template	insulin
renalcellcarcinoma	subjects	cycles	combination	-RSB-	-2	-RSB-	interferon
aids	epidemic	decades	lower	women	infection	humanimmunodeficiencyvirus
hc	controls	sm	78	malaria
leptomeningealmetastases	patients	analyzed	quotient	albumin
insulin	techniques	participants	type2diabetes
trachoma	return	contributes	treatment	antibiotics
catscratchdisease	agent	reported	bartonellahenselae
influenza	proteins	exhibit	possible	provide	exposure	strains	influenzavirus
aviannecroticenteritis	pathogenesis	factor	similar	alpha-hemolysin
androgen	blockade	started	observed	diagnosed	having	cancer
malaria	programs	sustainability	threatens	increasing	receiving	resistance	insecticides	pyrethroid
pain	tolerable	hr	patches	fentanyl
attentiondeficithyperactivitydisorder	history	treated	atomoxetine
chemical	strain	raynaudâ	divided	mentioned	maurice	raynaud	describing	asphyxia
tuberculosis	constitutes	aggravated	number	strains	mycobacteriumtuberculosis
agitation	reducing	premedication	midazolam-based
gravesâ	basedowdisease
steroid	therapy	catheterization	identified	transfusion	hepaticfailure
virus	xinjiang	known	viruses
lipid	constituents	belonging	points	form	plane	belongs	fraction	mole
cancer	cells	differentiation	promotes	activation	receptor	vitamind
uc	patients	compared	efficacy	formulations	mesalamine
ticdisorders	patients	antipsychotic	aripiprazole
melanoma	lines	lysates	pulsed	dc	matured	gamma	interferon
adhesion	molecule-1	levels	propeptide	vwf
enzyme	complexes	defect	caused	decrease	synthesis	patients	cfs/me
insecticide	nets	used	inconsistent	evidence	confer	malaria
influenza	caused	strain	influenzavirus
hbv	loads	antigen	hbsag
mrsa	s.aureus
inflammation	associated	model	investigate	relevant	cd
sars	severeacuterespiratorysyndrome	illness	caused	virus	sarscoronavirus
tb	mtb
carcinoma	found	c-yes	member	family	tyrosine
estrogen	levels	responsible	proliferation	tumor
adiposity	control	changes	remained	control	lipid
cancer	examined	cases	identify	directed	mag1	antibody
methicillin-resistantstaphylococcusaureus	-rrb-	s.aureus
hbv-dna	suppression	adefovir	tenofovir
hypertension	management	care	used	clonidine
schizophrenia	trial	antipsychotics	olanzapine
insecticide-resistant	vectors	malaria
schizophrenia	patients	soc	olanzapine
oxaliplatin-based	regimens	established	accepted	patients	cancer
buruliulcer	disease	mycobacteriumulcerans
pupillarydilation	effects	phenylephrine
flush	response	shown	revealed	using	concentration	niacin
insulin	level	adjusted	value	value	value	indices	insulinresistance
enzymes	feeding	improved	recovered	respiratoryinfection
partialepilepsy	patients	likely	effective	gabapentin
dermatomyositis	patients	evaluated	treatment	immunosuppressive
gancyclovir	treatment	viremia
venousthrombosis	risk	are	benefit	therapy	warfarin
b-celllymphoma	characterized	presence	m	immunoglobulin
neurosyphilis	form	infection	caused	treponemapallidum
hiv/aids
hiv/aids
tuberculosis	disease	classified	wake	revolution	koch	identified	tuberculosisbacillus
hbv	variants	check	aware	sensitivity	hbsag
pain	relief	provides	oxymorphone
cll	investigated	sensitise	fludarabine
allergen	induced	allergy
anti-inflammatoryagents	induce	inflammation
tuberculosis	drug	ethambutol
hepatitisb	treatment	options	licensed	lamivudine
virus	h5n1	lineage	unclear	contribution	spread	viruses
oxaliplatin-containing	chemotherapy	era	delirium
hyperglycemia	resulting	deficiency	insulin
pain	hypersensitivity	metal
daunomycin	accumulation	increased	mice	blood	reduced	pumps	mrsa
iron	losses	hemodilution	factors	related	associated	renalinsufficiency
bacterialinfections	vancomycin
glaucoma	eyes	found	trabeculectomy	implantation	mitomycinc
gout	flares	frequency	occurs	required	prophylaxis	colchicine
hyperglycaemia	occurs	consequences	related	glucose
immunomodulator	effective	treatment	inflammatoryboweldisease	ibd
stroke	preventing	aspirin	efficacy	recognized	treatment	warfarin
calcium	homeostasis	role	attributed	effects	capacity	implicates	autoimmunediseases
hbv	recurrence	prevention	effective	prophylaxis	lamivudine
plasmodiumfalciparummalaria	laos	patients	conducted	trial	dihydroartemisinin-piperaquine	artesunate-mefloquine
obese	group	reduced	weight	fat
aids	progress	individuals	hiv-infected
malaria	preventing	means	therapy	sulfadoxine/pyrimethamine
type1diabetes	subacute	afford	opportunity	determine	induces	insulin
hsv	therapy	trial	enrolled	aciclovir
hyperlipidemia	development	suppressed	accumulation	fat
epilepsy	treatment	valproicacid
albino	mice	divided	groups	-lrb-	group	ii	received	loperamide
dye-labeled	albumin	vitro	leak	evans
mrsa	-rrb-	caused	proportion	decreased	increased	proportion	infections	s.aureus
tumor	originates	add
hiv/aids
genitalwarts	development	prophylaxis	anti-hpv
hyperuricaemia	use	diuretic
pain	conditions	efficacious	medicated	lidocaine
ca	patients	frequency	matched	stage	tumor
paraffin	samples	allow	help	studies	history	inflammation
pain	score	8	given	mg.kgâˆ	pethidine
tb	shifted	treated	bcg-vaccination
hypersensitivity	firing	c-fibres
precociouspuberty	diagnosis	test	gnrh
add	mean	predicting	retinopathy
aids	stage	hiv
viralinfections	transmission	harm	forms	resulted	prevalent	users	idu
tb	culture	impact	scant	represents	culture	mycobacteriumtuberculosis
falciparummalaria	treatment	quinine
atp	production	glycolysis	utilize	cells	cancer
tuberculosis	treatment	reduced	use	test	mtb/rif
hiv/aids
hivinfection	prevalence	%	patients	population	screening	hiv
essentialtremor	propranolol
permethrin	performed	adults	collected	assess	susceptibility	vectors	malaria
constipation	patients	improved	mg	tegaserod
malaria	incidence	reduced	reduced	reduced	sulphadoxine-pyrimethamine
type2diabetes	patients	therapy	metformin
oa	patients	bp	compared	effects	ibuprofen
type2diabetes	representative	randomized	metformin
hiv/aids
glucose	status	associations	comorbidities	type2diabetes
malaria	treatment	changed	artemether-lumefantrine
type2diabetes	secretion	insulin
vivaxmalaria	reappearance	related	factors	included	dosage	primaquine
oa	symptoms	reduce	walking	minimum	steps	sulphate	glucosamine
rickets	occurrence	preventing	permitted	vitamind
allergy
diarrhea	onset	time	reduced	extract	aurea	drug	loperamide
lysine	632	ar
cll	patients	fludarabine
malaria	parasites	chloroquine-resistant
hepatitisc	hcv
oa	osteoarthritis	drug	chondroitinsulfate
insulin	insulinresistance
lipid	metabolism	glucoseintolerance
hyperglycemia	induced	streptozotocin	stz
malaria	changed	cq	artemisinin	therapies	sulphadoxine/pyrimethamine
bronchialasthma	symptoms	improves	suppression	chemokines	levels	theophylline
hiv/aids
cholera	named	disease	causes	-rrb-	v.cholerae
scabies	treat	used	creams	component	permethrin
tb	candidates	showed	response	results	mtb
cancer	therapy	inhibitors	tyrosine
stroke	recurrence	reduce	pioglitazone	benefit	warfarin
chickenpox	infection	vzv
rheumatoidarthritis	patients	tb	risk	thought	risk	etanercept
lipid	metabolism	role	recognized	diabetickidneydisease
aml	cells	daunorubicin
reovirusinfection	signaling	nf-îºb	relationship	unknown	implicated	apoptosis	reovirus-induced
smallpox	caused	variolavirus
type2diabetes	men	total	assigned	diet	carbohydrate	con	carbohydrateproteinfat
asthma	controls	aspirin-tolerant
tb	vaccines	designing	stimulate	contribute	bcg
hyperglycemia	women	fattyacids	impaired	test	glucose
hypertension	patients	reduced	conclusions	regimen	hctz
irondeficiency	associated	locations	identify	performed	using	dna	collected	men	aged	y	¥	controls	replete	iron
insulin	sensitivity	status	lead	play	inflammation
obese	individuals	samples	adults	children	undergoing	testing	glucose
gonococcal	population	displayed	antimicrobials	recommended	treatment	exception	spectinomycin
type2diabetesmellitus	levels	control	agent	exenatide
bisphosphonates	effects	evidence	increasing	supporting	use	treatment	bonedisease
gold	standard	diagnosis	infection	malaria
hepatitisc	livercirrhosis	patients	controls	patients	infected	hcv
priondiseases	develop	due	mutations	gene	prionprotein
hemorrhage	associated	patients	mpa
schizophrenia	patients	compare	retrieved	search	trials	injectables	haloperidoldecanoate
hepatitisc	patients	therapy	response	predicted	genotype	hcv
type2diabetes	associated	triglycerides
metal	revised	hips	tissues	particles	causes	hypersensitivity
hbv	hepatitisbvirus
melanoma	cells	melanocytes	basal	interferon-alpha
type2diabetes	leads	mechanism	represents	insulin-resistance
gbs	patients	have	treatment	ivig
tb	mycobacteriumtuberculosis
silicosis	lungdisease	caused	inhalation	silicadust
type1diabetesmellitus	aged	subjects	combination	insulin	insulin
obstructivepulmonarydisease	exacerbations	oxygen
allergy
hbv	positive	hbsag
androgens	estrogens	risk	cancer
a/h5n1	avianinfluenzavirus
virus	marekâ	viruses
hiv/aids	program	effect	examine	using	analyzed	changes	volume	services	hiv
tuberculosis	exposure	history	tst	tst	combination	vaccination	bcg
pain	prevent	strategy	develop	evaluated	factors	affect	injection	propofol
type2diabetes	patients	sitagliptin
multiplemyeloma	patients	transplantation	stem	used	alpha	interferon
pain	compare	ketamine
diarrhea	treated	loperamide
tuberculosis	rifampicin-resistant
plague	model	protect	v-antigens	are	are	antibodies	monoclonal	yersiniapestis
hivinfection	prevent	strategy	hiv
onchocerciasis	co-infected	individuals	safe	treatment	ivermectin
hepatitisb	viruses
aids	hiv
smallpox	used	vaccinations	smallpoxvirus
hivpositive	hiv
inflammation	development	investigate	mechanism	effect	asa
tuberculoma	misinterpreted	treatment	anti-tuberculosis
cortisol	arterialhypertension
tb	disease	patients	mtb
typhus	group	tg	rickettsiae	define	ogs	identifying	bolster	reclassification	rickettsia
hbv	protein	x	leading	protein	hepatitisbvirus
hepatitiscvirusrna	hepatitiscvirus
type1diabetes	protected	required	activity	ccl4
insulin	adiposity
tumour	development	mechanisms	suggesting	similar	dynamics	dm
pain	relief	achieved	%	patients	respectively	amitriptyline
insulin	proteins	engaged	pathways	signaling	insulin	many	deciphered	myers	dr.
lassafever	patients	sera	contains	lassavirus
mono-nucleotide	cofactors	-rrb-	flavin-adenosine
viralinfection	papuamide	show	viruses
ocularhypertension	patients	timololmaleate	evaluate	analogs	prostaglandin
cd	work	related	factors	associated	cardiovasculardiseases
viralculture	standard	diagnosis	chikungunyafever
osteomyelitis	treated	azithromycin
hypothyroid	state	provoke	increase	t3/t4
postpartumhaemorrhage	and	medline	ergonovine
pain	treatment	used	acetaminophen
tb	drug	treatment	regimen	components	rifampicin
breasttumours	measured	evaluated	benefit	tumours	receiving	tamoxifen
adhd	treatment	used	atomoxetine
cancers	subsets	produced	blockade	signaling	inhibitors	tyrosine
lipoprotein-cholesterol	levels	hypertension	obesity
obesity	status	vitamind
cmv	results	shown	utilizing	model	infection	hcmv
schizophrenia	heterogeneity	focused	treatment	chlorpromazine
duodenalulcers	administered	dose	omeprazole
mrsa	isolates	observed	contained	antibiotics
irondeficiencyanaemia	supplementation	iron
polycysticovarysyndrome	patients	evaluate	affects	administration	metformin
morphine	rescued	reduced	induction	inflammation
i-bar	subfamily	member	regulators	altered	number	cancers
hepatitisb	patients	increased	risk	emergence	adefovirdipivoxil
mycobacteriumtuberculosis	resistant	drugs	isoniazid
fat	depots	adipocytes	determined	size	genes	hypoxia-dependent


ebvinfection	associated	infections	ebv
tuberculosis	granulomas	collections	cells	comprised	cells	form	infection	mycobacteriumtuberculosis
rigidity	correlated	parameters	base
acquiredimmunodeficiencysyndrome	description	after	in	learned	agent	humanimmunodeficiencyvirus
virus	lacking	gene	viruses
hiv/aids
urticarial	attacks	associated	presence	antibodies
cavity	nasal	characterized	causes	diphtheriae	bacterium
acetaminophen-induced	liverfailure
ironoverload	degree	corresponding	brain	increased	expression	hepcidin	iron
virus	tomatoes	diseases	causing	viruses
pain	scores	boluses	dose	bupivacaine
hypertension	failure	treatment	indicated	²	carvedilol
calcium	inhibitors	rates	terms	models	differences	are	exhibiting	leftventricularhypertrophy
opioid	analgesia	intensity	postoperativepain
influenza	patterns	explaining	insufficient	rendered	reports	levels	activity	influenzavirus
aids	distinguished	ks	patients	hiv
tuberculosis	tb	caused	mycobacteriumtuberculosis
hypertension	fibrosis	limited	use	csa
lungdisease	inform
mono-drug	resistance	proportions	%	%	ethambutol
cd	ulcerativecolitis
vomiting	motivated	evaluate	combined	with	dexamethasone
hiv/tb	adults	rifampicin
brucellosis	patients	samples	identify	species	brucella
cardiovasculardisease	patients	therapy	statin
ca-mrsainfections
venezuelanequineencephalitis	1993	vee
virus	virus	viruses
fluorescein	angiography	patient	albuminsolutionallergy
bacterialmeningitis	patients	analyzed	quotient	albumin
oa	toxins
hiv/aids
rsvinfections	attendance	order	found	number	children	family	age	onset	season	rsv
primarybiliarycirrhosis	pregnancy	cholestasis
sugar	content	increased	conditions	deficit
oxygen	delivery	limiting	predispose	insulinresistance
cholesterol	biomarkers	evaluated	patients	acromegalic
stroke	complications	risk	patients	millions	places	adherence	warfarin
chronichepatitisc	patients	replication	hcv
hbv	infection	hepatitisbvirus
hypoglycemia	preventing	minimize	peaks	glucose
influenza	infection	model	proteins	immunogenicity	demonstrating	resulted	immunization	pigs	influenzavirus
tuberculosis	-rrb-	vaccine	-rrb-	bcg
type2diabetes	treatment	metformin	glimepiride
virus	growth	evolved	viruses
acne	treatment	used	derivative	tetracycline
dcm	dilatedcardiomyopathy
anti-hbv	vaccines
hivinfection	acquired	enrolled	transmission	$	nevirapineâ
glucagon	suppression	impaired	delayed	duration	marked	present	insulinresistance
type2diabetes	presumably	glucose
pain	propofol-induced
malaria	co-exist	interesting	investigate	has	mefloquine
malaria	incidence	reduced	reduced	reduced	sulphadoxine-pyrimethamine
leprosy	control	assessed	benefits	rifampicin
pneumococcalinfections	studied	causes	streptococcuspneumoniae
il-2	cd40	induced	expression	tumors
polymyositis	patients	synthase	treatment	immunosuppressive
hivpositive	individuals	assess	responses	hiv-specific
tamoxifen	inhibitors	therapies	cancer
hc-030031	using	demonstrated	plays	role	responsible	hypersensitivity
hivinfection	preventing	value	considered	risk	resistance	associated	prophylaxis	nvp
stroke	having	taking	medication	warfarin
aids	epidemic	incidence	escalation	hiv-infection
progesterone	receptor	expression	tumor
asthma	symptoms	intercurrent	showed	smokers	treated	budesonide/formoterol
malaria	infants	using	sulfadoxine-pyrimethamine
anti-cmv	therapy	cidofovir
type2diabetes	exenatide	sitagliptin
erythromycin	resistant	jejuni	bacteremia
cross-sectional	sample	idus
uc	patients	compared	efficacy	formulations	mesalamine
smallpox	treatment	developed	cmx001	analog	propan-1-ol
virus	cvv	virus	detected	viruses
asthma	assess	seretide	fluticasone/salmeterol
fat-3	$	gla
hiv/aids
measles	programme	success	monitoring	help	knowledge	circulating	genotype	measlesvirus
virus	virus	outline	discuss	expand	viruses
tuberculosis	caused	mycobacteriumtuberculosis	mtb
cancer	treatment	become	gemcitabine
tularemia	agent	francisellatularensis
cancer	patients	accepted	established	treatment	gold
type2diabetesmellitus	results	and/or	action	insulin

mrsa	-rrb-	beta-lactamantibiotics	s.aureus
thrombo-embolism	risk	eliminate	prevent	formation	clot
virus	took	pcr	confirmed	existence	viruses
hiv/aids
alzheimerâ	treatment	compound	donepezil
malaria	programme	mali	efficacy	chloroquine
osteoarthritis	knee	compared	glucosamine
cholesterol	disorders	alzheimerdisease
dm	diabetesmellitus
clindamycin	penicilling	antibiotics	contained	observed	isolates	mrsa
paraffin-embedded	tissues	reaction	using	using	pyrosequencing	tumor
cancer	regimens	used	agent	5-fluorouracil
anti-hbv	antibody	antigen	hbsag
sirs	non-infectioussystemicinflammatoryresponsesyndrome
hivpositive	3.90	hiv
malaria	season	spanning	placebo	given	bimonthly	sulphadoxine-pyrimethamine
pain	reduce	required	determine	patients	i-ii	asa
irondeficiency	causing	regulation	homeostasis	iron
malaria	case-management	describe	$	artemetherâ
squamouscellcarcinoma	patients	cisplatin
surfactant	relate	result	damage	hypoxic
hepatitisc	ab	anti-hcv
cll	patients	fludarabine
tuberculosis	agent	mycobacteriumtuberculosis
hypoglycemia	insulin	decrease	increased	remained	levels	glucagon
cd	mucosa	alteration	enterocytes	proliferation	causing	inflammation
osteolysis	associated	metal-polyethylene
aids	syndrome	recognized	investigate	occurrence	humanimmunodeficiencyvirus
alcohol	consumption	established	chronicrenaldisease
malaria	parasites	resistance	chloroquine
chickenpox	agent	alpha-herpesvirus	varicellazostervirus
hepatitisc	infection	hcv
antispasmodics	comparing	adults	irritablebowelsyndrome
impairedglucosetolerance	-RSB-	glucose
autism	values	reduced	bumetanide
hiv/aids	living	people	reach	provide	care	hiv
priondisease	phenotype	control	analyses	did	analysed	expression	model	infection	prion
cancers	containing	microarrays	performed	sections	paraffin
opioiddependence	syndrome	diagnosis	india	institute	administered	drug	opioid
priondisease	revealing	mice	is	activity	infection	prion
hbv	genotypes	comprising	origin	members	specificity	comparatively	a-f	subtypes	hbsag
irondeficiency	effects	determine	fed	control	id	fe
insulin	substrate	level	signaling	impaired	insulinresistance
h5n1	avianinfluenzavirus
allergicreactions	manifest	hypersensitivityreactions
virus	belong	any	genotypes	viruses
oxygen	species	molecules	adhesion
hemorrhagicshock	treatment	recommended	hydroxyethylstarch
influenza	antibodies	results	vaccines
cross-linking	available	interest	protein	antibody
tropicalspasticparaparesis	agent	humant-celllymphotropicvirustype1
ham/tsp	treatment	decreased	expression	cell	htlv-1-infected
sle	turnover	patients	undergoing	therapy	glucocorticoid
chf	f	concentrate	replaced	lipids	diet	chow	low-fat
diabeticretinopathy	-RSB-	$	-RSB-	age	eyes	study	assigned	ranibizumab
insulin	components	polymorphisms	associated	pcos
hbv	reactivation	hepatitisbvirus
tuberculosis	have	suggest	drives	bcgvaccine
hivinfections	reduction	associated	decrease	$	hiv
rise	give	b-celllymphomas
chronichepatitisc	treatment	evolved	therapy	combination	interferon
hyperglycemia	controls	insulin
hiv/aids
aids	hiv
smallpox	used	vaccinations	smallpoxvirus
mrsa	s.aureus
nephroticsyndrome	those	followed	agents	cyclophosphamide
rheumatoidarthritis	treatment	reducing	leflunomide
hbv	transcriptase	hepatitisbvirus
sarcomas	factors	suggested	factors	exposures	chemicals	herbicides
malaria	treat	piloting	use	artemether-lumefantrine
varicella	vaccines	stability	increasing	useful	suggests	ability	ride	enhance	infectivity	vzv
ranolazine	reduced	incidence	atrialfibrillation
acutepromyelocyticleukaemia	protein	±	$	receptor	retinoicacid
base	tumors
adhd	atomoxetine
adhd	options	increased	introduction	formulations	methylphenidate
obesity	composition	fattyacid
paraffin	panel	associated	cancer	interrogate	based	spectrometric	tested	characterize	mutations	genes	tumor
crystal	structure	consists	ring	tetraâhedrally	coordinated
mdr-tb	classified	rifampicin
autoimmunediseases	patients	estimated	levels	interferon-alpha
adiposity	increase	occurs	dysfunction	atherosclerosis	protect	estrogen
virus	originate	insertion	motif	5	ncr	occurred	origin	viruses
irondeficiency	disorders	develop	help	understanding	interplay	factors	involved	regulation	metabolism	iron
insulin	delivery	predicted	type1diabetes
hbv	infection	transmit	used	antigen	hbsag
asthma	quality	questionnaire	twice	âµg	budesonide
bleeding	complications	occurrence	reduction	associated	undergoing	intervention	abciximab
hivinfection
hiv/aids
breasttumours	oestrogen
anti-cavity	rinse	fluoride
enzymes	covered	sites	number	accounts	parameter	includes	provided	fit
irondeficiency	one	cause	depletion	iron
bowelobstruction	placement	peg
h5n1	influenzavirus
anorectic	responses	glucose
hypertension	nisoldipine
jia	patients	treatment	proves	start	sulphasalazine
newcastledisease	virus	caused	nd	ndv
eclampsia	management	recommending	use	magnesiumsulphate
anti-reflux	agent	treatment	compare	that	mg	esomeprazole
hyperglycemia	caused	nonsignificant	increase	level	glucose
amnesia	scopolamine-induced


scd	cd36	synthesis	regulation	lipid-related
insulin	treatment	control	neuropathyindiabetes
pain	reduce	dose	lidocaine
hyperglycemia	reducing	increased	saline	â	minâˆ	-rrb-	uptake	-lrb-	glucose
hivinfection	reported	unknown	trends	prevalence	associations	hiv
influenza	project	gathered	information	integrates	database	analysis	sequences	published	resource	influenzavirus
bisphosphonate	treatment	effect	bisphosphonate-associatedosteonecrosisofthejaws
obstructivepulmonarydisease	objectives	compare	treatment	oxygen
kd	â	log	negligible	sorption	venlafaxine
hc	elevated	with	values	bd	than	in	group	sz
asthma	caused	anti-inflammatorydrugs	aspirin
bartonellainfection	factor	indicating	higher	encountered	antibodies	bartonella
tachycardia	accompanied	making	atropine
hypertension	treatment	blocker	²	one	propranololhydrochloride
parvovirusb19infection	pathogenesis	describe	discuss	evidence	parvovirusb19
insulin	infused	type	ten
granulomas	expressed	genes	sequestration	lipid
asthma	model	inhibited	acid	asa
ecstasy	displayed	anorexia
hypoglycemia	rates	mg/dl	<	bloodglucose
cfs/me	patients	synthesis	atp
hivseropositive	hiv
hiv/aids
acetaminophen	toxicity	models	lack	knowledge	limited	development	therapies	acuteliverfailure
arterialhypertension	olmesartan
cd	patients	collected	irritablebowelsyndrome
hypertension	patients	proved	superior	antihypertensiveagents	atenolol
acutepromyelocyticleukemia	patients	induce	arsenictrioxide
hivinfection	probability	%	%	babies	regimen	zidovudine
mrsa	-rrb-	differ	â	s.aureus
hypersensitivity	history	dicloxacillin	allergicreaction
anthrax	agent	bacillusanthracis
apl	patient	derived	atra
obese	children	abnormalities	prevalence	is	present	markers	abnormalities	glucose
aspirin-inducedasthma	patients	have	suggesting	relationship	aspirin
nitricoxide	upregulated	conditions	hypoxic
vf	episodes	number	reducing	lidocaine
lys-7	$	$	number	expression	associated	bacterialinfection	susceptibility	result	deficiencies	sda
tb	cases	higher	circulating	secretion	antibodies	bcg-specific
tuberculosis	test	mtb/rif
insulin-dependentdiabetesmellitus	therapy	cells	search	sources	insulin
type2diabetes	evokes	effects	women	insulin-resistant
t3	pathway	disturbances	described	renalcellcarcinoma
type2diabetes	treatment	metformin	rosiglitazone
cd	-rrb-	ibd	ulcerativecolitis	inflammatoryboweldiseases
asthma	symptoms	intercurrent	showed	smokers	treated	budesonide/formoterol
poliomyelitis	eradication	challenges	include	excretion	poliovirus
gdn-hcl	gate	development	step	design	diagnosis	priondiseases
cross-talk	suggest	corroborate	confirm	controls	metabolism	nitrogen
acutehivinfection	stage	occurs	described	patients	stages	infection	humanimmunodeficiencyvirus
hiv/aids
chronichepatitisc	response	patients	developed	therapy	ifn
pain	incidence	causes	propofol
corpulmonale	presenting	lungdisease
cross-sectional	study	enrolled	triglycerides
sepsis	induced	sodium	dextran
alcoholaddiction	treated	women	total	assessed	period	using	inventory	alcohol
vaccinia	outbreaks	strains	similar	vacciniavirus
antibody	antagonist	dosed	established	inflammation
tumor	xenografts	imaging	exhibited	expressing	treatment	cisplatin
hiv/aids
lungtb	caused	mycobacteriumtuberculosis
hbv	hepatitisbvirus
eclampsia	manage	used	included	included	recording	incidence	effect	resulting	use	magnesiumsulfate
bubonicplague	results	y.pestis
tyrosine	kinase	mutations	play	role	pathogenesis	tumors
tuberculosis	caused	strains	mycobacteriumtuberculosis
paracetamol	g	efficacy	determine	carried	study	administered	patients	openangleglaucoma
type2diabetes	patients	function	function	insulin-stimulated
lymeborreliosis	pathogen	borreliaburgdorferi
malaria	treat	piloting	use	artemether-lumefantrine
fungalinfections	prophylaxis	approved	posaconazole
oxygen	exposed	hypoxia
eczema	linked	administration	antibiotic
antibodies	pbc-specific
ham/tsp	develop	remain	majority	individuals	$	htlv-1â
pain	score	patients	class	asa
condylomaacuminata	warts	caused	humanpapillomavirus	hpv
d3	expression	observed	crucial	progression	malignantmelanoma
hyperglycemia	induced	content	mice	content	fat
schistosomiasis	drugs	discover	need	is	praziquantel
swinedysentery	spirochete
pain	management	practice	revolutionized	include	advances	introduction	remifentanil
testosterone	concentrations	deficits	due	cause	infertility
infection	hivinfection
inform	data	prevalence	congenitalmalaria
type2diabetes	associated	states	insulin-resistant
hiv/aids
tb	cases	resistance	presence	inh
lupus	patients	serum	levels	found	steroid	dhea
ribavirin	drug	with	combined	pegylated	therapy	patients	chronichepatitisc
type2diabetes	epcs	number	decreased	was	correlation	glucose
cholesterol	syndrome	hypertension
rheumatoidarthritis	treatment	ccii	efficacy	evaluate	conducted	mtx	methotrexate
myocardialinfarction	patients	requirements	associated	cyp4f2	investigate	study	aspirin
nsaids	increase	risk	âˆ	pepticulcerdisease
hiv/aids
tuberculosis	detect	test	mtb/rif
aids	strategies	hiv
tumor-specific	biomarkers	inform
high-fat	mice	mice	underlying	downregulation	obesity-induced
rabies	lyssavirus	rabiesvaccine	rabiesimmunoglobulin
cancer	st	elevation	evidence	based	reagent	react	lipids
plague	prophylaxis	used	y.pestis
myelomeningocele	mmc
chronichepatitisc	virus	patients	autoimmunethyroiditis	evaluate	therapy	ifn-alpha
tb	agent	mycobacteriumtuberculosis
leucine	neuronals	neurexins	series	links	disorder	autism
vehicle	therapy	tumor

hyperglycemia	dependence	insulin
adjuvant	therapy	obesity
cll	patients	included	disease	received	lines	treatment	fludarabine
type2diabetes	compared	bid	exenatide
cross-tolerance	produce	effects	alcohol
malaria	treatment	investigated	sulphadoxine-pyrimethamine
hbv	genotypes	comprising	origin	members	specificity	comparatively	a-f	subtypes	hbsag
type1diabetes	demonstrated	lowered	doses	insulin
malaria	pregnancy	sulphadoxine-pyrimethamine
stroke	rates	embolism	similar	those	associated	warfarin
liverinflammation	dependent	composition	fat
chronichepatitisc	started	ribavirin
pain	enhanced	capsaicin
zinc-free	insulin	decrease	suppressed	increased	decrease	insulin	hypoglycemia
mrsa	staphylococcusaureus
hypoglycemia	experience	have	need	systems	glucose
cross-reactivity	rather	showed	heparinpreparations
hbv	levels	reductions	produced	baseline	log10iu/ml	lamivudine
daptomycin	rates	%	%	%	bacteraemia
aids-defining	malignancy	presence	regimens	hiv
lipid	lowering	blockade	with	statins	$	reninâ	control	control	strategies	used	increased	contribution	end-stagekidneydisease
cancer	protection	leading	effects	exerts	±	ifn-î
acutepromyelocyticleukemia	treating	established	arsenictrioxide
rotavirusdisease	resolution	correlate	demonstrated	strains	rotavirus
tuberculosis	cases	933	detected	testing	mtb/rif
lipid	metabolism	alters	induces	glucoseintolerance
ironoverload	leading	is	impairment	homeostasis	iron
hiv/aids
hypertension	patients	used	small	effect	candesartan
aids	patients	present	antibody	hiv
carotene	-RSB-	²	showed	exhibited	showed	sites	stratified	type	fa
asthmatic	control	treatment	budesonide
carotene	-RSB-	²	showed	exhibited	showed	sites	stratified	type	carcinoma
cavity	bacteria
ham/tsp	tropicalspasticparaparesis	carriers	htlv-1
il-2	cd40	treatment	mice	tumor-bearing
tumor	samples	data	patients	sts
type1diabetes	patients	exhibit	absence	insulin
chronichepatitisc	chc	patients	pbmcs	individuals	injection	ifn
tb	shifted	treated	bcg-vaccination
tb	coinfection	studied	recipients	rifampicin
hiv/aids
alzheimerâ	disorders	emerging	exists	have	agents	metrifonate	tacrine
staphylococcalinfections	treatment	agent	oxacillin
hbv	total	220	hbsag
tb	tuberculosis	augment	strategy	represents	vaccination	bcg
cancer	cells	induces	paclitaxel
cancer	provide	lapatinib	combination	non-chemotherapeuticagents
chronichepatitisc	chc	treatment	î	results	ribavirin
aids	battle	playing	chinese	vct	2	increasing	understanding	individuals	hiv
hiv/aids
irondeficiency	associated	risk	deficient	iron
asthma	pathogenesis	involved	downregulate	budesonide
malaria	treatment	artemether-lumefantrine
toxin	investigated	patients	urticaria
methicillinresistantstaphylococcusaureus	staphylococcusaureus
stroke	risk	estimates	explore	perceptions	risks	anticoagulation	warfarin
tuberculosisinfection	markers	considered	complexes	m.tuberculosis
tb-complex	bcg
aml	patients	etoposide
peripheralneuropathy	included	toxicity	thalidomide
iii-v	latencies	interpeak	abnormalities	patients	cp
mrsainfection	patients	achieved	patients	infection	s.aureus
pain	reduce	dose	lidocaine
type1diabetes	improved	decreased	requirements	insulin
hbv	period	hbig
rheumatoidarthritis	history	aged	methotrexate
stroke	recurrence	reduce	pioglitazone	benefit	warfarin
glucose	those	higher	related	insulinresistance
anti-tuberculosis	regimen	component	pyrazinamide
sodium-iodide	gene	expressed	cells	cancer
vomiting	episode	tolerate	administration	antiemetics
angleclosureglaucoma	case	report	ingestion	methazolamide
type2diabetes	risk	using	assessed	locus	secretion	insulin
bupivacaine	delivers	implant	xaracoll	reduce	postoperativepain
pcr/hsv	negative	treated	acyclovir
tropicalspasticparaparesis	agent	humant-celllymphotropicvirustype1	htlv-1
hbv	variants	lamivudine
hivinfection	determinants	explain	levels	hiv
anti-tuberculosis	treatment	accompanied	mtb-antigens
depressivedisorder	treatment	compare	that	imipramine
pain	reduced	injection	propofol
lactamantibiotics	effect	enhanced	in	vivo	related	accumulation	antibiotics	mrsa
androgens	circulating	risk	cancer
positivehiv	results	linked	determine	proportion	infants	linked	care	hiv
hypoglycemia	risk	holds	mechanism	glucose-dependent
aids	diagnosis	hiv
melanoma	carcinoma	released	treated	temozolomide
pain	incidence	scores	need	boluses	dose	bupivacaine
oa	treatment	recommendations	evidence	risks	associated	treatments	nsaid
influenza	seasons	monitor	influenzaviruses
virus	became	emphasized	significance	viruses
bradycardiaâ	pairing	propranolol
pain	level	assess	association	nsaid
leucine	neuronals	neurexins	series	link	ts
tumor	cells	performed	confound	alterations	epi
anti-inflammatoryagents	induce	inflammation
hypersensitivityreaction
dengue	igm	using	circulating	antibodies
malnutrition	marker	albumin
cd	relevant	investigate	model	associated	changes	similar	those	ibd
aids	diagnosis	hiv
obesity	development	influence	ups	involved	regulating	synthesis	production	lipid
vomiting	incidence	lower	vs.	ondansetron
groupb	discontinued	discontinuation	beta-blockers
schizophrenia	exacerbation	evaluate	efficacy	ziprasidone
methicillin-resistantstaphylococcusaureus	-rrb-	s.aureus
tumors	group	sarcoma	sts
brucellosis	involvement	uncommon	have	%	patient	infected	species	brucella
type1diabetes	randomized	nasal	insulin
epileptic	subjects	fosphenytoinsodium
oa	symptoms	reduce	walking	minimum	steps	sulphate	glucosamine
ham/tsp	patients	fluid	correlated	hbz	htlv-1
asthma	history	includes	ingestion	aspirin
cancer	vaccines
hivinfection	outcome	determinants	influencing	stages	infection	efficiency	transmission	hiv
sars	outbreak	transmitted	sars-cov
anti-osteoporosis	measure	consume	calciumcarbonate
pancreatitis	cases	reported	sitagliptin
antithrombiniii	fibrinogen	model	insulinresistance
aids	initiative	carried	review	links	$	œhiv
jia	attenuated	mtx
hbv	diversity	hbsag
adrenocorticotropin	hormone	secretion	caused	endocrinedisease	cushingsyndrome
asthma	symptoms	intercurrent	showed	smokers	treated	budesonide/formoterol
ammonia	effects	examined	role	astrocyte	swelling
tamoxifen	subtype	cancer
diabetes-relatedcomplications	pa	practices	discussed	diabetesmellitus
enzyme-linked	assay	determined	73	ibs
pain	incidence	reduced	injection	propofol
hyperglycemia	eliminate	promote	²	cell	production	insulin
tick-bornerickettsioses	risk	is	show	infection	results	distribution	rickettsiae
hivinfection	identifying	become	areas	prevalence	hiv
otitismedia	meta-analysis	effects	amoxicillin
gonococcal	sequences	comparing	altering	elements	role	suggested	contribute	n.gonorrhoeae
ammonia	co-treatment	-lrb-	cytokines	increased	cell	showed	swelling
breasttumours	prognosis	predict	genes	continuous/late/estrogen-response
typhoidfever	cases	children	culture	negative	the	s.typhi
pain	preventing	effective	mg	lidocaine
reduced	levels	levels	cytokine	anti-inflammatory/regulatory
cocaineabuse	complication	occur	insufflated	cocaine
androgen	negative	pc-3	line	cancer
rheumatoidarthritis	treating	approved	adalimumab
pge2	production	inhibition	inhibits	suggesting	possesses	properties	warrants	treatment	ibd
tb	ability	enhance	immunity	bcg
m.tuberculosisinfection	upregulated	carbonmonoxide
ions	transport	involved	cp
aids	epidemic	overlap	increase	coinfection	hiv
malaria	adopted	artemether/lumefantrine
enzyme	activity	decreased	strains	lacking	rida
malaria	agent	falciparum	become	resistant	chemotherapies	chloroquine
coldagglutinindisease	develops	directed	result	production	auto-antibody
uncoordinated	molâecules	solvent
obstructivepulmonarydisease	patients	subgroup	arm	n	226	n	oxygen
aids	survey	couples	analyzed	hiv
hypothyroidism	31	hypothyroidism	thyroxin
aids	died	living	hiv
hfrs	hemorrhagicfeverwithrenalsyndrome	hantaanvirusinfection
tb	regimen	treatment	rifampin
ondansetronhydrochloride	antiemeticdrug	used	treat	vomiting
tb	programs	burden	worsening	noted	strains	inh
hypothyroidism	detected	started	replacement	l-thyroxine
rotavirusinfection	control	involved	mechanisms	known	characterized	responses	rotavirus-induced
methicillin-resistant	s.aureus	-rrb-	mrsa
hivinfection	acquisition	therapy	impact	assess	men	hiv
stz	rats	affecting	hyperglycemia
adhesion	complex	²	$	cellâ	binds	dynamics	f-actin
type1diabetes	perform	investigate	insulin
falciparummalaria	patients	mefloquine
amoxicillin-clavulanicacid	regimen	inferior	protocol	administered	dogs	uti
thromboembolism	risk	reduce	drug	warfarin
h5n1	influenzaviruses
bacterialdisease	levofloxacin
tb	clinics	used	aid	diagnosis	mycobacteriumtuberculosis
pain	than	groups	remifentanil
ham/tsp	development	involved	agent	virus	htlv-1
asthma	symptoms	intercurrent	showed	smokers	treated	budesonide/formoterol
tuberculosisinfection	diagnosed	received	mg	isoniazid
chickenpox	epidemiology	investigate	studied	population	bissau	has	age	infection	vzv
pain	reduce	dose	lidocaine
hivinfection	absence	inhibits	replication	hiv
bleeding	risk	cost	at	clopidogrel
nitricoxide	studies	technique	measuring	resistance	ar
aids	hiv
tumor	samples	based	patients	sts
carboplatin	treated	involvement	patient	chest	painful
hpvantigen	stained	negative	hpv
pain	incidence	disappeared	that	group	lidocaine
adhd	symptoms	changes	reliable	changes	outcomes	atomoxetine
chronichepatitisc	subjected	interferonâ
pesticide	scheme	recommended	prevention	malaria
atorvastatin	mg	showed	patients	stroke	tia
mono	formed	post-translationally	hydrolyze	bond	ester
alcoholism	neurodegeneration	involved	acth
pain	provides	study	bupivacaine
myocardialinfarction	endpoint	reduced	clopidogrel
coeliacdisease	intestine	caused	gluten
hypoglycaemia	concurred	features	disruption	infusion	glucose
tb	infection	those	quantiferon	compared	mycobacteriumtuberculosis
hyperglycemia	characterized	disease	diabetesmellitus	dm
mrsa	-rrb-	-lrb-	concern	treatment	s.aureus
dronedarone	developed	therapy	patients	atrialfibrillation
hivpositive	patients	mucins	inhibit	aidsvirus
hiv/aids
hyperglycemia	abnormalities	variety	due	exhibit	absence	insulin
pulmonarytuberculosis	diagnosis	useful	culturing	m.tuberculosis
hbv	infection	transmit	used	testing	hepatitisbsurfaceantigen
ionophore	treatment	had	effect	inducing	swelling
dha	acid	fa
chloroquine	-rrb-	treatment	vivaxmalaria
type2diabetes	patients	common	examined	association	insulin
tannin-treated	group	difference	observed	number	cells	seeded	bottom	wells
cr	rates	had	patients	metastaticcancer
clozapine	given	symptoms	psychotic
tb	tuberculosis	rin	bcg
hivinfection
hiv/aids
glucocorticoid	revealed	hypertension
tuberculosis	strategies	guide	mycobacteriumtuberculosis
ham/tsp	called	presentation	contributing	mechanisms	elucidate	investigated	cohort	patients	htlv-1
type1diabetes	patients	sensitivity	insulin
hivdisease	associated	others	consistent	hla	over-representation	associated	correlated	magnitude	response	hiv-specific
pain	relief	iv	injected	injection	propofol
fungalinfections	preventing	delivery	use	evidence	limited	voriconazole
virus	escape	ribavirin
hypersensitivityreaction	metal
tumors	management	chemotherapy	temozolomide
aids	divided	confirmed	patients	hiv-negative
painful	diabeticneuropathy	amitriptyline
celiacdisease	incidence	increase	attributable	increase	content	gluten
hivinfection	screening	importance	reduce	risk	rna	hiv
omega-3fattyacid	supplementation	suggest	reduce	symptoms	ptsd
melioidosis	agent	burkholderiapseudomallei
type2diabetes	receiving	insulin
htlv-1-associatedmyelopathy	tropicalspasticparaparesis	agent	humant-celllymphotropicvirustype1	htlv-1
acutepromyelocyticleukemia	treat	arsenictrioxide
ev	entry	inhibited	amiloride
plaquepsoriasis	treatment	evaluated	efficacy	safety	ustekinumabâ	study	failed	medications	cyclosporine
hiv/aids	clinic	patients	hiv-infected
myocardialinfarction	presenting	patients	use	warfarin
bacteraemia	observed	infected	mc58-278-1220	bacteria
enoxaparin	terms	ischemia
venom	profiles	observed	similarity	cross-species
hbv-dna	predicted	predicted	loss	hbsag
type2diabetes	patients	offspring	insulin-resistant
malaria	of	mefloquine
hepatitiscviral	replication	affect	work	explore	present	study	chemical
cancers	progression	involved	met	kinase	tyrosine
b-celllymphoma	patients	had	treatment	rituximab
hyperglycemia	prevent	insulin
hiv/aids
ten-fold	dramatically	atp
tuberculosis	vaccine	employed	japan	bcg
ami	patients	enough	dose	clopidogrel
thromboembolism	prevention	enoxaparin
virus	xinjiang	known	viruses
des-arg9-bk	agonist	administration	effects	measured	manifestations	neuropathicpain
ocd	obsessive-compulsive-disorder	treatment	effective	fluoxetine
tuberculosis	illness	experienced	weeks	initiating	treatment	antituberculosis
hbsag	positive	percent	subjects	hivpositive
opioidwithdrawal
chickenpox	agent	alpha-herpesvirus	varicellazostervirus
malaria	therapy	chloroquine
leftventricularhypertrophy	nitrates
esophagitis	treatment	for	in	reflected	duration	suppression	omeprazole
viralculture	viruses
obesity	investigate	effects	feeding	high-fat
priondiseases	caused	pathogens	termed	prions
adhd	treatment	studied	modafinil
multiplemyeloma	treatment	bortezomib
haemorrhagicfever	viruses
hiv/aids-related
tb	pulmonarytuberculosis	subjected	antituberculardrugs
hivinfection	association	found	is	prevalence	children	johannesburg	setting	prevalence	co-infection	hiv
caries-implicated	mutans	bacterium
tb	contraindication	vaccine	bcg
myocardialinfarction	risk	different	have	treatment	statin
uc	patients	assess	treatments	mesalamine
hiv/aids	epidemic	affected	area	region	outcomes	non-hiv-specific
hivinfection	unaware	persons	hiv-infected
neutropenia	doxorubicin	vinblastine
schizophrenia	schizoaffectivedisorder	patients	assigned	mg/day	olanzapine
asthma	evaluate	safety	inhaler	mometasonefuroate/formoterol
echinococcosis	related	showed	tomography	fluoro-deoxy-glucose-positron
malaria	incidence	reduced	reduced	reduced	sulphadoxine-pyrimethamine
base	pretreated	materials	eg1	proportion	ex3	endo-î
schizophrenia	trial	antipsychotics	olanzapine
melanoma	patients	interferons
ventricularfibrillation	episode	prevent	estimated	have	prophylaxis	lidocaine
malaria	infections	treatment	chloroquine
pupillarydilation	effects	tropicamide
irondeficiency	anemia	evaluated	depletion	lack	stores	iron
type1diabetes	perform	investigate	insulin
obstructivepulmonarydisease	patients	%	oxygen
silicosis	development	related	define	describe	features	patients	exposed	silica
pneumonia	$	group	group	min	consumption	survival	delivery	oxygen
tumor	resection	updated	basis	results	trial	comparing	therapy	adjuvant
oxygen	use	depression	scores	dyspnea
cancer	active	demonstrated	synergy	docetaxel
hyperglycemia	combination	gip	increased	uptake	glucose
hivpositive	option	promote	hiv
tb	culture	impact	scant	represents	culture	mycobacteriumtuberculosis
ifn-î	±	influence	responsiveness	cells	melanoma
hepatitis	vaccination	receive	msm	sampled	pride	reported	used	stimulant	cocaine
asthma	exacerbations	definitions	aligned	metric	bud	effect	inhaler	pressurized	budesonide/formoterol
vomiting	increased	prescribing	antibiotic
immunosuppressive	implicated	capable	modulating	responses	virus-specific

hivinfection	transmitted	tested	hiv
dcm	dilatedcardiomyopathy	performed	patients	chf
pain	induction	inhibited	amitriptyline
hyperprolactinemia	treated	$	dopamineagonistâ
fibrosis	exacerbates	retinoicacid
viralmeningoencephalitis	patients	parameters	basic
worms	effective	drug	praziquantel
m.tuberculosis
type1diabetes	benefit	exenatide
onychomycosis	cure	achieving	effective	itraconazole

phn	preventing	remain	knowledge	role	therapy	antiviral
antipyretics	received	patients	characteristics	compare	evaluate	children	upperrespiratorytractinfections
inflammatoryboweldisease	development	role	play	species	oxygen
allergy
evans	dye	elicits	excitation	345-nm
cancer	cluster	prognosis	negative	receptor	estrogen
lowbackpain	symptoms	associated	force	adopted	model	fe
chickenpox	cause	varicella-zostervirus	vzv
hiv/aids
hyperglycemia	worsens	is	advocated	concerns	effects	presenting	load	glucose
hbv	period	hbig	suggest	shown	globulin	populations	result	acquisition	hepatitisbvirus
cp	spezyme	superior	effective	mixtures	enzyme
gvhd	graft-versus-hostdisease	cause	mycophenolatemofetil
hyperglycemia	responses	sensitivity	insulin
melanoma	therapy	used	chemotherapeutics	dacarbazine	temozolomide
rheumatoidarthritis	diagnosed	patients	receive	-lrb-	leflunomide
asthmatic	groupbut	that	less	ratâ	mrna	group	budesonide
obstructivepulmonarydisease	progression	factors	recognized	tension	delivery	oxygen
type2diabetes	patients	life	quality	insulinglargine
inflammation	malnutrition	marker	albumin
hbv	antigen	antibody	antigen	hbsag
aids	hiv
leptospirosis	outbreak	study	association	clone	leptospiral
hypertension	peaks	experienced	taking	mg	atenolol
hiv/aids
hypertension	events	associated	anti-inflammatorydrugs	-RSB-	nsaids
influenza	patients	coughing	emits	particles	containing	influenzavirus
oa	cartilage	increased	treatment	calcitonin
aids	acquiredimmunodeficiencysyndrome	infected	people	number	estimates	used	constructed	take	hiv
hypoparathyroidism	condition	requires	analogues	vitamind
falciparummalaria	patients	treated	ap	atovaquone/proguanil
hiv/aids
impairments	release	epinephrine
transmissibleminkencephalopathy	affected	hamsters	lavages	analysis	gave	$	release	infectivity	prion
tumor	formation	abrogated	suppressed	inhibitor	chloroquinephosphate
breasttumors	doxorubicin
type1diabetes	patients	receiving	replacement	insulin
boneneoplasms	involve	base
hiv/aids
melanoma	cells	triggers	o6-methylguanine	tmz-induced
nsclc	patients	treated	nedaplatin	$	mâˆ	irinotecan
cancer	risk	women	altered	upa	expression	prostaglandin
cholera	causing	vibriocholeraeo1
chf	dox
o2	followed	min	submitted	piglets	ten

type2diabetes	treatment	available	agent	insulin-sensitizing
schizophrenia	criteria	classification	meeting	patients	assigned	1â	risperidone
hiv/aids
vitaminb12deficiency	exceeds	hypothesised	using	threshold	%	indicative	prevalence	vitaminb12

srhr-hiv/aids
bipolardisorder	patients	augmentation	olanzapine	trial	items	â	¥	analyzed	days	monotherapy	divalproex
falciparummalaria	subjects	received	mefloquine
cancers	studies	includes	beginning	2013	â	$	œantibodies
adenine	dinucleotide	down-regulation	accompanied	mdsc	synthase	caused	microenvironment	tumor
pain	shortens	addition	acetaminophen
hiv/aids
pulmonarytuberculosis	suspected	patients	cultures	m.tuberculosis

tb	regimen	treatment	rifampin
vibriocholerae	research	bacterium
tb	control	therapy	isoniazid
dwarf	mice	isolated	circulating	levels	mice	growthhormone
bacterialinfection	osteomyelitis	treatment	filling	bone	rifampicin
ofvitaminadeficiency	contributed	levels	levels	awareness	vitamina
oa	people	participation	evaluated	effects	intake	glucosamine
postmenopausalosteoporosis	review	uses	teriparatide
cross-link	leading	iron
hivdisease	associated	dyslipidemia	reduce	established	unknown	role	predicting	patients	hiv
interleukin-2	±	gene	il2ra/cd25	emerging	gene	multiplesclerosis
hbv	reactivation	prevent	lamivudine
antibiotics	prescribed	allergicdisorders
obesity	high-fat
irondeficiency	defined	receptor	plus	depletion	iron
androgen-target	genes	c-termini	facilitating	enhancing	necessary	methylation	ar
adhesion	induced	integrins	collagen
glucose	concentrations	measured	men	aged	delhi
topiramate	essentialtremor
type1diabetes	therapy	potential	has	exenatide
ticdisorders	children	treated	haloperidol
androgen	receptors	ar
priondisease	seen	diversity	part	likely	compared	properties	prions
hyperglycemia	induced	content	mice	content	fat
h5n1	avianinfluenzavirus
pain	score	group	remifentanil
sars-coronavirus
fungalinfections	afflicted	populations	broaden	insights	basis	toxicity	fungi
tb	drug	treatment	regimen	components	isoniazid
ham/tsp	leukemia	agent	htlv-i
pneumonicplague	agent	reported	undetectable	infection	expression	y.pestis
rise	give	subgroups	ependymoma
enoxaparin	noninferior	shown	efficacious	prevention	heparins	veinthrombosis
vehicle	analysis	indicate	differences	burden	plaque
pain-reliefmedication	prescribed	gp	strength	level	pain
lc-maldi-tof/tof	chromatography	assisted	analysis	desorption-time	assisted	matrix	coupled	exchange	ion
hiv/aids
breasttumor-derived	genotypes	enzymes	tamoxifen-metabolizing
mrsa	-rrb-	-lrb-	cause	staphylococcusaureus
mesothelioma	origins	view	hazard	burden	fibre
constipation	aged	patients	carried	identify	trials	polyethyleneglycol	peg
m.tb	mycobacteriumtuberculosis
open-angleglaucoma	patients	haemodynamics	bimatoprost	assess	effect	dorzolamidehydrochloride
formalin-ether	katz	techniques	harada
hypoglycemia	responsive	diazoxide
chronichepatitisc	combined	interferon
chronichepatitisc	virus	patients	total	hcv
hiv/aids	linkages	pointed	need	resources	hiv
gbs	treatment	intravenousimmunoglobulin	ivig
hbv	recurrence	protocol	based	milligrams	lamivudine
atrialfibrillation	associated	strokes	prevent	explain	utilization	warfarin
anti-cmv	therapy	ganciclovir
non-smallcelllungcancer	patients	shown	controversial	efficacy	chemotherapy	docetaxel
hepatitisc	patients	therapy	response	predicted	genotype	hcv
pain	preventing	injection	propofol
vaccines	control	infestations
hiv/aids
cd	patients	disease	crohnâ
penicilling	antibiotics	contained	observed	isolates	mrsa
melatonin	time	shift	determined	changed	stroke
influenza	season	compared	influenzaviruses
interferon	evident	inflammation
lipid	metabolism	dysregulation	caseation	development	granuloma	tb
ironoverload-associated	dysfunction	patients	applied	therapy	iron
hiv/aids
mrsa	antibiotics	accumulation	related	vivo	in	enhanced	effect	antibacterial
vibriocholerae	unable	utilize	compounds	down-regulation	enzymes
chronichepatitisc	patients	frequency	genotype	genotype	hcv
hiv/tb	adults	rifampicin
oa	ptx
alcoholabuse	cause	related	effects	alcohol
gonorrhoea	control	obstacle	emergence	resistance	agents	neisseriagonorrhoeae
hsv	acyclovir-resistant
hepatitisc	viruses	hcv
ebvinfection	controlling	ineffective	transplant	ptld	ebv-associated
tumor-bearing	mice	treated	treatment	bcg
tuberculosis	causes	pathogen	mycobacteriumtuberculosis
overweight/obese	group	times	have	levels	cholesterol
hiv/aids	knowledge	possessing	barrier	testing	hiv
pain	compare	lidocaine
inflammation	kinds	treatment	used	indomethacin
progesterone	therapy	increases	cancer
hypertension	treated	recommend	use	thiazidediuretics
inflammation	leads	response	activate	particles	metal
chemotherapy-inducednauseaandvomiting	associated	chemotherapy	emetogenic
mrsa	-rrb-	-lrb-	concern	treatment	s.aureus
leukemia	cells	engraftment	delay	sensitize	vincristine
hbv	positive	hbsag
aids	evident	hiv
asthma	cells	levels	mp	formoterol
cholesterol	levels	have	weight	likely	children	obese
olanzapine	mg/day	assigned	patients	schizoaffectivedisorder	schizophrenia
hbv	infection	contributes	route	hepatitisbvirus
hypoglycemia	reduced	-lrb-	rates	glucose
varicella	infected	reported	receiving	vaccination	vzv
hbv	virus	vaccinated	donors	observed	correlation	stimulated	titers	antibody
aids	examined	hiv
bronchitis	exacerbation	patients	levofloxacin
falciparummalaria	treatment	-rrb-	sulphadoxine-pyrimethamine
breasttumour	oestrogen-positive
chf	grade	verify	performed	controls	dox
dengue	antigen	testing	antibody
type1diabetes	patients	improved	innovations	formulations	insulin
melatonin	rhythms	timing	impacts	indicating	induces	stroke
type2diabetes	patients	total	received	insulinglargine
neutropenia	topotecan
africantrypanosomiasis	$	human	of	combination	eflornithine
dha	reduces	synthesis	cells	cancer
silicosis	observed	$	silica
aids	epidemic	drivers	conclude	led	strength	evidence	linking	hiv
priondiseases	are	under	from	prnp	gene	encodes	prionprotein
viralinfection	mechanism	innate	essential	replication	viruses
hivinfection	method	considered	counseling	hiv
sugars	containing	eating	develop	angst	pain
type2diabetes	goals	control	benefits	reviews	overcoming	initiation	insulin
melanoma	lines	is	data	reported	cells	treated	tmz
chickenpox	agent	alpha-herpesvirus	varicellazostervirus	vzv
pain	prevention	examined	injection	propofol
asthmatic	control	treatment	budesonide
hbv	patients	did	receive	lamivudine
gastroduodenalulcers	diseases	prevent	prescribed	regimens	thwarted	resistance	antibiotic
poliomyelitis	endemic	notified	countries	endemic	poliovirus
hivinfection	timing	differ	mutations	nvp-resistance
type2diabetes	patients	life	quality	insulinglargine	starting	on	therapy	insulin
hiv/aids
pain	decreases	lidocaine
chemical	strain	raynaudâ	divided	mentioned	maurice	raynaud
tuberculosis	agent	mycobacteriumtuberculosis
hiv/aids
allergicreactions	suggesting	appears	seem	types	hypersensitivity
epilepsy	treated	valproicacid
footulcer	department	hospitalized	design	enrolled	free	treatment	antibiotic
mycophenolicacid	parameters	determined	patients	sle
pv	atom	attached	substituents	lie	coplanar	substituent	attached	carbon
cholera	research	bacterium
hiv/aids
hypertension	diagnosis	lower	mmhg	were	not	on	medication	antihypertensive
nsclc	evaluate	efficacy	combination	docetaxel
hiv/aids
hiv/aids
pain	associated	injection	propofol
type2diabetes	initiators	monotherapy	glipizide
cancer	men	standard	gold
hbv	hepatitisbvirus
depressivedisorder	patients	venlafaxine
asthma	cells	levels	mp	formoterol	albuterol
cancer	samples	examined	detected	antibodies
uc-mscs	activitiy	immunosuppressive
antibodies	ama	profile	established	diagnosis	pbc
tb	infection	elispot	controls	bcg-vaccinated
hypoglycemia	diabetes	treatment	acting	regulating	level	bloodglucose
aaa	development	associated	mismatch	allotypes	adalimumab
pancreatitis	risk	compare	sitagliptin
caries	increment	reduced	programs	using	dentifrice	fluoride
influenza	believed	avianinfluenzaviruses
infantbotulism	case	sample	dna	c.botulinum

insulin	analogs	decrease	risk	diabeticketoacidosis
hiv/aids	epidemic	face	attributes	attitudes	hiv
severeacuterespiratorysyndrome-associated	coronavirus
anti-inflammatory	drug	used	analgesic	rheumatism
antiviral	therapy	responses	fibrosis
hsv	therapy	trial	enrolled	aciclovir
tuberculosis	detect	test	mtb/rif
asthma	control	components	budesonide
insulin	substrate	level	signaling	impaired	insulinresistance
deficiencyoffolicacid	anaemia	had	suggesting	constitute	deficiencies	folicacid
mrsa	-rrb-	responsible	-lrb-	s.aureus
renalcellcarcinoma	subjects	cycles	combination	-RSB-	-2	-RSB-	ifn
multiplemyeloma	lesions	increased	inhibited	suggesting	result	bortezomib
cu	patients	prevalences	differences	focusing	investigated	toxin	toxicshocksyndrome
allergicreactions
hiv/aids
calcium	levels	elevated	cardiomyopathy	musculardystrophy
virus	d222y	detected	viruses
hiv/aids
malaria	recommendations	promoting	accompanied	change	policy	malaria	sulfadoxine-pyrime-thamine	artemether-lumefantrine
granulomas	resulted	improved	treatment	inh
type1diabetes	regimen	part	bloodglucose	compare	effects	ly2605541	insulinglargine
sodium-iodide	gene	expressed	cells	cancer
pain	paracetamol
hivpositive	had	had	status	hiv
progesterone	receptor	status	size	tumour
uc	ulcerativecolitis	patients	64	crohn	cd
steroid	deficiency	accounts	%	cases	congenitaladrenalhyperplasia
mrsa	methicillin-resistantstaphylococcusaureus	oxacillin
hiv/aids
multiplemyeloma	have	bortezomib
drugsofabuse	exposure	induces	modifications	system	dopaminergic
lipid	peroxidation	inhibition	oxidant	hyperglycemia
pain	preventing	injection	propofol
fattyacid	oxidation	suggesting	different	control	obese
ca-mrsa	aureus	isolate	containing	each	consisting	generated	enhance	capabilities	investigators	interested	staphylococcusaureus
schistosomiasis	reductions	observed	praziquantel
ulcer	outcome	predict	help	contribute	use	antibiotics
type2diabetes	treatment	inhibition	experiences	focus	sitagliptin
malaria	treatment	sp	sulphadoxine-pyrimethamine

acne	prescribed	isotretinoin
malaria	parasites	chloroquine-resistant
mycoplasmosis	causes	synovie	mycoplasma
non-tuberculous	-rrb-	m.tuberculosis
estrogen	increases	cancer
hiv/aids	population	tb	prevalence	reviewed	prevalence	hivinfection
psychotic	present	prompting	select	medication	haloperidol
lymedisease	satisfied	patients	cohort	followed	later	demonstrating	growth	borrelia
hepatitisc	hiv	hcv
hivinfection	prevalence	report	conduct	produce	estimate	association	hiv
infectiveendocarditis	cases	number	number	prescriptions	prophylaxis	consisting	dose	amoxicillin
infectiveendocarditis	cases	number	measures	dose	clindamycin
type2diabetes	taking	metformin
enzyme	5,10-methylenetetrahydrofolate-reductase	gene	mutation	fibrinogen	model	insulinresistance
impairedglucosetolerance	-RSB-	glucose
tuberculosis	agent	mycobacteriumtuberculosis
granulomas	analysis	confirmed	biochemical	caseum	identified	esters
anti-tuberculosis	drugs	%	achieve	m.tuberculosisinfections
mycosis	representing	azole	posaconazole
risperidone	tachycardia	tachycardia
pain	remission	gave	treatment	ketamine
candidalinfection	lesions	reviews	describes	mechanisms	involved	candida
mrsa	infections	s.aureus	infections	staphylococcusaureus
aids	monitor	receiving	therapy	3tc	lamivudine
type2diabetes	glucose
tsc	malformations	formation	hamartomas
type2diabetes	pathophysiology	attributed	triad	secretion	insulin
hepatitis	patients	sera	tested	igm	anti-hav
uri	results	show	correlation	pm10	so2
atrialfibrillation	benefit	warfarin
diabeticretinopathy	dr	triglycerides
basic	factors	cultured	showed	cells	tumour
hypothyroid	patients	therapy	report	continue	dissatisfied	outcome	monotherapy	levothyroxine
hivdna
breasttumors	±	therapy	tamoxifen
multiplemyeloma	patients	peripheralneuropathy	bortezomib-associated
tb	incidence	correlation	year	introduction	rifampin
primarybiliarycirrhosis	pregnancy	cholestasis
dentalfluorosis	influenced	concentration	fluoride
hypertension	patients	proved	superior	antihypertensiveagents	perindopril
aids	hiv
lipid	autacoids	acting	mediators	play	role	regulation	homeostasis	inflammation
hivinfection
malaria	treatment	observed	use	chloroquine
enterotoxin	enterotoxin	toxin	toxicshocksyndrome
pain	injection	propofol
tumor	location	gender	adjuvant
daptomycin	rates	%	%	%	bacteraemia
vitamind	status	optimization	impact	risk	and/or	course	multiplesclerosis
malaria	exposure	-rrb-	trial	doxycycline	chloroquine
cardiacarrest	treatment	epinephrine
hivpositive	hiv
methacholine	pc20	correlated	correlated	ige	râ	â	asthmatics
fungalinfections	preventing	delivery	use	evidence	limited	voriconazole
obese	mice	action	investigated	effects	ea

2-ar	antigonist	abrogated	expression	isoproterenol-induced
asthma	symptoms	relief	used	combination	budesonide/formoterol
glanders	cause	burkholderiamallei
aids-like	illnesses	associated	used	model	study	humanimmunodeficiencyvirus
hivpositive	associated	influences	mitigate	developed	advent	numbers	children	infected	hiv
chronichepatitisc	patients	frequency	genotype	genotype	hcv
infectiousmononucleosis	patients	ebv
leukemia	growth	inhibit	influence	activity	vincristine
hbv	variants	changes	hbsag	predicted	undetectable	hbsag
pain	reduce	required	concentrations	remifentanil
virus	use	exposure/release	concerns	alleviating	antibodies
apl	treatment	based	administration	all-transretinoicacid
urinaryincontinence	episodes	improves	release	tolterodine
chemically	glutathione	inhibition	allowed	escape	arrest
chronicrenalfailure	rats	reduced	rapidly	calciumcarbonate
tumor	aggressive	precludes	seems	therapy	adjuvant
hiv/aids	field	identified	strengthen	prevention	hiv
pain	features	presenting	years	aged	sex	patients	subjected	injection	tramadol
cross-sectionally	studied	reported	index	visits	absenteeism	use	antibiotics
influenzapneumonia	patients	identified	confirmed	presence	influenzavirus
malaria	treatment	six-dose	three-dose	suspension	artemether-lumefantrine
neuroblastoma	lines	agent	5-aza-2
enzymes	expression	cells	choriocarcinoma
fat	accumulation	suppressed	insulinresistance
type2diabetes	compared	efficacy	monotherapy	metformin
hivinfection	elisa	patients	hiv-positive
uc	cd
tb-antigens	boost	increased	compared	to	animals	primed	bcg
tumor	necrosis	fattyacids	increases	injection	protein-1	mcp-1
pain	intensity	anesthetics	desflurane
hiv/aids	had	score	msm	jiamusi	those	those	searching	those	performed	testing	hiv
insecticide-impregnated	papers	assess	susceptibility	vectors	malaria
obese	patients	levels	antibodies
cholesterol	disorders	cancers
mycophenolatemofetil	pharmacokinetics	determine	prednisone	predict	systemiclupuserythematosus
priondisease	susceptibility	determinant	shown	leading	valine	residue	prionprotein
malaria	parasites	drug	use	pyrimethamine
fivinfection	environment	activated	prominent	influence	treg	pathogenesis	fiv
ionophore-inducible	egress	mechanism	suggests	evidence	parasitophorous	dependent	swelling
dengue	outbreaks	prediction	goals	included	share	expertise	tests	identify	used	denguevirus
psychotic-like	symptoms	induce	anesthetic	ketamine
fibrosis	exacerbates	retinoicacid
testosterone	levels	collected	associated	risk	cancer
allergicconjunctivitis	conditions	atopy-associated

antibody	e4g10	tumor
ptsd	examined	ptg	focusing	each	factors	ptg
cross	study	conducted	hospital	thc
enzymes	use	review	aids
estrogen	receptor	grade	examined	enrolled	institute	cancer
hivinfection
obesity	region	mass	fat
smallpox	treatment	developed	cmx001	analog	propan-1-ol	cidofovir
ipv	prevalence	describe	inform
virus	comparison	•	display	viruses
promyelocyticleukemia	treat	used	as2o3	arsenictrioxide
pain	injection	propofol
hypoglycemia	enhance	response	glucose
tb	associated	have	infection	macrophages	individuals	manifestations	mycobacteriumtuberculosis
calcium	inhibitors	rates	terms	models	differences	are	exhibiting	stage	development	cardiomyopathy
mrsa	studied	strains	staphylococcusaureus
gonorrhea	options	diminishing	developed	neisseriagonorrhoeae
hyperglycemia	reduced	prevention	reabsorption	glucose
type2diabetes	lower	time	peak	lispro

hiv/aids
tar	elements	products	reduce	suggesting	find	suppression	silencing	replicating	virus
hyperglycemia	glucose
hivinfection
pain	group	included	patients	meperidine
type2diabetes	treatment	critical	restoration	secretion	insulin
tyrosine	kinases	tumors
urinarytractinfections	support	use	levofloxacin
virus	discovery	highlights	need	expand	source	viruses
shingles	risk	reduces	seen	used	vaccine	vzv
hyperglycemia	with	than	more	capacity	insulin
cross-reacting	antibodies
onychomycosis	cure	achieving	effective	analysis	terbinafine
ions	cns	cp
rheumatoidarthritis	treatment	reducing	leflunomide	combination	hydroxychloroquine
rapa	proliferation	cells	carcinoma
metal	revised	hips	tissues	particles	causes	hypersensitivity
hypothyroid	due	concentrations	t4
insulinresistance	indices	value	rate	glucose
asthma	management	medication	classes	include	bronchodilating	theophyllines
pulmonaryembolism	thrombolysis	offer	thrombocytopaenia	heparin-induced
strokes	prevents	receive	warfarin
inflammation	model	effect	have	combination	mometasonefuroate
methicillinresistantstaphylococcusaureus	strains	showed	activity	antibacterial
hypoglycemia	instances	enhancement	glucose-dependent
lgv	proctitis	caused	chlamydiatrachomatis
type2diabetes	risk	individuals	function	play	d	associated	sensitivity	insulin
hepatitisb	treatment	options	licensed	lamivudine
cancer	ivb	committee	disease	care	standard	chemoradiotherapy	cisplatin-based
heparins	suggested	hypersensitivity
bacteremia	group	group	measured	counts	bacteria
type2diabetes	initiators	monotherapy	glyburide
hiv/aids
hepatitisb	patients	lamivudine-resistant
aids-defining	condition	increase	infection	humanimmunodeficiencyvirus
highbloodpressure	amlodipinebesylate	olmesartanmedoxomil
busulfan	drugs	pretreated	animals	affected	bm-hscs	sca-1
thromboembolism	prevention	indications	agents	include	unfractionatedheparin
thromboembolism	patients	treated	experience	number	warfarin
postpartumhaemorrhage	and	medline	ergonovine
insulin	techniques	participants	type2diabetes
plague	disease	caused	yersiniapestis
chronichepatitisc	male	treated	therapy	-rrb-	interferon
viralinfection	improve	suggest	used	characterize	viruses
malaria	morbidity	reduces	treatment	infants	sulphadoxine-pyrimethamine
ifn-î	production	increased	î	injections	tgf-î	<	production	microenvironment	fibrosarcoma
type2diabetesmellitus	patients	found	product	released	insulin
chronichepatitisc	patients	administered	interferon-alfa	ifn
sulfide	levels	experience	worms
influenza	avianinfluenzaviruses
fibrosis	exacerbates	retinoicacid
nausea	=	control	had	patients	receiving	prochlorperazine
gonorrhoea	therapy	used	pakistan	be	ciprofloxacin	azithromycin
type2diabetes	patients	control	levels	lowering	results	secretion	insulin
tb	regimen	treatment	equivalent	regimen	amikacin	ethionamide
aki	patients	summarizes	trial	infusion	furosemide
tumor	dissemination	controlled	chemotherapy	adjuvant
hbv	dna	rate	higher	those	group	adefovir
ebvinfection	occurs	infection	titers	ebv
type2diabetes	evaluate	patients	metformin-treated
fungalinfections	patients	refractory	deoxycholate	amb
celiacdisease	likelihood	determines	efficiency	presentation	gluten
ziprasidoneâ	base	extends	indicated	schizophrenia
chronichepatitisc	therapy	effects	management	documented	discussion	therapy	ifn
type1diabetes	subjects	underwent	insulin
malaria	returning	exhibited	atovaquone-proguanil
osteoporosis	reducing	supporting	efficacy	2	strontiumranelate
aids	hiv
cll	investigated	sensitise	fludarabine
type1diabetes	measured	concentrations	glucagon
cancer	specimens	technique	remains	paraffin-embedding
cryptococcusneoformans	yeast	species	cryptococcal
tuberculosisinfection	diagnosed	received	mg	isoniazid	inh
hyperglycemia	weight	response	load	glucose
ondansetron	efficacy	compare	treatment	vomiting
malaria	diagnosed	recommends	use	rdt	treat	artemether-lumefantrine
cr	remission	+	patients	aml
cavity-causing	mutans	bacterium
tuberculosis	-rrb-	agent	member	-rrb-	complex	m.tuberculosis
hiv/aids
malaria	season	end	receive	sulfadoxine-pyrimethamine
insulin	anthropometry	insulinresistance
esophagitis	effective	shown	studies	esomeprazole
betablocker	therapy	were	cad
cortisol	insulinresistance
non-tuberculosis	samples	2846	specific	·	·	sensitivity	mtb/rif
acquiredimmunedeficiencysyndrome	patients	humanimmunodeficiencyvirus
melanoma	lines	is	data	reported	cells	treated	tmz
tuberculosis	containing	pyrazinamide
ventriculartachycardia	incidence	reduced	ranolazine
hiv/aids
schistosomiasis	control	choice	compound	praziquantel
androgen	ablation	assessed	growth	cancer
hivinfection	timing	differ	mutations	nvp-resistance
pain	developed	administration	course	mg/m2	bortezomib
alcohol	consumption	established	hypertension
influenza	subtypes	clades	samples	individuals	infected	influenzaviruses
hivinfection	activation	present	discuss	understanding	immunopathogenesis	hiv
cancer	lines	mda-mb-231	er	negative	receptor	estrogen
mrsa	associated	bacteraemia	s.aureus
hiv/aids	related	assess	investigate	prevalence	hiv
tb	-rrb-	tuberculosis	infection	transition	cause	transmission	m.tuberculosis
type2diabetes	patients	outcomes	differing	evaluate	effects	diets	low-fat
hbv	hepatitisbvirus
pain	injection	propofol
asbestos	burden	hazard	view	origins	mesothelioma
melanoma	cells	resistance	acquired	indicate	found	correlation	expression	sensitivity	tmz
lymedisease	disease	caused	borreliaburgdorferi
irondeficiencyanemia	children	role	the	unclear	increased	hepcidin	regulator	homeostasis	iron
immunomodulator	effective	treatment	inflammatoryboweldisease
methicillin-resistantstaphylococcusaureus	staphylococcusaureus
alcoholiclivercirrhosis	patients	sustains	metabolism	alcohol
gabapentin	effects	expression	model	neuropathicpain
type2diabetes	impact	aim	associated	therapy	glimepiride
i-vi	expression	studied	survival	braintumors
mycobacterialdisease	isolated	complex	gordonae	mycobacteria
bullouspemphigoid	lotion	cream	dipropionate	clobetasol
melanoma	treatment	states	therapy	2b	interferon-alpha
tachycardia	accompanied	making	atropine
cancer	increases	therapy	hormone
stimulants	develop	understanding	anorexia	inflammation-associated
hivpositive	hiv
chikungunya	patients	identified	epidemic	chikungunyavirus
glucocorticoid	resistance	reported	production	hypertension
anti-tuberculous	treatment	accompanied	decrease	antigens	mtb-specific
ctx	collagen	telopeptides	alkaline	concentrations	necrosis	tumor
t2d	updated	include	therapy	combination	metformin
myocardialinfarction	reducing	efficacy	is	therapy	aspirin
virus	approaches	using	viruses
hypertension	study	randomized	controlled	comparing	effects	diuretics	amlodipine
obese	patients	occurs	conversion	estrogens
melanoma	mda5	rig
type1diabetes	adults	pump	objective	insulin
kuru	prions	prion	equivalent	those	prions
cholesterol	hypertension
shortstature	obtained	data	deficiency	growthhormone
hiv/aids
type1diabetes	patients	sensitivity	insulin
high-fat	obesity
highbloodpressure	levels	intervention	provided	analysis	performed	olmesartanmedoxomil
tb	infection	elispot	controls	bcg-vaccinated
exenatide	sitagliptin	compare	risk	pancreatitis
epilepsy	patients	advance	represents	vigabatrin
influenza	phase	vaccine	useful	vaccine	prepared	influenzavirus
tuberculosis	detection	systems	case	mycobacteriumtuberculosis
cholesterol	levels	reduction	prevention	reduced	incidence	stroke
acutehepatitise	followed	tests	rna	hev
v.cholerae
antibodies	anti-h5n1
asthma	outcomes	achieves	therapy	budesonide/formoterol
viraldiseases	control	vaccines	production	isolation	viruses
tuberculosis	management	weaknesses	reveals	emergence	threat	mycobacteriumtuberculosis
obese	control	greater	reduced	excretion	bodies	ketone

irondeficiencyanemia	investigate	effect	repletion	iron
hypersensitivityreactions	manifest	allergicreactions
t2d	development	prevent	safe	considered	ranges	showed	levels	insulin
enzymes	reductase	role	investigated	mediating	injury	ischemia-reperfusion
varicellainfection	students	assess	screening	antibodies	varicellavirus
malaria	prevention	recommended	treatment	malaria	sulphadoxine-pyrimethamine
hypertension	prevented	spironolactone
fishoil-supplemented	diet	increases	cells	tumor
collagens	matrix	adhesion
ards	patients	omega-3fattyacids
virus	mimivirus	prototype	addition	family	viruses
cd	model	investigated	result	associated	inflammation
hiv/aids
apl	patients	specimens	metabolites	arsenic
tb	diagnosis	improve	plasmablasts	bcg-specific
irondeficiency	phenotype	indicates	levels	iron
m.tb	mycobacteriumtuberculosis	levels	antitubercular
tb	programs	burden	worsening	noted	strains	inh
aids	living	idus	mortality	decreased	increasing	services	hiv
stroke	displayed	majority	rats	showing	onset	melatonin
hit	heparin-inducedthrombocytopenia	cause	drug	employed	substitute	heparin
nicotineaddiction	mimics	extent	suggests	drug	abuse	nicotine
polio	vaccine	rapidly	eliminated	all	disease	caused	temperate	inadequate	is	circulation	polioviruses
m.tb	mycobacteriumtuberculosis
abscess	resection	perform	led	effect	abscess	antibiotics
ovariantumors	resistance	carboplatin
hypoglycemia	euglycemia	mmol/l	bloodglucose
multiplemyeloma	patients	treatment	stem	melphalan
septicemia	fulminant	due	died	combination	ceftazidime	amoxy-clavulanicacid
hbv-dna	disappearance	effect	had	therapy	lamivudine
type2diabetes	patients	protein-1	factor	determine	explains	importance	growth	insulin
hbv	variants	changes	hbsag	predicted	undetectable	hbsag
pulmonarytb	patients	collected	tested	susceptibility	isoniazid
brucellosis	causes	bacteria	group	brucella
hypersensitivity	types	seem	appears	suggesting	allergicreactions
oestrogen	receptor	status	size	tumour
melioidosis	disease	caused	burkholderiapseudomallei
hypoglycemia	occurred	1â	glucose
tuberculosis	exposure	data	calmetteâ	obtained	$	bcg
venlafaxine	treated	individuals	depressivedisorder
secondary	outcomes	include	measures	monitoring	bloodglucose
ulcerativecolitis	patients	controls	hc
cholesterol	biomarkers	presented	group	patients	acromegalic
aids	indinavir
chemical	strategy	executed	engineering	cavities
inflammation	induce	known	meal	components	carbohydrates	induce	saturated	fat
chickenpox	causes	varicella-zostervirus
aids	hiv
cholesterol	homeostasis	inflammation
aids	epidemic	drivers	conclude	led	strength	evidence	linking	hiv
fungaldisease	caused	histoplasmacapsulatum	fungus
uc-mscs	effects	immunosuppressive
pain	incidence	associated	use	remifentanil

enterotoxin	enterotoxin	toxin	toxicshocksyndrome
melanoma	lines	expressed	tool	xmrk	tyrosine
aids	claimed	estimated	have	hiv
antibodies	feature	found	patients	ham/tsp

hbv	antiâhepatitisbvirus
aids	pandemic	identified	been	hiv
tuberculosis	efficacy	©	vaccine	bcg
rabies	spread	control	helping	applicable	rabiesvaccines
osteoporosis	evaluate	effects	supplementation	oliveoil
multiplemyeloma	treatment	evaluation	is	regimen	consisting	bortezomib
immunodeficiency	treated	stably	trials	dosages	subcutaneous	immuneglobulin
thyrotoxicosis	unit	admitted	containing	levels	thyroxin
asthmatic	control	treatment	budesonide
depressivedisorder	disorders	treatment	approved	antipsychoticdrug	aripiprazole
methacholine	pc20	correlated	correlated	ige	râ	â	asthmatics
msa	atrophy	disease	alzheimerâ
leprosy	patients	material	amplified	mycobacteriumleprae
hyperglycemia	exposed	have	levels	glucose
malaria	settings	patients	progress	required	antibiotics
mito-mice	induced	resulting	phenotypes	renalfailure
asthma	aspirin-exacerbated
type2diabetes	caused	defects	secretion	insulin
pain	reducing	determine	dose	remifentanil
type2diabetesmellitus	patients	compare	treated	comparators	sitagliptin
malaria	burden	majority	responsible	recommend	chloroquine
hyperglycemia	diabetics	group	group	group	control	glucose
influenza	efficacy	vaccine	virusinfluenza
virus	tomatoes	diseases	causing	viruses
malaria	treated	drug	artemether-lumefantrine
dcm	coronaryarterydisease
mrsa	compared	study	studied	variation	s.aureus
pain	insertion	ease	relation	designed	investigate	alternative	propofol
nm	$	bay-60â	-LSB-	is	treating	atherosclerosis
pain	level	evaluate	instillation	eyedrops	eyedrops	tetracaine
tb	programs	burden	worsening	noted	strains	inh
syphilis	multi-stage	disease	caused	treponemapallidum
metastases	patients	radioembolisation	evaluation	failed	regimens	irinotecan-based
nonsteroidalanti-inflammatorydrugs	-RSB-	associated	events	hypertension
hypoglycemia	euglycemia	mmol/l	bloodglucose
b-celllymphoma	disorders	treatment	used	agent	antibody	rituximab
veinthrombosis	heparins
5-fu	receiving	patients	cancer
melanoma	patients	treatment	approved	interferon
mrsa	staphylococcusaureus	bacteria	species	effective	demonstrated	methicillin	staphylococcusaureus	staphylococcusaureus
cancer	cells	identified	stimulation	isoproterenol
antiplateletdrugs	registered	medication	used	arterialhypertension
h5n1	influenzaviruses
pneumonia	risk	increased	vitamine
diseasecausedbybordetellapertussis	infection	pertussis
hiv/aids
type2diabetes-low	patients	had	uptake	glucose
type1diabetes	woman	patients	sitagliptin
uc	reduced	hc
oxygen	species	$	phosphateâ	dinucleotide	down-regulation	accompanied	mdsc	synthase	caused	microenvironment	tumor
shock	disorders	patients	drug	used	inhibitor	trypsin
type1diabetes	13â	subjects	evaluate	impact	intensive	treatment	insulin
tb	caused	mycobacteriumtuberculosis
epileptic	activity	induced	pentylenetetrazol
anti-inflammatoryagents	propose	risks	events	hypertension
oa	management	be	use	unsaponifiables	chondroitinsulfate
malaria	patients	ethiopia	effectiveness	-rrb-	chloroquine
atherosclerosis	cause	hyperinsulinemia	prevent	added	thiazolidinediones
bladdertumor	immunotherapy	bcg
cancer	cells	proliferation	inhibits	mechanism	remains	shown	´	vitamine
adjuvant	therapy	type2diabetes
hypoglycaemia	therapy	8	dextrose
insulinglargine	use	associated	incidence	dka
hbv	infection	marker	served	antigen	hbsag
postoperativenauseaandvomiting	prevention	dexamethasone	metoclopramide
anti-influenza	drugs	realization	facilitate	further	cells	influenzavirus-infected
tuberculosis	diagnosed	given	antituberculosis
tb	cases	higher	circulating	secretion	antibodies	bcg-specific
seizures	using	magnesiumsulfate
neuroblastomas	growth	mechanisms	cyclophosphamide
ham/tsp	discriminate	did	detected	subsets	individuals	htlv-1-infected
pain	tourniquet	adjuncts	compare	effect	adding	as	ketamine
type2diabetesmellitus	predispose	limiting	delivery	insulin
sodiumretention	less	restricted	given	intake	sodiumbicarbonate
hiv/tb	adults	rifampicin
carcinoma	lines	used	ovarian	a2780cis	cisplatin-resistant
cancer	improved	adding	trastuzumab
ca-mrsa	carriage	prevalence	remains	suggest	results	based	analysis	s.aureus
hivinfection	eradicate	reactivation	expression	hiv
hypertension	diabetes	prevent	opportunity	provides	discovery	1	activate	blocker	telmisartan
amnesia	models	scopolamine
depressivedisorder	patients	associated	changes	changes	associated	administration	sertraline
insecticide-resistant	vector	malaria
flush	response	reported	niacin
diabeticretinopathy	group	classified	diabeticretinopathy	diabeticnephropathy	rate	albumin
type2diabetes	patients	assess	effects	pioglitazone
insulin-sensitizing	properties	mediates	risk	type2diabetes	individuals	obese
mrsa	-rrb-	differ	â	s.aureus
aids	come	study	using	caregivers	hiv
ranolazine	prevents	accumulation	leads	ischemia
type1diabetes	therapy	cells	aav	containing	gene	preproinsulin
nephrocalcinosis	electrolyte
hyperglycemia	subjects	showed	levels	glucose
kidneydisease	diabetes	cholesterol
htlv-1infection	levels	allow	development	complications	htlv-1
bacterialvaginosis	treatment	therapy	metronidazole
cancer	examined	study	beta-carotene
hyperglycemia	controls	insulin
multiplesclerosis	development	factor	and/or	associated	levels	vitamind
ocd	those	treatment	remains	respond	clomipramine
hivinfection	reductions	predicts	modeling	expanding	adults	hiv-infected
jia	mtx
obese	population	more	progresses	expected	rise
breasttumor	samples	estrogen-receptor
influenza	pandemic	threat	real	reaffirm	influenzavirus
osteoarthritis	drugs	sulfate	glucosamine
pain	propofol
antibody	epidermal	enter	treatment	tumors
tb	cases	controls	bcg
type1diabetes	model	survival	define	effects	sitagliptin
systemiccandidiasis	risk	colonization	candida
activetrachoma	infection	c.trachomatis
type2diabetes	risk	mediates	properties	insulin-sensitizing
leucine-rich	repeat	proteins	expressed	transmembrane	adhesion
asthma	exacerbation	mimicking	challenges	tested	effect	budesonide
impairedglucosetolerance	glucose
asthma	outcomes	achieves	monotherapy	budesonide
hbv	distribution	identify	patients	hbsag-positive
hiv/aids
adenosine	cmr	techniques	cad
viralinfections	role	topic	appear	viruses
progesterone	pr	expression	analyzed	using	patients	cancer
hepatitisc	viruses	%	ribavirin

sarcomas	etoposide	doxorubicin	cyclophosphamide	alternating	ifosfamide
asbestos	burden	hazard	view	origins	mesothelioma
ironoverload	result	characterized	absorption	iron
hyperglycemia	diabetics	group	group	group	control	glucose

insulin-sensitizing	activity	independent	exerts	cardiovasculardisease
tuberculosis	syndrome	adherence	mycobacteriumtuberculosis
cytomegalovirus	measurements	received	ganciclovir
h5n1	avianinfluenzavirus
pain	scores	boluses	dose	bupivacaine
aml	analyzed	mutation	domain	tyrosine
